
<html lang="en"     class="pb-page"  data-request-id="d6f15ae4-ff59-439b-8fb9-3f3600e67871"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.8b00401;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2019.62.issue-1;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor" /></meta><meta name="dc.Creator" content="Christopher&#xA;T.  Wild" /></meta><meta name="dc.Creator" content="Joanna M.  Miszkiel" /></meta><meta name="dc.Creator" content="Eric A.  Wold" /></meta><meta name="dc.Creator" content="Claudia A.  Soto" /></meta><meta name="dc.Creator" content="Chunyong  Ding" /></meta><meta name="dc.Creator" content="Rachel M.  Hartley" /></meta><meta name="dc.Creator" content="Mark A.  White" /></meta><meta name="dc.Creator" content="Noelle C.  Anastasio" /></meta><meta name="dc.Creator" content="Kathryn A.  Cunningham" /></meta><meta name="dc.Creator" content="Jia  Zhou" /></meta><meta name="dc.Description" content="An impaired signaling capacity of the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) has been implicated in the neurobehavioral processes that promote relapse vulnerability in cocaine use disorder (CUD..." /></meta><meta name="Description" content="An impaired signaling capacity of the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) has been implicated in the neurobehavioral processes that promote relapse vulnerability in cocaine use disorder (CUD..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 5, 2018" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00401" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00401" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00401" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00401" /></link>
        
    
    

<title>Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00401" /></meta><meta property="og:title" content="Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0013.jpeg" /></meta><meta property="og:description" content="An impaired signaling capacity of the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) has been implicated in the neurobehavioral processes that promote relapse vulnerability in cocaine use disorder (CUD). Restoration of the diminished 5-HT2CR signaling through positive allosteric modulation presents a novel therapeutic approach. Several new molecules with the 4-alkylpiperidine-2-carboxamide scaffold were designed, synthesized, and pharmacologically evaluated, leading to the discovery of selective 5-HT2CR positive allosteric modulators (PAMs). Compound 16 (CYD-1-79) potentiated 5-HT-evoked intracellular calcium release in cells stably expressing the human 5-HT2CR but not the 5-HT2AR cells. A topographically distinct allosteric site was identified based on the newly solved 5-HT2CR structure. Compound 16 modulated 5-HT2CR-mediated spontaneous ambulation, partially substituted for the training dose of the 5-HT2CR agonist WAY163909, synergized with a low dose of WAY163909 to substitute fully for the stimulus effects of WAY163909, and attenuated relapse vulnerability as assessed in a rodent self-administration model, indicating its therapeutic promise for CUD." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00401"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00401">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00401&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00401&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00401&amp;href=/doi/10.1021/acs.jmedchem.8b00401" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 1</span><span class="cit-fg-pageRange">, 288-305</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/1" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00368" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b00857" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT<sub>2C</sub> Receptor</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Christopher T. Wild</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher T. Wild</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Addiction Research,  Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher%0AT.++Wild">Christopher T. Wild</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joanna M. Miszkiel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joanna M. Miszkiel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Addiction Research, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joanna+M.++Miszkiel">Joanna M. Miszkiel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric A. Wold</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric A. Wold</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Addiction Research,  Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric+A.++Wold">Eric A. Wold</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6434-7562" title="Orcid link">http://orcid.org/0000-0001-6434-7562</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Claudia A. Soto</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claudia A. Soto</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Addiction Research, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claudia+A.++Soto">Claudia A. Soto</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5214-9136" title="Orcid link">http://orcid.org/0000-0002-5214-9136</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chunyong Ding</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chunyong Ding</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Addiction Research,  Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chunyong++Ding">Chunyong Ding</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rachel M. Hartley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rachel M. Hartley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Addiction Research, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rachel+M.++Hartley">Rachel M. Hartley</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark A. White</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark A. White</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Sealy Center for Structural Biology and Molecular Biophysics, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark+A.++White">Mark A. White</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Noelle C. Anastasio</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Noelle C. Anastasio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Addiction Research,  Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: (409)-772-9656. Fax: (409)-772-7050. E-mail: <a href="/cdn-cgi/l/email-protection#c9a7aaa8a7a8babda889bcbda4abe7acadbc"><span class="__cf_email__" data-cfemail="bdd3dedcd3dccec9dcfdc8c9d0df93d8d9c8">[email protected]</span></a> (N. C. Anastasio).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Noelle+C.++Anastasio">Noelle C. Anastasio</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5579-4213" title="Orcid link">http://orcid.org/0000-0001-5579-4213</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kathryn A. Cunningham</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kathryn A. Cunningham</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Addiction Research,  Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: (409)-772-9629. Fax: (409)-772-7050. E-mail: <a href="/cdn-cgi/l/email-protection#e18a82948f8f888f86a194958c83cf848594"><span class="__cf_email__" data-cfemail="e18a82948f8f888f86a194958c83cf848594">[email protected]</span></a> (K. A. Cunningham).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kathryn+A.++Cunningham">Kathryn A. Cunningham</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4257-1739" title="Orcid link">http://orcid.org/0000-0002-4257-1739</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Jia Zhou</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jia Zhou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Addiction Research,  Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Tel: (409) 772-9748. Fax: (409) 772-9648. E-mail: <a href="/cdn-cgi/l/email-protection#86eceffceee9f3c6f3f2ebe4a8e3e2f3"><span class="__cf_email__" data-cfemail="c6acafbcaea9b386b3b2aba4e8a3a2b3">[email protected]</span></a> (J. Zhou).</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jia++Zhou">Jia Zhou</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2811-1090" title="Orcid link">http://orcid.org/0000-0002-2811-1090</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00401&amp;href=/doi/10.1021%2Facs.jmedchem.8b00401" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 1</span><span class="cit-pageRange">, 288–305</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 5, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>12 March 2018</li><li><span class="item_label"><b>Published</b> online</span>5 April 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 January 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00401" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00401</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D288%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DChristopher%250AT.%2BWild%252C%2BJoanna%2BM.%2BMiszkiel%252C%2BEric%2BA.%2BWold%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D1%26contentID%3Dacs.jmedchem.8b00401%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BCharacterization%2Bof%2B4-Undecylpiperidine-2-carboxamides%2Bas%2BPositive%2BAllosteric%2BModulators%2Bof%2Bthe%2BSerotonin%2B%25285-HT%2529%2B5-HT2C%2BReceptor%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D305%26publicationDate%3DJanuary%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00401"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2268</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">13</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00401" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Characterization of 4-Undecylpiperidine-2-carboxamides as Positive Allosteric Modulators of the Serotonin (5-HT) 5-HT2C Receptor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Christopher\nT.&quot;,&quot;last_name&quot;:&quot;Wild&quot;},{&quot;first_name&quot;:&quot;Joanna&quot;,&quot;last_name&quot;:&quot;M. Miszkiel&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;A. Wold&quot;},{&quot;first_name&quot;:&quot;Claudia&quot;,&quot;last_name&quot;:&quot;A. Soto&quot;},{&quot;first_name&quot;:&quot;Chunyong&quot;,&quot;last_name&quot;:&quot;Ding&quot;},{&quot;first_name&quot;:&quot;Rachel&quot;,&quot;last_name&quot;:&quot;M. Hartley&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;A. White&quot;},{&quot;first_name&quot;:&quot;Noelle&quot;,&quot;last_name&quot;:&quot;C. Anastasio&quot;},{&quot;first_name&quot;:&quot;Kathryn&quot;,&quot;last_name&quot;:&quot;A. Cunningham&quot;},{&quot;first_name&quot;:&quot;Jia&quot;,&quot;last_name&quot;:&quot;Zhou&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;05&quot;,&quot;issue&quot;:&quot;1&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;288-305&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00401&quot;},&quot;abstract&quot;:&quot;An impaired signaling capacity of the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) has been implicated in the neurobehavioral processes that promote relapse vulnerability in cocaine use disorder (CUD). Restoration of the diminished 5-HT2CR signaling through positive allosteric modulation presents a novel therapeutic approach. Several new molecules with the 4-alkylpiperidine-2-carboxamide scaffold were designed, synthesized, and pharmacologically evaluated, leading to the discovery of selective 5-HT2CR positive allosteric modulators (PAMs). Compound 16 (CYD-1-79) potentiated 5-HT-evoked intracellular calcium release in cells stably expressing the human 5-HT2CR but not the 5-HT2AR cells. A topographically distinct allosteric site was identified based on the newly solved 5-HT2CR structure. Compound 16 modulated 5-HT2CR-mediated spontaneous ambulation, partially substituted for the training dose of the 5-HT2CR agonist WAY163909, synergized with a low dose of WAY163909 to substitute fully for the stimulus effects of&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00401&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00401" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00401&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00401" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00401&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00401" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00401&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00401&amp;href=/doi/10.1021/acs.jmedchem.8b00401" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00401" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00401" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00401%26sid%3Dliteratum%253Aachs%26pmid%3D29620897%26genre%3Darticle%26aulast%3DWild%26date%3D2019%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BCharacterization%2Bof%2B4-Undecylpiperidine-2-carboxamides%2Bas%2BPositive%2BAllosteric%2BModulators%2Bof%2Bthe%2BSerotonin%2B%25285-HT%2529%2B5-HT2C%2BReceptor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D1%26spage%3D288%26epage%3D305%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291713" title="Polyacrylamide">Polyacrylamide</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/1" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/jmcmar.2019.62.issue-1/20190110/jmcmar.2019.62.issue-1.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">An impaired signaling capacity of the serotonin (5-HT) 5-HT<sub>2C</sub> receptor (5-HT<sub>2C</sub>R) has been implicated in the neurobehavioral processes that promote relapse vulnerability in cocaine use disorder (CUD). Restoration of the diminished 5-HT<sub>2C</sub>R signaling through positive allosteric modulation presents a novel therapeutic approach. Several new molecules with the 4-alkylpiperidine-2-carboxamide scaffold were designed, synthesized, and pharmacologically evaluated, leading to the discovery of selective 5-HT<sub>2C</sub>R positive allosteric modulators (PAMs). Compound <b>16</b> (CYD-1-79) potentiated 5-HT-evoked intracellular calcium release in cells stably expressing the human 5-HT<sub>2C</sub>R but not the 5-HT<sub>2A</sub>R cells. A topographically distinct allosteric site was identified based on the newly solved 5-HT<sub>2C</sub>R structure. Compound <b>16</b> modulated 5-HT<sub>2C</sub>R-mediated spontaneous ambulation, partially substituted for the training dose of the 5-HT<sub>2C</sub>R agonist WAY163909, synergized with a low dose of WAY163909 to substitute fully for the stimulus effects of WAY163909, and attenuated relapse vulnerability as assessed in a rodent self-administration model, indicating its therapeutic promise for CUD.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/62/1"><issue-title>Allosteric Modulators</issue-title></a> special issue.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The United States is reeling from a public health crisis driven by the misuse of psychoactive drugs, the pervasive trajectory to substance use disorders (SUDs), and the limited access to efficacious treatment strategies. A 61% increase in adults initiating cocaine use coupled with the highest cocaine overdoses reported since 2006 reveal alarming trends<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and signal the potential for a resurgence in the incidence of cocaine use disorder (CUD), an acquired brain disorder marked by habitual cocaine-seeking despite adverse consequences. Core challenges in recovering from CUD include the risk for relapse promoted in part by the attentional orientation toward motivationally relevant, drug-associated stimuli (cue reactivity) that support drug-seeking during abstinence.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> New, effective, and accessible modalities for the treatment of CUD are needed to combat relapse risk to alleviate the chronic psychological and physical burdens of this disorder.</div><div class="NLM_p">Dysfunctional serotonin (5-hydroxytryptamine; 5-HT) neurotransmission contributes to the neurobiological states that precipitate relapse events in CUD and is an important target in the quest to develop effective medications for CUD.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> Serotonin is involved in essential brain functions as diverse as appetite, cognition, reward, and motor control.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> The actions of 5-HT are transduced by 14 receptor subtypes, which are classified into seven receptor families based upon the conjunction of genetic and molecular structure, intracellular transduction mechanisms, and pharmacological criteria. The 5-HT<sub>2</sub> receptor (5-HT<sub>2</sub>R) subtype family of 5-HT receptors is composed of three G protein-coupled receptors (GPCRs), 5-HT<sub>2A</sub>R, 5-HT<sub>2B</sub>R, and 5-HT<sub>2C</sub>R, that share a high level of amino acid sequence homology within transmembrane regions.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> In particular, hypofunctional 5-HT<sub>2C</sub>R neurotransmission is implicated as a core mediator of relapse vulnerability, and selective 5-HT<sub>2C</sub>R agonists are efficacious to blunt cocaine cue reactivity as well as the rewarding effects of cocaine in preclinical models<a onclick="showRef(event, 'ref2 ref3 ref6 ref7 ref8 ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref6 ref7 ref8 ref9 ref10 ref11 ref12">(2,3,6−12)</a> but lack abuse liability on their own.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> However, achieving receptor subtype selectivity versus the highly homologous 5-HT<sub>2A</sub>R and 5-HT<sub>2B</sub>R is an essential requisite for the successful development of 5-HT<sub>2C</sub>R ligands because activation of the related 5-HT<sub>2A/2B</sub>R systems can result in significant adverse CNS (5-HT<sub>2A</sub>R) and cardiovascular (5-HT<sub>2B</sub>R) effects.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Despite advances in the past decade,<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> attaining high 5-HT<sub>2C</sub>R selectivity remains a challenge yet to be solved. For instance, dexfenfluramine is a 5-HT<sub>2C</sub>R agonist that was previously approved for antiobesity therapy. However, this drug was later withdrawn from the market because of side effects caused by its potent agonist activity at the 5-HT<sub>2B</sub>R.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Lorcaserin, a conformationally restricted analogue of dexfenfluramine, is a 5-HT<sub>2C</sub>R agonist that has recently been approved by the FDA for treatment of obesity. However, lorcaserin is classified as a Schedule IV drug due to potential side effects, and like most other 5-HT<sub>2C</sub>R agonists, its selectivity for 5-HT<sub>2C</sub>R (<i>K</i><sub>i</sub> = 15 nM) is only modest with a 7.5-fold selectivity over the 5-HT<sub>2A</sub>R (112 nM) and 11.6-fold selectivity versus the 5-HT<sub>2B</sub>R (174 nM).<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><div class="NLM_p">Most therapeutic compounds that target GPCRs interact at the orthosteric site, which accommodates the endogenous ligand, to control downstream intracellular signaling. However, with an increasing emphasis on cellular functional screens, a growing number of allosteric modulators of GPCRs have been discovered and are under investigation as potential medications. These small molecules do not bind to the orthosteric ligand site but instead act at a topographically distinct allosteric site on the receptor and either potentiate or inhibit the binding or signaling of an orthosteric ligand. There are theoretical reasons that allosteric ligands may be preferred therapeutics, including the prospects for increased subtype selectivity, avoidance of receptor desensitization, better control of physiological systems, and upper ceiling effects, as well as separate control of affinity and efficacy of orthosteric ligands.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> In recent years, multiple allosteric modulators of GPCRs have been developed and predicted to have robust effects in a variety of CNS disorders.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21−23)</a> The recent preclinical indications of efficacy, coupled with the launch of cinacalcet<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and maraviroc<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> as the first marketed GPCR allosteric modulators, provide strong validation of the clinical utility of both positive and negative allosteric modulators, respectively. The validated proof of concept is fueling the discovery of highly selective ligands for other GPCRs that have been previously intractable. Therefore, allosteric modulators of 5-HT<sub>2C</sub>R present a novel pharmacological strategy to fine-tune binding or signaling in response to endogenous 5-HT or synthetic ligands in a site- and event-specific manner. Such a strategy may address issues concerning receptor subtype selectivity, toxicity, desensitization, and long-term changes in receptor up or down regulation that orthosteric ligands may promote.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_p">An analogue of the antibiotic lincomycin, PNU-69176E (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), was identified via a chemical library screen as a 5-HT<sub>2C</sub>R positive allosteric modulator (PAM).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Nevertheless, little effort has been made on structural modifications of chemical lead <b>1</b> to optimize its PAM activity, and thus the relevant structure–activity relationship (SAR) studies remain sparse. Structurally, <b>1</b> consists of two moieties directly attached to the piperidine-2-carboxamide core scaffold, an undecyl lipophilic tail (LT) and a polar head (PH) moiety including a complex α-<span class="smallcaps smallerCapital">d</span>-galactopyranoside, neither of which are optimal for displaying drug-like properties such as cLogP, tPSA, and bioavailability [see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Supporting Information</a> (SI), Table S1]. We have established the only reported method to readily access <b>1</b> and its diastereomer and demonstrated that <b>1</b> exhibits a profile of 5-HT<sub>2C</sub>R PAM activity with no intrinsic agonist activity at the 5-HT<sub>2C</sub>R or 5-HT<sub>2A</sub>R.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(28)</a> While the lead 5-HT<sub>2C</sub>R PAM recently described was shown to suppress locomotor activity, food intake, and body weight gain,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(29)</a> the impact of 5-HT<sub>2C</sub>R PAMs remains to be explored with <i>in vivo</i> models to uncover interaction with exogenous 5-HT<sub>2C</sub>R stimulation and to determine efficacy to suppress relapse vulnerability in CUD. These combined observations clearly justify our structural optimization campaign to further explore the SAR of structural modifications of <b>1</b> and develop new 5-HT<sub>2C</sub>R putative PAMs with an enhanced pharmacological profile for the treatment of CUD. Herein, we describe our efforts for the rational design, chemical synthesis, and pharmacological evaluation of novel, simplified 5-HT<sub>2C</sub>R PAMs based on <b>1</b> as the chemical lead. The identification of small molecule 5-HT<sub>2C</sub>R PAMs affords novel chemical probes for elucidating the neurobiology of 5-HT<sub>2C</sub>R signaling and new opportunities for proof of concept studies to develop pharmacotherapies for CUD arising from deficient 5-HT<sub>2C</sub>R signaling capacity.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0001.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Initial design strategy for novel 5-HT<sub>2C</sub>R positive allosteric modulators based on <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38332" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38332" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">Very little is known about allosteric modulation of the 5-HT<sub>2C</sub>R, and the binding site of <b>1</b> remains unclear. In our drug design strategy, we speculate that <b>1</b> consists of three possible moieties important for binding, including the previously described PH and LT, and the N–H of the core piperidine, as depicted in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>. This hypothesis was formulated initially on the basis of the available pharmacophore-directed homology modeling of the human 5-HT<sub>2C</sub>R<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> and the limited SAR studies on <b>1</b> that showed that shorter alkyl chains (methyl to <i>n</i>-hexyl groups) or the undecyl derivatives with the headgroup of <i>N</i>-phenyl, <i>N</i>,<i>N</i>-diethyl, <i>N</i>-[2-(dimethylamino)ethyl]-<i>N</i>-methyl, or <i>N</i>-(4-acetoamido-1-naphthylsulfonyl) in place of the specific polar sugar moiety failed to exert positive allosteric modulation on 5-HT<sub>2C</sub>R.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> This suggests that the PH and LT are likely important pharmacophore groups required for allosteric modulation. Considering the poor drug-like properties of <b>1</b>, our initial effort was directed to simplify and optimize the PH. The N–H of the piperidine was kept intact so that the target compounds could form HCl salts for improved aqueous solubility.</div><div class="NLM_p">We first designed a series of new analogues to optimize the PH by keeping the <i>n</i>-undecyl LT intact while replacing the sugar moiety of <b>1</b> with a variety of simple amino alcohols (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). These simplified PHs structurally resemble fragments of the polar α-<span class="smallcaps smallerCapital">d</span>-galactopyranoside moiety of <b>1</b>, which presumably undergo selective binding via hydrogen bonding or dipole–dipole interactions near the membrane surface. These new analogues, with simplified and readily accessible PHs, have enhanced drug-like properties (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Table S1</a>) and development potential. According to our previously established synthetic route,<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(28)</a> a four-step protocol affords <b>3</b>, which undergoes Sonogashira coupling with 1-undecyne, resulting in the alkynylated picolinic derivative <b>4</b>. Metal-catalyzed hydrogenation readily provided the (<i>cis</i>-2,4)-piperidyl carboxylate <b>5</b>. Boc-protection and hydrolysis of <b>5</b> provided <b>6</b> as the key intermediate in high yield on the multigram scale (68% yield from <b>3</b>). Direct deprotection of <b>6</b> afforded the parent amino acid <b>7</b>. With <b>6</b> in hand, amidation coupling with a variety of amino alcohols using HBTU/DIPEA followed by Boc-deprotection with TFA generated a series of novel derivatives <b>8</b>–<b>22</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) with diverse, simplified PHs in 63–88% yields (2 steps, <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). It was noted that the diastereomers <b>12</b>–<b>15</b> could be separated through preparative TLC (PTLC) when the phenyl amino alcohols were employed as the PHs. The other compounds were inseparable enantiomeric or diastereomeric mixtures of isomers by TLC.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0009.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of PNU-69176E Analogs with Simplified Polar Heads (PH)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) see ref <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(28)</a>; (b) 1-undecyne, CuI, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Et<sub>3</sub>N, rt, 12 h, 94%; (c) H<sub>2</sub> (60 psi), PtO<sub>2</sub>, HCl/MeOH/H<sub>2</sub>O, rt, 16 h, 95%; (d) (i) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, MeOH, rt, 16 h, 90%; (ii) LiOH, THF/H<sub>2</sub>O (v/v = 2:1), rt, 48 h, 85%; (e) (i) amino alcohols, HBTU, DIPEA, DMF, rt, 16 h; (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 63–88% (two steps).</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Effects of 4-Alkylpiperdine-2-carboxamides (1 nM) on 5-HT-Induced Ca<sub>i</sub><sup>2+</sup> Release in h5-HT<sub>2C</sub>R-CHO Cells</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0011.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0012.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Maximum 5-HT-induced Ca<sub>i</sub><sup>2+</sup> release (<i>E</i><sub>max</sub>) in the presence of 1 nM of test compound; the screen utilized concentrations of 5-HT (vehicle, 10<sup>–11</sup> to 10<sup>–6</sup> M) to establish the <i>E</i><sub>max</sub> of 5-HT in the presence of the test compound as described in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Figure S2</a>. * indicates <i>p</i> < 0.05. The <i>E</i><sub>max</sub> for the test compound plus 5-HT was normalized to the <i>E</i><sub>max</sub> for 5-HT alone. Subsequent post hoc comparisons between means for <i>E</i><sub>max</sub> were made using an unpaired <i>t</i> test with Welch’s correction (GraphPad Prism). All statistical analyses were conducted with an experiment-wise error rate of α = 0.05.</p></div></div><div></div></div><div class="NLM_p">To further explore the SAR of the LT attached to the core piperidinyl scaffold, replacement of the long alkyl chain with other saturated moieties (cyclohexyl, cyclohexylethyl or 4-methylcyclohexylethyl) were investigated. The 2-amino-1-phenyl-1,3-propanediol PHs consistently resulted in separable isomers when coupled with the piperidine scaffold bearing an undecyl tail; therefore, these polar heads were retained with the cyclohexyl tails with the hope that the isomers would again be separable by TLC. As shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>, Suzuki coupling of <b>3</b> with phenylboronic acid or Sonogashira coupling of <b>3</b> with ethynylbenzene or 1-ethynyl-4-methylbenzene afforded requisite substituted picolinic derivatives <b>23</b>–<b>25</b>. Metal-catalyzed hydrogenation of compounds on a Parr hydrogenator at 60 psi in the presence of 0.4 equiv of PtO<sub>2</sub> and 1 equiv of 37% aq HCl readily provided compounds <b>26</b>–<b>28</b>. Boc-protection and hydrolysis of <b>26</b>–<b>28</b> provided <b>29</b>–<b>31</b> as the key intermediates in high yield on the multigram scale. Amidation coupling with (1<i>S</i>,2<i>S</i>)- or (1<i>R</i>,2<i>R</i>)-(−)-2-amino-1-phenyl-1,3-propanediol followed by removal of Boc groups with TFA furnished a series of novel derivatives <b>32</b>–<b>37</b> with compact LTs in 83–86% yields (two steps). As previously observed, each amidation coupling reaction also produced a pair of diastereoisomers, which could be separated by PTLC after the Boc-deprotection. It was our expectation that the compact LTs would result in final compounds that could form crystals suitable for X-ray diffraction. To our delight, two of the six compounds were crystallized and characterized. As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the absolute stereochemistry of compounds <b>32</b> and <b>35</b> was unambiguously determined by their X-ray crystallography analyses (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Table S2, Figure S1</a>), from which the stereochemistry of the other diastereoisomers could also be deduced as described in our previous work.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(28)</a></div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of PNU-69176E Analogs with Compact Lipophilic Tails (LT)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Suzuki coupling, (i) phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, EtOH/H<sub>2</sub>O/PhMe = 2:1:1, reflux; (ii) H<sub>2</sub>SO<sub>4</sub>, methanol, reflux, 98% (two steps); or Sonogashira coupling, ethynylbenzene or 1-ethynyl-4-methylbenzene, CuI, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Et<sub>3</sub>N, rt, 12 h, 88% to 97%; (b) (i) H<sub>2</sub> (60 psi), PtO<sub>2</sub>, HCl/MeOH/H<sub>2</sub>O, rt, 16 h, 97–98%; (ii) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, MeOH, rt, 16 h, 96–98%; (c) LiOH, THF/H<sub>2</sub>O (v/v = 2:1), rt, 48 h, quantitative yield; (d) (i) amino alcohols, HBTU, DIPEA, DMF, rt, 16 h; (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 83–86% (two steps).</p></p></figure><figure id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Determination of absolute configuration of chiral carbons 2 and 4 of the piperdinyl ring. X-ray crystallography structures of analogues (2<i>S</i>,4<i>R</i>)-<b>32</b> and (2<i>R</i>,4<i>S</i>)-<b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> <i>In Vitro</i> Ca<sub>i</sub><sup>2+</sup> Release Assay in h5-HT<sub>2C</sub>R-CHO Cells</h3><div class="NLM_p">The best-characterized intracellular pathway of 5-HT<sub>2C</sub>R signaling is the activation of phospholipase Cβ (PLCβ) via G<sub>αq/11</sub> proteins followed by the production of inositol-1,4,5-trisphosphate (IP<sub>3</sub>) and diacylglycerol (DAG), leading to increased Ca<sub>i</sub><sup>2+</sup> release from intracellular stores.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Therefore, <i>in vitro</i> functional characterization of these synthetic compounds can be determined by utilizing a fluorescence-based, live cell Ca<sub>i</sub><sup>2+</sup> release assay to measure activation of the 5-HT<sub>2C</sub>R signaling pathway. The Ca<sub>i</sub><sup>2+</sup> levels can be regarded as a primary readout, as has been utilized in a multitude of 5-HT<sub>2C</sub>R drug discovery projects.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Our assay was conducted in Chinese hamster ovary (CHO) cells stably transfected with the human 5-HT<sub>2C</sub>R (unedited INI isoform; h5-HT<sub>2C</sub>R-CHO cells).<a onclick="showRef(event, 'ref29 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref29 ref34 ref35">(28,34,35)</a> The maximum capacity of 5-HT to promote Ca<sub>i</sub><sup>2+</sup> release (<i>E</i><sub>max</sub>) was established and set to 100% response. All compounds are reported relative to the <i>E</i><sub>max</sub> of 5-HT. Previous titration studies with compound <b>1</b> revealed an upward shift of 5-HT-evoked Ca<sub>i</sub><sup>2+</sup> release at the concentration effective to evoke 20% response (EC<sub>20</sub>), while 1 nM of <b>1</b> produced a leftward shift of the 5-HT-evoked Ca<sub>i</sub><sup>2+</sup> response curve.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(28)</a> Therefore, all compounds were initially screened at 1 nM for their ability to enhance 5-HT-induced Ca<sub>i</sub><sup>2+</sup> release evoked by increasing concentrations of 5-HT in h5-HT<sub>2C</sub>R-CHO cells (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Figure S2</a>). The cells were pretreated for 15 min with each test compound to establish an absence of intrinsic agonist activity in each assay. The analysis of novel compounds on maximum 5-HT-induced Ca<sub>i</sub><sup>2+</sup> release in h5-HT<sub>2C</sub>R-CHO cells is summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>.</div><div class="NLM_p">None of the 24 new analogs screened exhibited intrinsic efficacy at 1 nM to induce Ca<sub>i</sub><sup>2+</sup> release in h5-HT<sub>2C</sub>R-CHO cells in the absence of 5-HT (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Figure S2</a>). Compound <b>7</b>, the deprotected amino acid of the key intermediate <b>6</b> (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), exhibited no significant PAM activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Topographical analysis of <b>1</b> revealed 2- or 3-carbon long chains to the nearest heteroatom (O and Cl) in the sugar-like PH. Therefore, the selection of PHs emphasized the incorporation of −OH(s) two carbons away from the amide linker. The coupling of ethanolamine with the key intermediate afforded <b>8</b>. Similar to <b>7</b>, no significant PAM activity with <b>8</b> was observed (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Incorporation of two −OH groups (a 1,3-propandiol fragment, <b>9</b>) provided a negligible increase in 5-HT-induced Ca<sub>i</sub><sup>2+</sup> release, though statistically significant. Various analogues that retained the 1,3-propanediol fragment with the addition of a methyl or phenyl group (<b>10</b>–<b>15</b>) did not provide for the desired PAM activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). However, compound <b>14</b>, which was a separable isomer with the (2<i>S</i>,4<i>R</i>) configuration at the piperidine ring and the (1<i>R</i>,2<i>R</i>) configuration for the PH moiety, displayed significant activity consistent as a negative allosteric modulator (NAM, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Next, the use of an additional carbon spacer between the amide linker and the most distal −OH was explored through the incorporation of a 1,2-propanediol fragment (<b>16</b>). The glycol moiety proved fruitful. Compound <b>16</b> displayed significant PAM activity and increased the 5-HT-evoked Ca<sub>i</sub><sup>2+</sup> release ∼23% above the 5-HT <i>E</i><sub>max</sub> value (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). The enantiomerically pure versions of the PH of <b>16</b> were incorporated into the scaffold and were tested and showed a stereochemical preference for PAM activity. Compound <b>16a</b>, the <i>R</i>-variant at the PH, lacked appreciable PAM activity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C), while the <i>S</i>-configuration (<b>16b</b>), like <b>16</b>, displayed significant PAM activity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Incorporation of a terminal −Cl abolished statistically significant activity (<b>17</b>). Additional attempts to incorporate various hydrogen bond donor/acceptor moieties as PHs did not produce compounds with PAM activity [<i>N</i>-ethyl morpholino (<b>18</b>), methyl esters of threonine (<b>19</b>), serine (<b>20</b>), tyrosine (<b>21</b>), and tryptophan (<b>22</b>)]. The lactate dehydrogenase assay was employed to predict the cytotoxicity of compounds at 0.1 nM and 1 μM; none of the tested compounds exhibited values in this assay indicative of cellular toxicity (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Table S3</a>).</div><figure id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of select compounds on Ca<sub>i</sub><sup>2+</sup> release in live h5-HT<sub>2C</sub>R-CHO cells in the absence (black circles) and in the presence of the test compound (red triangles) against the concentration–response curve for 5-HT, vehicle (blue circle), or vehicle in the presence of test compound (green triangle). (A) Compound <b>14</b> (1 nM), representative example of a potential NAM; (B) compound <b>16</b> (1 nM), representative example of a potential PAM; (C) compound <b>16a</b> (1 nM), representative example of an inactive compound. The maximum 5-HT-induced Ca<sub>i</sub><sup>2+</sup> release in the absence of the test compounds was set as 100%. The <i>E</i><sub>max</sub> of 5-HT in the presence of the test compounds are listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Concentration–response curves for remaining compounds are in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Figure S2</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>16</b> promoted an upward shift of 5-HT-evoked Ca<sub>i</sub><sup>2+</sup> release at multiple concentrations (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A) without a leftward shift, an indication that <b>16</b> promotes improved 5-HT efficacy but did not impact 5-HT potency at the 5-HT<sub>2C</sub>R (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A). To determine the selectivity of <b>16</b> for allosteric modulation of the 5-HT<sub>2C</sub>R over the 5-HT<sub>2A</sub>R, multiple concentrations of <b>16</b> were employed to assess 5-HT-evoked Ca<sub>i</sub><sup>2+</sup> release in h5-HT<sub>2A</sub>R-CHO cells (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B).<a onclick="showRef(event, 'ref29 ref34'); return false;" href="javascript:void(0);" class="ref ref29 ref34">(28,34)</a> Compound <b>16</b> produced no change in the 5-HT <i>E</i><sub>max</sub> or EC<sub>50</sub> at the 5-HT<sub>2A</sub>R (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B). These data provide the conceptual framework for the continued development of selective PAMs of the 5-HT<sub>2C</sub>R given the ability of <b>16</b> to affect 5-HT efficacy at the 5-HT<sub>2C</sub>R (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A), but not the 5-HT<sub>2A</sub>R (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B).</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of <b>16</b> on Ca<sub>i</sub><sup>2+</sup> release in live h5-HT<sub>2C</sub>R-CHO cells (A) and h5-HT<sub>2A</sub>R-CHO cells (B) against the concentration–response curve for 5-HT. (A) Compound <b>16</b> (1 pM, 1 nM, 1 μM) demonstrates an upward shift in h5-HT<sub>2C</sub>R-CHO cells. (B) Compound <b>16</b> (1 pM, 1 nM, 1 μM) does not alter 5-HT-induced signaling in h5-HT<sub>2A</sub>R-CHO cells. The maximum 5-HT-induced Ca<sub>i</sub><sup>2+</sup> release in the absence of the test compounds was set as 100%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The compounds synthesized according to <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> retained the 1-phenyl-1,3-propandiol PH in an effort to produce separable isomers to further explore the impact of changes made to the LT. Preserving the PH used in the potential NAM <b>14</b>, which produced a decrease in 5-HT-mediated Ca<sub>i</sub><sup><i>2+</i></sup> release, while changing the LT from the undecyl tail to an ethylcyclohexyl moiety, afforded a NAM that promoted a slight but significant decrease in 5-HT-induced Ca<sub>i</sub><sup>2+</sup> release (<b>32</b>, 96.0% ± 1.9%). All other attempts to utilize various LTs failed to produce any compounds with allosteric effects (<b>34</b>–<b>37</b>). Exploration of the remaining chemical space, in particular with regard to the LT, will be reported in due course.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Molecular Docking to 5-HT<sub>2C</sub>R</h3><div class="NLM_p">To explore a potential binding mode and provide additional lines of evidence that the described compounds are allosteric modulators, molecular docking using the Schrödinger Drug Discovery Suite was employed to identify the allosteric binding site relative to the orthosteric binding site (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">SI</a> for details on docking protocol). Until recently, the only solved structures of serotonin receptors were the 5-HT<sub>1B</sub>R and 5-HT<sub>2B</sub>R.<a onclick="showRef(event, 'ref36 ref37 ref38'); return false;" href="javascript:void(0);" class="ref ref36 ref37 ref38">(36−38)</a> However, the very recently disclosed 5-HT<sub>2C</sub>R structure has afforded the opportunity to conduct the first allosteric-5-HT<sub>2C</sub>R docking study.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> With compound <b>16b</b> displaying positive allosteric modulation, molecular docking using the active state of the 5-HT<sub>2C</sub>R was used to search the extracellular portion of the receptor for a suitable allosteric site.</div><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A depicts a global view of the 5-HT<sub>2C</sub>R and the docked endogenous ligand 5-HT (pink space-fill) in the orthosteric site engaging residues consistent with previous reports based on site-directed mutagenesis studies.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The red cluster overlay of <b>16b</b> (red wire-representation of top five poses using Schrödinger Glide scoring function) highlighted a possible binding pocket for the proposed PAM as being topologically distinct from the orthosteric site.</div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding poses of (A) global view of 5-HT<sub>2C</sub>R (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6BQG">6BQG</a>) with 5-HT (pink space-fill representation) at the orthosteric site and <b>16b</b> (red stick representation overlay of top five poses) at the proposed allosteric site; (B) representative pose of <b>16b</b> (red stick representation) engaged with residues of proposed allosteric site (superscript designation represents Ballesteros–Weinstein notation);<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (C) representative pose of <b>16a</b> (red stick representation).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The allosteric site (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A) is near extracellular loop 2 (EL2) accommodating the PH of the proposed PAM, an observation also made when describing similar binding modes of other class A GPCRs.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a><a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>B depicts the 1,2-diol PH moiety with the <i>S</i>-configuration engaging in a bidentate, H-bonding interaction with the backbone carbonyl L209 of EL2, a residue conserved in the 5-HT<sub>2</sub>R subfamily. Additionally, the ionizable N atom of the piperidine ring engages in an H-bond with the −OH side chain of S334 of transmembrane helix VI (TMH VI), which is not present in either the 5-HT<sub>2A</sub>R or 5-HT<sub>2B</sub>R, thus suggesting a predicted molecular basis for the 5-HT<sub>2C</sub>R subtype functional selectivity over the 5-HT<sub>2A</sub>R as described in our cell-based studies. The predicted bridging effect of <b>16b</b> between EL2 and TMH VI may result in a drawing in of the extracellular portion of TMH VI and, thereby, promote the outward shift of the intracellular portion of TMH VI, consistent with reports that this helical movement is associated with the active state of the receptor.<a onclick="showRef(event, 'ref39 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref39 ref43 ref44">(39,43,44)</a> Compound <b>16a</b>, containing the 1,2-diol PH with the <i>R</i>-configuration, does not form the same EL2-to-TMH VI bridge (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C), providing a potential explanation as to why <b>16a</b> is inactive in the described cell-based assay.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> <i>In Vitro</i> Assessment of Off-target Effects of Compound <b>16</b></h3><div class="NLM_p">Preliminary data from a broad-panel assay generously provided by the National Institute of Mental Health (NIMH) Psychoactive Drug Screening Program (PDSP)<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> showed that the most promising PAM, compound <b>16</b> assessed at 10 μM displayed no significant ability to displace binding to a variety of related receptors (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Specifically, at 10 μM, <b>16</b> did not displace binding of radioligands to 5-HT receptors (5-HT<sub>1A</sub>R, 5-HT<sub>1B</sub>R, 5-HT<sub>1D</sub>R, 5-HT<sub>1E</sub>R, 5-HT<sub>2A</sub>R, 5-HT<sub>2B</sub>R, 5-HT<sub>2C</sub>R, 5-HT<sub>3</sub>R, 5-HT<sub>5A</sub>R, 5-HT<sub>6</sub>R, 5-HT<sub>7</sub>R), dopamine receptors (D<sub>1</sub>, D<sub>2</sub>, D<sub>4</sub>, D<sub>5</sub>), or monoamine transporters [5-HT transporter (SERT) and norepinephrine transporter (NET)]. Compound <b>16</b> (10 μM) shows weak to no displacement of binding to other evaluated receptors and monoamine transporters (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Table S4</a>). Compound <b>16</b> (10 μM) did display significant inhibition (defined as greater than 50%) of radioligand binding at the dopamine transporter (DAT; 66.3%), dopamine D<sub>3</sub> receptor (71.7%), or α<sub>2A</sub> and α<sub>2B</sub> receptors (85.1% and 80.7%, respectively). However, the concentration (10 μM) tested in the radioligand displacement assay is significantly higher than the concentrations of <b>16</b> (1 pM, 1 nM, 1 μM) screened for activity in the functional assay. Therefore, in total, compound <b>16</b> appears to be promising with regard to displaying minimal off-target effects, a commonly postulated advantage of allosteric modulators of GPCRs.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Moreover, <b>16</b> showed little to no interaction with the orthosteric sites of the tested 5-HT receptor subtypes.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Displacement of Radioligand Binding by Compound <b>16</b> (10 μM) in a Broad Panel of Receptors and Transporters<a class="ref internalNav" href="#tbl2-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">receptor or transporter</th><th class="colsep0 rowsep0" align="center">radioligand</th><th class="colsep0 rowsep0" align="center" char=".">% inhib (10 μM)<a class="ref internalNav" href="#t2fn1" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>K</i><sub>i</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1A</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-8-OH-DPAT</td><td class="colsep0 rowsep0" align="char" char=".">25.7</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1B</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-GR125743</td><td class="colsep0 rowsep0" align="char" char=".">–18.1</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1D</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-GR125743</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>1E</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-5-HT</td><td class="colsep0 rowsep0" align="char" char=".">0.7</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2A</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-ketanserin</td><td class="colsep0 rowsep0" align="char" char=".">37.1<a class="ref internalNav" href="#t2fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2B</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-LSD</td><td class="colsep0 rowsep0" align="char" char=".">15.1<a class="ref internalNav" href="#t2fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>2C</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-mesulergine</td><td class="colsep0 rowsep0" align="char" char=".">9.8<a class="ref internalNav" href="#t2fn3" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>3</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-LY278584</td><td class="colsep0 rowsep0" align="char" char=".">27.0</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>5A</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-LSD</td><td class="colsep0 rowsep0" align="char" char=".">17.2</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>6</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-LSD</td><td class="colsep0 rowsep0" align="char" char=".">18.1</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5-HT<sub>7</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-LSD</td><td class="colsep0 rowsep0" align="char" char=".">26.8</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>1</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-SCH23390</td><td class="colsep0 rowsep0" align="char" char=".">29.3</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>2</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-<i>N</i>-methylspiperone</td><td class="colsep0 rowsep0" align="char" char=".">28.8</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>3</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-<i>N</i>-methylspiperone</td><td class="colsep0 rowsep0" align="char" char=".">71.4</td><td class="colsep0 rowsep0" align="char" char=".">4.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>4</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-<i>N</i>-methylspiperone</td><td class="colsep0 rowsep0" align="char" char=".">–14.2</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">D<sub>5</sub></td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-SCH23390</td><td class="colsep0 rowsep0" align="char" char=".">32.5</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DAT</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-WIN35428</td><td class="colsep0 rowsep0" align="char" char=".">66.3</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SERT</td><td class="colsep0 rowsep0" align="left">[<sup>3</sup>H]-citalopram</td><td class="colsep0 rowsep0" align="char" char=".">24.8</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t2fn4" aria-label="e">e</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl2-fn1"><div class="footnote" id="tbl2-fn1"><sup><sup>a</sup></sup><p class="last">National Institute of Mental Health (NIMH) Psychoactive Drug Screening Program (PDSP).<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Receptor binding profiles were generously provided by NIMH PDSP, Contract no. HHSN-271-2013-00017-C. The PDSP is directed by Bryan L. Roth, M.D., Ph.D., at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscoll at NIMH, Bethesda MD, USA.</p></div><div class="footnote" id="t2fn1"><sup><sup>b</sup></sup><p class="last">Data represent mean % inhibition (<i>n</i> = 4) for compound <b>16</b> assessed for displacement of binding at targets. Inhibition of binding >50% at 10 μM of compound <b>16</b> resulted in determination of <i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t2fn2"><sup><sup>c</sup></sup><p class="last">Data represent <i>K</i><sub>i</sub> (μM) values obtained from nonlinear regression of radioligand competition isotherms. <i>K</i><sub>i</sub> values are calculated from best fit IC<sub>50</sub> values using the Cheng–Prusoff equation.</p></div><div class="footnote" id="t2fn3"><sup><sup>d</sup></sup><p class="last">Data for 5-HT<sub>2</sub> receptor subtypes represent the average of the mean % inhibition (<i>n</i> = 8) for compound <b>16</b>.</p></div><div class="footnote" id="t2fn4"><sup><sup>e</sup></sup><p class="last">Not tested.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> <i>In Vivo</i> Pharmacokinetic (PK) Profile of Compound <b>16</b></h3><div class="NLM_p">The PK profile of <b>16</b> was assessed in a pilot study to investigate whether this class of molecules exhibits favorable drug-like properties. The PK parameters of <b>16</b> were evaluated in rats after single iv (5 mg/kg) or po (10 mg/kg) administration. As summarized in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, Compound <b>16</b> displays a decent half-life (<i>T</i><sub>1/2</sub>) after administration of 5 mg/kg iv (<i>t</i><sub>1/2</sub> = 6.59 ± 0.26 h) or 10 mg/kg po (5.82 ± 0.37 h). The time of maximum concentration (<i>T</i><sub>max</sub>) after 10 mg/kg po was 3.3 ± 0.58 h. The plasma clearance (CL) of <b>16</b> was 5.37 ± 0.61 L h<sup>–1</sup> kg<sup>–1</sup> after 5 mg/kg iv, while the volume of distribution plasma distribution (<i>V</i><sub>ss</sub>) was 35.07 ± 4.66 L/kg. Compound <b>16</b> displayed a maximum serum concentration (<i>C</i><sub>max</sub>) of 68.1 ± 6.8 ng/mL after 10 mg/kg po, while <b>16</b> exhibited moderate plasma exposure (AUC<sub>0–inf</sub>) after administration of 5 mg/kg iv (939 ± 108 ng·h·mL<sup>–1</sup>) or 10 mg/kg po (737 ± 56 ng·h·mL<sup>–1</sup>). Decent oral bioavailability (<i>F</i>) was observed (10 mg/kg po; 39.1%). We also calculated the central nervous system (CNS) multiparameter optimization (MPO) value for compound <b>16</b> to be 4.5; collective scores range from 0 to 6 with higher MPO scores predicted to be more desirable for CNS medication candidates (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Table S5</a>).<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Based upon these data, compound <b>16</b> was selected for subsequent evaluation of <i>in vivo</i> efficacy.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>In Vivo</i> Pharmacokinetic Profile of Compound <b>16</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="±" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>max</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">CL (L h<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center" char="±">AUC<sub>0–inf</sub> (ng·h·mL<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">5, iv</td><td class="colsep0 rowsep0" align="char" char=".">6.59 ± 0.26</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">5.37 ± 0.61</td><td class="colsep0 rowsep0" align="char" char=".">35.07 ± 4.66</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="±">939 ± 108</td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10, po</td><td class="colsep0 rowsep0" align="char" char=".">5.82 ± 0.37</td><td class="colsep0 rowsep0" align="char" char=".">3.3 ± 0.58</td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char="."><a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="char" char=".">68.1 ± 6.8</td><td class="colsep0 rowsep0" align="char" char="±">737 ± 56</td><td class="colsep0 rowsep0" align="char" char=".">39.1</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Values are the average of three runs. Vehicle, DMSO/Tween 80/saline (v/v 1:3:6). <i>T</i><sub>1/2</sub>, half-life; <i>T</i><sub>max</sub>, time of maximum concentration; CL, plasma clearance; <i>V</i><sub>ss</sub>, volume of distribution; <i>C</i><sub>max</sub>, maximum concentration; AUC<sub>0–inf</sub>, area under the plasma concentration–time curve; <i>F</i>, oral bioavailability.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Not determined.</p></div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Effects of Compound <b>16</b> on Spontaneous Locomotor Activity</h3><div class="NLM_p">Our candidate 5-HT<sub>2C</sub>R PAM could be expected to enhance the effects of endogenous (5-HT) or exogenous 5-HT<sub>2C</sub>R agonists <i>in vivo</i>. Selective and nonselective agonists of the 5-HT<sub>2C</sub>R induce dose-dependent suppression of spontaneous locomotor activity in rodents, which is reversed by selective 5-HT<sub>2C</sub>R antagonists.<a onclick="showRef(event, 'ref9 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref9 ref47 ref48">(9,47,48)</a> In the present experiment, we tested the hypothesis that <b>16</b> would evoke a modest suppression of motor activity in adult male Sprague–Dawley rats similar to the observations made for a recently evaluated candidate 5-HT<sub>2C</sub>R PAM.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(29)</a> We assessed the effects of compound <b>16</b> (0.5, 1, or 5 mg/kg ip) on spontaneous locomotor activity over a 90 min session. As the effects of compound <b>16</b> were confined to the initial 30 min of the session, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a> presents ambulations totaled for that 30 min. A main effect of compound <b>16</b> was observed for mean total ambulations (±SEM) [<i>F</i><sub>(3,25)</sub> = 3.44, <i>p</i> = 0.03]. <i>A priori</i> comparisons revealed that 5 mg/kg of compound <b>16</b> significantly reduced mean total ambulations (±SEM) vs saline (<i>p</i> < 0.05; <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). A main effect of compound <b>16</b> treatment was also observed for mean total vertical activity (±SEM) in 30 min [<i>F</i><sub>(3,25)</sub> = 9.14, <i>p</i> = 0.0003]. <i>A priori</i> comparisons revealed that 5 mg/kg of compound <b>16</b> significantly reduced mean total vertical activity (±SEM) vs saline (<i>p</i> < 0.05; data not shown). Ambulation and vertical activity are often positively correlated; however, these measures are actually independent of one another, can be pharmacologically dissociated, and appear to be mediated by different neural circuitry.<a onclick="showRef(event, 'ref49 ref50 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51 ref52">(49−52)</a></div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of compound <b>16</b> on spontaneous locomotor activity. (A) Groups of rats (<i>n</i> = 7–8/group) naive to the activity monitors were injected with a single dose of saline or compound <b>16</b> (0.5, 1, or 5 mg/kg; ip) immediately prior to the start of locomotor assessment. (B) Groups of rats (<i>n</i> = 9–10/group) naive to the activity monitors were injected with a single dose of the 5-HT<sub>2C</sub>R antagonist SB242084 (1 mg/kg; ip; 15 min pretreatment) and the 5-HT<sub>2C</sub>R agonist WAY163909 (1 mg/kg; ip) in combination with compound <b>16</b> (5 mg/kg; ip) immediately prior to the start of locomotor assessment. The mean total ambulations (±SEM) in 30 min are plotted. *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p"><a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B illustrates the allosteric effects of compound <b>16</b> (5 mg/kg) in combination with the selective 5-HT<sub>2C</sub>R orthosteric agonist WAY163909 (1 mg/kg) on spontaneous locomotor activity in the presence or absence of the 5-HT<sub>2C</sub>R antagonist SB242084 (1 mg/kg). Pretreatment with SB242084 inhibits WAY163909-evoked suppression of ambulations, but not vertical activity (data not shown). A main effect of treatment was observed for ambulations totaled across the 30 min session [<i>F</i><sub>(3,34)</sub> = 8.25, <i>p</i> = 0.0003]. <i>A priori</i> comparisons revealed that the combination of compound <b>16</b> plus WAY163909 reduced total ambulations versus WAY163909 alone (<i>p</i> < 0.05; <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B); this effect was prevented by SB242084 (<i>p</i> < 0.05; <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). A main effect of treatment was observed for vertical activity totaled across the 30 min session [<i>F</i><sub>(3,34)</sub> = 19.19, <i>p</i> < 0.0001]; <i>a priori</i> comparisons revealed that the combination of compound <b>16</b> plus WAY163909 reduced vertical activity versus WAY163909 alone (<i>p</i> < 0.05; data not shown); this effect was only marginally prevented by SB242084 pretreatment (<i>p</i> < 0.05; data not shown).</div><div class="NLM_p last">These data demonstrate that the 5-HT<sub>2C</sub>R is engaged in the effects of compound <b>16</b> to suppress motor activity in the presence of exogenous 5-HT<sub>2C</sub>R stimulation with WAY163909. Furthermore, compound <b>16</b> may augment endogenous 5-HT<sub>2C</sub>R signaling <i>in vivo</i> to suppress spontaneous ambulations, as might be expected of a PAM.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Effects of Compound <b>16</b> in a WAY163909 vs Saline Drug Discrimination Assay</h3><div class="NLM_p">We employed the drug discrimination assay to explore the impact of compound <b>16</b> in the context of endogenous or exogenous 5-HT<sub>2C</sub>R stimulation. The drug discrimination assay is widely recognized as one of the major methods in neuropharmacology and drug discovery.<a onclick="showRef(event, 'ref53 ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref53 ref54 ref55">(53−55)</a> This assay has face validity for modeling the subjective effects of drugs that penetrate the blood–brain barrier as well as to assess the influence of the novel compounds on the interoceptive effects of receptor-selective agonists or other ligands, including allosteric modulators.<a onclick="showRef(event, 'ref56 ref57 ref58 ref59'); return false;" href="javascript:void(0);" class="ref ref56 ref57 ref58 ref59">(56−59)</a> Drug discrimination procedures have been extensively used to characterize the neuropharmacological profile of novel small molecules as well as 5-HT<sub>2</sub>R subtype agonists, including 5-HT<sub>2C</sub>R agonists (e.g., <i>m</i>-chlorophenylpiperazine, Ro 60-0175).<a onclick="showRef(event, 'ref60 ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62 ref63">(60−63)</a> Here, we trained rats to discriminate 0.75 mg/kg of the selective 5-HT<sub>2C</sub>R agonist WAY163909 from saline in a two-lever drug discrimination protocol. The mean number of sessions required to meet the criterion for acquisition of the WAY163909 (0.75 mg/kg, ip; 15 min pretreatment) versus saline discrimination was 44 training sessions (range 39–57). During dose–response tests, WAY163909 (0.125–1.0 mg/kg, ip) elicited a dose-dependent increase in WAY163909-appropriate responding whereas saline resulted in <10% WAY163909-appropriate responding (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A, closed circles). Greater than 95% WAY163909-appropriate responding was observed at the training dose (0.75 mg/kg, ip). Response rates were stable across all test doses of WAY163909 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A, open triangles). The time course of WAY163909-appropriate responding at 0.75 mg/kg (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Figure S3</a>) indicated that the stimulus effects of the training dose of WAY163909 (0.75 mg/kg, ip) are maximal at a 15 min pretreatment time and decline until 120 min at which time rats cannot discriminate this dose of WAY163909 (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Figure S3</a>). The dose predicted to elicit 50% of WAY163909-lever responding (ED<sub>50</sub>) in rats is 0.53 mg/kg.</div><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0007.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dose–response relationship of WAY163909, compound <b>16</b>, and the combination in a WAY163909 vs saline drug discrimination assay. The dose–response curves (<i>n</i> = 7–9/dose) for (A) WAY163909 (ip) and (B) compound <b>16</b> (ip) are presented. Closed circles (solid lines) denote the mean percentage of WAY163909-appropriate responding (±SEM; left axis), and open triangles (dotted lines) denote the mean responses/min (±SEM; right axis). *<i>p</i> < 0.05 vs 0.75 mg/kg WAY163909. (C) The results of substitution tests in which WAY163909 alone or in combination with compound <b>16</b> are presented. The dotted line represents the % WAY163909-lever response observed for the training dose of WAY163909 (0.75 mg/kg). *<i>p</i> < 0.05 vs 0.5 mg/kg of compound <b>16</b>;<b>̂</b><i>p</i> < 0.05 vs 0.5 mg/kg of WAY163909.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>16</b> alone did not stimulate Ca<sub>i</sub><sup>2+</sup> release in live h5-HT<sub>2C</sub>R-CHO cells, indicating an inability to act as a 5-HT<sub>2C</sub>R agonist <i>in vitro</i>; therefore, we hypothesized that compound <b>16</b> would not substitute fully for the full 5-HT<sub>2C</sub>R agonist WAY163909 in rats trained to discriminate WAY163909 from saline. Compound <b>16</b> (0.125–0.5 mg/kg; ip) evoked a maximum of 45% ± 20% (SEM) WAY163909-appropriate responding at a dose of 1 mg/kg (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B, closed circles). All doses of <b>16</b> elicited WAY163909-lever responding that was significantly different than the training dose (0.75 mg/kg, <i>p</i> < 0.05); this lack of substitution of <b>16</b> suggests a dissociation between the stimulus effects of the full 5-HT<sub>2C</sub>R agonist WAY163909 and compound <b>16</b>. Response rates (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B, open triangles) were stable across the lowest doses of compound <b>16</b> (0.125–0.5 mg/kg). At the highest dose of compound <b>16</b> tested (1 mg/kg), seven out of the nine rats tested completed the lever press response criterion; the response rate for these rats was significantly decreased relative to the training dose of WAY163909 (<i>p</i> < 0.05). While this observation may reflect motor suppression evoked by <b>16</b>, the maximal dose of <b>16</b> (1 mg/kg) employed in drug discrimination studies was not associated with suppressed ambulations (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). In general, responding in an operant task is relatively more sensitive than is locomotor activity, and it is important to note that modifications in response rates are dissociable from response choice.<a onclick="showRef(event, 'ref60 ref65'); return false;" href="javascript:void(0);" class="ref ref60 ref65">(60,64)</a></div><div class="NLM_p">The observation that compound <b>16</b> partially substituted for WAY163909 may not be unexpected given that the effects of endogenous 5-HT could be enhanced by a 5-HT<sub>2C</sub>R PAM. Coupled with data that compound <b>16</b> does not have intrinsic activity in the h5-HT<sub>2C</sub>R-CHO assay, these data support the contention that compound <b>16</b> does not exhibit appreciable efficacy as a 5-HT<sub>2C</sub>R agonist and are consistent with other findings regarding the discriminative stimulus effects of allosteric modulators.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(65)</a></div><div class="NLM_p last">We also postulated that a 5-HT<sub>2C</sub>R PAM would enhance the effects of the 5-HT<sub>2C</sub>R agonist WAY163909 to evoke its discriminative stimulus effects. To further probe this premise, rats were injected with low doses of WAY163909 (0.5 mg/kg) in combination with compound <b>16</b> (0.5 mg/kg; <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>C); each evokes ∼30% WAY163909-appropriate responding with rates of ∼30 responses/min. Interestingly, the coadministration of 0.5 mg/kg of WAY163909 <i>plus</i> 0.5 mg/kg of compound <b>16</b> synergized to evoke a full substitution for WAY163909 (∼95% WAY163909-lever responding). The response rate seen with the combination (15 ± 2.0 responses/min) did not differ from 0.5 mg/kg of WAY163909 (31.0 ± 4.4 responses/min), but was significantly lower than 0.5 mg/kg of compound <b>16</b> (27.4 ± 5.8 responses/min) administered alone (<i>p</i> < 0.05). Taken together, these data suggest that compound <b>16</b> acts <i>in vivo</i> to augment 5-HT<sub>2C</sub>R agonist-mediated signaling <i>in vivo</i>.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Effects of Compound <b>16</b> on Cocaine Cue Reactivity</h3><div class="NLM_p">We employed a rat model of cocaine self-administration to establish the efficacy of compound <b>16</b> to suppress relapse vulnerability assessed by responding for the discrete cue complex paired with cocaine intake (cue reactivity).<a onclick="showRef(event, 'ref8 ref9 ref12 ref67 ref68'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref12 ref67 ref68">(8,9,12,66,67)</a> Selective 5-HT<sub>2C</sub>R agonists effectively suppress cocaine cue reactivity and cocaine intake in the self-administration paradigm,<a onclick="showRef(event, 'ref9 ref12 ref47 ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref9 ref12 ref47 ref69 ref70">(9,12,47,68,69)</a> with no evidence of abuse liability on their own.<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> Relapse during abstinence from cocaine use is a major hurdle for the successful treatment of CUD; an effective pharmacotherapy that improves inhibitory control in the context of exposure to cocaine-associated cues would represent a first-in-class drug useful for those suffering from CUD.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a></div><div class="NLM_p">The self-administration assay has the greatest face validity for modeling human drug-taking and cue-reactivity and for therapeutic drug discovery. Cocaine self-administration training consisted of 14 daily 180 min sessions during which rats were trained to lever press for cocaine infusions (0.75 mg/kg per 0.1 mL infusion, iv).<a onclick="showRef(event, 'ref6 ref8 ref9 ref11'); return false;" href="javascript:void(0);" class="ref ref6 ref8 ref9 ref11">(6,8,9,11)</a> Schedule completions on the active lever resulted in delivery of a cocaine infusion paired simultaneously with illumination of the house and stimulus lights and activation of the infusion pump (discrete cue complex paired with cocaine delivery); inactive lever presses produced no scheduled consequences. Following stable acquisition, rats were reintroduced to the self-administration chambers 24 h later and assayed in a cue reactivity test session comprised of two sequential components. The first component (10 min) evaluated whether rats would exhibit differential levels of lever presses when placed in the context in the absence of the discrete cue complex. The second component (60 min) was signaled by a single, nonresponse contingent delivery of the discrete cue complex presented immediately at the termination of the first component.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">We assessed the effects of compound <b>16</b> (1 mg/kg; ip) on cocaine cue reactivity across both components of the test session. A main effect of treatment [(<i>F</i><sub>(1,14)</sub> = 7.28, <i>p</i> = 0.0173], time [(<i>F</i><sub>(13,182)</sub> = 82.07, <i>p</i> < 0.0001], and a treatment × time interaction [(<i>F</i><sub>(13,182)</sub> = 4.58, <i>p</i> < 0.0001] for previously active lever presses was observed. Previously active lever presses reinforced by the discrete cue complex were significantly lower following pretreatment with <b>16</b> vs saline (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>; <i>p</i> < 0.05); compound <b>16</b> did not significantly alter inactive lever presses vs saline (data not shown). These <i>in vivo</i> data provide the first reported <i>in vivo</i> evidence that a putative 5-HT<sub>2C</sub>R PAM suppresses a key facet of relapse vulnerability in CUD.</div><figure id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effects of compound <b>16</b> on cocaine cue reactivity in rats (<i>n</i> = 7/treatment group). Mean (±SEM) previously active lever are presented for the cue reactivity test session following administration for saline or compound <b>16</b>. The first component of the cue reactivity session (initial 10 min) evaluated lever presses in the absence of the discrete cue complex. The second component was signaled by the single delivery of the discrete cue complex (denoted by arrow). Presses on the previously active lever in the 60 min second component were reinforced by the discrete cue complex; inactive lever presses were recorded but produced no scheduled consequences. Rats were injected with saline (1 mL/kg, ip) or compound <b>16</b> (1 mg/kg; ip) 15 min prior to a cocaine cue reactivity test session. Compound <b>16</b> suppressed cue reactivity vs saline (*<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53286" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53286" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A series of structurally simplified analogues have been rationally designed and synthesized based on the 5-HT<sub>2C</sub>R PAM <b>1</b>. The allosteric modulatory SAR of the 5-HT<sub>2C</sub>R was explored using a fluorescence-based, 5-HT-evoked Ca<sub>i</sub><sup>2+</sup> release assay. The stereochemistry of the synthesized compounds was secured by X-ray crystallographic analysis of compounds <b>32</b> and <b>35</b>. Simplification of the PH of <b>1</b> is tolerable or even favorable for potentiation of 5-HT<sub>2C</sub>R-evoked Ca<sub>i</sub><sup>2+</sup> release. None of the compounds exhibited 5-HT<sub>2C</sub>R agonist efficacy when tested alone, and <b>16</b> (CYD-1-79) potentiated 5-HT-evoked Ca<sub>i</sub><sup>2+</sup> release in h5-HT<sub>2C</sub>R-CHO cells with receptor subtype selectivity versus the 5-HT<sub>2A</sub>R. Radioligand binding results suggest that these compounds do not bind to the orthosteric site of the 5-HT<sub>2C</sub>R; a topographically distinct site was identified by our molecular docking analyses. Compound <b>16</b> exhibited a favorable overall pharmacokinetic profile such as decent oral bioavailability and half-life, and a respectable CNS MPO value (4.5 out of 6). Compound <b>16</b> evoked a modulation of 5-HT<sub>2C</sub>R-mediated spontaneous ambulations, partially substituted for the training dose of WAY163909, synergized with a low dose of WAY163909 to substitute fully for the stimulus effects of this selective 5-HT<sub>2C</sub>R agonist, and attenuated cocaine cue reactivity in rats. Our current knowledge of the selectivity and specificity of compound <b>16</b> is driving our future studies to develop drug-like 5-HT<sub>2C</sub>R PAMs with constrained off-target effects.</div><div class="NLM_p last">Our success in the chemical design, synthesis, and pharmacological evaluation of these new molecules opens new doors to a greater understanding of 5-HT<sub>2C</sub>R allosteric modulation and the development of novel pharmacotherapeutics for CUD characterized by deficient 5-HT<sub>2C</sub>R signaling capacity.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2,3)</a> To the best of our knowledge, this report includes the only <i>in vivo</i> investigation of a 5-HT<sub>2C</sub>R PAM in a proof-of-concept study toward the treatment of CUD and is the only study that proposes allosteric binding sites for candidate PAMs on the 5-HT<sub>2C</sub>R. As impaired signaling capacity of the 5-HT<sub>2C</sub>R may contribute to the neurobehavioral processes that underlie chronic health issues such as depression, impulsivity disorders, obesity, and schizophrenia, the full potential for novel molecules with actions as selective 5-HT<sub>2C</sub>R PAMs remains to be elucidated. Continued medicinal chemistry efforts toward structural optimization, in particular at the LT, and <i>in vitro</i> and <i>in vivo</i> cellular evaluations are underway.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41752" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41752" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Chemistry</h3><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General</h4><div class="NLM_p last">All commercially available starting materials and solvents were reagent grade and used without further purification. Reactions were performed under a nitrogen atmosphere in dry glassware with magnetic stirring. Preparative column chromatography was performed using silica gel 60, particle size 0.063–0.200 mm (70–230 mesh, flash). Analytical TLC was carried out employing silica gel 60 F254 plates (Merck, Darmstadt). Visualization of the developed chromatograms was performed with detection by UV (254 nm). NMR spectra were recorded on a Bruker-600 (<sup>1</sup>H, 600 MHz; <sup>13</sup>C, 150 MHz) spectrometer or Bruker-300 (<sup>1</sup>H, 300 MHz; <sup>13</sup>C, 75 MHz). <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded with TMS as an internal reference. Chemical shifts were expressed in ppm, and <i>J</i> values were given in Hz. High-resolution mass spectra (HRMS) were obtained from Thermo Fisher LTQ Orbitrap Elite mass spectrometer. Parameters include the following: Nano ESI spray voltage was 1.8 kV; capillary temperature was 275 °C, and the resolution was 60 000; ionization was achieved by positive mode. Melting points were measured on a Thermo Scientific electrothermal digital melting point apparatus and were uncorrected. Purity of final compounds was determined by analytical HPLC, which was carried out on a Shimadzu HPLC system (model CBM-20A LC-20AD SPD-20A UV/vis). HPLC analysis conditions were as follows: Waters μBondapak C18 (300 mm × 3.9 mm); flow rate 0.5 mL/min; UV detection at 270 and 254 nm; linear gradient from 30% acetonitrile in water (0.1% TFA) to 100% acetonitrile (0.1% TFA) in 20 min followed by 30 min of the last-named solvent. All newly synthesized compounds have been fully characterized with <sup>1</sup>H NMR, <sup>13</sup>C NMR, HRMS, and HPLC analyses to ensure a purity >95% prior to the biological evaluations.</div></div><div id="sec4_1_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (<i>cis</i>-2,4)-4-Undecylpiperidine-2-carboxylic acid (<b>7</b>)</h4><div class="NLM_p last">Compound <b>6</b> (54 mg, 0.14 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (1 mL). TFA (0.25 mL) was added to the solution at rt. The reaction mixture was stirred for 2 h at rt, and the reaction was judged complete by TLC. The reaction mixture was then concentrated under reduced pressure to afford an oily , which was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (15 mL) and a saturated solution of NaHCO<sub>3</sub> (5 mL). The organic layer was treated with anhydrous Na<sub>2</sub>SO<sub>4</sub> (5 mL), filtered, and concentrated under reduced pressure. The crude mixture was loaded on a PTLC plate (hexanes/EtOAc; 5:1) which afforded <b>7</b> (22.5 mg, 40%) as a white solid; mp 185–187 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 9.55 (s, 1H), 8.77 (s, 1H), 3.44 (t, <i>J</i> = 12.4 Hz, 2H), 3.01–2.76 (m, 1H), 2.34 (d, <i>J</i> = 13.2 Hz, 1H), 1.81 (d, <i>J</i> = 11.5 Hz, 1H), 1.64–1.42 (m, 2H), 1.30 (s, 21H), 0.93 (t, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 174.12, 59.64, 43.72, 36.17, 35.05, 33.50, 31.91, 29.68, 29.64, 29.62, 29.34, 28.70, 26.48, 22.68, 14.09. HRMS (ESI) calcd for C<sub>17</sub>H<sub>33</sub>NO<sub>2</sub> [M + H]<sup>+</sup> 284.2584; found 284.2580.</div></div><div id="sec4_1_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> <i>cis</i>-<i>N</i>-(2-Hydroxyethyl)-4-undecylpiperidine-2-carboxamide (<b>8</b>)</h4><div class="NLM_p last">To a solution of <b>6</b> (70 mg, 0.18 mmol) and 2-aminoethanol (11 mg, 0.18 mmol) in 4 mL of DMF was added HBTU (89 mg, 0.23 mmol) and DIPEA (58 mg, 0.45 mmol). The resulting mixture was stirred at room temperature for 16 h. The DMF was removed under vacuum to give a brown oily residue, which was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (50 mL) and 10% citric aqueous solution (10 mL). The organic layer was separated and washed with saturated aqueous NaHCO<sub>3</sub> (10 mL). After drying over anhydrous Na<sub>2</sub>SO<sub>4</sub>, the solvent was removed under vacuum to give an oily residue. This residue was purified with a silica gel column (5% MeOH in CH<sub>2</sub>Cl<sub>2</sub>) and afforded the Boc-protected amide (58 mg, 75%). The amide (58 mg, 0.13 mmol) was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (1 mL), followed by the addition of TFA (250 μL). The resulting mixture was stirred at room temperature. After 2 h, TLC showed that the starting material had disappeared. The solvent was removed under vacuum to give an oily residue. The residue was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and saturated NaHCO<sub>3</sub> aqueous solution (10 mL). The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give an oily residue. This residue was purified with a silica gel column (eluting with 10% MeOH in CH<sub>2</sub>Cl<sub>2</sub>), affording <b>8</b> (34 mg, 73%) as a colorless amorphous gel. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.54 (d, 1H, <i>J</i> = 4.8 Hz), 4.11 (br s, 2H), 3.71 (s, 2H), 3.46 (d, 2H, <i>J</i> = 10.2 Hz), 3.32 (m, 1H), 3.24 (d, 1H, <i>J</i> = 12.0 Hz), 2.78 (t, 1H, <i>J</i> = 11.4 Hz), 2.09 (d, 1H, <i>J</i> = 12.6 Hz), 1.73 (d, 1H, <i>J</i> = 13.2 Hz), 1.48 (br s, 1H), 1.25 (m, 22H), 0.88 (t, 3H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 173.5, 61.2, 60.0, 45.1, 42.2, 36.8, 36.0, 35.3, 31.9, 31.4, 29.8, 29.7, 29.6, 29.4 (4C), 26.4, 22.7, 14.1. HRMS Calcd for C<sub>19</sub>H<sub>38</sub>N<sub>2</sub>O<sub>2</sub>: [M + H]<sup>+</sup> 327.3006; found 327.3010.</div></div><div id="sec4_1_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> <i>cis</i>-<i>N</i>-(1,3-Dihydroxypropan-2-yl)-4-undecylpiperidine-2-carboxamide (<b>9</b>)</h4><div class="NLM_p last">Compound <b>9</b> (50 mg) was prepared in 76% yield (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. The title compound was obtained as a colorless amorphous gel. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 3.89 (t, 1H, <i>J</i> = 4.2 Hz), 3.66 (m, 4H), 3.15 (m, 1H), 2.62 (m, 1H), 1.99 (d, 1H, <i>J</i> = 12.0 Hz), 1.71 (d, 1H, <i>J</i> = 12.6 Hz), 1.43 (m, 1H), 1.26 (m, 20H), 1.02 (m, 2H), 0.88 (t, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 174.5, 60.9, 60.1, 52.1, 45.1, 36.7, 36.4, 35.6, 32.1, 31.5 (2C), 29.4, 29.3 (3C), 29.0 (2C), 26.0, 22.3, 13.5. HRMS Calcd for C<sub>20</sub>H<sub>40</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 357.3112; found 357.3119.</div></div><div id="sec4_1_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> <i>cis-N</i>-((2<i>S</i>,3<i>S</i>)-1,3-Dihydroxybutan-2-yl)-4-undecylpiperidine-2-carboxamide (<b>10</b>)</h4><div class="NLM_p last">Compound <b>10</b> (48 mg) was prepared in 71% yield (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. The title compound was obtained as a colorless amorphous gel. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.59 (m, 1H), 4.78 (br s, 3H), 4.06 (m, 1H), 3.74 (m, 3H), 3.5 (m, 1H), 3.22 (m, 1H), 2.73 (q, 1H, <i>J</i> = 13.8 Hz), 2.06 (m, 1H), 1.74 (t, 1H, <i>J</i> = 13.8 Hz), 1.47 (m, 1H), 1.25 (m, 19H), 1.15 (m, 5H), 0.87 (t, 3H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 173.7, 172.9, 67.6, 67.4, 63.4, 60.4, 59.7, 55.5, 45.3, 44.8, 36.8, 36.2, 36.0, 35.6, 35.2, 31.9, 31.3, 30.9, 29.8, 29.6, 29.4, 26.5, 26.4, 22.7, 20.4, 14.1. HRMS Calcd for C<sub>21</sub>H<sub>42</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 371.3274; found 371.3270.</div></div><div id="sec4_1_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> <i>cis-N</i>-((2<i>R</i>,3<i>R</i>)-1,3-Dihydroxybutan-2-yl)-4-undecylpiperidine-2-carboxamide (<b>11</b>)</h4><div class="NLM_p last">Compound <b>11</b> (52 mg) was prepared in 77% yield (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. The title compound was obtained as a colorless amorphous gel. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.27 (m, 1H), 4.10 (m, 1H), 3.77 (m, 6H), 3.31 (dd, 1H, <i>J</i> = 2.4 Hz, 12.0 Hz), 3.25 (dd, 1H, <i>J</i> = 2.4 Hz, 11.4 Hz), 3.15 (m, 1H), 2.65 (t, 1H, <i>J</i> = 12.6 Hz), 2.05 (m, 1H), 1.68 (m, 1H), 1.43 (m, 1H), 1.25 (m, 19H), 1.17 (m, 3H), 1.08 (m, 2H), 0.88 (t, 3H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 174.8, 174.2, 67.8, 67.7, 63.7, 61.0, 60.4, 54.9, 45.7, 45.3, 37.0, 36.9, 36.0, 35.7, 32.2, 31.9, 29.9, 29.7, 29.4, 26.5, 26.4, 22.7, 20.5, 20.4, 14.1. HRMS Calcd for C<sub>21</sub>H<sub>42</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 371.3274; found 371.3258.</div></div><div id="sec4_1_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (2<i>R</i>,4<i>S</i>)-<i>N</i>-((1<i>S</i>,2<i>S</i>)-1,3-Dihydroxy-1-phenylpropan-2-yl)-4-undecylpiperidine-2-carboxamide ((2<i>R</i>,4<i>S</i>)-<b>12</b>) and (2<i>S</i>,4<i>R</i>)-<i>N</i>-((1<i>S</i>,2<i>S</i>)-1,3-Dihydroxy-1-phenylpropan-2-yl)-4-undecylpiperidine-2-carboxamide ((2<i>S</i>,4<i>R</i>)-<b>13</b>)</h4><div class="NLM_p last">Compounds (2<i>R</i>,4<i>S</i>)-<b>12</b> (14 mg, 35%) and (2<i>S</i>,4<i>R</i>)-<b>13</b> (15 mg, 35%) were prepared (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. These two isomers could be separated by preparative TLC as colorless amorphous gels. (2<i>R</i>,4<i>S</i>)-<b>12</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 7.37 (m, 2H), 7.32 (t, 2H, <i>J</i> = 7.2 Hz), 7.24 (t, 1H, <i>J</i> = 6.6 Hz), 4.98 (m, 1H), 4.03 (d, 1H, <i>J</i> = 4.2 Hz), 3.69 (m, 1H), 3.62 (m, 1H), 3.10 (d, 2H, <i>J</i> = 11.4 Hz), 2.60 (t, 1H, <i>J</i> = 12.0 Hz), 1.78 (d, 1H, <i>J</i> = 12.6 Hz), 1.67 (d, 1H, <i>J</i> = 12.6 Hz), 1.33 (m, 1H), 1.26 (m, 20H), 1.18 (m, 1H), 1.01 (m, 1H), 0.88 (t, 3H, <i>J</i> = 6.6 Hz), 0.75 (t, 1H, <i>J</i> = 12.6 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 174.7, 141.2, 128.0 (2C), 127.3, 125.8 (2C), 72.3, 62.1, 60.2, 56.2, 45.2, 36.7, 36.1, 35.5, 31.9, 31.7, 29.6, 29.5 (2C), 29.4 (2C), 29.1, 26.1, 22.5, 13.8. HRMS Calcd for C<sub>26</sub>H<sub>44</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 433.3425; found 433.3415. (2<i>S</i>,4<i>R</i>)-<b>13</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.41 (m, 1H), 7.38 (m, 1H), 7.31 (t, 2H, <i>J</i> = 7.2 Hz), 7.25 (m, 1H), 5.06 (s, 1H), 4.08 (m, 1H), 3.80 (m, 4H), 3.22 (d, 1H, <i>J</i> = 10.8), 3.03 (d, 1H, <i>J</i> = 12.0 Hz), 2.54 (t, 1H, <i>J</i> = 12.0 Hz), 1.77 (d, 1H, <i>J</i> = 12.0 Hz), 1.61 (d, 1H, <i>J</i> = 12.6 Hz), 1.27 (m, 20H), 1.13 (m, 2H), 0.95 (m, 1H), 0.88 (t, 3H, <i>J</i> = 6.6 Hz), 0.81 (m, 1H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 173.6, 141.4, 128.2 (2C), 127.4, 125.8 (2C), 73.3, 63.2, 60.0, 56.4, 44.9, 36.7, 36.2, 35.2, 31.8, 31.6, 29.7, 29.6 (3C), 29.3 (2C), 26.2, 22.6, 14.0. HRMS Calcd for C<sub>26</sub>H<sub>44</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 433.3425; found 433.3427.</div></div><div id="sec4_1_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (2<i>S</i>,4<i>R</i>)-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1,3-Dihydroxy-1-phenylpropan-2-yl)-4-undecylpiperidine-2-carboxamide ((2<i>S</i>,4<i>R</i>)-<b>14</b>) and (2<i>R</i>,4<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1,3-Dihydroxy-1-phenylpropan-2-yl)-4-undecylpiperidine-2-carboxamide ((2<i>R</i>,4<i>S</i>)-<b>15</b>)</h4><div class="NLM_p last">Compounds (2<i>S</i>,4<i>R</i>)-<b>14</b> (35 mg, 43%) and (2<i>R</i>,4<i>S</i>)-<b>15</b> (37 mg, 45%) were prepared (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. These two isomers could be separated by preparative TLC as colorless amorphous gels. (2<i>S</i>,4<i>R</i>)-<b>14</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 7.67 (br s, 1H), 7.40 (d, 2H, <i>J</i> = 7.8 Hz), 7.31 (t, 2H, <i>J</i> = 7.8 Hz), 1.24 (t, 1H, <i>J</i> = 7.8 Hz), 4.94 (d, 1H, <i>J</i> = 4.8 Hz), 4.10 (m, 1H), 3.67 (dd, 1H, <i>J</i> = 6.0 Hz, 11.4 Hz), 3.52 (dd, 1H, <i>J</i> = 6.0 Hz, 11.4 Hz), 3.17 (d, 1H, <i>J</i> = 12.6 Hz), 2.71 (m, 1H), 1.93 (d, 1H, <i>J</i> = 13.2 Hz), 1.75 (d, 1H, <i>J</i> = 13.8 Hz), 1.46 (br s, 1H), 1.28 (s, 20H), 1.14 (m, 1H), 0.97 (q, 1H, <i>J</i> = 12.6 Hz), 0.89 (t, 3H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 172.9, 141.8, 128.0 (2C), 127.3, 126.0 (2C), 71.7, 61.4, 59.5, 56.7, 44.5, 36.5, 35.5, 35.1, 31.7, 30.6, 29.6 (4C), 29.4, 29.1, 26.1, 22.4, 13.5. HRMS Calcd for C<sub>26</sub>H<sub>44</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 433.3425; found 433.3427. (2<i>R</i>,4<i>S</i>)-<b>15</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.40 (d, 1H, <i>J</i> = 8.4 Hz), 7.35 (d, 2H, <i>J</i> = 7.2 Hz), 7.28 (m, 2H), 7.21 (t, 1H, <i>J</i> = 7.8 Hz), 5.02 (d, 1H, <i>J</i> = 3.0 Hz), 4.52 (br s, 2H), 4.08 (m, 1H), 3.77 (m, 1H), 3.71 (m, 1H), 3.13 (dd, 1H, <i>J</i> = 1.8 Hz, 12.0 Hz), 2.94 (d, 1H, <i>J</i> = 11.4 Hz), 2.43 (m, 1H), 1.71 (d, 1H, <i>J</i> = 12.6 Hz), 1.56 (d, 1H, <i>J</i> = 12.0 Hz), 1.26 (m, 20H), 0.99 (m, 2H), 0.88 (t, 3H, <i>J</i> = 7.2 Hz), 0.73 (q, 1H, <i>J</i> = 12.0 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 173.8, 141.7, 128.2 (2C), 127.4, 125.9 (2C), 72.9, 63.0, 60.0, 56.3, 44.9, 36.8, 36.4, 35.4, 31.9, 31.8, 29.8, 29.7 (4C), 29.4, 26.3, 22.7, 14.1. HRMS Calcd for C<sub>26</sub>H<sub>44</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 433.3425; found 433.3427.</div></div><div id="sec4_1_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>cis</i>-4-Undecyl-piperidine-2-carboxylic Acid (2,3-Dihydroxypropyl)amide (<b>16</b>)</h4><div class="NLM_p last">Compound <b>16</b> (45 mg) was prepared in 68% yield (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. The title compound was obtained as a colorless amorphous gel. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.49 (m, 1H), 3.82 (m, 4H), 3.50 (m, 3H), 3.36 (m, 1H), 3.29 (d, 1H, <i>J</i> = 10.5 Hz), 3.15 (m, 1H), 2.66 (t, 1H, <i>J</i> = 11.1 Hz), 2.03 (m, 1H), 1.69 (d, 1H, <i>J</i> = 12.9 Hz), 1.42 (m, 1H), 1.25 (br s, 20 H), 1.02 (m, 2H), 0.88 (t, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 175.2, 70.9 (2C), 63.8, 63.7, 60.4, 45.6, 42.0, 37.0, 36.7, 35.8, 32.2, 31.9, 29.8, 29.7, 29.4, 26.5, 22.7, 14.1. HRMS Calcd for C<sub>20</sub>H<sub>40</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 357.3112; found 357.3116.</div></div><div id="sec4_1_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>cis</i>-<i>N</i>-((<i>R</i>)-2,3-Dihydroxypropyl)-4-undecylpiperidine-2-carboxamide (<b>17</b>)</h4><div class="NLM_p last">Compound <b>17</b> (54 mg) was prepared in 80% yield (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. The title compound was obtained as a colorless amorphous gel. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.54 (m, 1H), 3.99 (br s, 3H), 3.77 (d, 1H, <i>J</i> = 2.1 Hz), 3.56 (m, 1H), 3.50 (m, 1H), 3.35 (s, 1H), 3.33 (m, 1H), 3.29 (d, 1H, <i>J</i> = 5.4 Hz), 3.15 (d, 1H, <i>J</i> = 5.4 Hz), 2.66 (t, 1H, <i>J</i> = 6.0 Hz), 2.02 (d, 1H, <i>J</i> = 5.7 Hz), 1.69 (d, 1H, <i>J</i> = 6.3 Hz), 1.43 (br s, 1H), 1.25 (br s, 20 H), 1.04 (m, 2H), 0.88 (t, 3H, <i>J</i> = 3.6 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 175.0, 70.8, 63.8 (2C), 60.4, 45.5, 42.0, 37.0, 36.7, 35.7, 32.1, 31.9, 29.9, 29.7, 29.4, 26.5, 22.7, 14.1. HRMS Calcd for C<sub>20</sub>H<sub>40</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 357.3112; found 357.3113.</div></div><div id="sec4_1_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>cis</i>-<i>N</i>-((<i>S</i>)-2,3-Dihydroxypropyl)-4-undecylpiperidine-2-carboxamide (<b>18</b>)</h4><div class="NLM_p last">Compound <b>18</b> (44 mg) was prepared in 67% yield (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. The title compound was obtained as a colorless amorphous gel. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.34 (m, 1H), 5.77 (br s, 3H), 3.82 (s, 2H), 3.52 (m, 4H), 3.20 (dd, 1H, <i>J</i> = 3.0 Hz), 2.89 (m, 1H), 2.12 (d, 1H, <i>J</i> = 4.5 Hz), 1.79 (d, 1H, <i>J</i> = 5.1 Hz), 1.57 (br s, 1H), 1.36 (m, 1H), 1.25 (br s, 22H), 0.88 (t, 3H, <i>J</i> = 3.6 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 171.6, 70.8, 70.6, 63.7, 59.1, 44.6, 42.3, 36.5, 34.7, 32.0, 29.9, 29.7, 29.4, 26.5, 22.7, 14.1. HRMS Calcd for C<sub>20</sub>H<sub>40</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 357.3112; found 357.3115.</div></div><div id="sec4_1_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>cis</i>-<i>N</i>-((<i>S</i>)-3-Chloro-2-hydroxypropyl)-4-undecylpiperidine-2-carboxamide (<b>19</b>)</h4><div class="NLM_p last">Compound <b>19</b> (43 mg) was prepared in 63% yield (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. The title compound was obtained as a colorless amorphous gel. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.38 (br s, 1H), 3.89 (br s, 3H), 3.53 (m, 3H), 3.36 (m, 2H), 3.16 (m, 1H), 2.69 (t, 1H, <i>J</i> = 11.4 Hz), 2.07 (m, 1H), 1.70 (m, 1H), 1.43 (m, 1H), 1.26 (br s, 20H), 1.06 (m, 2H), 0.88 (t, 3H, <i>J</i> = 6.6 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 175.2, 70.7, 70.5, 60.4, 46.4 (2C), 45.6, 45.5, 43.0, 42.9, 36.9, 36.6, 35.7, 35.6, 32.0, 31.9, 29.8, 29.7, 29.6, 29.4, 26.4, 22.7, 14.1. HRMS Calcd for C<sub>20</sub>H<sub>39</sub>ClN<sub>2</sub>O<sub>2</sub>: [M + H]<sup>+</sup> 375.2773; found 375.2776.</div></div><div id="sec4_1_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> <i>cis</i>-<i>N</i>-(3-Morpholinopropyl)-4-undecylpiperidine-2-carboxamide (<b>20</b>)</h4><div class="NLM_p last">Compound <b>20</b> (55 mg) was prepared in 74% yield (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. The title compound was obtained as a colorless amorphous gel. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 4.05 (d, 2H, <i>J</i> = 12.6 Hz), 3.79 (m, 3H), 3.48 (d, 2H, <i>J</i> = 10.8 Hz), 3.37 (m, 2H), 3.22 (m, 5H), 2.98 (m, 1H), 2.21 (d, 1H, <i>J</i> = 13.2 Hz), 1.94 (m, 3H), 1.66 (br s, 1H), 1.25 (m, 22H), 0.84 (t, 3H, <i>J</i> = 7.2 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 169.2, 63.8, 58.0, 54.8, 52.1, 51.9, 43.6, 36.2, 36.1, 35.8, 33.9, 33.4, 31.7, 29.5 (2C), 29.4 (2C), 29.2, 28.0, 26.2, 23.7, 22.4, 13.2. HRMS Calcd for C<sub>24</sub>H<sub>47</sub>N<sub>3</sub>O<sub>2</sub>: [M + H]<sup>+</sup> 396.3585; found 396.3588.</div></div><div id="sec4_1_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Methyl((<i>cis</i>-2,4)-4-undecylpiperidine-2-carbonyl)-<span class="smallcaps smallerCapital">l</span>-allothreoninate (<b>21</b>)</h4><div class="NLM_p last">Compound <b>21</b> (14 mg) was prepared as a whitish wax in 87.5% yield (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.43 (t, <i>J</i> = 9.8 Hz, 1H), 4.58 (td, <i>J</i> = 9.1, 2.6 Hz, 1H), 4.44–4.30 (m, 1H), 3.78 (d, <i>J</i> = 1.1 Hz, 3H), 3.30 (dd, <i>J</i> = 11.6, 2.7 Hz, 1H), 3.22–3.11 (m, 1H), 2.68 (tt, <i>J</i> = 11.6, 2.6 Hz, 1H), 2.45 (s, 3H), 2.11 (d, <i>J</i> = 13.4 Hz, 1H), 1.70 (d, <i>J</i> = 12.9 Hz, 1H), 1.52–1.37 (m, 1H), 1.27 (s, 22H), 1.11–0.98 (m, 2H), 0.89 (t, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 174.76, 171.48, 67.99, 67.80, 60.91, 60.71, 57.07, 56.89, 52.54, 45.86, 45.70, 36.98, 36.64, 35.95, 32.52, 32.34, 31.92, 29.81, 29.68, 29.64, 29.35, 26.45, 22.69, 20.05, 14.12. HRMS (ESI) calcd for C<sub>22</sub>H<sub>42</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 399.3217; found 399.3208.</div></div><div id="sec4_1_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Methyl((<i>cis</i>-2,4)-4-undecylpiperidine-2-carbonyl)-<span class="smallcaps smallerCapital">l</span>-serinate (<b>22</b>)</h4><div class="NLM_p last">Compound <b>22</b> (16 mg) was prepared as a whitish wax in 89.0% yield (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.51 (dd, <i>J</i> = 20.8, 7.7 Hz, 1H), 4.70–4.58 (m, 1H), 4.07–3.83 (m, 2H), 3.79 (s, 3H), 3.25 (d, <i>J</i> = 11.5 Hz, 1H), 3.15 (d, <i>J</i> = 12.1 Hz, 1H), 2.83 (s, 2H), 2.66 (t, <i>J</i> = 12.2 Hz, 1H), 2.07 (t, <i>J</i> = 10.4 Hz, 1H), 1.69 (d, <i>J</i> = 13.0 Hz, 1H), 1.41 (s, 1H), 1.27 (s, 20H), 1.14–0.94 (m, 2H), 0.89 (t, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 174.61, 174.21, 170.98, 170.92, 62.86, 60.64, 54.48, 54.45, 52.67, 45.88, 45.65, 37.03, 36.99, 36.77, 36.54, 35.99, 35.85, 32.57, 32.51, 31.92, 29.81, 29.68, 29.64, 29.35, 26.45, 26.40, 22.69, 14.12. HRMS (ESI) calcd for C<sub>21</sub>H<sub>45</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup> 385.3061; found 385.3058.</div></div><div id="sec4_1_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Methyl((<i>cis</i>-2,4)-4-undecylpiperidine-2-carbonyl)-<span class="smallcaps smallerCapital">l</span>-tyrosinate (<b>23</b>)</h4><div class="NLM_p last">Compound <b>23</b> (32 mg) was prepared as a white solid in 86.0% yield (2 steps) by a procedure similar to that used to prepare compound <b>8</b>; mp 129.0–129.6 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.07 (dd, <i>J</i> = 36.9, 8.4 Hz, 1H), 6.95 (dd, <i>J</i> = 8.4, 3.6 Hz, 2H), 6.67 (dd, <i>J</i> = 13.6, 8.5 Hz, 2H), 4.91–4.75 (m, 1H), 3.74 (d, <i>J</i> = 1.8 Hz, 3H), 3.24–3.03 (m, 3H), 2.95 (td, <i>J</i> = 14.2, 7.0 Hz, 1H), 2.61 (ddd, <i>J</i> = 12.1, 9.8, 5.6 Hz, 1H), 1.99 (t, <i>J</i> = 14.3 Hz, 1H), 1.74–1.55 (m, 1H), 1.27 (s, 22H), 1.10–0.93 (m, 3H), 0.89 (t, <i>J</i> = 6.7 Hz, 3H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 174.38, 173.99, 172.24, 172.20, 155.80, 130.34, 130.17, 126.93, 126.70, 115.66, 115.61, 60.52, 60.39, 53.01, 52.94, 52.40, 45.79, 45.46, 37.22, 36.95, 36.91, 36.65, 35.90, 35.75, 32.37, 32.29, 31.92, 29.81, 29.68, 29.66, 29.36, 26.43, 26.37, 22.69, 14.13. HRMS (ESI) calcd for C<sub>27</sub>H<sub>44</sub>N<sub>2</sub>O<sub>4</sub> [M + H]<sup>+</sup> 461.3374; found 461.3362.</div></div><div id="sec4_1_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Methyl((<i>cis</i>-2,4)-4-undecylpiperidine-2-carbonyl)-<span class="smallcaps smallerCapital">l</span>-tryptophanate (<b>24</b>)</h4><div class="NLM_p last">Compound <b>21</b> (43 mg) was prepared as a white solid in 83% yield (2 steps) by a procedure similar to that used to prepare compound <b>8</b>; mp 112.6–113.8 °C. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.56 (d, <i>J</i> = 13.5 Hz, 1H), 7.56 (dd, <i>J</i> = 7.6, 3.3 Hz, 1H), 7.35 (d, <i>J</i> = 7.9 Hz, 1H), 7.15 (ddd, <i>J</i> = 14.8, 10.9, 6.9 Hz, 3H), 6.97 (s, 1H), 4.96 (td, <i>J</i> = 10.1, 5.7 Hz, 1H), 3.71 (d, <i>J</i> = 5.6 Hz, 3H), 3.43–3.23 (m, 2H), 3.12 (dt, <i>J</i> = 11.5, 3.1 Hz, 1H), 3.05–2.92 (m, 1H), 2.62–2.46 (m, 1H), 2.08–1.93 (m, 1H), 1.59 (d, <i>J</i> = 11.0 Hz, 2H), 1.29 (s, 20H), 1.21–1.11 (m, 2H), 1.06–0.82 (m, 4H). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>) δ 174.22, 174.10, 172.49, 172.42, 136.15, 136.12, 127.73, 127.70, 122.81, 122.72, 122.11, 119.47, 119.39, 118.69, 118.47, 111.42, 111.32, 110.12, 110.03, 60.66, 60.61, 52.61, 52.52, 52.34, 45.77, 37.05, 36.97, 36.74, 36.71, 36.01, 35.94, 32.65, 32.46, 31.94, 29.85, 29.82, 29.66, 29.37, 27.71, 27.57, 26.44, 22.71, 14.14. HRMS (ESI) calcd for C<sub>29</sub>H<sub>45</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup> 484.3534; found 484.3517.</div></div><div id="sec4_1_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> (2<i>R</i>,4<i>S</i>)-4-(2-Cyclohexylethyl)-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1,3-dihydroxy-1-phenylpropan-2-yl)piperidine-2-carboxamide ((2<i>R</i>,4<i>S</i>)-<b>35</b>) and (2<i>S</i>,4<i>R</i>)-4-(2-Cyclohexylethyl)-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1,3-dihydroxy-1-phenylpropan-2-yl)piperidine-2-carboxamide ((2<i>S</i>,4<i>R</i>)-<b>34</b>)</h4><div class="NLM_p last">Compounds (2<i>R</i>,4<i>S</i>)-<b>35</b> (53 mg, 44%) and (2<i>S</i>,4<i>R</i>)-<b>34</b> (50 mg, 42%) were prepared from <b>33</b> in 2 steps by a procedure similar to that used to prepare compound <b>8</b>. These two isomers could be separated by preparative TLC as colorless amorphous gels. Compound <b>35</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.77 (d, 1H, <i>J</i> = 6.0 Hz), 7.32 (d, 2H, <i>J</i> = 7.2 Hz), 7.26 (m, 2H), 7.19 (t, 1H, <i>J</i> = 7.2 Hz), 5.50 (br s, 2H), 4.97 (d, 1H), 4.12 (d, 1H, <i>J</i> = 3.0 Hz), 3.74 (m, 2H), 3.39 (d, 1H, <i>J</i> = 11.4 Hz), 3.03 (d, 1H, <i>J</i> = 9.0 Hz), 2.50 (m, 1H), 1.69 (m, 6H), 1.58 (d, 1H, <i>J</i> = 9.6 Hz), 1.19 (m, 10H), 0.97 (m, 1H), 0.86 (m, 2H), 0.74 (q, 1H, <i>J</i> = 12.0 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 172.3, 141.5, 128.1 (2C), 127.3, 125.8 (2C), 72.6, 62.7, 59.2, 56.5, 44.3, 37.8, 35.2, 34.9, 34.0, 33.7, 33.4 (2C), 30.3, 26.7, 26.4 (2C). HRMS Calcd for C<sub>23</sub>H<sub>36</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 389.2799; found 389.2802. Compound <b>34</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub> + CD<sub>3</sub>OD) δ 7.69 (br s, 1H), 7.39 (d, 2H, <i>J</i> = 7.8 Hz), 7.31 (t, 2H, <i>J</i> = 7.8 Hz), 7.23 (t, 1H, <i>J</i> = 7.8 Hz), 4.97 (d, 1H, <i>J</i> = 4.2 Hz), 4.09 (m, 1H), 3.70 (m, 1H), 3.5 (m, 1H), 3.15 (dd, 1H, <i>J</i> = 2.4 Hz, 12.0 Hz), 3.11 (d, 1H, <i>J</i> = 12.0 Hz), 2.63 (m, 1H), 1.80 (m, 1H), 1.69 (m, 7H), 1.20 (m, 10H), 0.89 (m, 1H), 0.82 (q, 1H, <i>J</i> = 12.6 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 174.5, 141.9, 127.9 (2C), 127.2, 125.9 (2C), 71.5, 61.5, 60.1, 56.2, 45.0, 37.7, 36.3, 35.8, 33.9, 33.2 (2C), 31.7, 29.3, 26.5, 26.2 (2C). HRMS Calcd for C<sub>23</sub>H<sub>36</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 389.2799; found 389.2802.</div></div><div id="sec4_1_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (2<i>S</i>,4<i>S</i>)-<i>N</i>-((1<i>S</i>,2<i>S</i>)-1,3-Dihydroxy-1-phenylpropan-2-yl)-4-(2-(4-methylcyclohexyl)ethyl)piperidine-2-carboxamide ((2<i>R</i>,4<i>S</i>)-<b>36</b>) and (2<i>S</i>,4<i>R</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1,3-Dihydroxy-1-phenylpropan-2-yl)-4-(2-(4-methylcyclohexyl)ethyl)piperidine-2-carboxamide ((2<i>S</i>,4<i>R</i>)-<b>37</b>)</h4><div class="NLM_p last">Compounds (2<i>R</i>,4<i>S</i>)-<b>36</b> (40 mg, 41%) and (2<i>S</i>,4<i>R</i>)-<b>37</b> (42 mg, 43%) were prepared from <b>33</b> in 2 steps by a procedure similar to that used to prepare compound <b>8</b>. These two isomers could be separated by preparative TLC as colorless amorphous gels. Compound <b>36</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.32 (m, 5H), 4.99 (d, 1H, <i>J</i> = 7.2 Hz), 4.08 (m, 1H), 3.70 (m, 1H), 3.62 (m, 1H), 3.34 (m, 1H), 3.09 (m, 2H), 2.61 (m, 1H), 1.46 (m, 4H), 1.27 (m, 13H), 0.89 (m, 3H), 0.76 (q, 1H, <i>J</i> = 12.6 Hz). <sup>13</sup>C NMR (75 MHz, CDCl<sub>3</sub>): δ 175.6, 142.2, 128.5, 127.8, 126.4, 72.4, 62.4, 60.9, 56.9, 45.8, 38.0, 37.0, 36.5, 35.7, 35.1, 34.7, 33.8, 33.7, 33.3, 32.7, 31.1 (2C), 30.7, 29.2, 29.1, 22.8, 20.4. HRMS Calcd for C<sub>24</sub>H<sub>38</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 403.2955; found 403.2955. Compound <b>37</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.31 (m, 5H), 7.22 (t, 1H, <i>J</i> = 7.2 Hz), 5.03 (d, 1H, <i>J</i> = 3.6 Hz), 4.08 (m, 1H), 3.93 (br s, 3H), 3.78 (m, 1H), 3.72 (m, 1H), 3.13 (dd, 1H, <i>J</i> = 2.4 Hz, 12.0 Hz), 2.99 (d, 1H, <i>J</i> = 10.8 Hz), 2.48 (m, 1H), 1.74 (m, 1H), 1.67 (m, 1H), 1.60 (m, 2H), 1.44 (m, 3H), 1.20 (m, 10H), 0.91 (d, 3H, <i>J</i> = 6.6 Hz), 0.87 (m, 2H), 0.78 (q, 1H, <i>J</i> = 12.6 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 174.0, 141.6, 128.2, 127.4, 125.9, 73.1, 63.1, 60.2, 56.4, 50.5, 45.1, 37.5, 36.4, 35.7, 35.3, 34.6, 34.2, 34.0, 33.3, 32.9, 32.0, 30.8, 30.1, 28.7, 22.6, 20.2. HRMS Calcd for C<sub>24</sub>H<sub>38</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 403.2955; found 403.2953.</div></div><div id="sec4_1_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> (2<i>S</i>,4<i>R</i>)-4-Cyclohexyl-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1,3-dihydroxy-1-phenylpropan-2-yl)piperidine-2-carboxamide (<b>38</b>) and (2<i>R</i>,4<i>S</i>)-4-Cyclohexyl-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1,3-dihydroxy-1-phenylpropan-2-yl)piperidine-2-carboxamide (<b>39</b>)</h4><div class="NLM_p last">Compounds <b>38</b> (70 mg, 40%) and <b>39</b> (74 mg, 43%) were prepared from <b>33</b> (2 steps) by a procedure similar to that used to prepare compound <b>8</b>. These two isomers could be separated by preparative TLC as colorless amorphous gel. Compound <b>38</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.48 (d, 1H, <i>J</i> = 8.4 Hz), 7.38 (d, 2H, <i>J</i> = 7.2 Hz), 7.28 (m, 2H), 7.22 (t, 1H, <i>J</i> = 7.8 Hz), 4.98 (d, 1H, <i>J</i> = 4.8 Hz), 4.30 (br s, 3H), 4.08 (m, 1H), 3.70 (m, 1H), 3.62 (m, 1H), 3.11 (dd, 1H, <i>J</i> = 2.4 Hz, 12.0 Hz), 2.97 (m, 1H), 2.46 (m, 1H), 1.72 (m, 2H), 1.59 (m, 4H), 1.13 (m, 5H), 0.99 (m, 2H), 0.84 (m, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 174.5, 141.7, 128.2 (2C), 127.4, 126.2 (2C), 72.9, 62.7, 61.0, 56.6, 45.5, 42.7, 41.0, 33.3, 29.8, 28.6 (2C), 26.6, 26.5 (2C). HRMS Calcd for C<sub>21</sub>H<sub>32</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 361.2486; found 361.2488. Compound <b>39</b>. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>+CD<sub>3</sub>OD) δ 7.48 (s, 1H), 7.37 (d, 2H, <i>J</i> = 7.2 Hz), 7.30 (m, 2H), 7.23 (t, 1H, <i>J</i> = 7.2 Hz), 4.99 (d, 1H, <i>J</i> = 3.6 Hz), 4.10 (m, 1H), 3.72 (m, 1H), 3.62 (m, 1H), 3.13 (m, 2H), 2.58 (dt, 1H, <i>J</i> = 3.0 Hz, 12.6 Hz), 1.75 (m, 3H), 1.66 (m, 4H), 1.15 (m, 6H), 0.93 (m, 2H), 0.87 (q, 1H, <i>J</i> = 12.0 Hz). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>): δ 173.9, 141.7, 128.0 (2C), 127.2, 125.8 (2C), 71.9, 62.0, 60.0, 56.3, 45.1, 42.7, 41.0, 33.5, 29.8, 29.7, 28.7, 26.5, 26.4 (2C). HRMS Calcd for C<sub>21</sub>H<sub>32</sub>N<sub>2</sub>O<sub>3</sub>: [M + H]<sup>+</sup> 361.2486; found 361.2487.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>In Vitro</i> Pharmacology</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Intracellular Calcium (Ca<sub>i</sub><sup>2+</sup>) Release Assay in Live h5-HT<sub>2</sub>R-CHO Cells</h4><div class="NLM_p last">Chinese hamster ovary (CHO) cells stably transfected with human unedited (INI) h5-HT<sub>2C</sub>R (h5-HT<sub>2C</sub>R-CHO cells) or the human 5-HT<sub>2A</sub>R (h5-HT<sub>2A</sub>R-CHO cells) were a generous gift of Drs. Kelly A. Berg and William P. Clarke (University of Texas Health Science Center, San Antonio). Cells were grown at 37 °C, 5% CO<sub>2</sub>, and 85% relative humidity environment in GlutaMax-MEM medium (Invitrogen, Carlsbad CA) containing 5% fetal bovine serum (Atlanta Biologicals, Atlanta GA) and 100 μg/mL hygromycin (Mediatech, Manassas VA) and were passaged when they reached 80% confluence. The Ca<sub>i</sub><sup>2+</sup> release assay was performed according to our recent publications.<a onclick="showRef(event, 'ref9 ref29 ref71'); return false;" href="javascript:void(0);" class="ref ref9 ref29 ref71">(9,28,70)</a> Briefly, cells (150 μL; passages 6–16) were plated in serum-replete medium at a density of 14 000–16 000 (FlexStation 3; Molecular Devices) or 30 000 cells/well (FLIPR<sup>TETRA</sup>; Molecular Devices) in black-wall 96-well culture plates with optically clear flat bottoms. To ensure even plating of cells, the source reservoir was frequently agitated or triturated, and plates were maintained on a rotary shaker at low speed for 20 min after plating and returned to the incubator overnight. Approximately 24 h following plating, the medium was replaced with serum-free (SF) GlutaMax-MEM medium supplemented with 20 nM to 100 μM putrescine (Sigma-Aldrich, St. Louis, MO), 20 nM to 100 μM progesterone (Sigma-Aldrich), and 1:100 ITS (1000 mg/L human recombinant insulin, 550 mg/L human recombinant transferrin, 0.67 mg/L selenious acid; Corning Inc., Corning, NY) (SF+ medium). Following a 3 h incubation, SF+ medium was replaced with 40 μL of Hank’s balanced saline solution (HBSS; without CaCl<sub>2</sub> or MgCl<sub>2</sub>, pH 7.4) plus 40 μL of Calcium 4 dye solution (FLIPR No-wash kit, Molecular Devices, Sunnyvale, CA, part no. R8142) supplemented with 2.5 mM of water-soluble probenicid (Sigma) to inhibit extracellular transport of the dye. Plates were incubated for 60 min at 37 °C followed by 15 min at room temperature in the dark. Drug dilutions were prepared at 5× final concentration in 1× HBSS; delivery of compound (20 μL/well) was followed 15 min later by 5-HT (10 pM to 10 μM; 25 μL/well). A baseline was established for each well before addition of the test compound and again before addition of 5-HT. The fluorescence read after compound addition was used to establish potential intrinsic agonist activity of the compounds. The fluorescence read following the addition of 5-HT was used to assess allosteric modulation of 5-HT-evoked Ca<sub>i</sub><sup>2+</sup> release. Fluorescence was measured using a FlexStation 3 (Molecular Devices) or FLIPR<sup>TETRA</sup> (130 gain, 60% intensity, 0.3 s exposure). For the FlexStation 3, a 17 s baseline was established before addition of compounds following which fluorescence was recorded every 1.7 s for 240 s. Maximum peak height was determined by the SoftMax software (Pro 5.4.5) for each well. For the FLIPR<sup>TETRA</sup>, a 10 s baseline was established before addition of compounds following which fluorescence was recorded every 1 s for 120 s following compound or for 360 s following 5-HT. Maximum peak height was determined by ScreenWorks 4.0 software for each well. After the final readings, cells were fixed in 2% paraformaldehyde (Sigma) overnight. The maximum 5-HT-induced Ca<sub>i</sub><sup>2+</sup> release (<i>E</i><sub>max</sub>) in the presence of test compound was determined using 4-parameter nonlinear regression analysis (GraphPad Prism 7.04) and calculated from at least three biological replicates, each conducted in technical triplicates. The <i>E</i><sub>max</sub> for the test compound plus 5-HT was normalized to the <i>E</i><sub>max</sub> for 5-HT alone. Subsequent post hoc comparisons between means for <i>E</i><sub>max</sub> were made using an unpaired <i>t</i> test with Welch’s correction (GraphPad Prism). All statistical analyses were conducted with an experiment-wise error rate of α = 0.05.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>In Vivo</i> Pharmacokinetics and Behavior</h3><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Pharmacokinetic Analysis</h4><div class="NLM_p">Male Sprague–Dawley rats were randomly assigned into control and treatment groups (<i>n</i> = 3/group). Rats in the control group were injected with vehicle [DMSO/Tween 80/saline (v/v 1:3:6)], and rats in the treatment groups were administered compound <b>16</b> at 5 mg/kg iv or 10 mg/kg po. Blood samples (0.3 mL) were collected from the retro-orbital sinus vein before dosing and at 5 min and 0.25, 0.5, 1.0, 2.0, 3.0, 4.0, 5.0, 7.0, 9.0, and 24 h postdosing for iv administration and 0.25, 0.5, 1.0, 2.0, 3.0, 4.0, 5.0, 7.0, 9.0, and 24 h postdosing for po administration. Blood samples were placed in heparinized tubes and immediately centrifuged at 12 000<i>g</i> for 5 min at 4 °C. All samples were stored at −20 °C until analysis.</div><div class="NLM_p last">The pharmacokinetic parameters of compound <b>16</b> were calculated according to a noncompartmental model using WinNonlin (Pharsight Corporation, ver 5.3, Mountain View, CA, USA). The peak concentration (<i>C</i><sub>max</sub>) and time of peak concentration (<i>T</i><sub>max</sub>) were directly obtained by visual inspection of the plasma concentration–time profile. The elimination rate constant (λ) was obtained by the least-squares fitted terminal log–linear portion of the slope of the plasma concentration–time profile. The elimination half-life (<i>T</i><sub>1/2</sub>) was evaluated according to 0.693/λ. The area under the plasma concentration–time curve from 0 to time <i>t</i> (AUC<sub>0–<i>t</i></sub>) was evaluated using the linear trapezoidal rule and further extrapolated to infinity (AUC<sub>0–inf</sub>) according to the following equation: AUC<sub>0–inf</sub> = AUC<sub>0–<i>t</i></sub> + <i>C</i><sub>last</sub>/λ. The pharmacokinetic parameters were presented as mean ± SD.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Effects of Compound <b>16</b> on Spontaneous Locomotor Activity</h4><div id="sec4_3_2_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i45" class="anchor-spacer"></div><h5 class="article-section__title" id="_i45"> Animals</h5><div class="NLM_p last">A total of 67 male Sprague–Dawley rats (Harlan, Inc., Indianapolis, IN) weighing 225–325 g at the start of the experiments were used. Rats were housed two per cage and allowed to acclimate for 5–7 days in a colony room at a constant temperature (21–23 °C) and humidity (45–50%) on a 12 h light–dark cycle (lights on 0700–1900 h). Food and water were available <i>ad libitum</i>. Rats were handled for 1 week prior to the start of behavioral testing. All experiments were carried out in accordance with the National Institutes of Health <i>Guide for the Care and Use of Laboratory Animals</i> (2011) and with the approval of the UTMB Institutional Animal Care and Use Committee. All efforts were made to minimize animal suffering, to reduce the number of animals used, and to utilize alternatives to <i>in vivo</i> techniques, when available.</div></div><div id="sec4_3_2_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> Drugs</h5><div class="NLM_p last">WAY163909 [(7b-<i>R</i>,10a-<i>R</i>)-1,2,3,4,8,9,10,10a-octahydro-7b<i>H</i>-cyclopenta[<i>b</i>][1,4]diazepino[6,7,1<i>hi</i>]indole] was a gift from Pfizer, Inc. (New York, NY) and dissolved in 0.9% NaCl (vehicle employed for comparison to WAY163909). SB242084 [6-chloro-5-methyl-1-[[2-(2-methylpyrid-3-yloxy)pyrid-5-yl]carbamoyl]indoline dihydrochloride; Sigma Chemical Co., St. Louis, MO, USA] was dissolved in saline containing 10 mmol/L citric acid (Sigma Chemical Co.) and 8% 2-hydroxypropyl-β-cyclodextrin (Trappsol Hydroxpropyl Beta Cyclodextrin, pharmaceutical grade, Cyclodextrin Technologies Development Inc., High Springs, FL, USA) with the final pH of the solution adjusted to 5.6. SB242084, WAY163909, and compound <b>16</b> were injected intraperitoneally (ip) at a volume of 1 mL/kg.</div></div><div id="sec4_3_2_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> Locomotor Activity Assessments</h5><div class="NLM_p last">Locomotor activity was monitored and quantified under low light conditions using a modified open field activity system (San Diego Instruments, San Diego, CA) according to previous publications with minor modifications.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Clear plexiglass chambers (40 × 40 × 40 cm<sup>3</sup>) were surrounded by a 4 × 4 photobeam matrix positioned 4 cm from the chamber floor. Total ambulations were quantified as the sum of consecutive photobeam breaks that occurred within the inner central 16 × 16 cm<sup>2</sup> perimeter and in the surrounding outer peripheral 16 × 16 cm<sup>2</sup> perimeter of the activity monitor. Vertical activity counts (rearing) were quantified as the sum of breaks in the upper row of 16 photobeams positioned 16 cm from the monitor floor.<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(i)</td><td colspan="5" valign="top" class="paragraph"><p class="last">A between-subjects design was employed to study the efficacy of compound <b>16</b> to impact spontaneous motor activity. Rats (<i>n</i> = 29) were administered vehicle (saline, 1 mL/kg, ip) or compound <b>16</b> (0.5, 1, or 5 mg/kg, ip) immediately prior to placement in activity monitors on the test day; ambulations and vertical activity counts were monitored in 5 min bins for 90 min.</p></td></tr><tr class="li1"><td valign="top">(ii)</td><td colspan="5" valign="top" class="paragraph"><p class="last">A between-subjects design was used to investigate the selectivity of compound <b>16</b> to allosterically modulate WAY163909-mediated suppression of spontaneous motor activity. Rats (<i>n</i> = 38) were pretreated with SB242084 (1 mg/kg, ip) or vehicle (8% 2-hydroxypropyl-β-cyclodextrin) 15 min prior to ip administration of WAY163909 (1 mg/kg) plus compound <b>16</b> (5 mg/kg) and immediately placed into activity monitors on the test day; ambulations and vertical activity counts were monitored in 5 min bins for 90 min.</p></td></tr></table></div></div><div id="sec4_3_2_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i48" class="anchor-spacer"></div><h5 class="article-section__title" id="_i48"> Statistical Analyses</h5><div class="NLM_p last">Locomotor activity data are presented as mean total ambulations (±SEM) summed in 30 min. The main effect of treatment on total ambulations or vertical activity was analyzed with a one-way analysis of variance using the GLM procedure (SAS version 9.4 for Windows). Subsequent <i>a priori</i> comparisons to vehicle were made with Dunnett’s procedure (experiment i) or a Bonferroni multiple comparisons test (experiment ii). All statistical analyses were conducted with an experiment-wise error rate of α = 0.05.</div></div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> Effects of Compound <b>16</b> in a WAY163909 versus Saline Drug Discrimination Assay</h4><div id="sec4_3_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i50" class="anchor-spacer"></div><h5 class="article-section__title" id="_i50"> Animals</h5><div class="NLM_p last">Male Sprague–Dawley rats (<i>n</i> = 9; Harlan, Inc.) weighing 300–325 g at the beginning of the experiment were housed two per cage in a temperature- (21–23 °C) and humidity- controlled (45–50%) environment; lighting was maintained under a 12 h light–dark cycle (0700–1900 h). Rats were maintained at 80–90% of their free-feeding weights by restricting access to water. Rats received water during daily training sessions (5–6 mL/rat/session), in the afternoon several hours after training (20 min), and over the weekend (36 h). Experiments were conducted during the light phase of the light–dark cycle (between 0900 and 1200 h) and were carried out in accordance with the National Institutes of Health <i>Guide for the Care and Use of Laboratory Animals</i> and with the approval of the Institutional Animal Care and Use Committee at University of Texas Medical Branch.</div></div><div id="sec4_3_3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> Drug Discrimination Procedures</h5><div class="NLM_p">Standard two-lever, water-reinforced drug discrimination procedures were used (Med Associates, St. Albans, USA). Each chamber was equipped with a water-filled dispenser mounted equidistantly between two retractable response levers on the wall and housed in a light- and sound-proof cubicle. Illumination came from a 28-V house light; ventilation and masking noise were provided by a ventilation fan. A computer with Med-PC IV software was used to run programs and record all experimental events.</div><div class="NLM_p">Rats were trained to discriminate an injection of WAY163909 (0.75 mg/kg; 1.0 mL/kg, ip) from saline (1.0 mL/kg, ip) administered 15 min before start of training sessions (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Supporting Information</a> for WAY163909 time course). Daily sessions lasted 15 min and were conducted Monday through Friday. During the phase of errorless training, only the stimulus-appropriate (drug or saline) lever was present. Training began under a fixed ratio 1 (FR1) schedule of water reinforcement, and the FR requirement was incremented until all animals were responding reliably under an FR20 schedule for each experimental condition. For half of the rats, left lever responses were reinforced after WAY163909 administration, whereas right lever responses were reinforced after saline administration; conditions were reversed for the remaining animals. During this phase of training, WAY163909 and saline were administered irregularly with the restriction that neither condition prevailed for more than three consecutive sessions. After responding stabilized, both levers were presented simultaneously during 15 min training sessions. The rats were required to respond on the stimulus-appropriate (correct) lever to obtain water reinforcement. There were no programmed consequences for responding on the incorrect lever. This phase of training continued until the performance of all rats attained criterion (defined as mean accuracies of at least 80% stimulus-appropriate responding for ten consecutive sessions).</div><div class="NLM_p">Test sessions were initiated and conducted once or twice per week following attainment of criterion. Training sessions were run during the intervening days to maintain discrimination accuracy. Rats were required to maintain accuracies of at least 80% correct for saline and WAY163909 maintenance sessions, which immediately preceded a test. During test sessions, animals were placed in the chambers and, upon completion of 20 responses on either lever, a single reinforcer was delivered and the house lights were turned off. The rat was removed from the chamber, returned to the colony, and allowed free access to water for 15 min beginning 15–30 min after the end of each test. The test sessions were terminated after 15 min if the rats did not complete 20 responses on either lever; only data from rats that accomplished the FR20 during test sessions within 15 min were employed in data analysis.</div><div class="NLM_p last">Time course, substitution and combination tests were conducted. To determine the time course of WAY163909, rats were pretreated with WAY163909 (0.75 mg/kg, ip) 15, 30, 60, or 120 min prior to placement into the chambers. In substitution tests, rats were administered WAY163909 (0.125, 0.25, 0.5, 0.75, or 1.0 mg/kg, ip), compound <b>16</b> (0.125, 0.25, 0.5, 1.0 mg/kg, ip), or saline 15 min prior to test. In combination tests, rats were tested for lever selection following simultaneous ip administration of compound <b>16</b> (0.5 mg/kg) and WAY163909 (0.5 mg/kg) and placed in the operant chamber 15 min later. The doses of WAY163909 and compound <b>16</b> employed were based upon the results of the substitution tests as producing <50% drug-appropriate responding. Full substitution was defined as ≥80% drug-appropriate responding and not statistically different from the training drug, and partial substitution as ≥40% and <80% drug-appropriate responding.</div></div><div id="sec4_3_3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52"> Statistical Analyses</h5><div class="NLM_p last">Accuracy was defined as the percentage of correct responses to total responses before the delivery of the first reinforcer. During test sessions, performance was expressed as the percentage of drug-lever responses to total responses upon completion of an FR20 on either lever. The response rate (responses per minute) was calculated as the total number of responses emitted before completion of the first FR20 divided by the number of minutes taken to complete the first ratio. For compound <b>16</b> dose–response tests, Student’s <i>t</i>-test for repeated measures was used to compare the percentage of drug-lever responding and response rate during test sessions with the corresponding values for the previous saline session (substitution tests). A two-way ANOVA for repeated measures was employed to analyze the effects of pretreatment with compound <b>16</b> (factor 1) and WAY163909 dose (factor 2; SAS for Windows, version 9.4). <i>A priori</i> comparisons were calculated to compare the effects of each dose of WAY163909 in the presence versus absence of compound <b>16</b> using a Bonferonni-corrected test. Log-probit analyses were used to estimate the dose of WAY163909 predicted to elicit 50% WAY163909-appropriate responding (ED<sub>50</sub>).<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Only data from animals that completed the FR20 during the test sessions were used. All statistical analyses were conducted with an experiment-wise error rate of α = 0.05.</div></div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Effects of Compound <b>16</b> on Cocaine Cue Reactivity</h4><div id="sec4_3_4_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> Animals</h5><div class="NLM_p last">Male, outbred Sprague–Dawley rats (<i>n</i> = 17; Harlan, Houston, TX) weighing 250–275 g upon arrival were housed two per cage under a 12-h light–dark cycle with controlled temperature (21–23 °C) and humidity (40–50%). Animals were acclimated for 7 days to the colony room prior to the start of handling and experimental procedures. All experiments were conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals (2011) and with the University of Texas Medical Branch Institutional Animal Care and Use Committee approval.</div></div><div id="sec4_3_4_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i55" class="anchor-spacer"></div><h5 class="article-section__title" id="_i55"> Drugs</h5><div class="NLM_p last">(−)-Cocaine (National Institute on Drug Abuse, Research Triangle Park, NC) was dissolved in 0.9% NaCl.</div></div><div id="sec4_3_4_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i56" class="anchor-spacer"></div><h5 class="article-section__title" id="_i56"> Cocaine Self-Administration and Cue Reactivity Analyses</h5><div class="NLM_p">Cocaine self-administration studies employed standard operant conditioning chambers (Med-Associates, Inc., St. Albans, VT, USA) housed in ventilated, sound-attenuating cubicles with fans (Med-Associates, Inc.). Each chamber was outfitted with two retractable response levers, a stimulus light above each response lever, a houselight opposite the levers, and a magazine-type pellet dispenser. The cocaine infusions were delivered via syringes attached to infusion pumps (Med Associates, Inc.) located outside the cubicles. The infusion pumps were connected to liquid swivels (Instech, Plymouth Meeting, PA, USA) that were fastened to the catheters via polyethylene 20 tubing encased inside a metal spring leash (Plastics One, Roanoke, VA).</div><div class="NLM_p">Rats were anesthetized (8.6 mg/kg of xylazine, 1.5 mg/kg of acepromazine, 43 mg/kg of ketamine in bacteriostatic saline) and implanted with intravenous catheters with back mounts and allowed to recover for 5–7 days.<a onclick="showRef(event, 'ref6 ref8 ref9 ref47'); return false;" href="javascript:void(0);" class="ref ref6 ref8 ref9 ref47">(6,8,9,47)</a> Catheter patency was maintained by daily flushes with a solution of 0.1 mL of bacteriostatic saline containing heparin sodium (10 U/mL; American Pharmaceutical Partners, East Schaumburg, IL), streptokinase (0.67 mg/mL; Sigma Chemical), and ticarcillin disodium (66.67 mg/mL; Research Products International, Mt. Prospect, IL) immediately following daily cocaine self-administration sessions.</div><div class="NLM_p">Cocaine self-administration training consisted of 14 daily 180 min sessions during which rats were trained to lever press for cocaine infusions (0.75 mg/kg per 0.1 mL infusion).<a onclick="showRef(event, 'ref6 ref8 ref9 ref47'); return false;" href="javascript:void(0);" class="ref ref6 ref8 ref9 ref47">(6,8,9,47)</a> Schedule completions on the active lever resulted in delivery of a cocaine infusion over a 6 s period paired simultaneously with illumination of the house and stimulus lights and activation of the infusion pump (discrete cue complex paired with cocaine delivery); inactive lever presses produced no scheduled consequences. Following reinforcer delivery, the stimulus light as well as the infusion pump were inactivated; the house light remained on for an additional 20 s to indicate a timeout period during which lever presses had no scheduled consequences. Rats were trained on a FR1 schedule of reinforcement and progressed to an FR5 schedule after achieving seven infusions per hour with less than 10% variability for three consecutive days. Upon achieving stability on the FR5 schedule (less than 10% variability for a minimum of three consecutive days), rats were pseudorandomly assigned to either vehicle or compound <b>16</b> and returned to their home cages for the appropriate time period. Rats that exhibited diminished catheter patency were excluded from analysis (<i>n</i> = 3).</div><div class="NLM_p last">Rats were reintroduced to the self-administration chambers 24 h after the last self-administration session and assayed in a test session comprised of two sequential components. In the first component, responses on either lever were recorded, but no discrete cues (e.g., stimulus light, pump) were present nor delivered during the 10 min period. The second component was signaled by the single delivery of the discrete cue complex presented at the termination of the first 10 min component. To assess cocaine cue reactivity, presses on the previously active lever in the 60 min second component were reinforced by the discrete cue complex on an FR1; inactive lever presses were recorded but produced no scheduled consequences.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Rats received an injection of vehicle (0.9% NaCl, 1 mL/kg, ip) or compound <b>16</b> (1.0 mg/kg, ip) 15 min prior to the cue reactivity session.</div></div><div id="sec4_3_4_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> Statistical Analyses</h5><div class="NLM_p last">The data from the self-administration and cue reactivity phases were analyzed separately. For the cue reactivity tests, a two-way ANOVA for repeated measures was employed to analyze the effects of treatment with compound <b>16</b> (factor 1) and time (factor 2; SAS for Windows, version 9.4) on previously active or inactive lever presses. <i>A priori</i> comparisons were calculated to compare the effects of compound <b>16</b> at each time point using Fishers LSD test. All statistical analyses were conducted with an experiment-wise error rate of a α = 0.05.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i58"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00401" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07124" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07124" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00401" class="ext-link">10.1021/acs.jmedchem.8b00401</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Calculated physicochemical properties, radioligand binding data, cytotoxicity data, additional cellular assay data, CNS-MPO values, docking protocol, drug discrimination time course study, <sup>1</sup>H and <sup>13</sup>C NMR spectra for the compounds described in this paper, X-ray data for compounds <b>32</b> and <b>35</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf">jm8b00401_si_001.pdf (3.24 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_002.csv">jm8b00401_si_002.csv (2.01 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00401" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Noelle C. Anastasio</span> - <span class="hlFld-Affiliation affiliation">Center
for Addiction Research, 
    Department of Pharmacology and Toxicology, 
    , , and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5579-4213" title="Orcid link">http://orcid.org/0000-0001-5579-4213</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bbd5d8dad5dac8cfdafbcecfd6d995dedfce"><span class="__cf_email__" data-cfemail="cca2afada2adbfb8ad8cb9b8a1aee2a9a8b9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathryn A. Cunningham</span> - <span class="hlFld-Affiliation affiliation">Center
for Addiction Research, 
    Department of Pharmacology and Toxicology, 
    , , and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4257-1739" title="Orcid link">http://orcid.org/0000-0002-4257-1739</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#8ae1e9ffe4e4e3e4edcafffee7e8a4efeeff"><span class="__cf_email__" data-cfemail="cca7afb9a2a2a5a2ab8cb9b8a1aee2a9a8b9">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia Zhou</span> - <span class="hlFld-Affiliation affiliation">Center
for Addiction Research, 
    Department of Pharmacology and Toxicology, 
    , , and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2811-1090" title="Orcid link">http://orcid.org/0000-0002-2811-1090</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#32585b485a5d477247465f501c575647"><span class="__cf_email__" data-cfemail="b1dbd8cbd9dec4f1c4c5dcd39fd4d5c4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher
T. Wild</span> - <span class="hlFld-Affiliation affiliation">Center
for Addiction Research, 
    Department of Pharmacology and Toxicology, 
    , , and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanna M. Miszkiel</span> - <span class="hlFld-Affiliation affiliation">Center
for Addiction Research, , and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric A. Wold</span> - <span class="hlFld-Affiliation affiliation">Center
for Addiction Research, 
    Department of Pharmacology and Toxicology, 
    , , and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6434-7562" title="Orcid link">http://orcid.org/0000-0001-6434-7562</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudia A. Soto</span> - <span class="hlFld-Affiliation affiliation">Center
for Addiction Research, , and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5214-9136" title="Orcid link">http://orcid.org/0000-0002-5214-9136</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chunyong Ding</span> - <span class="hlFld-Affiliation affiliation">Center
for Addiction Research, 
    Department of Pharmacology and Toxicology, 
    , , and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachel M. Hartley</span> - <span class="hlFld-Affiliation affiliation">Center
for Addiction Research, , and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark A. White</span> - <span class="hlFld-Affiliation affiliation">Sealy Center for
Structural Biology and Molecular Biophysics, , and , University of Texas Medical Branch, Galveston, Texas 77555, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>C.T.W., J.M.M., and E.A.W. contributed equally to this work. J.Z., K.A.C., and N.C.A. developed the concepts and approaches as well as supervised the work. C.T.W., E.A.W., and C.D. synthesized, purified, and characterized the reported compounds. J.M.M., C.A.S., and R.M.H. performed and analyzed the in vitro cellular studies. N.C.A. and K.A.C. analyzed the in vitro and in vivo studies. C.T.W., N.C.A., K.A.C., and J.Z., wrote the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d134e5512-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i60">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55848" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55848" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by Grants R21 MH093844 (J.Z./K.A.C.), R01 DA038446 (J.Z./K.A.C.), K05 DA020087 (K.A.C.), P30 DA28821 (K.A.C.), T32 DA07287 (C.T.W. and E.A.W.), F31 DA038922 (C.T.W.), and F31 DA045511 (E.A.W.) from the National Institutes of Health, R.A. Welch Foundation Chemistry and Biology Collaborative Grant from Gulf Coast Consortia (GCC) for Chemical Genomics, a training fellowship from the Keck Center for Interdisciplinary Bioscience Training of the GCC (NIGMS Grant T32 GM089657-03, C.T.W.), Sealy and Smith Foundation grant (to the Sealy Center for Structural Biology and Molecular Biophysics), John Sealy Memorial Endowment Fund, and the Center for Addiction Research at UTMB. We thank Lawrence C. Sowers, Jacob A. Theruvathu, and Tianzhi Wang for the NMR spectroscopy assistance, Robert G. Fox, Gongliang Zhang, and Sonja J. Stutz for performing and analyzing <i>in vivo</i> studies, Claudia M. Crawford, Carrie E. McAllister, and Konrad Pazdrak for conducting <i>in vitro</i> assays, and Marcy B. Jordan for helpful discussions during the development of this project. Receptor binding profiles and agonist functional data was generously provided by the National Institute of Mental Health’s Psychoactive Drug Screening Program, Contract no. HHSN-271-2013-00017-C (NIMH PDSP). The NIMH PDSP is directed by Bryan L. Roth at the University of North Carolina at Chapel Hill and Project Officer Jamie Driscoll at NIMH, Bethesda MD, USA.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">serotonin</p></td></tr><tr><td class="NLM_term">5-HT<sub>2A</sub>R</td><td class="NLM_def"><p class="first last">5-HT<sub>2A</sub> receptor</p></td></tr><tr><td class="NLM_term">5-HT<sub>2B</sub>R</td><td class="NLM_def"><p class="first last">5-HT<sub>2B</sub> receptor</p></td></tr><tr><td class="NLM_term">5-HT<sub>2C</sub>R</td><td class="NLM_def"><p class="first last">5-HT<sub>2C</sub> receptor</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G protein-coupled receptor</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">U.S. Food and Drug Administration</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">NAM</td><td class="NLM_def"><p class="first last">negative allosteric modulator</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">tPSA</td><td class="NLM_def"><p class="first last">total polar surface area</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl-<i>O</i>-(1<i>H</i>-benzotriazol-1-yl)uronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">PTLC</td><td class="NLM_def"><p class="first last">preparative thin layer chromatographic</p></td></tr><tr><td class="NLM_term">PLCβ</td><td class="NLM_def"><p class="first last">phospholipase Cβ</p></td></tr><tr><td class="NLM_term">IP3</td><td class="NLM_def"><p class="first last">inositol-1,4,5-trisphosphate</p></td></tr><tr><td class="NLM_term">DAG</td><td class="NLM_def"><p class="first last">diacylglycerol</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">CCR5</td><td class="NLM_def"><p class="first last">C–C chemokine receptor type 5</p></td></tr><tr><td class="NLM_term">PLD</td><td class="NLM_def"><p class="first last">phospholipase D</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">ADMET</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion, and toxicity</p></td></tr><tr><td class="NLM_term">EL</td><td class="NLM_def"><p class="first last">extracellular loop</p></td></tr><tr><td class="NLM_term">TMH</td><td class="NLM_def"><p class="first last">transmembrane helix</p></td></tr><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">multiparameter optimization</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i62">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71813" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71813" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 70 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, A.</span>; <span class="NLM_string-name">Williams, M. R.</span>; <span class="NLM_string-name">Lipari, R. N.</span>; <span class="NLM_string-name">Van Horn, S.</span></span> <span> </span><span class="NLM_article-title">State Estimates of Past Year Cocaine Use among Young Adults: 2014 and 2015</span>;  <i>The CBHSQ Report of 2016</i>; Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, <span class="NLM_publisher-name">U.S. Government Printing Office</span>: <span class="NLM_publisher-loc">Rockville, MD</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Hughes&author=M.+R.+Williams&author=R.+N.+Lipari&author=S.+Van+Horn&title=The+CBHSQ+Report+of+2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DA.%26atitle%3DState%2520Estimates%2520of%2520Past%2520Year%2520Cocaine%2520Use%2520among%2520Young%2520Adults%253A%25202014%2520and%25202015%26btitle%3DThe%2520CBHSQ%2520Report%2520of%25202016%26pub%3DU.S.%2520Government%2520Printing%2520Office%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span> <span> </span><span class="NLM_article-title">Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">Pt B</span>),  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.06.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.neuropharm.2013.06.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23850573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SksLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=460-478&issue=Pt+B&author=K.+A.+Cunninghamauthor=N.+C.+Anastasio&title=Serotonin+at+the+nexus+of+impulsivity+and+cue+reactivity+in+cocaine+addiction&doi=10.1016%2Fj.neuropharm.2013.06.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction</span></div><div class="casAuthors">Cunningham, Kathryn A.; Anastasio, Noelle C.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">PB</span>),
    <span class="NLM_cas:pages">460-478</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cocaine abuse and addiction remain great challenges on the public health agendas in the U.S. and the world.  Increasingly sophisticated perspectives on addiction to cocaine and other drugs of abuse have evolved with concerted research efforts over the last 30 years.  Relapse remains a particularly powerful clin. problem as, even upon termination of drug use and initiation of abstinence, the recidivism rates can be very high.  The cycling course of cocaine intake, abstinence and relapse is tied to a multitude of behavioral and cognitive processes including impulsivity (a predisposition toward rapid unplanned reactions to stimuli without regard to the neg. consequences), and cocaine cue reactivity (responsivity to cocaine-assocd. stimuli) cited as two key phenotypes that contribute to relapse vulnerability even years into recovery.  Preclin. studies suggest that serotonin (5-hydroxytryptamine; 5-HT) neurotransmission in key neural circuits may contribute to these interlocked phenotypes well as the altered neurobiol. states evoked by cocaine that ppt. relapse events.  As such, 5-HT is an important target in the quest to understand the neurobiol. of relapse-predictive phenotypes, to successfully treat this complex disorder and improve diagnostic and prognostic capabilities.  This review emphasizes the role of 5-HT and its receptor proteins in key addiction phenotypes and the implications of current findings to the future of therapeutics in addiction.This article is part of a Special Issue entitled NIDA 40th Anniversary Issue'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyS7RfoN3mB7Vg90H21EOLACvtfcHk0lgTomLZlyQoVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SksLvM&md5=3ba5409e7102c92a5ceec177c7f2839c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.06.030%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26atitle%3DSerotonin%2520at%2520the%2520nexus%2520of%2520impulsivity%2520and%2520cue%2520reactivity%2520in%2520cocaine%2520addiction%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D76%26issue%3DPt%2520B%26spage%3D460%26epage%3D478%26doi%3D10.1016%2Fj.neuropharm.2013.06.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howell, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1124/pr.114.009514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1124%2Fpr.114.009514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=25505168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=176-197&author=L.+L.+Howellauthor=K.+A.+Cunningham&title=Serotonin+5-HT2+receptor+interactions+with+dopamine+function%3A+implications+for+therapeutics+in+cocaine+use+disorder&doi=10.1124%2Fpr.114.009514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder</span></div><div class="casAuthors">Howell, Leonard L.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">176-197, 22 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Cocaine exhibits prominent abuse liability, and chronic abuse can result in cocaine use disorder with significant morbidity.  Major advances have been made in delineating neurobiol. mechanisms of cocaine abuse; however, effective medications to treat cocaine use disorder remain to be discovered.  The present review will focus on the role of serotonin (5-HT; 5-hydroxytryptamine) neurotransmission in the neuropharmacol. of cocaine and related abused stimulants.  Extensive research suggests that the primary contribution of 5-HT to cocaine addiction is a consequence of interactions with dopamine (DA) neurotransmission.  The literature on the neurobiol. and behavioral effects of cocaine is well developed, so the focus of the review will be on cocaine with inferences made about other monoamine uptake inhibitors and releasers based on mechanistic considerations. 5-HT receptors are widely expressed throughout the brain, and several different 5-HT receptor subtypes have been implicated in mediating the effects of endogenous 5-HT on DA.  However, the 5-HT2A and 5-HT2C receptors in particular have been implicated as likely candidates for mediating the influence of 5-HT in cocaine abuse as well as to traits (e.g., impulsivity) that contribute to the development of cocaine use disorder and relapse in humans.  Lastly, new approaches are proposed to guide targeted development of serotonergic ligands for the treatment of cocaine use disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrr8S3_2aD27Vg90H21EOLACvtfcHk0lgTomLZlyQoVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oms7w%253D&md5=f16fdf974beaa29f82770b9efdb43363</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.009514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.009514%26sid%3Dliteratum%253Aachs%26aulast%3DHowell%26aufirst%3DL.%2BL.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DSerotonin%25205-HT2%2520receptor%2520interactions%2520with%2520dopamine%2520function%253A%2520implications%2520for%2520therapeutics%2520in%2520cocaine%2520use%2520disorder%26jtitle%3DPharmacol.%2520Rev.%26date%3D2015%26volume%3D67%26spage%3D176%26epage%3D197%26doi%3D10.1124%2Fpr.114.009514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">The expanded biology of serotonin</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1146/annurev.med.60.042307.110802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1146%2Fannurev.med.60.042307.110802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=19630576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlyntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=355-366&author=M.+Bergerauthor=J.+A.+Grayauthor=B.+L.+Roth&title=The+expanded+biology+of+serotonin&doi=10.1146%2Fannurev.med.60.042307.110802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The expanded biology of serotonin</span></div><div class="casAuthors">Berger, Miles; Gray, John A.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">355-366</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Serotonin is perhaps best known as a neurotransmitter that modulates neural activity and a wide range of neuropsychol. processes, and drugs that target serotonin receptors are used widely in psychiatry and neurol.  However, most serotonin is found outside the central nervous system, and virtually all of the 15 serotonin receptors are expressed outside as well as within the brain.  Serotonin regulates numerous biol. processes including cardiovascular function, bowel motility, ejaculatory latency, and bladder control.  Addnl., new work suggests that serotonin may regulate some processes, including platelet aggregation, by receptor-independent, transglutaminase-dependent covalent linkage to cellular proteins.  We review this new expanded serotonin biol. and discuss how drugs targeting specific serotonin receptors are beginning to help treat a wide range of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoz0HW5hdNOrVg90H21EOLACvtfcHk0lgdvVpFfpwf3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlyntb8%253D&md5=0557e01e6b79dbfb50559aca03f8b31f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1146%2Fannurev.med.60.042307.110802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.med.60.042307.110802%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DGray%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DThe%2520expanded%2520biology%2520of%2520serotonin%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2009%26volume%3D60%26spage%3D355%26epage%3D366%26doi%3D10.1146%2Fannurev.med.60.042307.110802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willins, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristiansen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroeze, W. K.</span></span> <span> </span><span class="NLM_article-title">5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1016/S0163-7258(98)00019-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2FS0163-7258%2898%2900019-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=9776378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFCrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1998&pages=231-257&author=B.+L.+Rothauthor=D.+L.+Willinsauthor=K.+Kristiansenauthor=W.+K.+Kroeze&title=5-Hydroxytryptamine2-family+receptors+%285-hydroxytryptamine2A%2C+5-hydroxytryptamine2B%2C+5-hydroxytryptamine2C%29%3A+where+structure+meets+function&doi=10.1016%2FS0163-7258%2898%2900019-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function</span></div><div class="casAuthors">Roth, Bryan L.; Willins, David L.; Kristiansen, Kurt; Kroeze, Wesley K.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-257</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with ∼250 refs.  5-Hydroxytryptamine2 (serotonin2, 5-HT2)-family receptors are important for mediating many physiol. functions, including vascular and nonvascular smooth muscle contraction, platelet aggregation, modulation of perception, mood, anxiety, and feeding behavior.  A large no. of psychopharmaceuticals, including atypical antipsychotic drugs, antidepressants, anxiolytics, and hallucinogens, mediate their actions, at least in part, via interactions with various 5-HT2-family receptors.  This review article summarizes information about structure-function aspects of 5-HT2-family receptors.  Evidence is presented that implies that conserved arom. and charged residues are essential for ligand binding to 5-HT2A receptors.  Addnl., findings are reviewed that are consistent with the hypothesis that residues located in intracellular loops 2 and 3 (i2 and i3) mediate coupling to specific Gα-subunits such as Gαq.  Studies are reviewed that suggest that 5-HT2-family receptors may be down-regulated by both agonists and antagonists, and usually this down-regulation is due to post-transcriptional mechanisms.  Finally, a model for regulation of 5-HT2-family receptors by receptor-mediated endocytosis is advanced, and the particular structural features responsible for the various endocytotic pathways are emphasized.  Taken together, these results suggest that discrete domains of the receptor structure are important for ligand binding, G-protein coupling, and internalization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPBigSMGYXgrVg90H21EOLACvtfcHk0lgdvVpFfpwf3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFCrsLo%253D&md5=1d9ebf499fda3a8fee1262f2dcd6f6d9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900019-9%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DWillins%26aufirst%3DD.%2BL.%26aulast%3DKristiansen%26aufirst%3DK.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3D5-Hydroxytryptamine2-family%2520receptors%2520%25285-hydroxytryptamine2A%252C%25205-hydroxytryptamine2B%252C%25205-hydroxytryptamine2C%2529%253A%2520where%2520structure%2520meets%2520function%26jtitle%3DPharmacol.%2520Ther.%26date%3D1998%26volume%3D79%26spage%3D231%26epage%3D257%26doi%3D10.1016%2FS0163-7258%2898%2900019-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swinford, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamon, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, F. G.</span></span> <span> </span><span class="NLM_article-title">Variation within the serotonin (5-HT) 5-HT(2)C receptor system aligns with vulnerability to cocaine cue reactivity</span>. <i>Transl. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e369</span>, <span class="refDoi"> DOI: 10.1038/tp.2013.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Ftp.2013.131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=24618688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVCnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=e369&author=N.+C.+Anastasioauthor=S.+Liuauthor=L.+Mailiauthor=S.+E.+Swinfordauthor=S.+D.+Laneauthor=R.+G.+Foxauthor=S.+C.+Hamonauthor=D.+A.+Nielsenauthor=K.+A.+Cunninghamauthor=F.+G.+Moeller&title=Variation+within+the+serotonin+%285-HT%29+5-HT%282%29C+receptor+system+aligns+with+vulnerability+to+cocaine+cue+reactivity&doi=10.1038%2Ftp.2013.131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Variation within the serotonin (5-HT) 5-HT2C receptor system aligns with vulnerability to cocaine cue reactivity</span></div><div class="casAuthors">Anastasio, N. C.; Liu, S.; Maili, L.; Swinford, S. E.; Lane, S. D.; Fox, R. G.; Hamon, S. C.; Nielsen, D. A.; Cunningham, K. A.; Moeller, F. G.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e369</span>CODEN:
                <span class="NLM_cas:coden">TPRSCF</span>;
        ISSN:<span class="NLM_cas:issn">2158-3188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cocaine dependence remains a challenging public health problem with relapse cited as a major determinant in its chronicity and severity.  Environmental contexts and stimuli become reliably assocd. with its use leading to durable conditioned responses ('cue reactivity') that can predict relapse as well as treatment success.  Individual variation in the magnitude and influence of cue reactivity over behavior in humans and animals suggest that cue-reactive individuals may be at greater risk for the progression to addiction and/or relapse.  In the present translational study, we investigated the contribution of variation in the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system in individual differences in cocaine cue reactivity in humans and rodents.  We found that cocaine-dependent subjects carrying a single nucleotide polymorphism (SNP) in the HTR2C gene that encodes for the conversion of cysteine to serine at codon 23 (Ser23 variant) exhibited significantly higher attentional bias to cocaine cues in the cocaine-word Stroop task than those carrying the Cys23 variant.  In a model of individual differences in cocaine cue reactivity in rats, we identified that high cocaine cue reactivity measured as appetitive approach behavior (lever presses reinforced by the discrete cue complex) correlated with lower 5-HT2CR protein expression in the medial prefrontal cortex and blunted sensitivity to the suppressive effects of the selective 5-HT2CR agonist WAY163909.  Our translational findings suggest that the functional status of the 5-HT2CR system is a mechanistic factor in the generation of vulnerability to cocaine-assocd. cues, an observation that opens new avenues for future development of biomarker and therapeutic approaches to suppress relapse in cocaine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4-6Q9fk9SyLVg90H21EOLACvtfcHk0lgdvVpFfpwf3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVCnsrk%253D&md5=9372b11e4f3479212fda09b936713bfc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Ftp.2013.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ftp.2013.131%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMaili%26aufirst%3DL.%26aulast%3DSwinford%26aufirst%3DS.%2BE.%26aulast%3DLane%26aufirst%3DS.%2BD.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DHamon%26aufirst%3DS.%2BC.%26aulast%3DNielsen%26aufirst%3DD.%2BA.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DMoeller%26aufirst%3DF.%2BG.%26atitle%3DVariation%2520within%2520the%2520serotonin%2520%25285-HT%2529%25205-HT%25282%2529C%2520receptor%2520system%2520aligns%2520with%2520vulnerability%2520to%2520cocaine%2520cue%2520reactivity%26jtitle%3DTransl.%2520Psychiatry%26date%3D2014%26volume%3D4%26spage%3De369%26doi%3D10.1038%2Ftp.2013.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swinford-Jackson, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sears, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiLeone, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Serotonin (5-HT) 5-HT2A receptor (5-HT2AR):5-HT2CR imbalance in medial prefrontal cortex associates with motor impulsivity</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1248</span>– <span class="NLM_lpage">1258</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.5b00094</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00094" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOktr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1248-1258&author=N.%0AC.+Anastasioauthor=S.+J.+Stutzauthor=L.+H.+Finkauthor=S.+E.+Swinford-Jacksonauthor=R.+M.+Searsauthor=R.+J.+DiLeoneauthor=K.+C.+Riceauthor=F.+G.+Moellerauthor=K.+A.+Cunningham&title=Serotonin+%285-HT%29+5-HT2A+receptor+%285-HT2AR%29%3A5-HT2CR+imbalance+in+medial+prefrontal+cortex+associates+with+motor+impulsivity&doi=10.1021%2Facschemneuro.5b00094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin (5-HT) 5-HT2A Receptor (5-HT2AR):5-HT2CR Imbalance in Medial Prefrontal Cortex Associates with Motor Impulsivity</span></div><div class="casAuthors">Anastasio, Noelle C.; Stutz, Sonja J.; Fink, Latham H. L.; Swinford-Jackson, Sarah E.; Sears, Robert M.; DiLeone, Ralph J.; Rice, Kenner C.; Moeller, F. Gerard; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1248-1258</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A feature of multiple neuropsychiatric disorders is motor impulsivity.  Recent studies have implicated serotonin (5-HT) systems in medial prefrontal cortex (mPFC) in mediating individual differences in motor impulsivity, notably the 5-HT2AR receptor (5-HT2AR) and 5-HT2CR.  We investigated the hypothesis that differences in the ratio of 5-HT2AR:5-HT2CR protein expression in mPFC would predict the individual level of motor impulsivity and that the engineered loss of the 5-HT2CR would result in high motor impulsivity concomitant with elevated 5-HT2AR expression and pharmacol. sensitivity to the selective 5-HT2AR antagonist M100907.  High and low impulsive rats were identified in a 1-choice serial reaction time task.  Native protein levels of the 5-HT2AR and the 5-HT2CR predicted the intensity of motor impulsivity and the 5-HT2AR:5-HT2CR ratio in mPFC pos. correlated with levels of premature responses in individual outbred rats.  The possibility that the 5-HT2AR and 5-HT2CR act in concert to control motor impulsivity is supported by the observation that high phenotypic motor impulsivity assocd. with a diminished mPFC synaptosomal 5-HT2AR:5-HT2CR protein:protein interaction.  Knockdown of mPFC 5-HT2CR resulted in increased motor impulsivity and triggered a functional disruption of the local 5-HT2AR:5-HT2CR balance as evidenced by a compensatory upregulation of 5-HT2AR protein expression and a leftward shift in the potency of M100907 to suppress impulsive behavior.  We infer that there is an interactive relationship between the mPFC 5-HT2AR and 5-HT2CR, and that a 5-HT2AR:5-HT2CR imbalance may be a functionally relevant mechanism underlying motor impulsivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0j4-Y1dOOErVg90H21EOLACvtfcHk0liujZuEctwRGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOktr%252FI&md5=f4b7994b1eeaab729b3e77bece3e89cc</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00094%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DFink%26aufirst%3DL.%2BH.%26aulast%3DSwinford-Jackson%26aufirst%3DS.%2BE.%26aulast%3DSears%26aufirst%3DR.%2BM.%26aulast%3DDiLeone%26aufirst%3DR.%2BJ.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DMoeller%26aufirst%3DF.%2BG.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DSerotonin%2520%25285-HT%2529%25205-HT2A%2520receptor%2520%25285-HT2AR%2529%253A5-HT2CR%2520imbalance%2520in%2520medial%2520prefrontal%2520cortex%2520associates%2520with%2520motor%2520impulsivity%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D1248%26epage%3D1258%26doi%3D10.1021%2Facschemneuro.5b00094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sears, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emeson, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiLeone, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">360</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1038/npp.2013.199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fnpp.2013.199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=360-372&author=N.+C.+Anastasioauthor=S.+J.+Stutzauthor=R.+G.+Foxauthor=R.+M.+Searsauthor=R.+B.+Emesonauthor=R.+J.+DiLeoneauthor=R.+T.+O%E2%80%99Neilauthor=L.+H.+Finkauthor=D.+Liauthor=T.+A.+Greenauthor=F.+G.+Moellerauthor=K.+A.+Cunningham&title=Functional+status+of+the+serotonin+5-HT2C+receptor+%285-HT2CR%29+drives+interlocked+phenotypes+that+precipitate+relapse-like+behaviors+in+cocaine+dependence&doi=10.1038%2Fnpp.2013.199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2013.199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2013.199%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DSears%26aufirst%3DR.%2BM.%26aulast%3DEmeson%26aufirst%3DR.%2BB.%26aulast%3DDiLeone%26aufirst%3DR.%2BJ.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DR.%2BT.%26aulast%3DFink%26aufirst%3DL.%2BH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DGreen%26aufirst%3DT.%2BA.%26aulast%3DMoeller%26aufirst%3DF.%2BG.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DFunctional%2520status%2520of%2520the%2520serotonin%25205-HT2C%2520receptor%2520%25285-HT2CR%2529%2520drives%2520interlocked%2520phenotypes%2520that%2520precipitate%2520relapse-like%2520behaviors%2520in%2520cocaine%2520dependence%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D360%26epage%3D372%26doi%3D10.1038%2Fnpp.2013.199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubar, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swinford, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbertson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig-Lipson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, F. G.</span></span> <span> </span><span class="NLM_article-title">Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1021/cn300072u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300072u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOntb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=110-121&author=K.+A.+Cunninghamauthor=N.+C.+Anastasioauthor=R.+G.+Foxauthor=S.+J.+Stutzauthor=M.+J.+Bubarauthor=S.+E.+Swinfordauthor=C.+S.+Watsonauthor=S.+R.+Gilbertsonauthor=K.+C.+Riceauthor=S.+Rosenzweig-Lipsonauthor=F.+G.+Moeller&title=Synergism+between+a+serotonin+5-HT2A+receptor+%285-HT2AR%29+antagonist+and+5-HT2CR+agonist+suggests+new+pharmacotherapeutics+for+cocaine+addiction&doi=10.1021%2Fcn300072u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Synergism Between a Serotonin 5-HT2A Receptor (5-HT2AR) Antagonist and 5-HT2CR Agonist Suggests New Pharmacotherapeutics for Cocaine Addiction</span></div><div class="casAuthors">Cunningham, Kathryn A.; Anastasio, Noelle C.; Fox, Robert G.; Stutz, Sonja J.; Bubar, Marcy J.; Swinford, Sarah E.; Watson, Cheryl S.; Gilbertson, Scott R.; Rice, Kenner C.; Rosenzweig-Lipson, Sharon; Moeller, F. Gerard</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-121</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Relapse to cocaine dependence, even after extended abstinence, involves a no. of liability factors including impulsivity (predisposition toward rapid, unplanned reactions to stimuli without regard to neg. consequences) and cue reactivity (sensitivity to cues assocd. with cocaine-taking which can promote cocaine-seeking).  These factors have been mechanistically linked to serotonin (5-hydroxytryptamine, 5-HT) signaling through the 5-HT2A receptor (5-HT2AR) and 5-HT2CR; either a selective 5-HT2AR antagonist or a 5-HT2CR agonist suppresses impulsivity and cocaine-seeking in preclin. models.  We conducted proof-of-concept analyses to evaluate whether a combination of 5-HT2AR antagonist plus 5-HT2CR agonist would have synergistic effects over these liability factors for relapse as measured in a 1-choice serial reaction time task and cocaine self-administration/reinstatement assay.  Combined administration of a dose of the selective 5-HT2AR antagonist M100907 plus the 5-HT2CR agonist WAY163909, each ineffective alone, synergistically suppressed cocaine-induced hyperactivity, inherent and cocaine-evoked impulsive action, as well as cue- and cocaine-primed reinstatement of cocaine-seeking behavior.  The identification of synergism between a 5-HT2AR antagonist plus a 5-HT2CR agonist to attenuate these factors important in relapse indicates the promise of a bifunctional ligand as an anti-addiction pharmacotherapeutic, setting the stage to develop new ligands with improved efficacy, potency, selectivity, and in vivo profiles over the individual mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraOi38lqJqXLVg90H21EOLACvtfcHk0liujZuEctwRGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOntb7J&md5=5f392443d0452d11cb30fc69c053d12c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fcn300072u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300072u%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DBubar%26aufirst%3DM.%2BJ.%26aulast%3DSwinford%26aufirst%3DS.%2BE.%26aulast%3DWatson%26aufirst%3DC.%2BS.%26aulast%3DGilbertson%26aufirst%3DS.%2BR.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DMoeller%26aufirst%3DF.%2BG.%26atitle%3DSynergism%2520between%2520a%2520serotonin%25205-HT2A%2520receptor%2520%25285-HT2AR%2529%2520antagonist%2520and%25205-HT2CR%2520agonist%2520suggests%2520new%2520pharmacotherapeutics%2520for%2520cocaine%2520addiction%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D110%26epage%3D121%26doi%3D10.1021%2Fcn300072u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubar, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span> <span> </span><span class="NLM_article-title">The serotonin 5-HT2C receptor in medial prefrontal cortex exerts rheostatic control over the motivational salience of cocaine-associated cues: new observations from preclinical animal research</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2319</span>– <span class="NLM_lpage">2321</span>, <span class="refDoi"> DOI: 10.1038/npp.2010.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fnpp.2010.119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=2319-2321&author=K.+A.+Cunninghamauthor=M.+J.+Bubarauthor=N.+C.+Anastasio&title=The+serotonin+5-HT2C+receptor+in+medial+prefrontal+cortex+exerts+rheostatic+control+over+the+motivational+salience+of+cocaine-associated+cues%3A+new+observations+from+preclinical+animal+research&doi=10.1038%2Fnpp.2010.119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2010.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2010.119%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DBubar%26aufirst%3DM.%2BJ.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26atitle%3DThe%2520serotonin%25205-HT2C%2520receptor%2520in%2520medial%2520prefrontal%2520cortex%2520exerts%2520rheostatic%2520control%2520over%2520the%2520motivational%2520salience%2520of%2520cocaine-associated%2520cues%253A%2520new%2520observations%2520from%2520preclinical%2520animal%2520research%26jtitle%3DNeuropsychopharmacology%26date%3D2010%26volume%3D35%26spage%3D2319%26epage%3D2321%26doi%3D10.1038%2Fnpp.2010.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubar, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbertson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig-Lipson, S.</span></span> <span> </span><span class="NLM_article-title">Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.neuropharm.2011.04.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=513-523&author=K.+A.+Cunninghamauthor=R.+G.+Foxauthor=N.+C.+Anastasioauthor=M.+J.+Bubarauthor=S.+J.+Stutzauthor=F.+G.+Moellerauthor=S.+R.+Gilbertsonauthor=S.+Rosenzweig-Lipson&title=Selective+serotonin+5-HT%282C%29+receptor+activation+suppresses+the+reinforcing+efficacy+of+cocaine+and+sucrose+but+differentially+affects+the+incentive-salience+value+of+cocaine-+vs.+sucrose-associated+cues&doi=10.1016%2Fj.neuropharm.2011.04.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DBubar%26aufirst%3DM.%2BJ.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DMoeller%26aufirst%3DF.%2BG.%26aulast%3DGilbertson%26aufirst%3DS.%2BR.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DSelective%2520serotonin%25205-HT%25282C%2529%2520receptor%2520activation%2520suppresses%2520the%2520reinforcing%2520efficacy%2520of%2520cocaine%2520and%2520sucrose%2520but%2520differentially%2520affects%2520the%2520incentive-salience%2520value%2520of%2520cocaine-%2520vs.%2520sucrose-associated%2520cues%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D513%26epage%3D523%26doi%3D10.1016%2Fj.neuropharm.2011.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swinford-Jackson, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Incubation of cocaine cue reactivity associates with neuroadaptations in the cortical serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2016.02.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.neuroscience.2016.02.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=26926963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFKis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2016&pages=50-61&author=S.+E.+Swinford-Jacksonauthor=N.+C.+Anastasioauthor=R.+G.+Foxauthor=S.+J.+Stutzauthor=K.+A.+Cunningham&title=Incubation+of+cocaine+cue+reactivity+associates+with+neuroadaptations+in+the+cortical+serotonin+%285-HT%29+5-HT2C+receptor+%285-HT2CR%29+system&doi=10.1016%2Fj.neuroscience.2016.02.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Incubation of cocaine cue reactivity associates with neuroadaptations in the cortical serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system</span></div><div class="casAuthors">Swinford-Jackson, S. E.; Anastasio, N. C.; Fox, R. G.; Stutz, S. J.; Cunningham, K. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-61</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Intensification of craving elicited by drug-assocd. cues during abstinence occurs over time in human cocaine users while elevation of cue reactivity ("incubation") is obsd. in rats exposed to extended forced abstinence from cocaine self-administration.  Incubation in rodents has been linked to time-dependent neuronal plasticity in the medial prefrontal cortex (mPFC).  We tested the hypothesis that incubation of cue reactivity during abstinence from cocaine self-administration is accompanied by lower potency and/or efficacy of the selective serotonin (5-HT) 5-HT2C receptor (5-HT2CR) agonist WAY163909 to suppress cue reactivity and a shift in the subcellular localization profile of the mPFC 5-HT2CR protein.  We obsd. incubation of cue reactivity (measured as lever presses reinforced by the discrete cue complex) between Day 1 and Day 30 of forced abstinence from cocaine relative to sucrose self-administration.  Pharmacol. and biochem. analyses revealed that the potency of the selective 5-HT2CR agonist WAY163909 to suppress cue reactivity, the expression of synaptosomal 5-HT2CR protein in the mPFC, and the membrane to cytoplasmic expression of the 5-HT2CR in mPFC were lower on Day 30 vs.  Day 1 of forced abstinence from cocaine self-administration.  Incubation of cue reactivity assessed during forced abstinence from sucrose self-administration did not assoc. with 5-HT2CR protein expression in the mPFC.  Collectively, these outcomes are the first indication that neuroadaptations in the 5-HT2CR system may contribute to incubation of cocaine cue reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh97yjelNSobVg90H21EOLACvtfcHk0lj5v-csPNev5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFKis7s%253D&md5=256f04de29bce55c99bf332657a9d396</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2016.02.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2016.02.052%26sid%3Dliteratum%253Aachs%26aulast%3DSwinford-Jackson%26aufirst%3DS.%2BE.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DIncubation%2520of%2520cocaine%2520cue%2520reactivity%2520associates%2520with%2520neuroadaptations%2520in%2520the%2520cortical%2520serotonin%2520%25285-HT%2529%25205-HT2C%2520receptor%2520%25285-HT2CR%2529%2520system%26jtitle%3DNeuroscience%26date%3D2016%26volume%3D324%26spage%3D50%26epage%3D61%26doi%3D10.1016%2Fj.neuroscience.2016.02.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shram, M. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1038/clpt.2011.20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fclpt.2011.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=21412231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVGnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2011&pages=683-692&author=M.+J.+Shram&title=Evaluation+of+the+abuse+potential+of+lorcaserin%2C+a+serotonin+2C+%285-HT2C%29+receptor+agonist%2C+in+recreational+polydrug+users&doi=10.1038%2Fclpt.2011.20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Abuse Potential of Lorcaserin, a Serotonin 2C (5-HT2C) Receptor Agonist, in Recreational Polydrug Users</span></div><div class="casAuthors">Shram, M. J.; Schoedel, K. A.; Bartlett, C.; Shazer, R. L.; Anderson, C. M.; Sellers, E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">683-692</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lorcaserin is a selective and potent serotonin 2C receptor subtype (5-HT2C) agonist under development for the treatment of obesity.  This study assessed the drug's abuse potential on the basis of its pharmacol. profile.  For this purpose, a double-blind, double-dummy, placebo-controlled, randomized seven-way crossover study with single oral doses of lorcaserin (20, 40, and 60 mg), zolpidem (15 and 30 mg), ketamine (100 mg), and placebo was conducted in recreational polydrug users (N = 35).  Subjective and objective measures were assessed up to 24 h after the dose.  We found that zolpidem and ketamine had significantly higher peak scores relative to placebo on the primary measures as well as on most of the secondary measures.  The subjective effects of a 20-mg dose of lorcaserin were similar to those of placebo, whereas supratherapeutic doses of lorcaserin were assocd. with significant levels of dislike by users as compared with placebo, zolpidem, and ketamine.  Perceptual effects were minimal after administration of lorcaserin and significantly lower than after administration of either ketamine or zolpidem.  The findings suggest that, at supratherapeutic doses, lorcaserin is assocd. with distinct, primarily neg., subjective effects and has low abuse potential.  Clin. Pharmacol. & Therapeutics (2011) 89 5, 683-692. doi:10.1038/clpt.2011.20.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocVZc136mBhLVg90H21EOLACvtfcHk0lj5v-csPNev5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVGnt7g%253D&md5=8781e2e09ea5c4350f6647f8d4223173</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2011.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2011.20%26sid%3Dliteratum%253Aachs%26aulast%3DShram%26aufirst%3DM.%2BJ.%26atitle%3DEvaluation%2520of%2520the%2520abuse%2520potential%2520of%2520lorcaserin%252C%2520a%2520serotonin%25202C%2520%25285-HT2C%2529%2520receptor%2520agonist%252C%2520in%2520recreational%2520polydrug%2520users%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2011%26volume%3D89%26spage%3D683%26epage%3D692%26doi%3D10.1038%2Fclpt.2011.20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. R.</span></span> <span> </span><span class="NLM_article-title">Lorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and women</span>. <i>Obesity</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1038/oby.2008.537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Foby.2008.537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=19057523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Oiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=494-503&author=S.+R.+Smith&title=Lorcaserin+%28APD356%29%2C+a+selective+5-HT%282C%29+agonist%2C+reduces+body+weight+in+obese+men+and+women&doi=10.1038%2Foby.2008.537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Lorcaserin (APD356), a Selective 5-HT2C Agonist, Reduces Body Weight in Obese Men and Women</span></div><div class="casAuthors">Smith, Steven R.; Prosser, Warren A.; Donahue, David J.; Morgan, Michael E.; Anderson, Christen M.; Shanahan, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Obesity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">494-503</span>CODEN:
                <span class="NLM_cas:coden">OBESAX</span>;
        ISSN:<span class="NLM_cas:issn">1930-7381</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lorcaserin (APD356) is a potent, selective 5-HT2C agonist with ∼15-fold and 100-fold selectivity vs. 5-HT2A and 5-HT2B receptors, resp.  This study evaluated the safety and efficacy of lorcaserin for wt. redn. in obese patients during a 12-wk period.  The randomized, double-blind, placebo-controlled, parallel-arm study enrolled 469 men and women between ages 18 and 65 and with BMI 30-45 kg/m2.  Patients received placebo, lorcaserin 10 mg q.d., lorcaserin 15 mg q.d., or lorcaserin 10 mg b.i.d. for 12 wk, and were counseled to maintain their usual diet and activity.  The primary end point was change in wt. from baseline to day 85 by completer anal.  Safety analyses included echocardiograms at Screening and day 85/study exit.  Lorcaserin was assocd. with progressive wt. loss of 1.8 kg, 2.6 kg, and 3.6 kg at 10 mg q.d., 15 mg q.d., and 10 mg b.i.d., resp., compared to placebo wt. loss of 0.3 kg (P < 0.001 for each group).  Similar results were seen by intent-to-treat last observation-carried forward (ITT-LOCF) anal.  The proportions of completers achieving ≥5% of initial body wt. were 12.8, 19.5, 31.2, and 2.3% in the 10 mg q.d., 15 mg q.d., 10 mg b.i.d., and placebo groups, resp.  The most frequent adverse events (AEs) were transient headache, nausea, and dizziness.  Echocardiograms showed no apparent drug-related effects on heart valves or pulmonary artery pressure (PAP).  Lorcaserin was well tolerated and efficacious for wt. redn. in this 12-wk study.  Longer-term trials employing behavior modification will be needed to more fully assess its safety and efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3-A04UsnZ2LVg90H21EOLACvtfcHk0lixitgSbGVpMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Oiu7Y%253D&md5=dd54cdbec71ec7eaa7c37e16c979e14f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Foby.2008.537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foby.2008.537%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%2BR.%26atitle%3DLorcaserin%2520%2528APD356%2529%252C%2520a%2520selective%25205-HT%25282C%2529%2520agonist%252C%2520reduces%2520body%2520weight%2520in%2520obese%2520men%2520and%2520women%26jtitle%3DObesity%26date%3D2009%26volume%3D17%26spage%3D494%26epage%3D503%26doi%3D10.1038%2Foby.2008.537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. R.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Multicenter, placebo-controlled trial of lorcaserin for weight management</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0909809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1056%2FNEJMoa0909809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=20647200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVOgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=245-256&author=S.+R.+Smith&title=Multicenter%2C+placebo-controlled+trial+of+lorcaserin+for+weight+management&doi=10.1056%2FNEJMoa0909809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Multicenter, placebo-controlled trial of lorcaserin for weight management</span></div><div class="casAuthors">Smith, Steven R.; Weissman, Neil J.; Anderson, Christen M.; Sanchez, Matilde; Chuang, Emil; Stubbe, Scott; Bays, Harold; Shanahan, William R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-256</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Lorcaserin is a selective serotonin 2C receptor agonist that could be useful in reducing body wt.  In this double-blind clin. trial, we randomly assigned 3182 obese or overweight adults (mean body-mass index [the wt. in kilograms divided by the square of the height in meters] of 36.2) to receive lorcaserin at a dose of 10 mg, or placebo, twice daily for 52 wk.  All patients also underwent diet and exercise counseling.  At week 52, patients in the placebo group continued to receive placebo but patients in the lorcaserin group were randomly reassigned to receive either placebo or lorcaserin.  Primary outcomes were wt. loss at 1 yr and maintenance of wt. loss at 2 years.  Serial echocardiog. was used to identify patients in whom valvulopathy (as defined by the Food and Drug Administration) developed.  At 1 yr, 55.4% of patients (883 of 1595) receiving lorcaserin and 45.1% of patients (716 of 1587) receiving placebo remained in the trial; 1553 patients continued into year 2.  At 1 yr, 47.5% of patients in the lorcaserin group and 20.3% in the placebo group had lost 5% or more of their body wt. (P < 0.001), corresponding to an av. loss of 5.8 ± 0.2 kg with lorcaserin and 2.2 ± 0.1 kg with placebo during year 1 (P < 0.001).  Among the patients who received lorcaserin during year 1 and who had lost 5% or more of their baseline wt. at 1 yr, the loss was maintained in more patients who continued to receive lorcaserin during year 2 (67.9%) than in patients who received placebo during year 2 (50.3%, P < 0.001).  Among 2472 patients evaluated at 1 yr and 1127 evaluated at 2 years, the rate of cardiac valvulopathy was not increased with the use of lorcaserin.  Among the most frequent adverse events reported with lorcaserin were headache, dizziness, and nausea.  The rates of serious adverse events in the 2 groups were similar.  In conjunction with behavioral modification, lorcaserin was assocd. with significant wt. loss and improved maintenance of wt. loss, as compared with placebo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVKMO5NV5jwLVg90H21EOLACvtfcHk0lixitgSbGVpMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVOgs74%253D&md5=66979aed566bcda525610ccf6d659e03</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0909809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0909809%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%2BR.%26atitle%3DMulticenter%252C%2520placebo-controlled%2520trial%2520of%2520lorcaserin%2520for%2520weight%2520management%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D245%26epage%3D256%26doi%3D10.1056%2FNEJMoa0909809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutcheson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merryman, W. D.</span></span> <span> </span><span class="NLM_article-title">Serotonin receptors and heart valve disease—It was meant 2B</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2011.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.pharmthera.2011.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=21440001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaksLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2011&pages=146-157&author=J.+D.+Hutchesonauthor=V.+Setolaauthor=B.+L.+Rothauthor=W.+D.+Merryman&title=Serotonin+receptors+and+heart+valve+disease%E2%80%94It+was+meant+2B&doi=10.1016%2Fj.pharmthera.2011.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin receptors and heart valve disease-It was meant 2B</span></div><div class="casAuthors">Hutcheson, Joshua D.; Setola, Vincent; Roth, Bryan L.; Merryman, W. David</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-157</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Carcinoid heart disease was one of the first valvular pathologies studied in mol. detail, and early research identified serotonin produced by oncogenic enterochromaffin cells as the likely culprit in causing changes in heart valve tissue.  Researchers and physicians in the mid-1960s noted a connection between the use of several ergot-derived medications with structures similar to serotonin and the development of heart valve pathologies similar to those obsd. in carcinoid patients.  The exact serotonergic target that mediated valvular pathogenesis remained a mystery for many years until similar cases were reported in patients using the popular diet drug Fen-Phen in the late 1990s.  The Fen-Phen episode sparked renewed interest in serotonin-mediated valve disease, and studies led to the identification of the 5-HT2B receptor as the likely mol. target leading to heart valve tissue fibrosis.  Subsequent studies have identified numerous other activators of the 5-HT2B receptor, and consequently, the use of many of these mols. has been linked to heart valve disease.  Herein, we: review the mol. properties of the 5-HT2B receptor including factors that differentiate the 5-HT2B receptor from other 5-HT receptor subtypes, discuss the studies that led to the identification of the 5-HT2B receptor as the mediator of heart valve disease, present current efforts to identify potential valvulopathogens by screening for 5-HT2B receptor activity, and speculate on potential therapeutic benefits of 5-HT2B receptor targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4R8A9Ia-r3LVg90H21EOLACvtfcHk0lixitgSbGVpMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaksLnO&md5=b97c1992208a501b1959c2f48f3ca9cd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2011.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DHutcheson%26aufirst%3DJ.%2BD.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DMerryman%26aufirst%3DW.%2BD.%26atitle%3DSerotonin%2520receptors%2520and%2520heart%2520valve%2520disease%25E2%2580%2594It%2520was%2520meant%25202B%26jtitle%3DPharmacol.%2520Ther.%26date%3D2011%26volume%3D132%26spage%3D146%26epage%3D157%26doi%3D10.1016%2Fj.pharmthera.2011.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">5-HT2C receptor modulators: a patent survey</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1429</span>– <span class="NLM_lpage">1455</span>, <span class="refDoi"> DOI: 10.1517/13543776.2010.518956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1517%2F13543776.2010.518956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=20849206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWmtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1429-1455&author=J.+Leeauthor=M.+E.+Jungauthor=J.+Lee&title=5-HT2C+receptor+modulators%3A+a+patent+survey&doi=10.1517%2F13543776.2010.518956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C receptor modulators: a patent survey</span></div><div class="casAuthors">Lee, Junwon; Jung, Myung Eun; Lee, Jinhwa</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1429-1455</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The 5-HT2C receptor is a GPCR and is one of the 14 subtypes that constitute the serotonin receptor family.  The 5-HT2C receptor is exclusively expressed in the CNS where it demonstrates a wide distribution and displays high-affinity interactions with a wide variety of psychiatric medications.  Modulators of 5-HT2C have been implicated as a potential treatment for diseases of significant unmet medical need, including obesity, schizophrenia, depression, anxiety, Parkinson's disease, drug addiction, erectile dysfunction and urinary incontinence.  Thus, there is a great interest in developing potent and selective 5-HT2C receptor modulators.  Areas covered in this review: This review article highlights the research progress in 5-HT2C receptor modulators published in the patent literature between Jan. 2003 and June 2010, giving emphasis to the medicinal chemist's standpoint.  What the reader will gain: Readers will rapidly gain an overview of the various 5-HT2C receptor modulators reported in the patent literature in the past 8 years.  Furthermore, the readers will learn which structure type can interact with the 5-HT2C receptor.  In addn., the readers will be aware of the pharmaceutical companies that have been the main players in the field.  Take home message: There is substantial evidence supporting the concept that a selective 5-HT2C receptor modulator should provide benefit in the treatment of a variety of CNS disorders.  Although research efforts have identified several promising 5-HT2C receptor modulators that display high functional selectivity, further clin. efficacy and safety data are needed to prove their actual clin. utility.  Therefore, the query for selectively acting 5-HT2C receptor modulators is still ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowsaQEKrg_R7Vg90H21EOLACvtfcHk0lixitgSbGVpMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWmtL%252FF&md5=43397f74d27751efdc505165ba96172c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.518956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.518956%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3D5-HT2C%2520receptor%2520modulators%253A%2520a%2520patent%2520survey%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D1429%26epage%3D1455%26doi%3D10.1517%2F13543776.2010.518956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartley, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbertson, S. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of tool compounds based on WAY163909, a 5-HT2C receptor agonist</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1004</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00439</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00439" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFCmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1004-1010&author=Y.-C.+Chenauthor=R.+M.+Hartleyauthor=N.+C.+Anastasioauthor=K.+A.+Cunninghamauthor=S.+R.+Gilbertson&title=Synthesis+and+structure%E2%80%93activity+relationships+of+tool+compounds+based+on+WAY163909%2C+a+5-HT2C+receptor+agonist&doi=10.1021%2Facschemneuro.6b00439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of Tool Compounds Based on WAY163909, a 5-HT2C Receptor Agonist</span></div><div class="casAuthors">Chen, Ying-Chu; Hartley, Rachel M.; Anastasio, Noelle C.; Cunningham, Kathryn A.; Gilbertson, Scott R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1004-1010</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of probe mols. that can be used to investigate G protein-coupled receptor (GPCR) pharmacol., trafficking, and relationship with other GPCRs is an important and growing area of research.  Here, the authors report the synthesis of analogs of the known selective serotonin (5-HT) 5-HT2C receptor (5-HT2CR) agonist WAY163909 which were designed to allow for the attachment of a second ligand, signaling or reporter mols., as well as immobilization agents to the parent mol. with the maintenance of agonist activity.  This goal was accomplished by the synthesis of novel mols. in which sites a-d were modified and resulting compds. were analyzed pharmacol. in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJeg1iODPDX7Vg90H21EOLACvtfcHk0liji-D0idF_hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFCmurc%253D&md5=812ac0958eaac00f68b73bd4899845ae</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00439%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.-C.%26aulast%3DHartley%26aufirst%3DR.%2BM.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DGilbertson%26aufirst%3DS.%2BR.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520tool%2520compounds%2520based%2520on%2520WAY163909%252C%2520a%25205-HT2C%2520receptor%2520agonist%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D1004%26epage%3D1010%26doi%3D10.1021%2Facschemneuro.6b00439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grottick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzaghi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes-Saldana, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espitia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuskin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whelan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Shamma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalmers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behan, D.</span></span> <span> </span><span class="NLM_article-title">Lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist: in vitro and in vivo pharmacological characterization</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>325</i></span>,  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">587</span>, <span class="refDoi"> DOI: 10.1124/jpet.107.133348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1124%2Fjpet.107.133348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=18252809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVOjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=577-587&author=W.+J.+Thomsenauthor=A.+J.+Grottickauthor=F.+Menzaghiauthor=H.+Reyes-Saldanaauthor=S.+Espitiaauthor=D.+Yuskinauthor=K.+Whelanauthor=M.+Martinauthor=M.+Morganauthor=W.+Chenauthor=H.+Al-Shammaauthor=B.+Smithauthor=D.+Chalmersauthor=D.+Behan&title=Lorcaserin%2C+a+novel+selective+human+5-hydroxytryptamine+2C+agonist%3A+in+vitro+and+in+vivo+pharmacological+characterization&doi=10.1124%2Fjpet.107.133348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization</span></div><div class="casAuthors">Thomsen, William J.; Grottick, Andrew J.; Menzaghi, Frederique; Reyes-Saldana, Hazel; Espitia, Stephen; Yuskin, Diane; Whelan, Kevin; Martin, Michael; Morgan, Michael; Chen, Weichao; Al-Shamma, Hussein; Smith, Brian; Chalmers, Derek; Behan, Dominic</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">577-587</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine (5-HT)2C receptor agonists hold promise for the treatment of obesity.  In this study, we describe the in vitro and in vivo characteristics of lorcaserin [(1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3 benzazepine], a selective, high affinity 5-HT2C full agonist.  Lorcaserin bound to human and rat 5-HT2C receptors with high affinity (Ki = 15±1 nM, 29±7 nM, resp.), and it was a full agonist for the human 5-HT2C receptor in a functional inositol phosphate accumulation assay, with 18- and 104-fold selectivity over 5-HT2A and 5-HT2B receptors, resp.  Lorcaserin was also highly selective for human 5-HT2C over other human 5-HT receptors (5-HT1A, 5-HT3, 5-HT4C, 5-HT55A, 5-HT6, and 5-HT7), in addn. to a panel of 67 other G protein-coupled receptors and ion channels.  Lorcaserin did not compete for binding of ligands to serotonin, dopamine, and norepinephrine transporters, and it did not alter their function in vitro.  Behavioral observations indicated that unlike the 5-HT2A agonist (±)-1-(2,5-dimethoxy-4-phenyl)-2-aminopropane, lorcaserin did not induce behavioral changes indicative of functional 5-HT2A agonist activity.  Acutely, lorcaserin reduced food intake in rats, an effect that was reversed by pretreatment with the 5-HT2C-selective antagonist 6-chloro-5-methyl-1-[6-(2-methylpyridin-3-yloxy)pyridin-3-yl-carbamoyl]indoline (SB242,084) but not the 5-HT2A antagonist (R)-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol (MDL 100,907), demonstrating mediation by the 5-HT2C receptor.  Chronic daily treatment with lorcaserin to rats maintained on a high fat diet produced dose-dependent redns. in food intake and body wt. gain that were maintained during the 4-wk study.  Upon discontinuation, body wt. returned to control levels.  These data demonstrate lorcaserin to be a potent, selective, and efficacious agonist of the 5-HT2C receptor, with potential for the treatment of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqDHE28aF3k7Vg90H21EOLACvtfcHk0liji-D0idF_hA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVOjtrc%253D&md5=0626c3dabb7e89066e45ecd12cbc81f8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.133348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.133348%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DW.%2BJ.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DMenzaghi%26aufirst%3DF.%26aulast%3DReyes-Saldana%26aufirst%3DH.%26aulast%3DEspitia%26aufirst%3DS.%26aulast%3DYuskin%26aufirst%3DD.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DChalmers%26aufirst%3DD.%26aulast%3DBehan%26aufirst%3DD.%26atitle%3DLorcaserin%252C%2520a%2520novel%2520selective%2520human%25205-hydroxytryptamine%25202C%2520agonist%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D577%26epage%3D587%26doi%3D10.1124%2Fjpet.107.133348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Allosteric modulation of G protein-coupled receptors: an emerging approach of drug discovery</span>. <i>Austin J. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=27148592" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=1101&author=C.+Wildauthor=K.+A.+Cunninghamauthor=J.+Zhou&title=Allosteric+modulation+of+G+protein-coupled+receptors%3A+an+emerging+approach+of+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DC.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DAllosteric%2520modulation%2520of%2520G%2520protein-coupled%2520receptors%253A%2520an%2520emerging%2520approach%2520of%2520drug%2520discovery%26jtitle%3DAustin%2520J.%2520Pharmacol.%2520Ther.%26date%3D2014%26volume%3D2%26spage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Melancon, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1445</span>– <span class="NLM_lpage">1464</span>, <span class="refDoi"> DOI: 10.1021/jm201139r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201139r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SmurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1445-1464&author=B.+J.+Melanconauthor=C.+R.+Hopkinsauthor=M.+R.+Woodauthor=K.+A.+Emmitteauthor=C.+M.+Niswenderauthor=A.+Christopoulosauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Allosteric+modulation+of+seven+transmembrane+spanning+receptors%3A+theory%2C+practice%2C+and+opportunities+for+central+nervous+system+drug+discovery&doi=10.1021%2Fjm201139r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery</span></div><div class="casAuthors">Melancon, Bruce J.; Hopkins, Corey R.; Wood, Michael R.; Emmitte, Kyle A.; Niswender, Colleen M.; Christopoulos, Arthur; Conn, P. Jeffrey; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1445-1464</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Allosteric modulation of Seven transmembrane spanning receptors and the opportunities for CNS drug discovery is reviewed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlr4lj_Wp-O7Vg90H21EOLACvtfcHk0lj1SAy9o8RvCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SmurnJ&md5=7c70f066f1581f1ff327c0dce37bb0e1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm201139r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201139r%26sid%3Dliteratum%253Aachs%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAllosteric%2520modulation%2520of%2520seven%2520transmembrane%2520spanning%2520receptors%253A%2520theory%252C%2520practice%252C%2520and%2520opportunities%2520for%2520central%2520nervous%2520system%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1445%26epage%3D1464%26doi%3D10.1021%2Fjm201139r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nickols, H.
H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span> <span> </span><span class="NLM_article-title">Development of allosteric modulators of GPCRs for treatment of CNS disorders</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2013.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.nbd.2013.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=24076101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FitVejsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2014&pages=55-71&author=H.%0AH.+Nickolsauthor=P.+J.+Conn&title=Development+of+allosteric+modulators+of+GPCRs+for+treatment+of+CNS+disorders&doi=10.1016%2Fj.nbd.2013.09.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development of allosteric modulators of GPCRs for treatment of CNS disorders</span></div><div class="casAuthors">Nickols Hilary Highfield; Conn P Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The discovery of allosteric modulators of G protein-coupled receptors (GPCRs) provides a promising new strategy with potential for developing novel treatments for a variety of central nervous system (CNS) disorders.  Traditional drug discovery efforts targeting GPCRs have focused on developing ligands for orthosteric sites which bind endogenous ligands.  Allosteric modulators target a site separate from the orthosteric site to modulate receptor function.  These allosteric agents can either potentiate (positive allosteric modulator, PAM) or inhibit (negative allosteric modulator, NAM) the receptor response and often provide much greater subtype selectivity than orthosteric ligands for the same receptors.  Experimental evidence has revealed more nuanced pharmacological modes of action of allosteric modulators, with some PAMs showing allosteric agonism in combination with positive allosteric modulation in response to endogenous ligand (ago-potentiators) as well as "bitopic" ligands that interact with both the allosteric and orthosteric sites.  Drugs targeting the allosteric site allow for increased drug selectivity and potentially decreased adverse side effects.  Promising evidence has demonstrated potential utility of a number of allosteric modulators of GPCRs in multiple CNS disorders, including neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, as well as psychiatric or neurobehavioral diseases such as anxiety, schizophrenia, and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5AaOVGoQQ2DEC-75aqa5AfW6udTcc2ebajtRSlPhDOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FitVejsA%253D%253D&md5=a1535b4448734bcae63e9797d2009737</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2013.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2013.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DNickols%26aufirst%3DH.%2BH.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DDevelopment%2520of%2520allosteric%2520modulators%2520of%2520GPCRs%2520for%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2014%26volume%3D61%26spage%3D55%26epage%3D71%26doi%3D10.1016%2Fj.nbd.2013.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Westhuizen, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Endogenous allosteric modulators of G protein–coupled receptors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.221606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1124%2Fjpet.114.221606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=25650376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVWntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2015&pages=246-260&author=E.+T.+van%0Ader+Westhuizenauthor=C.+Valantauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Endogenous+allosteric+modulators+of+G+protein%E2%80%93coupled+receptors&doi=10.1124%2Fjpet.114.221606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous allosteric modulators of G protein-coupled receptors</span></div><div class="casAuthors">van der Westhuizen, Emma T.; Valant, Celine; Sexton, Patrick M.; Christopoulos, Christopoulos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-260</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) are the largest superfamily of receptors encoded by the human genome, and represent the largest class of current drug targets.  Over the last decade and a half, it has become widely accepted that most, if not all, GPCRs possess spatially distinct allosteric sites that can be targeted by exogenous substances to modulate the receptors' biol. state.  Although many of these allosteric sites are likely to serve other (e.g., structural) roles, they nonetheless possess appropriate properties to be serendipitously targeted by synthetic mols.  However, there are also examples of endogenous substances that can act as allosteric modulators of GPCRs.  These include not only the obvious example, i.e., the G protein, but also a variety of ions, lipids, amino acids, peptides, and accessory proteins that display different degrees of receptor-specific modulatory effects.  This also suggests that some GPCRs may possess true "orphan" allosteric sites for hitherto unappreciated endogenous modulators.  Of note, the increasing identification of allosteric modulator lipids, inflammatory peptides, and GPCR-targeted autoantibodies indicates that disease context plays an important role in the generation of putative endogenous GPCR modulators.  If an endogenous allosteric substance can be shown to play a role in disease, this could also serve as an impetus to pursue synthetic neutral allosteric ligands as novel therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptdf28zfijQrVg90H21EOLACvtfcHk0lj1SAy9o8RvCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVWntb4%253D&md5=4e9eacb10df4523109feba729fbb9409</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.221606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.221606%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DE.%2BT.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DEndogenous%2520allosteric%2520modulators%2520of%2520G%2520protein%25E2%2580%2593coupled%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D353%26spage%3D246%26epage%3D260%26doi%3D10.1124%2Fjpet.114.221606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span> <span> </span><span class="NLM_article-title">Calcium sensing receptor activators: calcimimetics</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3027</span>– <span class="NLM_lpage">3034</span>, <span class="refDoi"> DOI: 10.2174/092986707782794096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.2174%2F092986707782794096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=18220738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=3027-3034&author=P.+E.+Harringtonauthor=C.+Fotsch&title=Calcium+sensing+receptor+activators%3A+calcimimetics&doi=10.2174%2F092986707782794096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium sensing receptor activators: calcimimetics</span></div><div class="casAuthors">Harrington, Paul E.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3027-3034</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The calcium sensing receptor (CaR) is a G protein-coupled receptor (GPCR) that plays a fundamental role in serum calcium homeostasis.  The CaR is expressed on the chief cells of the parathyroid gland and is responsible for controlling the secretion of parathyroid hormone (PTH).  PTH acts on several organs including the bone, kidney, and intestine to tightly regulate the concn. of serum calcium.  Substances other than calcium that activate the CaR are referred to as calcimimetics.  Calcimimetics that bind to the CaR as agonists are referred to as type I.  Type II calcimimetics bind to a site that is distinct from the physiol. ligand and function as pos. allosteric modulators of the CaR.  Type II calcimimetics amplify the sensitivity of the CaR to serum calcium and are thus able to lower the concn. of serum PTH.  Calcimimetics are being pursued as therapeutics for the treatment of disorders that are characterized by elevated levels of PTH such as primary and secondary hyperparathyroidism (primary HPT and secondary HPT).  In this review, we provide an overview of key results in the discovery of cinacalcet HCl (Sensipar in the US, Mimpara in Europe).  In addn., other recently disclosed type II calcimimetics are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBRgBPKixE4rVg90H21EOLACvtfcHk0li9YlOmey4GyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSrs7Y%253D&md5=7f519dd21f377ef76af4a43c722206f8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F092986707782794096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707782794096%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DP.%2BE.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DCalcium%2520sensing%2520receptor%2520activators%253A%2520calcimimetics%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D3027%26epage%3D3034%26doi%3D10.2174%2F092986707782794096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macartney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickett, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Burchnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armour, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros, M.</span></span> <span> </span><span class="NLM_article-title">Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4721</span>– <span class="NLM_lpage">4732</span>, <span class="refDoi"> DOI: 10.1128/AAC.49.11.4721-4732.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1128%2FAAC.49.11.4721-4732.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=16251317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Siu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=4721-4732&author=P.+Dorrauthor=M.+Westbyauthor=S.+Dobbsauthor=P.+Griffinauthor=B.+Irvineauthor=M.+Macartneyauthor=J.+Moriauthor=G.+Rickettauthor=C.+Smith-Burchnellauthor=C.+Napierauthor=R.+Websterauthor=D.+Armourauthor=D.+Priceauthor=B.+Stammenauthor=A.+Woodauthor=M.+Perros&title=Maraviroc+%28UK-427%2C857%29%2C+a+potent%2C+orally+bioavailable%2C+and+selective+small-molecule+inhibitor+of+chemokine+receptor+CCR5+with+broad-spectrum+anti-human+immunodeficiency+virus+type+1+activity&doi=10.1128%2FAAC.49.11.4721-4732.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</span></div><div class="casAuthors">Dorr, Patrick; Westby, Mike; Dobbs, Susan; Griffin, Paul; Irvine, Becky; Macartney, Malcolm; Mori, Julie; Rickett, Graham; Smith-Burchnell, Caroline; Napier, Carolyn; Webster, Rob; Armour, Duncan; Price, David; Stammen, Blanda; Wood, Anthony; Perros, Manos</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4721-4732</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Maraviroc (UK-427,857) is a selective CCR5 antagonist with potent antihuman immunodeficiency virus type 1 (HIV-1) activity and favorable pharmacol. properties.  Maraviroc is the product of a medicinal chem. effort initiated following identification of an imidazopyridine CCR5 ligand from a high-throughput screen of the Pfizer compd. file.  Maraviroc demonstrated potent antiviral activity against all CCR5-tropic HIV-1 viruses tested, including 43 primary isolates from various clades and diverse geog. origin (geometric mean 90% inhibitory concn. of 2.0 nM).  Maraviroc was active against 200 clin. derived HIV-1 envelope-recombinant pseudoviruses, 100 of which were derived from viruses resistant to existing drug classes.  There was little difference in the sensitivity of the 200 viruses to maraviroc, as illustrated by the biol. cutoff in this assay (= geometric mean plus two std. deviations [SD] of 1.7-fold).  The mechanism of action of maraviroc was established using cell-based assays, where it blocked binding of viral envelope, gp120, to CCR5 to prevent the membrane fusion events necessary for viral entry.  Maraviroc did not affect CCR5 cell surface levels or assocd. intracellular signaling, confirming it as a functional antagonist of CCR5.  Maraviroc has no detectable in vitro cytotoxicity and is highly selective for CCR5, as confirmed against a wide range of receptors and enzymes, including the hERG ion channel (50% inhibitory concn., > 10 μM), indicating potential for an excellent clin. safety profile.  Studies in preclin. in vitro and in vivo models predicted maraviroc to have human pharmacokinetics consistent with once- or twice-daily dosing following oral administration.  Clin. trials are ongoing to further investigate the potential of using maraviroc for the treatment of HIV-1 infection and AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN0Z8KdsHODrVg90H21EOLACvtfcHk0li9YlOmey4GyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Siu7rM&md5=561aea68490f7c6d3ec0f65676450155</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.11.4721-4732.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.11.4721-4732.2005%26sid%3Dliteratum%253Aachs%26aulast%3DDorr%26aufirst%3DP.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DDobbs%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DIrvine%26aufirst%3DB.%26aulast%3DMacartney%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DRickett%26aufirst%3DG.%26aulast%3DSmith-Burchnell%26aufirst%3DC.%26aulast%3DNapier%26aufirst%3DC.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DArmour%26aufirst%3DD.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DStammen%26aufirst%3DB.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DPerros%26aufirst%3DM.%26atitle%3DMaraviroc%2520%2528UK-427%252C857%2529%252C%2520a%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520chemokine%2520receptor%2520CCR5%2520with%2520broad-spectrum%2520anti-human%2520immunodeficiency%2520virus%2520type%25201%2520activity%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D4721%26epage%3D4732%26doi%3D10.1128%2FAAC.49.11.4721-4732.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1038/nrd2760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fnrd2760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=19116626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCkurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=41-54&author=P.+J.+Connauthor=A.+Christopoulosauthor=C.+W.+Lindsley&title=Allosteric+modulators+of+GPCRs%3A+a+novel+approach+for+the+treatment+of+CNS+disorders&doi=10.1038%2Fnrd2760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders</span></div><div class="casAuthors">Conn, P. Jeffrey; Christopoulos, Arthur; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-54</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite G-protein-coupled receptors (GPCRs) being among the most fruitful targets for marketed drugs, intense discovery efforts for several GPCR subtypes have failed to deliver selective drug candidates.  Historically, drug discovery programs for GPCR ligands have been dominated by efforts to develop agonists and antagonists that act at orthosteric sites for endogenous ligands.  However, in recent years, there have been tremendous advances in the discovery of novel ligands for GPCRs that act at allosteric sites to regulate receptor function.  These compds. provide high selectivity, novel modes of efficacy and may lead to novel therapeutic agents for the treatment of multiple psychiatric and neurol. human disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmn5h5XCcPKbVg90H21EOLACvtfcHk0li9YlOmey4GyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCkurfF&md5=e109e94fe3e2c1fcfd480dc84c6609f7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrd2760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2760%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAllosteric%2520modulators%2520of%2520GPCRs%253A%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D41%26epage%3D54%26doi%3D10.1038%2Fnrd2760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Im, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chio, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D. M.</span></span> <span> </span><span class="NLM_article-title">Positive allosteric modulator of the human 5-HT 2C receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1124/mol.64.1.78</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1124%2Fmol.64.1.78" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=78-84&author=W.+B.+Imauthor=C.+L.+Chioauthor=G.+L.+Albertsauthor=D.+M.+Dinh&title=Positive+allosteric+modulator+of+the+human+5-HT+2C+receptor&doi=10.1124%2Fmol.64.1.78"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fmol.64.1.78&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.64.1.78%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DW.%2BB.%26aulast%3DChio%26aufirst%3DC.%2BL.%26aulast%3DAlberts%26aufirst%3DG.%2BL.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26atitle%3DPositive%2520allosteric%2520modulator%2520of%2520the%2520human%25205-HT%25202C%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D78%26epage%3D84%26doi%3D10.1124%2Fmol.64.1.78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Exploration of synthetic approaches and pharmacological evaluation of PNU-69176E and its stereoisomer as 5-HT2C receptor allosteric modulators</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">545</span>, <span class="refDoi"> DOI: 10.1021/cn300020x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300020x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=538-545&author=C.+Dingauthor=N.+M.+Bremerauthor=T.+D.+Smithauthor=P.+K.+Seitzauthor=N.+C.+Anastasioauthor=K.+A.+Cunninghamauthor=J.+Zhou&title=Exploration+of+synthetic+approaches+and+pharmacological+evaluation+of+PNU-69176E+and+its+stereoisomer+as+5-HT2C+receptor+allosteric+modulators&doi=10.1021%2Fcn300020x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of Synthetic Approaches and Pharmacological Evaluation of PNU-69176E and Its Stereoisomer as 5-HT2C Receptor Allosteric Modulators</span></div><div class="casAuthors">Ding, Chunyong; Bremer, Nicole M.; Smith, Thressa D.; Seitz, Patricia K.; Anastasio, Noelle C.; Cunningham, Kathryn A.; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">538-545</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Allosteric modulators of the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) present a unique drug design strategy to augment the response to endogenous 5-HT in a site- and event-specific manner with great potential as novel central nervous system probes and therapeutics.  To date, PNU-69176E is the only reported selective pos. allosteric modulator for the 5-HT2CR.  For the first time, an optimized synthetic route to readily access PNU-69176E (1) and its diastereomer 2 has been established in moderate to good overall yields over 10 steps starting from com. available picolinic acid.  This synthetic approach not only enables a feasible prepn. of a sufficient amt. of 1 for use as a ref. compd. for secondary pharmacol. studies, but also provides an efficient synthesis of key intermediates to develop novel and simplified 5-HT2CR allosteric modulators.  Compd. 1 and its diastereomer 2 were functionally characterized in Chinese hamster ovary (CHO) cells stably transfected with the 5-HT2CR using an intracellular calcium (Cai2+) release assay.  Compd. 1 demonstrated efficacy and potency as an allosteric modulator for the 5-HT2CR with no intrinsic agonist activity.  Compd. 1 did not alter 5-HT-evoked Cai2+ in CHO cells stably transfected with the highly homologous 5-HT2AR.  In contrast, the diastereomer 2 did not alter 5-HT-evoked Cai2+ release in 5-HT2AR-CHO or 5-HT2CR-CHO cells or exhibit intrinsic agonist activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-ZC-7cVkBGrVg90H21EOLACvtfcHk0lh5V1sze6w9Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOqsb0%253D&md5=1f635dd7796d2663f1ab08b92c7d7cb9</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn300020x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300020x%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26aulast%3DBremer%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BD.%26aulast%3DSeitz%26aufirst%3DP.%2BK.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DExploration%2520of%2520synthetic%2520approaches%2520and%2520pharmacological%2520evaluation%2520of%2520PNU-69176E%2520and%2520its%2520stereoisomer%2520as%25205-HT2C%2520receptor%2520allosteric%2520modulators%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D538%26epage%3D545%26doi%3D10.1021%2Fcn300020x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">García-Cárceles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Villa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codesido, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruces, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alén, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballesteros, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhamú, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez de Fonseca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span></span> <span> </span><span class="NLM_article-title">A positive allosteric modulator of the serotonin 5-HT2C receptor for obesity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9575</span>– <span class="NLM_lpage">9584</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00994</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00994" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9575-9584&author=J.+Garc%C3%ADa-C%C3%A1rcelesauthor=J.+M.+Decaraauthor=H.+V%C3%A1zquez-Villaauthor=R.+Rodr%C3%ADguezauthor=E.+Codesidoauthor=J.+Crucesauthor=J.+Breaauthor=M.+I.+Lozaauthor=F.+Al%C3%A9nauthor=J.+Bottaauthor=P.+J.+McCormickauthor=J.+A.+Ballesterosauthor=B.+Benham%C3%BAauthor=F.+Rodr%C3%ADguez+de+Fonsecaauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=A+positive+allosteric+modulator+of+the+serotonin+5-HT2C+receptor+for+obesity&doi=10.1021%2Facs.jmedchem.7b00994"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00994%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-C%25C3%25A1rceles%26aufirst%3DJ.%26aulast%3DDecara%26aufirst%3DJ.%2BM.%26aulast%3DV%25C3%25A1zquez-Villa%26aufirst%3DH.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DR.%26aulast%3DCodesido%26aufirst%3DE.%26aulast%3DCruces%26aufirst%3DJ.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DAl%25C3%25A9n%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DJ.%26aulast%3DMcCormick%26aufirst%3DP.%2BJ.%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DRodr%25C3%25ADguez%2Bde%2BFonseca%26aufirst%3DF.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DA%2520positive%2520allosteric%2520modulator%2520of%2520the%2520serotonin%25205-HT2C%2520receptor%2520for%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9575%26epage%3D9584%26doi%3D10.1021%2Facs.jmedchem.7b00994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farce, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthelot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavatte, P.</span></span> <span> </span><span class="NLM_article-title">Homology modelling of the serotoninergic 5-HT2c receptor</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1080/14756360600700608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1080%2F14756360600700608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=16918076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVKntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=285-292&author=A.+Farceauthor=S.+Dillyauthor=S.+Yousauthor=P.+Berthelotauthor=P.+Chavatte&title=Homology+modelling+of+the+serotoninergic+5-HT2c+receptor&doi=10.1080%2F14756360600700608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Homology modelling of the serotoninergic 5-HT2c receptor</span></div><div class="casAuthors">Farce, Amaury; Dilly, Sebastien; Yous, Said; Berthelot, Pascal; Chavatte, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">285-292</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Since its discovery, 5-hydroxytryptamine, more usually called serotonin, has been an elusive candidate as a major mood regulator.  This capacity gives it a great importance in the treatment of depression.  It is within this framework that the authors' work takes place, as it is related more particularly to a new therapeutic class whose leader is agomelatine.  This compd. binds to the melatoninergic receptors and to the serotoninergic 5-HT2c receptor, giving rise to the MASSA concept (Melatonin Agonist and Selective Serotonin Antagonist).  Like the majority of the serotoninergic receptors, the sub-type 5-HT2c is a G-protein coupled receptor (GPCR).  The three-dimensional structure of 5-HT2c is not exptl. known, and the authors thus resorted to comparative homol. modeling to build a model allowing the authors to study its interactions with agomelatine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKJDpbpA5GkbVg90H21EOLACvtfcHk0lh5V1sze6w9Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVKntLw%253D&md5=5ef644a7636eaab3fc9df8dee38a73f2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F14756360600700608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360600700608%26sid%3Dliteratum%253Aachs%26aulast%3DFarce%26aufirst%3DA.%26aulast%3DDilly%26aufirst%3DS.%26aulast%3DYous%26aufirst%3DS.%26aulast%3DBerthelot%26aufirst%3DP.%26aulast%3DChavatte%26aufirst%3DP.%26atitle%3DHomology%2520modelling%2520of%2520the%2520serotoninergic%25205-HT2c%2520receptor%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2006%26volume%3D21%26spage%3D285%26epage%3D292%26doi%3D10.1080%2F14756360600700608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, Z.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists</span>. <i>Acta Biochim. Biophys. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1111/j.1745-7270.2007.00295.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1111%2Fj.1745-7270.2007.00295.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=17558446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1KmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=413-422&author=Z.+Zuo&title=Pharmacophore-directed+homology+modeling+and+molecular+dynamics+simulation+of+G+protein-coupled+receptor%3A+study+of+possible+binding+modes+of+5-HT2C+receptor+agonists&doi=10.1111%2Fj.1745-7270.2007.00295.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists</span></div><div class="casAuthors">Zuo, Zhili; Chen, Gang; Luo, Xiaomin; Puah, Chummok; Zhu, Weiliang; Chen, Kaixian; Jiang, Hualiang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica et Biophysica Sinica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">413-422</span>CODEN:
                <span class="NLM_cas:coden">ABBSC2</span>;
        ISSN:<span class="NLM_cas:issn">1672-9145</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A new pharmacophore-based modeling procedure, including homol. modeling, pharmacophore study, flexible mol. docking, and long-time mol. dynamics (MD) simulations, was employed to construct the structure of the human 5-HT2C receptor and det. the characteristics of binding modes of 5-HT2C receptor agonists.  An agonist-receptor complex has been constructed based on homol. modeling and a pharmacophore hypothesis model based on some high active compds.  Then MD simulations of the ligand-receptor complex in an explicit membrane environment were carried out.  The conformation of the 5-HT2C receptor during MD simulation was explored, and the stable binding modes of the studied agonist were detd.  Flexible mol. docking of several structurally diverse agonists of the human 5-HT2C receptor was carried out, and the general binding modes of these agonists were investigated.  According to the models presented in this work and the results of Flexi-Dock, the involvement of the amino acid residues Asp134, Ser138, Asn210, Asn331, Tyr358, Ile131, Ser132, Val135, Thr139, Ile189, Val202, Val208, Leu209, Phe214, Val215, Gly218, Ser219, Phe223, Trp324, Phe327, and Phe328 in agonist recognition was studied.  The obtained binding modes of the human 5-HT2C receptor agonists have good agreement with the site-directed mutagenesis data and other studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9zYrIwMty4LVg90H21EOLACvtfcHk0lhF9321QF2kHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1KmsLk%253D&md5=3904d907fe4c10d429fd3c3c2768c371</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fj.1745-7270.2007.00295.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1745-7270.2007.00295.x%26sid%3Dliteratum%253Aachs%26aulast%3DZuo%26aufirst%3DZ.%26atitle%3DPharmacophore-directed%2520homology%2520modeling%2520and%2520molecular%2520dynamics%2520simulation%2520of%2520G%2520protein-coupled%2520receptor%253A%2520study%2520of%2520possible%2520binding%2520modes%2520of%25205-HT2C%2520receptor%2520agonists%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2007%26volume%3D39%26spage%3D413%26epage%3D422%26doi%3D10.1111%2Fj.1745-7270.2007.00295.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berg, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spampinato, U.</span></span> <span> </span><span class="NLM_article-title">Fine-tuning serotonin2c receptor function in the brain: Molecular and functional implications</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">969</span>– <span class="NLM_lpage">976</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.neuropharm.2008.06.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=969-976&author=K.+A.+Bergauthor=W.+P.+Clarkeauthor=K.+A.+Cunninghamauthor=U.+Spampinato&title=Fine-tuning+serotonin2c+receptor+function+in+the+brain%3A+Molecular+and+functional+implications&doi=10.1016%2Fj.neuropharm.2008.06.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DK.%2BA.%26aulast%3DClarke%26aufirst%3DW.%2BP.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DSpampinato%26aufirst%3DU.%26atitle%3DFine-tuning%2520serotonin2c%2520receptor%2520function%2520in%2520the%2520brain%253A%2520Molecular%2520and%2520functional%2520implications%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D969%26epage%3D976%26doi%3D10.1016%2Fj.neuropharm.2008.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurome, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzano, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malberg, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldarone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Selective 5-hydroxytryptamine 2C receptor aonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1885</span>– <span class="NLM_lpage">1902</span>, <span class="refDoi"> DOI: 10.1021/jm801354e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801354e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1885-1902&author=S.+J.+Choauthor=N.+H.+Jensenauthor=T.+Kuromeauthor=S.+Kadariauthor=M.+L.+Manzanoauthor=J.+E.+Malbergauthor=B.+Caldaroneauthor=B.+L.+Rothauthor=A.+P.+Kozikowski&title=Selective+5-hydroxytryptamine+2C+receptor+aonists+derived+from+the+lead+compound+tranylcypromine%3A+identification+of+drugs+with+antidepressant-like+action&doi=10.1021%2Fjm801354e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm801354e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801354e%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DKurome%26aufirst%3DT.%26aulast%3DKadari%26aufirst%3DS.%26aulast%3DManzano%26aufirst%3DM.%2BL.%26aulast%3DMalberg%26aufirst%3DJ.%2BE.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSelective%25205-hydroxytryptamine%25202C%2520receptor%2520aonists%2520derived%2520from%2520the%2520lead%2520compound%2520tranylcypromine%253A%2520identification%2520of%2520drugs%2520with%2520antidepressant-like%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1885%26epage%3D1902%26doi%3D10.1021%2Fjm801354e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berg, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sailstad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltzman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maayani, S.</span></span> <span> </span><span class="NLM_article-title">Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">484</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=477-484&author=K.+A.+Bergauthor=W.+P.+Clarkeauthor=C.+Sailstadauthor=A.+Saltzmanauthor=S.+Maayani&title=Signal+transduction+differences+between+5-hydroxytryptamine+type+2A+and+type+2C+receptor+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DK.%2BA.%26aulast%3DClarke%26aufirst%3DW.%2BP.%26aulast%3DSailstad%26aufirst%3DC.%26aulast%3DSaltzman%26aufirst%3DA.%26aulast%3DMaayani%26aufirst%3DS.%26atitle%3DSignal%2520transduction%2520differences%2520between%25205-hydroxytryptamine%2520type%25202A%2520and%2520type%25202C%2520receptor%2520systems%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D46%26spage%3D477%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbertson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubar, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swinford, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charendoff, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craft, J. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laezza, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1615</span>– <span class="NLM_lpage">1630</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2656-12.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1523%2FJNEUROSCI.2656-12.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23345234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVehsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1615-1630&author=N.+C.+Anastasioauthor=S.+R.+Gilbertsonauthor=M.+J.+Bubarauthor=A.+Agarkovauthor=S.+J.+Stutzauthor=Y.+Jengauthor=N.+M.+Bremerauthor=T.+D.+Smithauthor=R.+G.+Foxauthor=S.+E.+Swinfordauthor=P.+K.+Seitzauthor=M.+N.+Charendoffauthor=J.+W.+Craftauthor=F.+M.+Laezzaauthor=C.+S.+Watsonauthor=J.+M.+Briggsauthor=K.+A.+Cunningham&title=Peptide+inhibitors+disrupt+the+serotonin+5-HT2C+receptor+interaction+with+phosphatase+and+tensin+homolog+to+allosterically+modulate+cellular+signaling+and+behavior&doi=10.1523%2FJNEUROSCI.2656-12.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior</span></div><div class="casAuthors">Anastasio, Noelle C.; Gilbertson, Scott R.; Bubar, Marcy J.; Agarkov, Anton; Stutz, Sonja J.; Jeng, Yowjiun; Bremer, Nicole M.; Smith, Thressa D.; Fox, Robert G.; Swinford, Sarah E.; Seitz, Patricia K.; Charendoff, Marc N.; Craft, John W., Jr.; Laezza, Fernanda M.; Watson, Cheryl S.; Briggs, James M.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1615-1630</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Serotonin (5-hydroxytryptamine; 5-HT) signaling through the 5-HT2C receptor (5-HT2CR) is essential in normal physiol., whereas aberrant 5-HT2CR function is thought to contribute to the pathogenesis of multiple neural disorders.  The 5-HT2CR interacts with specific protein partners, but the impact of such interactions on 5-HT2CR function is poorly understood.  Here, the authors report convergent cellular and behavioral data that the interaction between the 5-HT2CR and protein phosphatase and tensin homolog (PTEN) serves as a regulatory mechanism to control 5-HT2CR-mediated biol. but not that of the closely homologous 5-HT2AR.  A peptide derived from the third intracellular loop of the human 5-HT2CR [3L4F (third loop, fourth fragment)] disrupted the assocn., allosterically augmented 5-HT2CR-mediated signaling in live cells, and acted as a pos. allosteric modulator in rats in vivo.  The authors identified the crit. residues within an 8 aa fragment of the 3L4F peptide that maintained efficacy (within the picomolar range) in live cells similar to that of the 3L4F peptide.  Last, mol. modeling identified key structural features and potential interaction sites of the active 3L4F peptides against PTEN.  These compelling data demonstrate the specificity and importance of this protein assembly in cellular events and behaviors mediated by 5-HT2CR signaling and provide a chem. guidepost to the future development of drug-like peptide or small-mol. inhibitors as neuroprobes to study 5-HT2CR allostery and therapeutics for 5-HT2CR-mediated disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxfvdVf-m7RrVg90H21EOLACvtfcHk0lhF9321QF2kHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVehsL4%253D&md5=f2b9ea10c27f043b1dee05e2a6890010</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2656-12.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2656-12.2013%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DGilbertson%26aufirst%3DS.%2BR.%26aulast%3DBubar%26aufirst%3DM.%2BJ.%26aulast%3DAgarkov%26aufirst%3DA.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DJeng%26aufirst%3DY.%26aulast%3DBremer%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BD.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DSwinford%26aufirst%3DS.%2BE.%26aulast%3DSeitz%26aufirst%3DP.%2BK.%26aulast%3DCharendoff%26aufirst%3DM.%2BN.%26aulast%3DCraft%26aufirst%3DJ.%2BW.%26aulast%3DLaezza%26aufirst%3DF.%2BM.%26aulast%3DWatson%26aufirst%3DC.%2BS.%26aulast%3DBriggs%26aufirst%3DJ.%2BM.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DPeptide%2520inhibitors%2520disrupt%2520the%2520serotonin%25205-HT2C%2520receptor%2520interaction%2520with%2520phosphatase%2520and%2520tensin%2520homolog%2520to%2520allosterically%2520modulate%2520cellular%2520signaling%2520and%2520behavior%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D1615%26epage%3D1630%26doi%3D10.1523%2FJNEUROSCI.2656-12.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melcher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span> <span> </span><span class="NLM_article-title">Structural basis for molecular recognition at serotonin receptors</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">610</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1126/science.1232807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1126%2Fscience.1232807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23519210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=610-614&author=C.+Wangauthor=Y.+Jiangauthor=J.+Maauthor=H.+Wuauthor=D.+Wackerauthor=V.+Katritchauthor=G.+W.+Hanauthor=W.+Liuauthor=X.-P.+Huangauthor=E.+Vardyauthor=J.+D.+McCorvyauthor=X.+Gaoauthor=E.+Zhouauthor=K.+Melcherauthor=C.+Zhangauthor=F.+Baiauthor=H.+Yangauthor=L.+Yangauthor=H.+Jiangauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevensauthor=H.+E.+Xu&title=Structural+basis+for+molecular+recognition+at+serotonin+receptors&doi=10.1126%2Fscience.1232807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Molecular Recognition at Serotonin Receptors</span></div><div class="casAuthors">Wang, Chong; Jiang, Yi; Ma, Jinming; Wu, Huixian; Wacker, Daniel; Katritch, Vsevolod; Han, Gye Won; Liu, Wei; Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Gao, Xiang; Zhou, X. Edward; Melcher, Karsten; Zhang, Chenghai; Bai, Fang; Yang, Huaiyu; Yang, Linlin; Jiang, Hualiang; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.; Xu, H. Eric</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">610-614</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Serotonin or 5-hydroxytryptamine (5-HT) regulates a wide spectrum of human physiol. through the 5-HT receptor family.  The authors report the crystal structures of the human 5-HT1B G protein-coupled receptor bound to the agonist antimigraine medications ergotamine and dihydroergotamine.  The structures reveal similar binding modes for these ligands, which occupy the orthosteric pocket and an extended binding pocket close to the extracellular loops.  The orthosteric pocket is formed by residues conserved in the 5-HT receptor family, clarifying the family-wide agonist activity of 5-HT.  Compared with the structure of the 5-HT2B receptor, the 5-HT1B receptor displays a 3 angstrom outward shift at the extracellular end of helix V, resulting in a more open extended pocket that explains subtype selectivity.  Together with docking and mutagenesis studies, these structures provide a comprehensive structural basis for understanding receptor-ligand interactions and designing subtype-selective serotonergic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLc0rOIqg_2bVg90H21EOLACvtfcHk0lha-im3B2NqRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksbw%253D&md5=ce0773088a86f6a2c83b6cb77a63e708</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1126%2Fscience.1232807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1232807%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DE.%26aulast%3DMelcher%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DBai%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DStructural%2520basis%2520for%2520molecular%2520recognition%2520at%2520serotonin%2520receptors%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D610%26epage%3D614%26doi%3D10.1126%2Fscience.1232807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structural features for functional selectivity at serotonin receptors</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1126/science.1232808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1126%2Fscience.1232808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23519215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=615-619&author=D.+Wackerauthor=C.+Wangauthor=V.+Katritchauthor=G.+W.+Hanauthor=X.-P.+Huangauthor=E.+Vardyauthor=J.+D.+McCorvyauthor=Y.+Jiangauthor=M.+Chuauthor=F.+Y.+Siuauthor=W.+Liuauthor=H.+E.+Xuauthor=V.+Cherezovauthor=B.+L.+Rothauthor=R.+C.+Stevens&title=Structural+features+for+functional+selectivity+at+serotonin+receptors&doi=10.1126%2Fscience.1232808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Features for Functional Selectivity at Serotonin Receptors</span></div><div class="casAuthors">Wacker, Daniel; Wang, Chong; Katritch, Vsevolod; Han, Gye Won; Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Jiang, Yi; Chu, Meihua; Siu, Fai Yiu; Liu, Wei; Xu, H. Eric; Cherezov, Vadim; Roth, Bryan L.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">615-619</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Drugs active at G protein-coupled receptors (GPCRs) can differentially modulate either canonical or noncanonical signaling pathways via a phenomenon known as functional selectivity or biased signaling.  The authors report biochem. studies showing that the hallucinogen lysergic acid diethylamide, its precursor ergotamine (ERG), and related ergolines display strong functional selectivity for β-arrestin signaling at the 5-HT2B 5-hydroxytryptamine (5-HT) receptor, whereas they are relatively unbiased at the 5-HT1B receptor.  To investigate the structural basis for biased signaling, the authors detd. the crystal structure of the human 5-HT2B receptor bound to ERG and compared it with the 5-HT1B/ERG structure.  Given the relatively poor understanding of GPCR structure and function to date, insight into different GPCR signaling pathways is important to better understand both adverse and favorable therapeutic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreo_QegM-j7bVg90H21EOLACvtfcHk0lha-im3B2NqRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksb0%253D&md5=16e96d0255be3ac367aeda7187aa4c15</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscience.1232808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1232808%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DM.%26aulast%3DSiu%26aufirst%3DF.%2BY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520features%2520for%2520functional%2520selectivity%2520at%2520serotonin%2520receptors%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D615%26epage%3D619%26doi%3D10.1126%2Fscience.1232808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schools, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of an LSD-bound human serotonin receptor</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.12.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.cell.2016.12.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=28129538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=377-389&author=D.+Wackerauthor=S.+Wangauthor=J.+D.+McCorvyauthor=R.+M.+Betzauthor=A.+J.+Venkatakrishnanauthor=A.+Levitauthor=K.+Lansuauthor=Z.+L.+Schoolsauthor=T.+Cheauthor=D.+E.+Nicholsauthor=B.+K.+Shoichetauthor=R.+O.+Drorauthor=B.+L.+Roth&title=Crystal+structure+of+an+LSD-bound+human+serotonin+receptor&doi=10.1016%2Fj.cell.2016.12.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an LSD-bound human serotonin receptor</span></div><div class="casAuthors">Wacker, Daniel; Wang, Sheng; McCorvy, John D.; Betz, Robin M.; Venkatakrishnan, A. J.; Levit, Anat; Lansu, Katherine; Schools, Zachary L.; Che, Tao; Nichols, David E.; Shoichet, Brian K.; Dror, Ron O.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-389.e12</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The prototypical hallucinogen, LSD, acts via serotonin receptors, and here the authors describe the crystal structure of LSD in complex with human serotonin receptor 5-HT2B.  The complex revealed conformational rearrangements to accommodate LSD, providing a structural explanation for the conformational selectivity of LSD's key diethylamide moiety.  LSD dissocd. exceptionally slow from both 5-HT2BR and 5-HT2AR, a major target for its psychoactivity.  Mol. dynamics (MD) simulations suggested that LSD's slow binding kinetics may be due to a "lid" formed by extracellular loop 2 (EL2) at the entrance to the binding pocket.  A mutation predicted to increase the mobility of this lid greatly accelerated LSD's binding kinetics and selectively dampened LSD-mediated β-arrestin 2 recruitment.  Thus, this study reveals an unexpected binding mode of LSD, illuminates key features of its kinetics, stereochem., and signaling, and provides a mol. explanation for LSD's actions at human serotonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcU-96ccslG7Vg90H21EOLACvtfcHk0limOtXledpz9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaqs7g%253D&md5=5eee71a2d385d97d9891b669e8c5afa1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.12.033%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DSchools%26aufirst%3DZ.%2BL.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DCrystal%2520structure%2520of%2520an%2520LSD-bound%2520human%2520serotonin%2520receptor%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D377%26epage%3D389%26doi%3D10.1016%2Fj.cell.2016.12.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harpsøe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolajsen, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjørn-Yoshimoto, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-J.</span></span> <span> </span><span class="NLM_article-title">5-HT2C receptor structures reveal the structural basis of GPCR polypharmacology</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.cell.2018.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=29398112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=719-730&author=Y.+Pengauthor=J.+D.+McCorvyauthor=K.+Harps%C3%B8eauthor=K.+Lansuauthor=S.+Yuanauthor=P.+Popovauthor=L.+Quauthor=M.+Puauthor=T.+Cheauthor=L.+F.+Nikolajsenauthor=X.-P.+Huangauthor=Y.+Wuauthor=L.+Shenauthor=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=K.+Dingauthor=D.+Wackerauthor=G.+W.+Hanauthor=J.+Chengauthor=V.+Katritchauthor=A.+A.+Jensenauthor=M.+A.+Hansonauthor=S.+Zhaoauthor=D.+E.+Gloriamauthor=B.+L.+Rothauthor=R.+C.+Stevensauthor=Z.-J.+Liu&title=5-HT2C+receptor+structures+reveal+the+structural+basis+of+GPCR+polypharmacology&doi=10.1016%2Fj.cell.2018.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology</span></div><div class="casAuthors">Peng, Yao; McCorvy, John D.; Harpsoee, Kasper; Lansu, Katherine; Yuan, Shuguang; Popov, Petr; Qu, Lu; Pu, Mengchen; Che, Tao; Nikolajsen, Louise F.; Huang, Xi-Ping; Wu, Yiran; Shen, Ling; Bjoern-Yoshimoto, Walden E.; Ding, Kang; Wacker, Daniel; Han, Gye Won; Cheng, Jianjun; Katritch, Vsevolod; Jensen, Anders A.; Hanson, Michael A.; Zhao, Suwen; Gloriam, David E.; Roth, Bryan L.; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">719-730.e14</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Drugs frequently require interactions with multiple targets-via a process known as polypharmacol.-to achieve their therapeutic actions.  Currently, drugs targeting several serotonin receptors, including the 5-HT2C receptor, are useful for treating obesity, drug abuse, and schizophrenia.  The competing challenges of developing selective 5-HT2C receptor ligands or creating drugs with a defined polypharmacol. profile, esp. aimed at G protein-coupled receptors (GPCRs), remain extremely difficult.  Here, we solved two structures of the 5-HT2C receptor in complex with the highly promiscuous agonist ergotamine and the 5-HT2A-C receptor-selective inverse agonist ritanserin at resolns. of 3.0 Å and 2.7 Å, resp.  We analyzed their resp. binding poses to provide mechanistic insights into their receptor recognition and opposing pharmacol. actions.  This study investigates the structural basis of polypharmacol. at canonical GPCRs and illustrates how understanding characteristic patterns of ligand-receptor interaction and activation may ultimately facilitate drug design at multiple GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooMwdaPWz7FLVg90H21EOLACvtfcHk0limOtXledpz9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSitrs%253D&md5=b6c7f55568544a8c363794fa12f18175</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DHarps%25C3%25B8e%26aufirst%3DK.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DPopov%26aufirst%3DP.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DNikolajsen%26aufirst%3DL.%2BF.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.-J.%26atitle%3D5-HT2C%2520receptor%2520structures%2520reveal%2520the%2520structural%2520basis%2520of%2520GPCR%2520polypharmacology%26jtitle%3DCell%26date%3D2018%26volume%3D172%26spage%3D719%26epage%3D730%26doi%3D10.1016%2Fj.cell.2018.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballesteros, J. A.</span>; <span class="NLM_string-name">Weinstein, H.</span></span> <span> </span><span class="NLM_article-title">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span>. In  <i>Methods in Neuroscience</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sealfon, S. C.</span></span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_year">1995</span>; Vol.  <span class="NLM_volume">25</span>, Chapter 19, pp  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">428</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=366-428&author=J.+A.+Ballesteros&author=H.+Weinsteinauthor=S.+C.+Sealfon&title=Methods+in+Neuroscience"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26atitle%3DIntegrated%2520methods%2520for%2520the%2520construction%2520of%2520three-dimensional%2520models%2520and%2520computational%2520probing%2520of%2520structure-function%2520relations%2520in%2520G%2520protein-coupled%2520receptors%26btitle%3DMethods%2520in%2520Neuroscience%26aulast%3DSealfon%26aufirst%3DS.%2BC.%26pub%3DAcademic%2520Press%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manivet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, B. t.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroteaux, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellermann, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, J.-M.</span></span> <span> </span><span class="NLM_article-title">The serotonin binding site of human and murine 5-HT2B receptors: molecular modeling and site-directed mutagenesis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">17170</span>– <span class="NLM_lpage">17178</span>, <span class="refDoi"> DOI: 10.1074/jbc.M200195200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1074%2Fjbc.M200195200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=17170-17178&author=P.+Manivetauthor=B.+t.+Schneiderauthor=J.+C.+Smithauthor=D.-S.+Choiauthor=L.+Maroteauxauthor=O.+Kellermannauthor=J.-M.+Launay&title=The+serotonin+binding+site+of+human+and+murine+5-HT2B+receptors%3A+molecular+modeling+and+site-directed+mutagenesis&doi=10.1074%2Fjbc.M200195200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M200195200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M200195200%26sid%3Dliteratum%253Aachs%26aulast%3DManivet%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DB.%2Bt.%26aulast%3DSmith%26aufirst%3DJ.%2BC.%26aulast%3DChoi%26aufirst%3DD.-S.%26aulast%3DMaroteaux%26aufirst%3DL.%26aulast%3DKellermann%26aufirst%3DO.%26aulast%3DLaunay%26aufirst%3DJ.-M.%26atitle%3DThe%2520serotonin%2520binding%2520site%2520of%2520human%2520and%2520murine%25205-HT2B%2520receptors%253A%2520molecular%2520modeling%2520and%2520site-directed%2520mutagenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D17170%26epage%3D17178%26doi%3D10.1074%2Fjbc.M200195200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seager, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graufelds, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCampbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shughrue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danziger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascarella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreatsoulas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipe, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuduk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinney, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seabrook, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, W. J.</span></span> <span> </span><span class="NLM_article-title">Selective activation of the M(1) muscarinic acetylcholine receptor achieved by allosteric potentiation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">15950</span>– <span class="NLM_lpage">15955</span>, <span class="refDoi"> DOI: 10.1073/pnas.0900903106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1073%2Fpnas.0900903106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=15950-15955&author=L.+Maauthor=M.+A.+Seagerauthor=M.+Wittmannauthor=M.+Jacobsonauthor=D.+Bickelauthor=M.+Burnoauthor=K.+Jonesauthor=V.+K.+Graufeldsauthor=G.+Xuauthor=M.+Pearsonauthor=A.+McCampbellauthor=R.+Gasparauthor=P.+Shughrueauthor=A.+Danzigerauthor=C.+Reganauthor=R.+Flickauthor=D.+Pascarellaauthor=S.+Garsonauthor=S.+Doranauthor=C.+Kreatsoulasauthor=L.+Vengauthor=C.+W.+Lindsleyauthor=W.+Shipeauthor=S.+Kudukauthor=C.+Surauthor=G.+Kinneyauthor=G.+R.+Seabrookauthor=W.+J.+Ray&title=Selective+activation+of+the+M%281%29+muscarinic+acetylcholine+receptor+achieved+by+allosteric+potentiation&doi=10.1073%2Fpnas.0900903106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900903106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900903106%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DGraufelds%26aufirst%3DV.%2BK.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DMcCampbell%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DR.%26aulast%3DShughrue%26aufirst%3DP.%26aulast%3DDanziger%26aufirst%3DA.%26aulast%3DRegan%26aufirst%3DC.%26aulast%3DFlick%26aufirst%3DR.%26aulast%3DPascarella%26aufirst%3DD.%26aulast%3DGarson%26aufirst%3DS.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DVeng%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DShipe%26aufirst%3DW.%26aulast%3DKuduk%26aufirst%3DS.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26atitle%3DSelective%2520activation%2520of%2520the%2520M%25281%2529%2520muscarinic%2520acetylcholine%2520receptor%2520achieved%2520by%2520allosteric%2520potentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D15950%26epage%3D15955%26doi%3D10.1073%2Fpnas.0900903106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deupi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schertler, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, M. M.</span></span> <span> </span><span class="NLM_article-title">Molecular signatures of G-protein-coupled receptors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>494</i></span>,  <span class="NLM_fpage">185</span>, <span class="refDoi"> DOI: 10.1038/nature11896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fnature11896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23407534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Wrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=494&publication_year=2013&pages=185&author=A.+J.+Venkatakrishnanauthor=X.+Deupiauthor=G.+Lebonauthor=C.+G.+Tateauthor=G.+F.+Schertlerauthor=M.+M.+Babu&title=Molecular+signatures+of+G-protein-coupled+receptors&doi=10.1038%2Fnature11896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular signatures of G-protein-coupled receptors</span></div><div class="casAuthors">Venkatakrishnan, A. J.; Deupi, Xavier; Lebon, Guillaume; Tate, Christopher G.; Schertler, Gebhard F.; Babu, M. Madan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">494</span>
        (<span class="NLM_cas:issue">7436</span>),
    <span class="NLM_cas:pages">185-194</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  G-protein-coupled receptors (GPCRs) are physiol. important membrane proteins that sense signaling mols. such as hormones and neurotransmitters, and are the targets of several prescribed drugs.  Recent exciting developments are providing unprecedented insights into the structure and function of several medically important GPCRs.  Here, through a systematic anal. of high-resoln. GPCR structures, we uncover a conserved network of non-covalent contacts that defines the GPCR fold.  Furthermore, our comparative anal. reveals characteristic features of ligand binding and conformational changes during receptor activation.  A holistic understanding that integrates mol. and systems biol. of GPCRs holds promise for new therapeutics and personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4fvI327bmkbVg90H21EOLACvtfcHk0lidQ1LY5-V55Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Wrt7Y%253D&md5=5dd040bf5f3b4b81249c02d493a1fbf3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature11896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11896%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DDeupi%26aufirst%3DX.%26aulast%3DLebon%26aufirst%3DG.%26aulast%3DTate%26aufirst%3DC.%2BG.%26aulast%3DSchertler%26aufirst%3DG.%2BF.%26aulast%3DBabu%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520signatures%2520of%2520G-protein-coupled%2520receptors%26jtitle%3DNature%26date%3D2013%26volume%3D494%26spage%3D185%26doi%3D10.1038%2Fnature11896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Preininger, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamm, H. E.</span></span> <span> </span><span class="NLM_article-title">Conformational flexibility and structural dynamics in GPCR-mediated G protein activation: a perspective</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>425</i></span>,  <span class="NLM_fpage">2288</span>– <span class="NLM_lpage">2298</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2013.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.jmb.2013.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23602809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt1aht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2013&pages=2288-2298&author=A.+M.+Preiningerauthor=J.+Meilerauthor=H.+E.+Hamm&title=Conformational+flexibility+and+structural+dynamics+in+GPCR-mediated+G+protein+activation%3A+a+perspective&doi=10.1016%2Fj.jmb.2013.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational flexibility and structural dynamics in GPCR-mediated G protein activation: A perspective</span></div><div class="casAuthors">Preininger, Anita M.; Meiler, Jens; Hamm, Heidi E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2288-2298</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The structure and dynamics of G proteins and their cognate receptors, both alone and in complex, are becoming increasingly accessible to exptl. techniques.  Understanding the conformational changes and timelines that govern these changes can lead to new insights into the processes of ligand binding and assocd. G protein activation.  Exptl. systems may involve the use of, or otherwise stabilize, non-native environments.  This can complicate the understanding of structural and dynamic features of processes such as the ionic lock, tryptophan toggle, and G protein flexibility.  While elements in the receptor's transmembrane helixes and the C-terminal α5 helix of Gα undergo well-defined structural changes, regions subject to conformational flexibility may be important in fine-tuning the interactions between activated receptors and G proteins.  The pairing of computational and exptl. approaches will continue to provide powerful tools to probe the conformation and dynamics of receptor-mediated G protein activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa8wRL2jIHBbVg90H21EOLACvtfcHk0lidQ1LY5-V55Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt1aht7g%253D&md5=7af4574924a9a9d6e7b01311ba21d6be</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2013.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2013.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DPreininger%26aufirst%3DA.%2BM.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DHamm%26aufirst%3DH.%2BE.%26atitle%3DConformational%2520flexibility%2520and%2520structural%2520dynamics%2520in%2520GPCR-mediated%2520G%2520protein%2520activation%253A%2520a%2520perspective%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D425%26spage%3D2288%26epage%3D2298%26doi%3D10.1016%2Fj.jmb.2013.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Besnard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abecassis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidah, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constam, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickerton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>492</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-220&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.+P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0lggsxZ2abjsOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lggsxZ2abjsOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubar, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbertson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig-Lipson, S.</span></span> <span> </span><span class="NLM_article-title">Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.neuropharm.2011.04.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=513-523&author=K.+A.+Cunninghamauthor=R.+G.+Foxauthor=N.+C.+Anastasioauthor=M.+J.+Bubarauthor=S.+J.+Stutzauthor=F.+G.+Moellerauthor=S.+R.+Gilbertsonauthor=S.+Rosenzweig-Lipson&title=Selective+serotonin+5-HT%282C%29+receptor+activation+suppresses+the+reinforcing+efficacy+of+cocaine+and+sucrose+but+differentially+affects+the+incentive-salience+value+of+cocaine-+vs.+sucrose-associated+cues&doi=10.1016%2Fj.neuropharm.2011.04.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DBubar%26aufirst%3DM.%2BJ.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DMoeller%26aufirst%3DF.%2BG.%26aulast%3DGilbertson%26aufirst%3DS.%2BR.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DSelective%2520serotonin%25205-HT%25282C%2529%2520receptor%2520activation%2520suppresses%2520the%2520reinforcing%2520efficacy%2520of%2520cocaine%2520and%2520sucrose%2520but%2520differentially%2520affects%2520the%2520incentive-salience%2520value%2520of%2520cocaine-%2520vs.%2520sucrose-associated%2520cues%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D513%26epage%3D523%26doi%3D10.1016%2Fj.neuropharm.2011.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halberstadt, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Heijden, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruderman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risbrough, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingrich, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, S. B.</span></span> <span> </span><span class="NLM_article-title">5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1958</span>– <span class="NLM_lpage">1967</span>, <span class="refDoi"> DOI: 10.1038/npp.2009.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fnpp.2009.29" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=1958-1967&author=A.+L.+Halberstadtauthor=I.+van+der+Heijdenauthor=M.+A.+Rudermanauthor=V.+B.+Risbroughauthor=J.+A.+Gingrichauthor=M.+A.+Geyerauthor=S.+B.+Powell&title=5-HT%282A%29+and+5-HT%282C%29+receptors+exert+opposing+effects+on+locomotor+activity+in+mice&doi=10.1038%2Fnpp.2009.29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2009.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2009.29%26sid%3Dliteratum%253Aachs%26aulast%3DHalberstadt%26aufirst%3DA.%2BL.%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DI.%26aulast%3DRuderman%26aufirst%3DM.%2BA.%26aulast%3DRisbrough%26aufirst%3DV.%2BB.%26aulast%3DGingrich%26aufirst%3DJ.%2BA.%26aulast%3DGeyer%26aufirst%3DM.%2BA.%26aulast%3DPowell%26aufirst%3DS.%2BB.%26atitle%3D5-HT%25282A%2529%2520and%25205-HT%25282C%2529%2520receptors%2520exert%2520opposing%2520effects%2520on%2520locomotor%2520activity%2520in%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D1958%26epage%3D1967%26doi%3D10.1038%2Fnpp.2009.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, D. M.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain</span>. <i>Psychopharmacologia</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1007/BF00429052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1007%2FBF00429052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1215445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaE28XpvFyrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1975&pages=139-149&author=D.+M.+Jackson&title=A+functional+effect+of+dopamine+in+the+nucleus+accumbens+and+in+some+other+dopamine-rich+parts+of+the+rat+brain&doi=10.1007%2FBF00429052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain</span></div><div class="casAuthors">Jackson, David M.; Anden, Nils E.; Dahlstrom, Annica</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacologia</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-49</span>CODEN:
                <span class="NLM_cas:coden">PSYPAG</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">Dopamine HCl (I HCl) [62-31-7] (5 to 50 μg) applied bilaterally to the nucleus accumbens of reserpine-nialamide pretreated rats produced a marked dose-dependent increase in coordinated locomotor activity, devoid of stereotypes such as gnawing, rearing and licking seen after I application (50 μg) to the neostriatum.  The locomotor activity was blocked by pimozide but not by phenoxybenzamine.  The effects of apomorphine-HCl [314-19-2] or d-noradrenaline bitartrate [51-40-1] were similar to those of I.  In contrast, l-noradrenaline bitartrate [51-40-1] produced a convulsive syndrome devoid of coordinated locomotor activity, and this convulsive syndrome was blocked by phenoxybenzamine but not by pimozide.  Release of endogenous I by d [51-63-8] or 1-amphetamine sulfate [51-62-7] (10 and 50 μg) in the nucleus accumbens produced an increase in coordinated activity, the d-isomer was about 4 times as potent as the l-isomer, and the effect of the d-isomer was blocked completely by α-methyltyrosine.  Bilateral application of trifluoperazine to the nucleus accumbens completely blocked the effect of systemically administered d-amphetamine (1.5 and 3.0 mg/kg), but similar application to the area of the central nucleus of the amygdala or the neostriatum was much less effective.  Local application of metatyramine HCl [3458-98-8] (200 μg) to the nucleus accumbens resulted in a higher level of basal activity than in control animals.  Application of dopamine or noradrenaline to the area of the central nucleus of the amygdala or to the olfactory tubercles did not lead to any consistent changes in locomotor activity.  The nucleus accumbens and olfactory tubercles contained most of the I in the limbic forebrain, with noradrenaline more evenly distributed.  The nucleus accumbens may play an important role in the locomotor activity in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmGISaREaEZLVg90H21EOLACvtfcHk0lgmfJ1Vi55bCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XpvFyrug%253D%253D&md5=a0d97f5e6fc213f81615a053c13d8d29</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2FBF00429052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00429052%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DD.%2BM.%26atitle%3DA%2520functional%2520effect%2520of%2520dopamine%2520in%2520the%2520nucleus%2520accumbens%2520and%2520in%2520some%2520other%2520dopamine-rich%2520parts%2520of%2520the%2520rat%2520brain%26jtitle%3DPsychopharmacologia%26date%3D1975%26volume%3D45%26spage%3D139%26epage%3D149%26doi%3D10.1007%2FBF00429052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lever, C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Rearing on hind legs, environmental novelty, and the hippocampal formation</span>. <i>Rev. Neurosci. (Berlin, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1515/REVNEURO.2006.17.1-2.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1515%2FREVNEURO.2006.17.1-2.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=16703946" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=111-133&author=C.+Lever&title=Rearing+on+hind+legs%2C+environmental+novelty%2C+and+the+hippocampal+formation&doi=10.1515%2FREVNEURO.2006.17.1-2.111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1515%2FREVNEURO.2006.17.1-2.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FREVNEURO.2006.17.1-2.111%26sid%3Dliteratum%253Aachs%26aulast%3DLever%26aufirst%3DC.%26atitle%3DRearing%2520on%2520hind%2520legs%252C%2520environmental%2520novelty%252C%2520and%2520the%2520hippocampal%2520formation%26jtitle%3DRev.%2520Neurosci.%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2006%26volume%3D17%26spage%3D111%26epage%3D133%26doi%3D10.1515%2FREVNEURO.2006.17.1-2.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, R. A.</span></span> <span> </span><span class="NLM_article-title">The Open-Field Test: a critical review</span>. <i>Psychol. bull.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1037/0033-2909.83.3.482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1037%2F0033-2909.83.3.482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=17582919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A280%3ADC%252BD2szmvVCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1976&pages=482-504&author=R.+N.+Walshauthor=R.+A.+Cummins&title=The+Open-Field+Test%3A+a+critical+review&doi=10.1037%2F0033-2909.83.3.482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The Open-Field Test: a critical review</span></div><div class="casAuthors">Walsh R N; Cummins R A</div><div class="citationInfo"><span class="NLM_cas:title">Psychological bulletin</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">482-504</span>
        ISSN:<span class="NLM_cas:issn">0033-2909</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYvoIgIf3zKFm8bhe6roZYfW6udTcc2eYqbJIxxStoKLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szmvVCrsg%253D%253D&md5=60c00d3638695d81c9a738e39a8c4b3d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1037%2F0033-2909.83.3.482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252F0033-2909.83.3.482%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DR.%2BN.%26aulast%3DCummins%26aufirst%3DR.%2BA.%26atitle%3DThe%2520Open-Field%2520Test%253A%2520a%2520critical%2520review%26jtitle%3DPsychol.%2520bull.%26date%3D1976%26volume%3D83%26spage%3D482%26epage%3D504%26doi%3D10.1037%2F0033-2909.83.3.482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice</span>. <i>Psychopharmacology (Berlin, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">256</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1007/s00213-004-1944-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1007%2Fs00213-004-1944-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=15290006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVyltLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2005&pages=256-263&author=J.+Wu&title=Bimodal+effects+of+MK-801+on+locomotion+and+stereotypy+in+C57BL%2F6+mice&doi=10.1007%2Fs00213-004-1944-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice</span></div><div class="casAuthors">Wu, Jinhua; Zou, Hong; Strong, Judith A.; Yu, Jun; Zhou, Xuedong; Xie, Qinglian; Zhao, Guoping; Jin, Meilei; Yu, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">256-263</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Systemic injection of the non-competitive NMDA (N-methyl-D-aspartate:) receptor antagonist MK-801 (dizocilpine maleate) causes both increased locomotion in rodents and various stereotypic behaviors that are proposed to model certain aspects of schizophrenic symptoms in humans.  This study presents a comprehensive characterization of the bimodal effects of MK-801 on locomotion and stereotypy in the C57BL/6 mouse strain, a strain commonly used for genetically modified mice.  We found that it is important to analyze both locomotion and stereotypy in parallel, as MK-801-induced stereotypy results in abnormal movements that are recorded as locomotion by automated beam detection systems.  Furthermore, it is important to analyze the bimodal effects of MK-801 over an extended time span, rather than the commonly used narrower time window, as at higher doses (e.g., above 0.3 mg/kg) the hyperlocomotion phase develops only after the stereotypic phase subsides.  We also obsd. that the apparent dose-response curve is very sensitive to the particular time window chosen for anal. because MK-801 affects both the time course and max. value of stimulated locomotion.  We show that analyzing the abs. peak value of locomotion induced for each animal, rather than group-averaged time courses, provides a measure that is sensitive over a wider range of MK-801 doses.  Interestingly, MK-801 even at a very low dose of 0.02 mg/kg suppressed rather than enhanced rearing behavior, differing in this regard from amphetamine.  The non-competitive NMDA receptor antagonist MK-801 induces a complex pattern of behavioral modification in mice with respect to both the time course and the dose-response relation of behavioral changes.  The results of this study provide a foundation and frame of ref. for the growing interest in studying MK-801-induced behavior in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0W0Mdl64ciLVg90H21EOLACvtfcHk0lgmfJ1Vi55bCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVyltLrM&md5=66981daa6134177f1544fcebfa898403</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs00213-004-1944-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-004-1944-1%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DBimodal%2520effects%2520of%2520MK-801%2520on%2520locomotion%2520and%2520stereotypy%2520in%2520C57BL%252F6%2520mice%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2005%26volume%3D177%26spage%3D256%26epage%3D263%26doi%3D10.1007%2Fs00213-004-1944-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colpaert, F. C.</span></span> <span> </span><span class="NLM_article-title">Drug discrimination in neurobiology</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1016/S0091-3057(99)00047-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2FS0091-3057%2899%2900047-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=337-345&author=F.+C.+Colpaert&title=Drug+discrimination+in+neurobiology&doi=10.1016%2FS0091-3057%2899%2900047-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2899%2900047-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252899%252900047-7%26sid%3Dliteratum%253Aachs%26aulast%3DColpaert%26aufirst%3DF.%2BC.%26atitle%3DDrug%2520discrimination%2520in%2520neurobiology%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1999%26volume%3D64%26spage%3D337%26epage%3D345%26doi%3D10.1016%2FS0091-3057%2899%2900047-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appel, J. B.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">The use of drug discrimination procedures to characterize hallucinogenic drug actions</span>. <i>Psychopharmacol. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">959</span>– <span class="NLM_lpage">967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=3797596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaL2sXislahsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1986&pages=959-967&author=J.+B.+Appel&title=The+use+of+drug+discrimination+procedures+to+characterize+hallucinogenic+drug+actions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The use of drug discrimination procedures to characterize hallucinogenic drug actions</span></div><div class="casAuthors">Appel, James B.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology Bulletin</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">959-67</span>CODEN:
                <span class="NLM_cas:coden">PSYBB9</span>;
        ISSN:<span class="NLM_cas:issn">0048-5764</span>.
    </div><div class="casAbstract">A review with 35 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquiDKeSuOAzrVg90H21EOLACvtfcHk0li68JZ-KCT7kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXislahsA%253D%253D&md5=08d9d6869e62031169377bfaa522700f</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520use%2520of%2520drug%2520discrimination%2520procedures%2520to%2520characterize%2520hallucinogenic%2520drug%2520actions%26jtitle%3DPsychopharmacol.%2520Bull.%26date%3D1986%26volume%3D22%26spage%3D959%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Negus, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, M. L.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic—pharmacodynamic (PKPD) analysis with drug discrimination</span>. <i>Curr. Top. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>, <span class="refDoi"> DOI: 10.1007/7854_2016_36</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1007%2F7854_2016_36" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=27571746" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+S.+Negusauthor=M.+L.+Banks&title=Pharmacokinetic%E2%80%94pharmacodynamic+%28PKPD%29+analysis+with+drug+discrimination&doi=10.1007%2F7854_2016_36"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2F7854_2016_36&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F7854_2016_36%26sid%3Dliteratum%253Aachs%26aulast%3DNegus%26aufirst%3DS.%2BS.%26aulast%3DBanks%26aufirst%3DM.%2BL.%26atitle%3DPharmacokinetic%25E2%2580%2594pharmacodynamic%2520%2528PKPD%2529%2520analysis%2520with%2520drug%2520discrimination%26jtitle%3DCurr.%2520Top.%2520Behav.%2520Neurosci.%26date%3D2016%26doi%3D10.1007%2F7854_2016_36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filip, M.</span></span> <span> </span><span class="NLM_article-title">Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>306</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">743</span>, <span class="refDoi"> DOI: 10.1124/jpet.102.045716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1124%2Fjpet.102.045716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=12721337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=734-743&author=M.+Filip&title=Hyperlocomotive+and+discriminative+stimulus+effects+of+cocaine+are+under+the+control+of+serotonin%282C%29+%285-HT%282C%29%29+receptors+in+rat+prefrontal+cortex&doi=10.1124%2Fjpet.102.045716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin2C (5-HT2C) receptors in rat prefrontal cortex</span></div><div class="casAuthors">Filip, Malgorzata; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">734-743</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The serotonin2C (5-hydroxytryptamine2C; 5-HT2C) receptor (5-HT2CR) is found in abundance in dopamine (DA) mesocorticolimbic pathways and is one of the important target proteins that modulates the behavioral effects of cocaine.  In the present study, the hypothesis was tested that the 5-HT2CR in the prefrontal cortex (PFC) may control either spontaneous or cocaine-evoked locomotor activity as well as the discriminative stimulus properties of cocaine.  In male Sprague-Dawley rats implanted with bilateral cannulae aimed at the PFC, local microinjections of the preferential 5-HT2CR agonist 6-chloro-2-(1-piperazinyl)pyrazine hydrochloride (MK 212) (0.05-0.5 μg/side) did not alter spontaneous activity, but dose-dependently decreased horizontal hyperactivity evoked by cocaine (10 mg/kg i.p.).  Given alone, the selective 5-HT2CR antagonist 8-5-[2,4-dimethoxy-5-(4-trifluorophenylsulfonamido)phenyl-5-oxopentyl]-1,3,8-triazo-spiro[4.5]decane-2,4-dione hydrochloride (RS 102221) (5 μg/side) increased basal locomotor activity of rats expressed in the vertical plane.  Microinjections of RS 102221 (5 μg/side, but not 0.15-1.5 μg/side) significantly enhanced the horizontal activity induced by cocaine (10 mg/kg).  In rats trained to discriminate cocaine (10 mg/kg i.p.) from saline (i.p.) in a two-lever, water-reinforced fixed ratio 20 task, intra-PFC microinjections of MK 212 (0.05 and 0.5 μg/side) did not substitute for cocaine, but attenuated the stimulus effects of cocaine.  However, intra-PFC microinjections of RS 102221 (1.5 and 5 μg/side) evoked 13 and 40% cocaine-lever responding when tested alone and enhanced the recognition of cocaine.  These data indicate that the PFC is a brain site at which the 5-HT2CR exerts an inhibitory control over the hyperactive and discriminative stimulus effects of cocaine known to be dependent upon activation of the DA mesoaccumbens circuit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb_926Wi6DpbVg90H21EOLACvtfcHk0li68JZ-KCT7kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGlu7k%253D&md5=32e74280183a2de46da0722986839325</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.045716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.045716%26sid%3Dliteratum%253Aachs%26aulast%3DFilip%26aufirst%3DM.%26atitle%3DHyperlocomotive%2520and%2520discriminative%2520stimulus%2520effects%2520of%2520cocaine%2520are%2520under%2520the%2520control%2520of%2520serotonin%25282C%2529%2520%25285-HT%25282C%2529%2529%2520receptors%2520in%2520rat%2520prefrontal%2520cortex%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D734%26epage%3D743%26doi%3D10.1124%2Fjpet.102.045716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCreary, A. C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discriminative stimulus properties of (/-)-fenfluramine: the role of 5-HT2 receptor subtypes</span>. <i>Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1037/0735-7044.117.2.212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1037%2F0735-7044.117.2.212" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2003&pages=212-221&author=A.+C.+McCreary&title=Discriminative+stimulus+properties+of+%28%2F-%29-fenfluramine%3A+the+role+of+5-HT2+receptor+subtypes&doi=10.1037%2F0735-7044.117.2.212"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1037%2F0735-7044.117.2.212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252F0735-7044.117.2.212%26sid%3Dliteratum%253Aachs%26aulast%3DMcCreary%26aufirst%3DA.%2BC.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520%2528%252F-%2529-fenfluramine%253A%2520the%2520role%2520of%25205-HT2%2520receptor%2520subtypes%26jtitle%3DBehav.%2520Neurosci.%26date%3D2003%26volume%3D117%26spage%3D212%26epage%3D221%26doi%3D10.1037%2F0735-7044.117.2.212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
La Garza, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Detailed investigations of 5-HT3 compounds in a drug discrimination model</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1016/0091-3057(95)02207-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2F0091-3057%2895%2902207-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1996&pages=533-540&author=R.+De%0ALa+Garzaauthor=P.+M.+Callahanauthor=K.+A.+Cunningham&title=Detailed+investigations+of+5-HT3+compounds+in+a+drug+discrimination+model&doi=10.1016%2F0091-3057%2895%2902207-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2895%2902207-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252895%252902207-4%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLa%2BGarza%26aufirst%3DR.%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DDetailed%2520investigations%2520of%25205-HT3%2520compounds%2520in%2520a%2520drug%2520discrimination%2520model%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1996%26volume%3D54%26spage%3D533%26epage%3D540%26doi%3D10.1016%2F0091-3057%2895%2902207-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(87)90333-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2F0014-2999%2887%2990333-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=2887435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaL2sXlt1Kqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1987&pages=29-36&author=K.+A.+Cunningham&title=Discriminative+stimulus+properties+of+8-hydroxy-2-%28di-n-propylamino%29tetralin+%288-OHDPAT%29%3A+implications+for+understanding+the+actions+of+novel+anxiolytics&doi=10.1016%2F0014-2999%2887%2990333-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT):  implications for understanding the actions of novel anxiolytics</span></div><div class="casAuthors">Cunningham, Kathryn A.; Callahan, Patrick M.; Appel, James B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-36</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">8-Hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT) has effects both characteristic of a serotonin (5-hydroxytryptamine; 5-HT) agonist and antagonist.  To investigate the mechanism(s) of action of 8-OHDPAT in vivo, rats were trained to discriminate 8-OHDPAT (0.4 mg/kg) from saline and given various neuroactive compds. during substitution test sessions.  Of the 5-HT agonists tested, d-lysergic acid diethylamide, 5-methoxy-n,n-dimethyltryptamine, quipazine, Ru 24969 and 1-(m-trifluoromethylphenyl)piperazine did not mimic the training drug; the dopamine agonists apomorphine and SKF 38393 as well as the α2-adrenoceptor agonist clonidine engendered predominantly saline-lever responding.  However, the novel anxiolytics buspirone and ipsapirone as well as the ergot deriv. lisuride substituted completely for 8-OHDPAT.  In combination tests, 5-HT (ketanserin, metergoline, methysergide, pirenperone), dopamine (haloperidol) and norepinephrine antagonists (prazosin, propranolol) failed to attenuate the 8-OHDPAT cue.  The similar stimulus properties of 8-OHDPAT and the novel anxiolytics (buspirone, ipsapirone) are mirrored by the common abilities of these agents to selectively inhibit 5-HT1A binding and release punished responding.  Thus, the subpopulation of 5-HT1A receptors may mediate the behavioral effects of these compds. in animals and, in turn, the anxiolytic effects of buspirone and ipsapirone in humans.  Although not primarily selective for 5-HT, lisuride may also mimic 8-OHDPAT by direct or indirect stimulation of 5-HT1A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwKhx2jaMKr7Vg90H21EOLACvtfcHk0li68JZ-KCT7kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlt1Kqt7c%253D&md5=43d7ba8b67098e39f738db0cc9e69d75</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2887%2990333-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252887%252990333-5%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%25208-hydroxy-2-%2528di-n-propylamino%2529tetralin%2520%25288-OHDPAT%2529%253A%2520implications%2520for%2520understanding%2520the%2520actions%2520of%2520novel%2520anxiolytics%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1987%26volume%3D138%26spage%3D29%26epage%3D36%26doi%3D10.1016%2F0014-2999%2887%2990333-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">1414</span>– <span class="NLM_lpage">1424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=7562516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaK2MXot1yjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1995&pages=1414-1424&author=P.+M.+Callahanauthor=K.+A.+Cunningham&title=Modulation+of+the+discriminative+stimulus+properties+of+cocaine+by+5-HT1B+and+5-HT2C+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors</span></div><div class="casAuthors">Callahan, Patrick M.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1414-24</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The present study assessed compds. displaying affinity for 5-HT1A, 5-HT1B, 5-HT2A and 5-HT2C receptors for their ability to substitute for, enhance or antagonize the discriminative stimulus effects of cocaine (10 mg/kg) in rats.  In substitution tests, the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT; 0.2-1.6 mg/kg), the 5-HT1A/B receptor agonists RU 24969 (0.25-2 mg/kg) and CGS 12066B (2-16 mg/kg), the 5-HT1B/2C receptor agonists m-chlorophenylpiperazine (mCPP; 0.25-2 mg/kg) and m-trifluoromethylphenylpiperazine (TFMPP; 0.125-2 mg/kg), the 5-HT2A/2C receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane ([±]-DOB; 0.0625-0.5 mg/kg), the 5-HT2C receptor agonist MK 212 (0.25-1 mg/kg) and the nonselective 5-HT receptor agonist quipazine (1-8 mg/kg) engendered 30% to 70% cocaine-appropriate responding.  The DA receptor antagonists SCH 23390 (0.025 or 0.05 mg/kg) and haloperidol (0.125 or 0.25 mg/kg) failed to block the partial substitution of RU 24969 (1mg/kg) for cocaine.  In combination tests, a fixed dose of either quipazine (4 mg/kg), RU 24969 (0.25, 0.5 or 1 mg/kg) or TFMPP (0.5 mg/kg) but not 8-OH-DPAT (0.4 mg/kg) or CGS 12066B (16 mg/kg) produced a leftward shift in the cocaine dose-response curve (0.625-5 mg/kg).  In contrast, coadministration of either mCPP (0.25-2 mg/kg) or MK 212 (0.125-2 mg/kg) plus a dose of cocaine (5 mg/kg) that produced >85% cocaine-appropriate responding when given alone partially antagonized cocaine; mCPP (1 mg/kg) also produced a rightward shift in the cocaine dose-response curve.  Neither 8-OH-DPAT (0.2-1.6 mg/kg), (±)-DOB (0.125-0.5 mg/kg) nor quipazine (2-8 mg/kg) blocked the cocaine stimulus.  The 5-HT1A receptor antagonist NAN 190 (0.2-0.8 mg/kg), the 5-HT2A/2C receptor antagonist LY 53857 (0.5-4 mg/kg) and the 5-HT/DA receptor antagonist pirenperone (0.5-4 mg/kg) neither substituted for not enhanced cocaine; however, pirenperone but not NAN 190 or LY 53857 partially blocked the cocaine (10 mg/kg) response.  Although 5-HT receptor compds. do not substitute for cocaine, several 5-HT receptor agonists (i.e., the indole deriv. RU 24969 and the arylpiperazines mCPP, MK 212, TFMPP and quipazine), but not antagonists, differentially modulate the stimulus effects of cocaine.  Moreover, 5-HT1B and 5-HT2C receptors may be responsible for the obsd. enhancements and antagonisms, resp., produced by the 5-HT receptor compds., whereas 5-HT1A and 5-HT2A receptors do not appear to modulate the cocaine discrimination in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosQbq4pssZw7Vg90H21EOLACvtfcHk0lg2kGTwxQfQMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXot1yjtrc%253D&md5=44ab623964643e18eefc06f6e1d3e4ae</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DModulation%2520of%2520the%2520discriminative%2520stimulus%2520properties%2520of%2520cocaine%2520by%25205-HT1B%2520and%25205-HT2C%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D274%26spage%3D1414%26epage%3D1424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP)</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>257</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(94)90690-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2F0014-2999%2894%2990690-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=8082704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1Kktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1994&pages=27-38&author=P.+M.+Callahanauthor=K.+A.+Cunningham&title=Involvement+of+5-HT2C+receptors+in+mediating+the+discriminative+stimulus+properties+of+m-chlorophenylpiperazine+%28mCPP%29&doi=10.1016%2F0014-2999%2894%2990690-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP)</span></div><div class="casAuthors">Callahan, Patrick M.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">27-38</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Rats were trained to discriminate the 5-HT receptor agonist m-chlorophenylpiperazine (mCPP; 1 mg/kg) from saline using a two-lever, water-reinforced drug discrimination task.  The antidepressant trazodone (1-8 mg/kg), the 5-HT1B/2C receptor agonists 1-(m-trifluoromethylphenyl)piperazine (TFMPP; 0.25-1 mg/kg) and MK 212 (0.125-1 mg/kg), and the mixed 5-HT1A/B receptor agonist RU 24969 (0.25-2 mg/kg) substituted fully for mCPP.  The 5-HT2A/2C receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI; 0.25-1 mg/kg) and d-lysergic acid diethylamide (LSD; 0.02-0.08 mg/kg) and the 5-HT releaser fenfluramine (0.5-2 mg/kg) also mimicked mCPP.  Agonists selective for the 5-HT1A or 5-HT3 receptor or the 5-HT reuptake site produced saline-lever responding.  The ergoline deriv. mesulergine (0.5-4 mg/kg) produced a partial agonist/antagonist profile.  The 5-HT1/2 receptor antagonist metergoline (0.125-1 mg/kg) completely blocked the mCPP cue whereas the 5-HT2A/2C receptor antagonists ketanserin and LY 53857 as well as all other 5-HT receptor antagonists failed to block the mCPP cue.  The dopamine receptor antagonists SCH 23390 and haloperidol were also ineffective mCPP antagonists.  Following pretreatment with the 5-HT synthesis inhibitor p-chlorophenylalanine (pCPA; 100 mg/kg/day) for 3 consecutive days, the discriminability of low doses of mCPP increased, whereas the effects of fenfluramine decreased.  The present results suggest that the discriminative stimulus effects of mCPP in rats are mediated primarily by postsynaptic 5-HT2C receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrebmnBj2zsK7Vg90H21EOLACvtfcHk0lg2kGTwxQfQMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1Kktrk%253D&md5=98623ad672842986facfc5cf3fa0a345</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2990690-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252990690-4%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DInvolvement%2520of%25205-HT2C%2520receptors%2520in%2520mediating%2520the%2520discriminative%2520stimulus%2520properties%2520of%2520m-chlorophenylpiperazine%2520%2528mCPP%2529%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D257%26spage%3D27%26epage%3D38%26doi%3D10.1016%2F0014-2999%2894%2990690-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Discriminative stimulus properties of clonidine: substitution by ergot derivatives</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(85)90299-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2F0014-2999%2885%2990299-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=2868902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaL28XotF2jtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1985&pages=225-229&author=K.+A.+Cunningham&title=Discriminative+stimulus+properties+of+clonidine%3A+substitution+by+ergot+derivatives&doi=10.1016%2F0014-2999%2885%2990299-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discriminative stimulus properties of clonidine:  substitution by ergot derivatives</span></div><div class="casAuthors">Cunningham, Kathryn A.; Callahan, Patrick M.; Craigmyle, Nancy A.; Appel, James B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-9</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Bromocriptine mesylate  [22260-51-1], lergotrile mesylate  [51473-23-5], and lisuride hydrogen maleate  [19875-60-6] but not apomorphine  [58-00-4], ergonovine maleate  [129-51-1], or LSD  [50-37-3] mimicked clonidine  [4205-90-7] in rats trained to discriminate this compd. (0.02 mg/kg) from saline.  BC 105 maleate  [24359-22-6], ketanserin tartrate  [83846-83-7] and haloperidol  [52-86-8] failed to block the clonidine cue.  Yohimbine  [146-48-5] was an effective antagonist of clonidine but not of the lisuride substitution for clonidine.  Since dopamine does not appear to be involved in the stimulus effects of clonidine, the behavioral similarities between clonidine and some ergots may be related to α-adrenoceptor stimulation; however, the role of blood pressure changes in the stimulus effects of all of these compds. should not be overlooked.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaVjl8mnDOi7Vg90H21EOLACvtfcHk0lg2kGTwxQfQMw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XotF2jtg%253D%253D&md5=59cde0c564026acc10f30927555ee473</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2885%2990299-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252885%252990299-7%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520clonidine%253A%2520substitution%2520by%2520ergot%2520derivatives%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1985%26volume%3D119%26spage%3D225%26epage%3D229%26doi%3D10.1016%2F0014-2999%2885%2990299-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">m-Chlorophenylpiperazine (mCPP) modulates the discriminative stimulus effects of cocaine through actions at the 5-HT2C receptor</span>. <i>Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1037/0735-7044.118.1.157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1037%2F0735-7044.118.1.157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=14979792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitVyqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=157-162&author=P.+S.+Frankelauthor=K.+A.+Cunningham&title=m-Chlorophenylpiperazine+%28mCPP%29+modulates+the+discriminative+stimulus+effects+of+cocaine+through+actions+at+the+5-HT2C+receptor&doi=10.1037%2F0735-7044.118.1.157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">m-Chlorophenylpiperazine (mCPP) modulates the discriminative stimulus effects of cocaine through actions at the 5-HT2C receptor</span></div><div class="casAuthors">Frankel, Paul S.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-162</span>CODEN:
                <span class="NLM_cas:coden">BENEDJ</span>;
        ISSN:<span class="NLM_cas:issn">0735-7044</span>.
    
            (<span class="NLM_cas:orgname">American Psychological Association</span>)
        </div><div class="casAbstract">Agonists acting at the serotonin-1B receptor (5-HT1BR) and 5-HT2CR have been reported to potentiate and block, resp., the discriminative stimulus effects of cocaine.  The present investigation reassessed the antagonistic effects of the mixed 5-HT2C/1BR agonist m-chlorophenylpiperazine (mCPP) on the discriminative stimulus effects of cocaine in the presence or absence of selective antagonism of the 5-HT1BR or 5-HT2CR.  The stimulus effects of cocaine were attenuated by mCPP at doses that reduced response rates.  The selective 5-HT2CR antagonist SB 242084, but not the selective 5-HT1BR antagonist GR 127935, reversed the mCPP-evoked attenuation of the cocaine cue and the suppression of response rates.  These results demonstrate that the suppressive effects of mCPP on cocaine discrimination are related to stimulation of the 5-HT2CR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq822S6caSBpLVg90H21EOLACvtfcHk0lj814R_feCHCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitVyqtb0%253D&md5=6c61e7a449610957fc9c819edec93d4c</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1037%2F0735-7044.118.1.157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252F0735-7044.118.1.157%26sid%3Dliteratum%253Aachs%26aulast%3DFrankel%26aufirst%3DP.%2BS.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3Dm-Chlorophenylpiperazine%2520%2528mCPP%2529%2520modulates%2520the%2520discriminative%2520stimulus%2520effects%2520of%2520cocaine%2520through%2520actions%2520at%2520the%25205-HT2C%2520receptor%26jtitle%3DBehav.%2520Neurosci.%26date%3D2004%26volume%3D118%26spage%3D157%26epage%3D162%26doi%3D10.1037%2F0735-7044.118.1.157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(97)00010-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2FS0028-3908%2897%2900010-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=373-381&author=P.+M.+Callahanauthor=K.+A.+Cunningham&title=Modulation+of+the+discriminative+stimulus+properties+of+cocaine%3A+comparison+of+the+effects+of+fluoxetine+with+5-HT1A+and+5-HT1B+receptor+agonists&doi=10.1016%2FS0028-3908%2897%2900010-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2897%2900010-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252897%252900010-5%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DModulation%2520of%2520the%2520discriminative%2520stimulus%2520properties%2520of%2520cocaine%253A%2520comparison%2520of%2520the%2520effects%2520of%2520fluoxetine%2520with%25205-HT1A%2520and%25205-HT1B%2520receptor%2520agonists%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D373%26epage%3D381%26doi%3D10.1016%2FS0028-3908%2897%2900010-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glennon, R. A.</span>; <span class="NLM_string-name">Young, R.</span></span> <span> </span><span class="NLM_article-title">Drug Discrimination and Development of Novel Agents and Pharmacological Tools</span>. In  <i>Drug Discrimination: Applications to Medicinal Chemistry and Drug Discovery</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glennon, R. A.</span>, <span class="NLM_string-name">Young, R.</span></span>, Eds.; <span class="NLM_publisher-name">John Wiley and Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">238</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1002%2F9781118023150.ch7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=217-238&author=R.+A.+Glennon&author=R.+Youngauthor=R.+A.+Glennon&author=R.+Young&title=Drug+Discrimination%3A+Applications+to+Medicinal+Chemistry+and+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2F9781118023150.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118023150.ch7%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDrug%2520Discrimination%2520and%2520Development%2520of%2520Novel%2520Agents%2520and%2520Pharmacological%2520Tools%26btitle%3DDrug%2520Discrimination%253A%2520Applications%2520to%2520Medicinal%2520Chemistry%2520and%2520Drug%2520Discovery%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26pub%3DJohn%2520Wiley%2520and%2520Sons%26date%3D2011%26spage%3D217%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neelakantan, H.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Lorcaserin suppresses oxycodone self-administration and relapse vulnerability in rats</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1065</span>– <span class="NLM_lpage">1073</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00413</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Klt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1065-1073&author=H.+Neelakantan&title=Lorcaserin+suppresses+oxycodone+self-administration+and+relapse+vulnerability+in+rats&doi=10.1021%2Facschemneuro.6b00413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats</span></div><div class="casAuthors">Neelakantan, Harshini; Holliday, Erica D.; Fox, Robert G.; Stutz, Sonja J.; Comer, Sandra D.; Haney, Margaret; Anastasio, Noelle C.; Moeller, F. Gerard; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1065-1073</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Opioid use disorder (OUD) is a major public health problem.  High relapse rates and poor treatment retention continue to pose major challenges in OUD treatment.  Of the abused opioids, oxycodone is well described to maintain self-administration and evoke the durable conditioned responses ("cue reactivity") that result from pairing of opioid-related stimuli (e.g., paraphernalia) with repeated abuse.  Serotonin (5-HT) neurotransmission, particularly through the 5-HT2C receptor (5-HT2CR), regulates psychostimulant reward and cue reactivity, and in the present expts., the authors investigated the hypothesis that the selective 5-HT2CR agonist lorcaserin, which is FDA-approved for the treatment of obesity, will suppress oxycodone self-administration and oxycodone-assocd. cue reactivity in rats.  The authors found that lorcaserin inhibited oxycodone intake, an effect blocked by the selective 5-HT2CR antagonist SB242084.  Lorcaserin also decreased responding for the discrete cue complex ("cue reactivity") previously assocd. with delivery of oxycodone (i.e., stimulus lights, infusion pump sounds) in both abstinence and extinction-reinstatement models.  The selected dose range of lorcaserin (0.25-1 mg/kg) does not overtly alter spontaneous behaviors nor operant responding on inactive levers in the present study.  Taken together, the ability of lorcaserin to reduce the oxycodone self-administration and decrease cue reactivity assocd. with relapse highlights the therapeutic potential for lorcaserin in the treatment of OUD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmhGr8KOEwb7Vg90H21EOLACvtfcHk0lj814R_feCHCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Klt7k%253D&md5=e67d9cd3074b5ea47b43d870b34e12b7</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00413%26sid%3Dliteratum%253Aachs%26aulast%3DNeelakantan%26aufirst%3DH.%26atitle%3DLorcaserin%2520suppresses%2520oxycodone%2520self-administration%2520and%2520relapse%2520vulnerability%2520in%2520rats%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D1065%26epage%3D1073%26doi%3D10.1021%2Facschemneuro.6b00413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. R.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">PPARγ agonism attenuates cocaine cue reactivity</span>. <i>Addict. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1111/adb.12471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1111%2Fadb.12471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=27862692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=55-68&author=W.+R.+Miller&title=PPAR%CE%B3+agonism+attenuates+cocaine+cue+reactivity&doi=10.1111%2Fadb.12471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">PPARγ agonism attenuates cocaine cue reactivity</span></div><div class="casAuthors">Miller, William R.; Fox, Robert G.; Stutz, Sonja J.; Lane, Scott D.; Denner, Larry; Cunningham, Kathryn A.; Dineley, Kelly T.</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-68</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-1600</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Cocaine use disorder is a chronic relapsing condition characterized by compulsive drug seeking and taking even after prolonged abstinence periods.  Subsequent exposure to drug-assocd. cues can promote intense craving and lead to relapse in abstinent humans and rodent models.  The responsiveness to these cocaine-related cues, or 'cue reactivity', can trigger relapse and cocaine-seeking behaviors; cue reactivity is measurable in cocaine-dependent humans as well as rodent models.  Cue reactivity is thought to be predictive of cocaine craving and relapse.  Here we report that PPARγ agonism during abstinence from cocaine self-administration reduced previously active lever pressing in Sprague Dawley rats during cue-reactivity tests, while administration of the PPARγ antagonist, GW9662, reversed this effect.  PPARγ agonism also normalized nuclear ERK activity in the medial prefrontal cortex and hippocampus which was reversed with GW9662.  Our results support the utility of PPARγ agonism as a relapse prevention strategy to maintain abstinence in the presence of cocaine-assocd. cues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp62oUcpb-5_7Vg90H21EOLACvtfcHk0lj814R_feCHCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKgtLg%253D&md5=a207ac0847d2f1512b42b7166357ebb7</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1111%2Fadb.12471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fadb.12471%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DW.%2BR.%26atitle%3DPPAR%25CE%25B3%2520agonism%2520attenuates%2520cocaine%2520cue%2520reactivity%26jtitle%3DAddict.%2520Biol.%26date%3D2018%26volume%3D23%26spage%3D55%26epage%3D68%26doi%3D10.1111%2Fadb.12471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grottick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, G. A.</span></span> <span> </span><span class="NLM_article-title">Studies to investigate the role of 5-HT2C receptors on cocaine- and food-maintained behavior</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>295</i></span>,  <span class="NLM_fpage">1183</span>– <span class="NLM_lpage">1191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=11082456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=1183-1191&author=A.+J.+Grottickauthor=P.+J.+Fletcherauthor=G.+A.+Higgins&title=Studies+to+investigate+the+role+of+5-HT2C+receptors+on+cocaine-+and+food-maintained+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Studies to investigate the role of 5-HT2C receptors on cocaine- and food-maintained behavior</span></div><div class="casAuthors">Grottick, Andrew J.; Fletcher, Paul J.; Higgins, Guy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1183-1191</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present series of studies were designed to investigate the 5-HT2C receptor agonist Ro 60-0175 on cocaine- and food-maintained behavior in the rat.  Ro 60-0175 (0.1-3 mg/kg, s.c.) reduced cocaine (15 mg/kg, i.p.)-induced hyperactivity.  This inhibitory effect of Ro 60-0175 (1 mg/kg, s.c.) was completely blocked by pretreatment with the selective 5-HT2C antagonist SB 242,084 (0.5 mg/kg, i.p.).  In further studies, Ro 60-0175 (1-3 mg/kg, s.c.) reduced responding for both food (45-mg Noyes pellet) and cocaine (0.25 mg/infusion) maintained under identical schedules of reinforcement (fixed ratio (5), time out 1 min, 60-min duration).  The effect on food-maintained responding was blocked by SB 242,084 (0.5 mg/kg, i.p.).  Ro 60-0175 (0.3-3 mg/kg, s.c.) also reduced the breakpoint for cocaine self-administration under a progressive ratio schedule of reinforcement.  After a period of extinction training, where cocaine soln. was substituted with saline, an acute priming injection of cocaine (15 mg/kg, i.p.) but not Ro 60-0175 (1 mg/kg, s.c.) reinstated cocaine responding.  In this model of relapse, Ro 60-0175 (1-3 mg/kg, s.c.) pretreatment attenuated the priming effect of acute cocaine injection.  In a final series of studies to examine the cataleptogenic properties of Ro 60-0175, very mild indexes of catalepsy were obsd. at the 3 mg/kg dose only.  These catalepsy scores were significantly lower than that produced by haloperidol (0.5 mg/kg, s.c.).  In further tests of motor function using the Rotarod, deficits were again seen at the 3 mg/kg dose, but not at lower doses.  Taken together, these studies suggest that, in addn. to reducing food intake, 5-HT2C receptor agonists reduce cocaine-reinforced behavior.  This would be consistent with electrophysiol. and biochem. evidence suggesting an important modulatory influence of 5-HT2C receptor activation on mesolimbic dopamine function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD1ztgAEhZKrVg90H21EOLACvtfcHk0li1zaQCGF6-Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKisb0%253D&md5=b0566e8a98afb4bc610a54456cf808ef</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DFletcher%26aufirst%3DP.%2BJ.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DStudies%2520to%2520investigate%2520the%2520role%2520of%25205-HT2C%2520receptors%2520on%2520cocaine-%2520and%2520food-maintained%2520behavior%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D1183%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neisewander, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acosta, J. I.</span></span> <span> </span><span class="NLM_article-title">Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats</span>. <i>Behav. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1097/FBP.0b013e3282f1c94b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1097%2FFBP.0b013e3282f1c94b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=791-800&author=J.+L.+Neisewanderauthor=J.+I.+Acosta&title=Stimulation+of+5-HT2C+receptors+attenuates+cue+and+cocaine-primed+reinstatement+of+cocaine-seeking+behavior+in+rats&doi=10.1097%2FFBP.0b013e3282f1c94b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1097%2FFBP.0b013e3282f1c94b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFBP.0b013e3282f1c94b%26sid%3Dliteratum%253Aachs%26aulast%3DNeisewander%26aufirst%3DJ.%2BL.%26aulast%3DAcosta%26aufirst%3DJ.%2BI.%26atitle%3DStimulation%2520of%25205-HT2C%2520receptors%2520attenuates%2520cue%2520and%2520cocaine-primed%2520reinstatement%2520of%2520cocaine-seeking%2520behavior%2520in%2520rats%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2007%26volume%3D18%26spage%3D791%26epage%3D800%26doi%3D10.1097%2FFBP.0b013e3282f1c94b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGinnis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. S.</span></span> <span> </span><span class="NLM_article-title">Quantitative changes in intracellular calcium and extracellular-regulated kinase activation measured in parallel in CHO cells stably expressing serotonin (5-HT) 5-HT2A or 5-HT2C receptors</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">25</span>, <span class="refDoi"> DOI: 10.1186/1471-2202-13-25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1186%2F1471-2202-13-25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=22397586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCgu7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=25&author=P.+K.+Seitzauthor=N.+M.+Bremerauthor=A.+McGinnisauthor=K.+A.+Cunninghamauthor=C.+S.+Watson&title=Quantitative+changes+in+intracellular+calcium+and+extracellular-regulated+kinase+activation+measured+in+parallel+in+CHO+cells+stably+expressing+serotonin+%285-HT%29+5-HT2A+or+5-HT2C+receptors&doi=10.1186%2F1471-2202-13-25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative changes in intracellular calcium and extracellular-regulated kinase activation measured in parallel in CHO cells stably expressing serotonin (5-HT) 5-HT2A or 5-HT2C receptors</span></div><div class="casAuthors">Seitz, Patricia K.; Bremer, Nicole M.; McGinnis, Andrew G.; Cunningham, Kathryn A.; Watson, Cheryl S.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25</span>CODEN:
                <span class="NLM_cas:coden">BNMEA6</span>;
        ISSN:<span class="NLM_cas:issn">1471-2202</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The serotonin (5-HT) 2A and 2C receptors (5-HT2AR and 5-HT2CR) are involved in a wide range of physiol. and behavioral processes in the mammalian central and peripheral nervous systems.  These receptors share a high degree of homol., have overlapping pharmacol. profiles, and utilize many of the same and richly diverse second messenger signaling systems.  We have developed quant. assays for cells stably expressing these two receptors involving minimal cell sample manipulations that dramatically improve parallel assessments of two signaling responses: intracellular calcium (Cai++) changes and activation (phosphorylation) of downstream kinases.  Such profiles are needed to begin to understand the simultaneous contributions from the multiplicity of signaling cascades likely to be initiated by serotonergic ligands.  Results: We optimized the Cai++ assay for stable cell lines expressing either 5-HT2AR or 5-HT2CR (including dye use and measurement parameters; cell d. and serum requirements).  We adapted a quant. 96-well plate immunoassay for pERK in the same cell lines.  Similar cell d. optima and time courses were obsd. for 5-HT2AR- and 5-HT2CR-expressing cells in generating both types of signaling.  Both cell lines also require serum-free preincubation for maximal agonist responses in the pERK assay.  However, 5-HT2AR-expressing cells showed significant release of Cai++ in response to 5-HT stimulation even when preincubated in serum-replete medium, while the response was completely eliminated by serum in 5-HT2CR-expressing cells.  Response to another serotonergic ligand (DOI) was eliminated by serum-replete preincubation in both cells lines.  Conclusions: These data expand our knowledge of differences in ligand-stimulated signaling cascades between 5-HT2AR and 5-HT2CR.  Our parallel assays can be applied to other cell and receptor systems for monitoring and dissecting concurrent signaling responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6M4u7LVn5PbVg90H21EOLACvtfcHk0li1zaQCGF6-Eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCgu7nL&md5=6b1b3b3c45590bda79f49f89d8e7fdbb</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-13-25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-13-25%26sid%3Dliteratum%253Aachs%26aulast%3DSeitz%26aufirst%3DP.%2BK.%26aulast%3DBremer%26aufirst%3DN.%2BM.%26aulast%3DMcGinnis%26aufirst%3DA.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DWatson%26aufirst%3DC.%2BS.%26atitle%3DQuantitative%2520changes%2520in%2520intracellular%2520calcium%2520and%2520extracellular-regulated%2520kinase%2520activation%2520measured%2520in%2520parallel%2520in%2520CHO%2520cells%2520stably%2520expressing%2520serotonin%2520%25285-HT%2529%25205-HT2A%2520or%25205-HT2C%2520receptors%26jtitle%3DBMC%2520Neurosci.%26date%3D2012%26volume%3D13%26spage%3D25%26doi%3D10.1186%2F1471-2202-13-25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref29':['cit29'],'ref28':['cit28'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 13 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Eric A. Wold, Erik J. Garcia, Christopher T. Wild, Joanna M. Miszkiel, Claudia A. Soto, Jianping Chen, Konrad Pazdrak, Robert G. Fox, Noelle C. Anastasio, Kathryn A. Cunningham, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 4-Phenylpiperidine-2-Carboxamide Analogues as Serotonin 5-HT2C Receptor-Positive Allosteric Modulators with Enhanced Drug-like Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7529-7544. <a href="https://doi.org/10.1021/acs.jmedchem.9b01953" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01953</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01953&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01953%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B4-Phenylpiperidine-2-Carboxamide%252BAnalogues%252Bas%252BSerotonin%252B5-HT2C%252BReceptor-Positive%252BAllosteric%252BModulators%252Bwith%252BEnhanced%252BDrug-like%252BProperties%26aulast%3DWold%26aufirst%3DEric%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D16122019%26date%3D07072020%26date%3D22062020%26volume%3D63%26issue%3D14%26spage%3D7529%26epage%3D7544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Qi Mao, Bingjie Zhang, Wanwan Li, Sheng Tian, Wenqing Shui, <span class="NLM_string-name hlFld-ContribAuthor">Na Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel 1-O-Substituted Aporphine Analogues as Potent 5-HT2C Receptor Agonists. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 549-559. <a href="https://doi.org/10.1021/acschemneuro.9b00563" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00563</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00563%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIdentification%252Bof%252BNovel%252B1-O-Substituted%252BAporphine%252BAnalogues%252Bas%252BPotent%252B5-HT2C%252BReceptor%252BAgonists%26aulast%3DMao%26aufirst%3DQi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D17102019%26date%3D22012020%26date%3D04022020%26date%3D22012020%26volume%3D11%26issue%3D4%26spage%3D549%26epage%3D559" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Eric A. Wold, Jianping Chen, Kathryn A. Cunningham, <span class="NLM_string-name hlFld-ContribAuthor">Jia Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 88-127. <a href="https://doi.org/10.1021/acs.jmedchem.8b00875" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00875</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00875%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAllosteric%252BModulation%252Bof%252BClass%252BA%252BGPCRs%25253A%252BTargets%25252C%252BAgents%25252C%252Band%252BEmerging%252BConcepts%26aulast%3DWold%26aufirst%3DEric%2BA.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D02062018%26date%3D28082018%26date%3D14082018%26volume%3D62%26issue%3D1%26spage%3D88%26epage%3D127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miao  Hu</span>, <span class="hlFld-ContribAuthor ">Yong  Jiang</span>, <span class="hlFld-ContribAuthor ">Nan  Sun</span>, <span class="hlFld-ContribAuthor ">Baoxiang  Hu</span>, <span class="hlFld-ContribAuthor ">Zhenlu  Shen</span>, <span class="hlFld-ContribAuthor ">Xinquan  Hu</span>, <span class="hlFld-ContribAuthor ">Liqun  Jin</span>. </span><span class="cited-content_cbyCitation_article-title">Nickel-catalyzed C3-alkylation of indoles with alcohols
              via
              a borrowing hydrogen strategy. </span><span class="cited-content_cbyCitation_journal-name">New Journal of Chemistry</span><span> <strong>2021,</strong> <em>45 </em>
                                    (22)
                                     , 10057-10062. <a href="https://doi.org/10.1039/D1NJ01581H" title="DOI URL">https://doi.org/10.1039/D1NJ01581H</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1NJ01581H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1NJ01581H%26sid%3Dliteratum%253Aachs%26jtitle%3DNew%2520Journal%2520of%2520Chemistry%26atitle%3DNickel-catalyzed%252BC3-alkylation%252Bof%252Bindoles%252Bwith%252Balcohols%252Bvia%252Ba%252Bborrowing%252Bhydrogen%252Bstrategy%26aulast%3DHu%26aufirst%3DMiao%26date%3D2021%26date%3D2021%26volume%3D45%26issue%3D22%26spage%3D10057%26epage%3D10062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas M.  Barnes</span>, <span class="hlFld-ContribAuthor ">Gerard P.  Ahern</span>, <span class="hlFld-ContribAuthor ">Carine  Becamel</span>, <span class="hlFld-ContribAuthor ">Joël  Bockaert</span>, <span class="hlFld-ContribAuthor ">Michael  Camilleri</span>, <span class="hlFld-ContribAuthor ">Severine  Chaumont-Dubel</span>, <span class="hlFld-ContribAuthor ">Sylvie  Claeysen</span>, <span class="hlFld-ContribAuthor ">Kathryn A.  Cunningham</span>, <span class="hlFld-ContribAuthor ">Kevin C.  Fone</span>, <span class="hlFld-ContribAuthor ">Michael  Gershon</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Di Giovanni</span>, <span class="hlFld-ContribAuthor ">Nathalie M.  Goodfellow</span>, <span class="hlFld-ContribAuthor ">Adam L.  Halberstadt</span>, <span class="hlFld-ContribAuthor ">Rachel M.  Hartley</span>, <span class="hlFld-ContribAuthor ">Ghérici  Hassaine</span>, <span class="hlFld-ContribAuthor ">Katharine  Herrick-Davis</span>, <span class="hlFld-ContribAuthor ">Ruud  Hovius</span>, <span class="hlFld-ContribAuthor ">Enza  Lacivita</span>, <span class="hlFld-ContribAuthor ">Evelyn K.  Lambe</span>, <span class="hlFld-ContribAuthor ">Marcello  Leopoldo</span>, <span class="hlFld-ContribAuthor ">Finn Olav  Levy</span>, <span class="hlFld-ContribAuthor ">Sarah C. R.  Lummis</span>, <span class="hlFld-ContribAuthor ">Philippe  Marin</span>, <span class="hlFld-ContribAuthor ">Luc  Maroteaux</span>, <span class="hlFld-ContribAuthor ">Andrew C.  McCreary</span>, <span class="hlFld-ContribAuthor ">David L.  Nelson</span>, <span class="hlFld-ContribAuthor ">John F.  Neumaier</span>, <span class="hlFld-ContribAuthor ">Adrian  Newman-Tancredi</span>, <span class="hlFld-ContribAuthor ">Hugues  Nury</span>, <span class="hlFld-ContribAuthor ">Alexander  Roberts</span>, <span class="hlFld-ContribAuthor ">Bryan L.  Roth</span>, <span class="hlFld-ContribAuthor ">Anne  Roumier</span>, <span class="hlFld-ContribAuthor ">Gareth J.  Sanger</span>, <span class="hlFld-ContribAuthor ">Milt  Teitler</span>, <span class="hlFld-ContribAuthor ">Trevor  Sharp</span>, <span class="hlFld-ContribAuthor ">Carlos M.  Villalón</span>, <span class="hlFld-ContribAuthor ">Horst  Vogel</span>, <span class="hlFld-ContribAuthor ">Stephanie W.  Watts</span>, <span class="hlFld-ContribAuthor ">Daniel  Hoyer</span>, . </span><span class="cited-content_cbyCitation_article-title">International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2021,</strong> <em>73 </em>
                                    (1)
                                     , 310-520. <a href="https://doi.org/10.1124/pr.118.015552" title="DOI URL">https://doi.org/10.1124/pr.118.015552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.118.015552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.118.015552%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DInternational%252BUnion%252Bof%252BBasic%252Band%252BClinical%252BPharmacology.%252BCX.%252BClassification%252Bof%252BReceptors%252Bfor%252B5-hydroxytryptamine%25253B%252BPharmacology%252Band%252BFunction%26aulast%3DBarnes%26aufirst%3DNicholas%2BM.%26date%3D2021%26date%3D2020%26volume%3D73%26issue%3D1%26spage%3D310%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Irene  Fasciani</span>, <span class="hlFld-ContribAuthor ">Francesco  Petragnano</span>, <span class="hlFld-ContribAuthor ">Gabriella  Aloisi</span>, <span class="hlFld-ContribAuthor ">Francesco  Marampon</span>, <span class="hlFld-ContribAuthor ">Marco  Carli</span>, <span class="hlFld-ContribAuthor ">Marco  Scarselli</span>, <span class="hlFld-ContribAuthor ">Roberto  Maggio</span>, <span class="hlFld-ContribAuthor ">Mario  Rossi</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric Modulators of G Protein-Coupled Dopamine and Serotonin Receptors: A New Class of Atypical Antipsychotics. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2020,</strong> <em>13 </em>
                                    (11)
                                     , 388. <a href="https://doi.org/10.3390/ph13110388" title="DOI URL">https://doi.org/10.3390/ph13110388</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph13110388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph13110388%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DAllosteric%252BModulators%252Bof%252BG%252BProtein-Coupled%252BDopamine%252Band%252BSerotonin%252BReceptors%25253A%252BA%252BNew%252BClass%252Bof%252BAtypical%252BAntipsychotics%26aulast%3DFasciani%26aufirst%3DIrene%26date%3D2020%26date%3D2020%26volume%3D13%26issue%3D11%26spage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Trevor  Sharp</span>, <span class="hlFld-ContribAuthor ">Nicholas M.  Barnes</span>. </span><span class="cited-content_cbyCitation_article-title">Central 5-HT receptors and their function; present and future. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>177 </em>, 108155. <a href="https://doi.org/10.1016/j.neuropharm.2020.108155" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2020.108155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2020.108155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2020.108155%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DCentral%252B5-HT%252Breceptors%252Band%252Btheir%252Bfunction%25253B%252Bpresent%252Band%252Bfuture%26aulast%3DSharp%26aufirst%3DTrevor%26date%3D2020%26volume%3D177%26spage%3D108155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">María L.  López-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Bellinda  Benhamú</span>, <span class="hlFld-ContribAuthor ">Henar  Vázquez-Villa</span>. </span><span class="cited-content_cbyCitation_article-title">Allosteric modulators targeting GPCRs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 195-241. <a href="https://doi.org/10.1016/B978-0-12-816228-6.00011-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-816228-6.00011-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816228-6.00011-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816228-6.00011-8%26sid%3Dliteratum%253Aachs%26atitle%3DAllosteric%252Bmodulators%252Btargeting%252BGPCRs%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DMar%25C3%25ADa%2BL.%26date%3D2020%26spage%3D195%26epage%3D241%26pub%3DElsevier%26atitle%3DGPCRs%26date%3D2020%26volume%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kathryn A.  Cunningham</span>, <span class="hlFld-ContribAuthor ">Leonard L.  Howell</span>, <span class="hlFld-ContribAuthor ">Noelle C.  Anastasio</span>. </span><span class="cited-content_cbyCitation_article-title">Serotonin neurobiology in cocaine use disorder. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 745-802. <a href="https://doi.org/10.1016/B978-0-444-64125-0.00040-2" title="DOI URL">https://doi.org/10.1016/B978-0-444-64125-0.00040-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-444-64125-0.00040-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-444-64125-0.00040-2%26sid%3Dliteratum%253Aachs%26atitle%3DSerotonin%252Bneurobiology%252Bin%252Bcocaine%252Buse%252Bdisorder%26aulast%3DCunningham%26aufirst%3DKathryn%2BA.%26date%3D2020%26spage%3D745%26epage%3D802%26pub%3DElsevier%26atitle%3DHandbook%252Bof%252Bthe%252BBehavioral%252BNeurobiology%252Bof%252BSerotonin%26date%3D2020%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guy A.  Higgins</span>, <span class="hlFld-ContribAuthor ">Paul J.  Fletcher</span>, <span class="hlFld-ContribAuthor ">William R.  Shanahan</span>. </span><span class="cited-content_cbyCitation_article-title">Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>205 </em>, 107417. <a href="https://doi.org/10.1016/j.pharmthera.2019.107417" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2019.107417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2019.107417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2019.107417%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DLorcaserin%25253A%252BA%252Breview%252Bof%252Bits%252Bpreclinical%252Band%252Bclinical%252Bpharmacology%252Band%252Btherapeutic%252Bpotential%26aulast%3DHiggins%26aufirst%3DGuy%2BA.%26date%3D2020%26volume%3D205%26spage%3D107417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric A.  Wold</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Wild</span>, <span class="hlFld-ContribAuthor ">Kathryn A.  Cunningham</span>, <span class="hlFld-ContribAuthor ">Jia  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2019,</strong> <em>19 </em>
                                    (16)
                                     , 1381-1398. <a href="https://doi.org/10.2174/1568026619666190709101449" title="DOI URL">https://doi.org/10.2174/1568026619666190709101449</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666190709101449&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666190709101449%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252B5-HT2C%252BReceptor%252Bin%252BBiological%252BContext%252Band%252Bthe%252BCurrent%252BState%252Bof%252B5-HT2C%252BReceptor%252BLigand%252BDevelopment%26aulast%3DWold%26aufirst%3DEric%2BA.%26date%3D2019%26volume%3D19%26issue%3D16%26spage%3D1381%26epage%3D1398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudia A.  Soto</span>, <span class="hlFld-ContribAuthor ">Huang-Chi  Du</span>, <span class="hlFld-ContribAuthor ">Robert G.  Fox</span>, <span class="hlFld-ContribAuthor ">Taegyun  Yang</span>, <span class="hlFld-ContribAuthor ">James  Hooson</span>, <span class="hlFld-ContribAuthor ">Noelle C.  Anastasio</span>, <span class="hlFld-ContribAuthor ">Scott R.  Gilbertson</span>, <span class="hlFld-ContribAuthor ">Kathryn A.  Cunningham</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo and In Vitro Analyses of Novel Peptidomimetic Disruptors for the Serotonin 5-HT2C Receptor Interaction With Phosphatase and Tensin Homolog. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fphar.2019.00907" title="DOI URL">https://doi.org/10.3389/fphar.2019.00907</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2019.00907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2019.00907%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DIn%252BVivo%252Band%252BIn%252BVitro%252BAnalyses%252Bof%252BNovel%252BPeptidomimetic%252BDisruptors%252Bfor%252Bthe%252BSerotonin%252B5-HT2C%252BReceptor%252BInteraction%252BWith%252BPhosphatase%252Band%252BTensin%252BHomolog%26aulast%3DSoto%26aufirst%3DClaudia%2BA.%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Zhou</span>, <span class="hlFld-ContribAuthor ">Kathryn A.  Cunningham</span>. </span><span class="cited-content_cbyCitation_article-title">Positive-allosteric modulation of the 5-HT2C receptor: implications for neuropsychopharmacology and neurotherapeutics. </span><span class="cited-content_cbyCitation_journal-name">Neuropsychopharmacology</span><span> <strong>2019,</strong> <em>44 </em>
                                    (1)
                                     , 230-231. <a href="https://doi.org/10.1038/s41386-018-0190-x" title="DOI URL">https://doi.org/10.1038/s41386-018-0190-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41386-018-0190-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41386-018-0190-x%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropsychopharmacology%26atitle%3DPositive-allosteric%252Bmodulation%252Bof%252Bthe%252B5-HT2C%252Breceptor%25253A%252Bimplications%252Bfor%252Bneuropsychopharmacology%252Band%252Bneurotherapeutics%26aulast%3DZhou%26aufirst%3DJia%26date%3D2019%26date%3D2018%26volume%3D44%26issue%3D1%26spage%3D230%26epage%3D231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0001.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Initial design strategy for novel 5-HT<sub>2C</sub>R positive allosteric modulators based on <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0009.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of PNU-69176E Analogs with Simplified Polar Heads (PH)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) see ref <a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(28)</a>; (b) 1-undecyne, CuI, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Et<sub>3</sub>N, rt, 12 h, 94%; (c) H<sub>2</sub> (60 psi), PtO<sub>2</sub>, HCl/MeOH/H<sub>2</sub>O, rt, 16 h, 95%; (d) (i) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, MeOH, rt, 16 h, 90%; (ii) LiOH, THF/H<sub>2</sub>O (v/v = 2:1), rt, 48 h, 85%; (e) (i) amino alcohols, HBTU, DIPEA, DMF, rt, 16 h; (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 63–88% (two steps).</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of PNU-69176E Analogs with Compact Lipophilic Tails (LT)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Suzuki coupling, (i) phenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub>, Na<sub>2</sub>CO<sub>3</sub>, EtOH/H<sub>2</sub>O/PhMe = 2:1:1, reflux; (ii) H<sub>2</sub>SO<sub>4</sub>, methanol, reflux, 98% (two steps); or Sonogashira coupling, ethynylbenzene or 1-ethynyl-4-methylbenzene, CuI, Pd(PPh<sub>3</sub>)<sub>2</sub>Cl<sub>2</sub>, Et<sub>3</sub>N, rt, 12 h, 88% to 97%; (b) (i) H<sub>2</sub> (60 psi), PtO<sub>2</sub>, HCl/MeOH/H<sub>2</sub>O, rt, 16 h, 97–98%; (ii) (Boc)<sub>2</sub>O, Et<sub>3</sub>N, MeOH, rt, 16 h, 96–98%; (c) LiOH, THF/H<sub>2</sub>O (v/v = 2:1), rt, 48 h, quantitative yield; (d) (i) amino alcohols, HBTU, DIPEA, DMF, rt, 16 h; (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 83–86% (two steps).</p></p></figure><figure data-id="fig2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Determination of absolute configuration of chiral carbons 2 and 4 of the piperdinyl ring. X-ray crystallography structures of analogues (2<i>S</i>,4<i>R</i>)-<b>32</b> and (2<i>R</i>,4<i>S</i>)-<b>35</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effects of select compounds on Ca<sub>i</sub><sup>2+</sup> release in live h5-HT<sub>2C</sub>R-CHO cells in the absence (black circles) and in the presence of the test compound (red triangles) against the concentration–response curve for 5-HT, vehicle (blue circle), or vehicle in the presence of test compound (green triangle). (A) Compound <b>14</b> (1 nM), representative example of a potential NAM; (B) compound <b>16</b> (1 nM), representative example of a potential PAM; (C) compound <b>16a</b> (1 nM), representative example of an inactive compound. The maximum 5-HT-induced Ca<sub>i</sub><sup>2+</sup> release in the absence of the test compounds was set as 100%. The <i>E</i><sub>max</sub> of 5-HT in the presence of the test compounds are listed in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Concentration–response curves for remaining compounds are in <a href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf" class="ext-link">Figure S2</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Effects of <b>16</b> on Ca<sub>i</sub><sup>2+</sup> release in live h5-HT<sub>2C</sub>R-CHO cells (A) and h5-HT<sub>2A</sub>R-CHO cells (B) against the concentration–response curve for 5-HT. (A) Compound <b>16</b> (1 pM, 1 nM, 1 μM) demonstrates an upward shift in h5-HT<sub>2C</sub>R-CHO cells. (B) Compound <b>16</b> (1 pM, 1 nM, 1 μM) does not alter 5-HT-induced signaling in h5-HT<sub>2A</sub>R-CHO cells. The maximum 5-HT-induced Ca<sub>i</sub><sup>2+</sup> release in the absence of the test compounds was set as 100%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding poses of (A) global view of 5-HT<sub>2C</sub>R (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6BQG">6BQG</a>) with 5-HT (pink space-fill representation) at the orthosteric site and <b>16b</b> (red stick representation overlay of top five poses) at the proposed allosteric site; (B) representative pose of <b>16b</b> (red stick representation) engaged with residues of proposed allosteric site (superscript designation represents Ballesteros–Weinstein notation);<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (C) representative pose of <b>16a</b> (red stick representation).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of compound <b>16</b> on spontaneous locomotor activity. (A) Groups of rats (<i>n</i> = 7–8/group) naive to the activity monitors were injected with a single dose of saline or compound <b>16</b> (0.5, 1, or 5 mg/kg; ip) immediately prior to the start of locomotor assessment. (B) Groups of rats (<i>n</i> = 9–10/group) naive to the activity monitors were injected with a single dose of the 5-HT<sub>2C</sub>R antagonist SB242084 (1 mg/kg; ip; 15 min pretreatment) and the 5-HT<sub>2C</sub>R agonist WAY163909 (1 mg/kg; ip) in combination with compound <b>16</b> (5 mg/kg; ip) immediately prior to the start of locomotor assessment. The mean total ambulations (±SEM) in 30 min are plotted. *<i>p</i> < 0.05.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0007.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Dose–response relationship of WAY163909, compound <b>16</b>, and the combination in a WAY163909 vs saline drug discrimination assay. The dose–response curves (<i>n</i> = 7–9/dose) for (A) WAY163909 (ip) and (B) compound <b>16</b> (ip) are presented. Closed circles (solid lines) denote the mean percentage of WAY163909-appropriate responding (±SEM; left axis), and open triangles (dotted lines) denote the mean responses/min (±SEM; right axis). *<i>p</i> < 0.05 vs 0.75 mg/kg WAY163909. (C) The results of substitution tests in which WAY163909 alone or in combination with compound <b>16</b> are presented. The dotted line represents the % WAY163909-lever response observed for the training dose of WAY163909 (0.75 mg/kg). *<i>p</i> < 0.05 vs 0.5 mg/kg of compound <b>16</b>;<b>̂</b><i>p</i> < 0.05 vs 0.5 mg/kg of WAY163909.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/medium/jm-2018-00401j_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Effects of compound <b>16</b> on cocaine cue reactivity in rats (<i>n</i> = 7/treatment group). Mean (±SEM) previously active lever are presented for the cue reactivity test session following administration for saline or compound <b>16</b>. The first component of the cue reactivity session (initial 10 min) evaluated lever presses in the absence of the discrete cue complex. The second component was signaled by the single delivery of the discrete cue complex (denoted by arrow). Presses on the previously active lever in the 60 min second component were reinforced by the discrete cue complex; inactive lever presses were recorded but produced no scheduled consequences. Rats were injected with saline (1 mL/kg, ip) or compound <b>16</b> (1 mg/kg; ip) 15 min prior to a cocaine cue reactivity test session. Compound <b>16</b> suppressed cue reactivity vs saline (*<i>p</i> < 0.05).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-1/acs.jmedchem.8b00401/20190107/images/large/jm-2018-00401j_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00401&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i62">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67664" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67664" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 70 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, A.</span>; <span class="NLM_string-name">Williams, M. R.</span>; <span class="NLM_string-name">Lipari, R. N.</span>; <span class="NLM_string-name">Van Horn, S.</span></span> <span> </span><span class="NLM_article-title">State Estimates of Past Year Cocaine Use among Young Adults: 2014 and 2015</span>;  <i>The CBHSQ Report of 2016</i>; Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, <span class="NLM_publisher-name">U.S. Government Printing Office</span>: <span class="NLM_publisher-loc">Rockville, MD</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=A.+Hughes&author=M.+R.+Williams&author=R.+N.+Lipari&author=S.+Van+Horn&title=The+CBHSQ+Report+of+2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DA.%26atitle%3DState%2520Estimates%2520of%2520Past%2520Year%2520Cocaine%2520Use%2520among%2520Young%2520Adults%253A%25202014%2520and%25202015%26btitle%3DThe%2520CBHSQ%2520Report%2520of%25202016%26pub%3DU.S.%2520Government%2520Printing%2520Office%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span> <span> </span><span class="NLM_article-title">Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>76</i></span> (<span class="NLM_issue">Pt B</span>),  <span class="NLM_fpage">460</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2013.06.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.neuropharm.2013.06.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23850573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SksLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=460-478&issue=Pt+B&author=K.+A.+Cunninghamauthor=N.+C.+Anastasio&title=Serotonin+at+the+nexus+of+impulsivity+and+cue+reactivity+in+cocaine+addiction&doi=10.1016%2Fj.neuropharm.2013.06.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction</span></div><div class="casAuthors">Cunningham, Kathryn A.; Anastasio, Noelle C.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">PB</span>),
    <span class="NLM_cas:pages">460-478</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Cocaine abuse and addiction remain great challenges on the public health agendas in the U.S. and the world.  Increasingly sophisticated perspectives on addiction to cocaine and other drugs of abuse have evolved with concerted research efforts over the last 30 years.  Relapse remains a particularly powerful clin. problem as, even upon termination of drug use and initiation of abstinence, the recidivism rates can be very high.  The cycling course of cocaine intake, abstinence and relapse is tied to a multitude of behavioral and cognitive processes including impulsivity (a predisposition toward rapid unplanned reactions to stimuli without regard to the neg. consequences), and cocaine cue reactivity (responsivity to cocaine-assocd. stimuli) cited as two key phenotypes that contribute to relapse vulnerability even years into recovery.  Preclin. studies suggest that serotonin (5-hydroxytryptamine; 5-HT) neurotransmission in key neural circuits may contribute to these interlocked phenotypes well as the altered neurobiol. states evoked by cocaine that ppt. relapse events.  As such, 5-HT is an important target in the quest to understand the neurobiol. of relapse-predictive phenotypes, to successfully treat this complex disorder and improve diagnostic and prognostic capabilities.  This review emphasizes the role of 5-HT and its receptor proteins in key addiction phenotypes and the implications of current findings to the future of therapeutics in addiction.This article is part of a Special Issue entitled NIDA 40th Anniversary Issue'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyS7RfoN3mB7Vg90H21EOLACvtfcHk0lgDybzYtDT-qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SksLvM&md5=3ba5409e7102c92a5ceec177c7f2839c</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2013.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2013.06.030%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26atitle%3DSerotonin%2520at%2520the%2520nexus%2520of%2520impulsivity%2520and%2520cue%2520reactivity%2520in%2520cocaine%2520addiction%26jtitle%3DNeuropharmacology%26date%3D2014%26volume%3D76%26issue%3DPt%2520B%26spage%3D460%26epage%3D478%26doi%3D10.1016%2Fj.neuropharm.2013.06.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howell, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">176</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1124/pr.114.009514</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1124%2Fpr.114.009514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=25505168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oms7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2015&pages=176-197&author=L.+L.+Howellauthor=K.+A.+Cunningham&title=Serotonin+5-HT2+receptor+interactions+with+dopamine+function%3A+implications+for+therapeutics+in+cocaine+use+disorder&doi=10.1124%2Fpr.114.009514"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder</span></div><div class="casAuthors">Howell, Leonard L.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">176-197, 22 pp.</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">1521-0081</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Cocaine exhibits prominent abuse liability, and chronic abuse can result in cocaine use disorder with significant morbidity.  Major advances have been made in delineating neurobiol. mechanisms of cocaine abuse; however, effective medications to treat cocaine use disorder remain to be discovered.  The present review will focus on the role of serotonin (5-HT; 5-hydroxytryptamine) neurotransmission in the neuropharmacol. of cocaine and related abused stimulants.  Extensive research suggests that the primary contribution of 5-HT to cocaine addiction is a consequence of interactions with dopamine (DA) neurotransmission.  The literature on the neurobiol. and behavioral effects of cocaine is well developed, so the focus of the review will be on cocaine with inferences made about other monoamine uptake inhibitors and releasers based on mechanistic considerations. 5-HT receptors are widely expressed throughout the brain, and several different 5-HT receptor subtypes have been implicated in mediating the effects of endogenous 5-HT on DA.  However, the 5-HT2A and 5-HT2C receptors in particular have been implicated as likely candidates for mediating the influence of 5-HT in cocaine abuse as well as to traits (e.g., impulsivity) that contribute to the development of cocaine use disorder and relapse in humans.  Lastly, new approaches are proposed to guide targeted development of serotonergic ligands for the treatment of cocaine use disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrr8S3_2aD27Vg90H21EOLACvtfcHk0lgDybzYtDT-qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oms7w%253D&md5=f16fdf974beaa29f82770b9efdb43363</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1124%2Fpr.114.009514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.114.009514%26sid%3Dliteratum%253Aachs%26aulast%3DHowell%26aufirst%3DL.%2BL.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DSerotonin%25205-HT2%2520receptor%2520interactions%2520with%2520dopamine%2520function%253A%2520implications%2520for%2520therapeutics%2520in%2520cocaine%2520use%2520disorder%26jtitle%3DPharmacol.%2520Rev.%26date%3D2015%26volume%3D67%26spage%3D176%26epage%3D197%26doi%3D10.1124%2Fpr.114.009514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">The expanded biology of serotonin</span>. <i>Annu. Rev. Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">366</span>, <span class="refDoi"> DOI: 10.1146/annurev.med.60.042307.110802</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1146%2Fannurev.med.60.042307.110802" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=19630576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD1MXitlyntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2009&pages=355-366&author=M.+Bergerauthor=J.+A.+Grayauthor=B.+L.+Roth&title=The+expanded+biology+of+serotonin&doi=10.1146%2Fannurev.med.60.042307.110802"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">The expanded biology of serotonin</span></div><div class="casAuthors">Berger, Miles; Gray, John A.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">355-366</span>CODEN:
                <span class="NLM_cas:coden">ARMCAH</span>;
        ISSN:<span class="NLM_cas:issn">0066-4219</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Serotonin is perhaps best known as a neurotransmitter that modulates neural activity and a wide range of neuropsychol. processes, and drugs that target serotonin receptors are used widely in psychiatry and neurol.  However, most serotonin is found outside the central nervous system, and virtually all of the 15 serotonin receptors are expressed outside as well as within the brain.  Serotonin regulates numerous biol. processes including cardiovascular function, bowel motility, ejaculatory latency, and bladder control.  Addnl., new work suggests that serotonin may regulate some processes, including platelet aggregation, by receptor-independent, transglutaminase-dependent covalent linkage to cellular proteins.  We review this new expanded serotonin biol. and discuss how drugs targeting specific serotonin receptors are beginning to help treat a wide range of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoz0HW5hdNOrVg90H21EOLACvtfcHk0liq7LyEN0Q4cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXitlyntb8%253D&md5=0557e01e6b79dbfb50559aca03f8b31f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1146%2Fannurev.med.60.042307.110802&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.med.60.042307.110802%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DM.%26aulast%3DGray%26aufirst%3DJ.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DThe%2520expanded%2520biology%2520of%2520serotonin%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2009%26volume%3D60%26spage%3D355%26epage%3D366%26doi%3D10.1146%2Fannurev.med.60.042307.110802" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Willins, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kristiansen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroeze, W. K.</span></span> <span> </span><span class="NLM_article-title">5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1016/S0163-7258(98)00019-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2FS0163-7258%2898%2900019-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=9776378" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaK1cXlsFCrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1998&pages=231-257&author=B.+L.+Rothauthor=D.+L.+Willinsauthor=K.+Kristiansenauthor=W.+K.+Kroeze&title=5-Hydroxytryptamine2-family+receptors+%285-hydroxytryptamine2A%2C+5-hydroxytryptamine2B%2C+5-hydroxytryptamine2C%29%3A+where+structure+meets+function&doi=10.1016%2FS0163-7258%2898%2900019-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function</span></div><div class="casAuthors">Roth, Bryan L.; Willins, David L.; Kristiansen, Kurt; Kroeze, Wesley K.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-257</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review, with ∼250 refs.  5-Hydroxytryptamine2 (serotonin2, 5-HT2)-family receptors are important for mediating many physiol. functions, including vascular and nonvascular smooth muscle contraction, platelet aggregation, modulation of perception, mood, anxiety, and feeding behavior.  A large no. of psychopharmaceuticals, including atypical antipsychotic drugs, antidepressants, anxiolytics, and hallucinogens, mediate their actions, at least in part, via interactions with various 5-HT2-family receptors.  This review article summarizes information about structure-function aspects of 5-HT2-family receptors.  Evidence is presented that implies that conserved arom. and charged residues are essential for ligand binding to 5-HT2A receptors.  Addnl., findings are reviewed that are consistent with the hypothesis that residues located in intracellular loops 2 and 3 (i2 and i3) mediate coupling to specific Gα-subunits such as Gαq.  Studies are reviewed that suggest that 5-HT2-family receptors may be down-regulated by both agonists and antagonists, and usually this down-regulation is due to post-transcriptional mechanisms.  Finally, a model for regulation of 5-HT2-family receptors by receptor-mediated endocytosis is advanced, and the particular structural features responsible for the various endocytotic pathways are emphasized.  Taken together, these results suggest that discrete domains of the receptor structure are important for ligand binding, G-protein coupling, and internalization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPBigSMGYXgrVg90H21EOLACvtfcHk0liq7LyEN0Q4cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXlsFCrsLo%253D&md5=1d9ebf499fda3a8fee1262f2dcd6f6d9</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0163-7258%2898%2900019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0163-7258%252898%252900019-9%26sid%3Dliteratum%253Aachs%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DWillins%26aufirst%3DD.%2BL.%26aulast%3DKristiansen%26aufirst%3DK.%26aulast%3DKroeze%26aufirst%3DW.%2BK.%26atitle%3D5-Hydroxytryptamine2-family%2520receptors%2520%25285-hydroxytryptamine2A%252C%25205-hydroxytryptamine2B%252C%25205-hydroxytryptamine2C%2529%253A%2520where%2520structure%2520meets%2520function%26jtitle%3DPharmacol.%2520Ther.%26date%3D1998%26volume%3D79%26spage%3D231%26epage%3D257%26doi%3D10.1016%2FS0163-7258%2898%2900019-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maili, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swinford, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamon, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, F. G.</span></span> <span> </span><span class="NLM_article-title">Variation within the serotonin (5-HT) 5-HT(2)C receptor system aligns with vulnerability to cocaine cue reactivity</span>. <i>Transl. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">e369</span>, <span class="refDoi"> DOI: 10.1038/tp.2013.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Ftp.2013.131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=24618688" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjsVCnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&pages=e369&author=N.+C.+Anastasioauthor=S.+Liuauthor=L.+Mailiauthor=S.+E.+Swinfordauthor=S.+D.+Laneauthor=R.+G.+Foxauthor=S.+C.+Hamonauthor=D.+A.+Nielsenauthor=K.+A.+Cunninghamauthor=F.+G.+Moeller&title=Variation+within+the+serotonin+%285-HT%29+5-HT%282%29C+receptor+system+aligns+with+vulnerability+to+cocaine+cue+reactivity&doi=10.1038%2Ftp.2013.131"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Variation within the serotonin (5-HT) 5-HT2C receptor system aligns with vulnerability to cocaine cue reactivity</span></div><div class="casAuthors">Anastasio, N. C.; Liu, S.; Maili, L.; Swinford, S. E.; Lane, S. D.; Fox, R. G.; Hamon, S. C.; Nielsen, D. A.; Cunningham, K. A.; Moeller, F. G.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e369</span>CODEN:
                <span class="NLM_cas:coden">TPRSCF</span>;
        ISSN:<span class="NLM_cas:issn">2158-3188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cocaine dependence remains a challenging public health problem with relapse cited as a major determinant in its chronicity and severity.  Environmental contexts and stimuli become reliably assocd. with its use leading to durable conditioned responses ('cue reactivity') that can predict relapse as well as treatment success.  Individual variation in the magnitude and influence of cue reactivity over behavior in humans and animals suggest that cue-reactive individuals may be at greater risk for the progression to addiction and/or relapse.  In the present translational study, we investigated the contribution of variation in the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system in individual differences in cocaine cue reactivity in humans and rodents.  We found that cocaine-dependent subjects carrying a single nucleotide polymorphism (SNP) in the HTR2C gene that encodes for the conversion of cysteine to serine at codon 23 (Ser23 variant) exhibited significantly higher attentional bias to cocaine cues in the cocaine-word Stroop task than those carrying the Cys23 variant.  In a model of individual differences in cocaine cue reactivity in rats, we identified that high cocaine cue reactivity measured as appetitive approach behavior (lever presses reinforced by the discrete cue complex) correlated with lower 5-HT2CR protein expression in the medial prefrontal cortex and blunted sensitivity to the suppressive effects of the selective 5-HT2CR agonist WAY163909.  Our translational findings suggest that the functional status of the 5-HT2CR system is a mechanistic factor in the generation of vulnerability to cocaine-assocd. cues, an observation that opens new avenues for future development of biomarker and therapeutic approaches to suppress relapse in cocaine dependence.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4-6Q9fk9SyLVg90H21EOLACvtfcHk0liq7LyEN0Q4cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjsVCnsrk%253D&md5=9372b11e4f3479212fda09b936713bfc</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Ftp.2013.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ftp.2013.131%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMaili%26aufirst%3DL.%26aulast%3DSwinford%26aufirst%3DS.%2BE.%26aulast%3DLane%26aufirst%3DS.%2BD.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DHamon%26aufirst%3DS.%2BC.%26aulast%3DNielsen%26aufirst%3DD.%2BA.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DMoeller%26aufirst%3DF.%2BG.%26atitle%3DVariation%2520within%2520the%2520serotonin%2520%25285-HT%2529%25205-HT%25282%2529C%2520receptor%2520system%2520aligns%2520with%2520vulnerability%2520to%2520cocaine%2520cue%2520reactivity%26jtitle%3DTransl.%2520Psychiatry%26date%3D2014%26volume%3D4%26spage%3De369%26doi%3D10.1038%2Ftp.2013.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swinford-Jackson, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sears, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiLeone, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Serotonin (5-HT) 5-HT2A receptor (5-HT2AR):5-HT2CR imbalance in medial prefrontal cortex associates with motor impulsivity</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1248</span>– <span class="NLM_lpage">1258</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.5b00094</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00094" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVOktr%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1248-1258&author=N.%0AC.+Anastasioauthor=S.+J.+Stutzauthor=L.+H.+Finkauthor=S.+E.+Swinford-Jacksonauthor=R.+M.+Searsauthor=R.+J.+DiLeoneauthor=K.+C.+Riceauthor=F.+G.+Moellerauthor=K.+A.+Cunningham&title=Serotonin+%285-HT%29+5-HT2A+receptor+%285-HT2AR%29%3A5-HT2CR+imbalance+in+medial+prefrontal+cortex+associates+with+motor+impulsivity&doi=10.1021%2Facschemneuro.5b00094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin (5-HT) 5-HT2A Receptor (5-HT2AR):5-HT2CR Imbalance in Medial Prefrontal Cortex Associates with Motor Impulsivity</span></div><div class="casAuthors">Anastasio, Noelle C.; Stutz, Sonja J.; Fink, Latham H. L.; Swinford-Jackson, Sarah E.; Sears, Robert M.; DiLeone, Ralph J.; Rice, Kenner C.; Moeller, F. Gerard; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1248-1258</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A feature of multiple neuropsychiatric disorders is motor impulsivity.  Recent studies have implicated serotonin (5-HT) systems in medial prefrontal cortex (mPFC) in mediating individual differences in motor impulsivity, notably the 5-HT2AR receptor (5-HT2AR) and 5-HT2CR.  We investigated the hypothesis that differences in the ratio of 5-HT2AR:5-HT2CR protein expression in mPFC would predict the individual level of motor impulsivity and that the engineered loss of the 5-HT2CR would result in high motor impulsivity concomitant with elevated 5-HT2AR expression and pharmacol. sensitivity to the selective 5-HT2AR antagonist M100907.  High and low impulsive rats were identified in a 1-choice serial reaction time task.  Native protein levels of the 5-HT2AR and the 5-HT2CR predicted the intensity of motor impulsivity and the 5-HT2AR:5-HT2CR ratio in mPFC pos. correlated with levels of premature responses in individual outbred rats.  The possibility that the 5-HT2AR and 5-HT2CR act in concert to control motor impulsivity is supported by the observation that high phenotypic motor impulsivity assocd. with a diminished mPFC synaptosomal 5-HT2AR:5-HT2CR protein:protein interaction.  Knockdown of mPFC 5-HT2CR resulted in increased motor impulsivity and triggered a functional disruption of the local 5-HT2AR:5-HT2CR balance as evidenced by a compensatory upregulation of 5-HT2AR protein expression and a leftward shift in the potency of M100907 to suppress impulsive behavior.  We infer that there is an interactive relationship between the mPFC 5-HT2AR and 5-HT2CR, and that a 5-HT2AR:5-HT2CR imbalance may be a functionally relevant mechanism underlying motor impulsivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0j4-Y1dOOErVg90H21EOLACvtfcHk0liq7LyEN0Q4cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVOktr%252FI&md5=f4b7994b1eeaab729b3e77bece3e89cc</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00094%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DFink%26aufirst%3DL.%2BH.%26aulast%3DSwinford-Jackson%26aufirst%3DS.%2BE.%26aulast%3DSears%26aufirst%3DR.%2BM.%26aulast%3DDiLeone%26aufirst%3DR.%2BJ.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DMoeller%26aufirst%3DF.%2BG.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DSerotonin%2520%25285-HT%2529%25205-HT2A%2520receptor%2520%25285-HT2AR%2529%253A5-HT2CR%2520imbalance%2520in%2520medial%2520prefrontal%2520cortex%2520associates%2520with%2520motor%2520impulsivity%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D1248%26epage%3D1258%26doi%3D10.1021%2Facschemneuro.5b00094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sears, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emeson, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiLeone, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neil, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fink, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">360</span>– <span class="NLM_lpage">372</span>, <span class="refDoi"> DOI: 10.1038/npp.2013.199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fnpp.2013.199" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2014&pages=360-372&author=N.+C.+Anastasioauthor=S.+J.+Stutzauthor=R.+G.+Foxauthor=R.+M.+Searsauthor=R.+B.+Emesonauthor=R.+J.+DiLeoneauthor=R.+T.+O%E2%80%99Neilauthor=L.+H.+Finkauthor=D.+Liauthor=T.+A.+Greenauthor=F.+G.+Moellerauthor=K.+A.+Cunningham&title=Functional+status+of+the+serotonin+5-HT2C+receptor+%285-HT2CR%29+drives+interlocked+phenotypes+that+precipitate+relapse-like+behaviors+in+cocaine+dependence&doi=10.1038%2Fnpp.2013.199"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2013.199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2013.199%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DSears%26aufirst%3DR.%2BM.%26aulast%3DEmeson%26aufirst%3DR.%2BB.%26aulast%3DDiLeone%26aufirst%3DR.%2BJ.%26aulast%3DO%25E2%2580%2599Neil%26aufirst%3DR.%2BT.%26aulast%3DFink%26aufirst%3DL.%2BH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DGreen%26aufirst%3DT.%2BA.%26aulast%3DMoeller%26aufirst%3DF.%2BG.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DFunctional%2520status%2520of%2520the%2520serotonin%25205-HT2C%2520receptor%2520%25285-HT2CR%2529%2520drives%2520interlocked%2520phenotypes%2520that%2520precipitate%2520relapse-like%2520behaviors%2520in%2520cocaine%2520dependence%26jtitle%3DNeuropsychopharmacology%26date%3D2014%26volume%3D39%26spage%3D360%26epage%3D372%26doi%3D10.1038%2Fnpp.2013.199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubar, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swinford, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbertson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig-Lipson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, F. G.</span></span> <span> </span><span class="NLM_article-title">Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">110</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1021/cn300072u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300072u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOntb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=110-121&author=K.+A.+Cunninghamauthor=N.+C.+Anastasioauthor=R.+G.+Foxauthor=S.+J.+Stutzauthor=M.+J.+Bubarauthor=S.+E.+Swinfordauthor=C.+S.+Watsonauthor=S.+R.+Gilbertsonauthor=K.+C.+Riceauthor=S.+Rosenzweig-Lipsonauthor=F.+G.+Moeller&title=Synergism+between+a+serotonin+5-HT2A+receptor+%285-HT2AR%29+antagonist+and+5-HT2CR+agonist+suggests+new+pharmacotherapeutics+for+cocaine+addiction&doi=10.1021%2Fcn300072u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Synergism Between a Serotonin 5-HT2A Receptor (5-HT2AR) Antagonist and 5-HT2CR Agonist Suggests New Pharmacotherapeutics for Cocaine Addiction</span></div><div class="casAuthors">Cunningham, Kathryn A.; Anastasio, Noelle C.; Fox, Robert G.; Stutz, Sonja J.; Bubar, Marcy J.; Swinford, Sarah E.; Watson, Cheryl S.; Gilbertson, Scott R.; Rice, Kenner C.; Rosenzweig-Lipson, Sharon; Moeller, F. Gerard</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-121</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Relapse to cocaine dependence, even after extended abstinence, involves a no. of liability factors including impulsivity (predisposition toward rapid, unplanned reactions to stimuli without regard to neg. consequences) and cue reactivity (sensitivity to cues assocd. with cocaine-taking which can promote cocaine-seeking).  These factors have been mechanistically linked to serotonin (5-hydroxytryptamine, 5-HT) signaling through the 5-HT2A receptor (5-HT2AR) and 5-HT2CR; either a selective 5-HT2AR antagonist or a 5-HT2CR agonist suppresses impulsivity and cocaine-seeking in preclin. models.  We conducted proof-of-concept analyses to evaluate whether a combination of 5-HT2AR antagonist plus 5-HT2CR agonist would have synergistic effects over these liability factors for relapse as measured in a 1-choice serial reaction time task and cocaine self-administration/reinstatement assay.  Combined administration of a dose of the selective 5-HT2AR antagonist M100907 plus the 5-HT2CR agonist WAY163909, each ineffective alone, synergistically suppressed cocaine-induced hyperactivity, inherent and cocaine-evoked impulsive action, as well as cue- and cocaine-primed reinstatement of cocaine-seeking behavior.  The identification of synergism between a 5-HT2AR antagonist plus a 5-HT2CR agonist to attenuate these factors important in relapse indicates the promise of a bifunctional ligand as an anti-addiction pharmacotherapeutic, setting the stage to develop new ligands with improved efficacy, potency, selectivity, and in vivo profiles over the individual mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraOi38lqJqXLVg90H21EOLACvtfcHk0lgTP2LDl8vy6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOntb7J&md5=5f392443d0452d11cb30fc69c053d12c</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fcn300072u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300072u%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DBubar%26aufirst%3DM.%2BJ.%26aulast%3DSwinford%26aufirst%3DS.%2BE.%26aulast%3DWatson%26aufirst%3DC.%2BS.%26aulast%3DGilbertson%26aufirst%3DS.%2BR.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26aulast%3DMoeller%26aufirst%3DF.%2BG.%26atitle%3DSynergism%2520between%2520a%2520serotonin%25205-HT2A%2520receptor%2520%25285-HT2AR%2529%2520antagonist%2520and%25205-HT2CR%2520agonist%2520suggests%2520new%2520pharmacotherapeutics%2520for%2520cocaine%2520addiction%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2013%26volume%3D4%26spage%3D110%26epage%3D121%26doi%3D10.1021%2Fcn300072u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubar, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span> <span> </span><span class="NLM_article-title">The serotonin 5-HT2C receptor in medial prefrontal cortex exerts rheostatic control over the motivational salience of cocaine-associated cues: new observations from preclinical animal research</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2319</span>– <span class="NLM_lpage">2321</span>, <span class="refDoi"> DOI: 10.1038/npp.2010.119</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fnpp.2010.119" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=2319-2321&author=K.+A.+Cunninghamauthor=M.+J.+Bubarauthor=N.+C.+Anastasio&title=The+serotonin+5-HT2C+receptor+in+medial+prefrontal+cortex+exerts+rheostatic+control+over+the+motivational+salience+of+cocaine-associated+cues%3A+new+observations+from+preclinical+animal+research&doi=10.1038%2Fnpp.2010.119"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2010.119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2010.119%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DBubar%26aufirst%3DM.%2BJ.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26atitle%3DThe%2520serotonin%25205-HT2C%2520receptor%2520in%2520medial%2520prefrontal%2520cortex%2520exerts%2520rheostatic%2520control%2520over%2520the%2520motivational%2520salience%2520of%2520cocaine-associated%2520cues%253A%2520new%2520observations%2520from%2520preclinical%2520animal%2520research%26jtitle%3DNeuropsychopharmacology%26date%3D2010%26volume%3D35%26spage%3D2319%26epage%3D2321%26doi%3D10.1038%2Fnpp.2010.119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubar, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbertson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig-Lipson, S.</span></span> <span> </span><span class="NLM_article-title">Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.neuropharm.2011.04.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=513-523&author=K.+A.+Cunninghamauthor=R.+G.+Foxauthor=N.+C.+Anastasioauthor=M.+J.+Bubarauthor=S.+J.+Stutzauthor=F.+G.+Moellerauthor=S.+R.+Gilbertsonauthor=S.+Rosenzweig-Lipson&title=Selective+serotonin+5-HT%282C%29+receptor+activation+suppresses+the+reinforcing+efficacy+of+cocaine+and+sucrose+but+differentially+affects+the+incentive-salience+value+of+cocaine-+vs.+sucrose-associated+cues&doi=10.1016%2Fj.neuropharm.2011.04.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DBubar%26aufirst%3DM.%2BJ.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DMoeller%26aufirst%3DF.%2BG.%26aulast%3DGilbertson%26aufirst%3DS.%2BR.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DSelective%2520serotonin%25205-HT%25282C%2529%2520receptor%2520activation%2520suppresses%2520the%2520reinforcing%2520efficacy%2520of%2520cocaine%2520and%2520sucrose%2520but%2520differentially%2520affects%2520the%2520incentive-salience%2520value%2520of%2520cocaine-%2520vs.%2520sucrose-associated%2520cues%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D513%26epage%3D523%26doi%3D10.1016%2Fj.neuropharm.2011.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swinford-Jackson, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Incubation of cocaine cue reactivity associates with neuroadaptations in the cortical serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>324</i></span>,  <span class="NLM_fpage">50</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2016.02.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.neuroscience.2016.02.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=26926963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFKis7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=324&publication_year=2016&pages=50-61&author=S.+E.+Swinford-Jacksonauthor=N.+C.+Anastasioauthor=R.+G.+Foxauthor=S.+J.+Stutzauthor=K.+A.+Cunningham&title=Incubation+of+cocaine+cue+reactivity+associates+with+neuroadaptations+in+the+cortical+serotonin+%285-HT%29+5-HT2C+receptor+%285-HT2CR%29+system&doi=10.1016%2Fj.neuroscience.2016.02.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Incubation of cocaine cue reactivity associates with neuroadaptations in the cortical serotonin (5-HT) 5-HT2C receptor (5-HT2CR) system</span></div><div class="casAuthors">Swinford-Jackson, S. E.; Anastasio, N. C.; Fox, R. G.; Stutz, S. J.; Cunningham, K. A.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">324</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">50-61</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Intensification of craving elicited by drug-assocd. cues during abstinence occurs over time in human cocaine users while elevation of cue reactivity ("incubation") is obsd. in rats exposed to extended forced abstinence from cocaine self-administration.  Incubation in rodents has been linked to time-dependent neuronal plasticity in the medial prefrontal cortex (mPFC).  We tested the hypothesis that incubation of cue reactivity during abstinence from cocaine self-administration is accompanied by lower potency and/or efficacy of the selective serotonin (5-HT) 5-HT2C receptor (5-HT2CR) agonist WAY163909 to suppress cue reactivity and a shift in the subcellular localization profile of the mPFC 5-HT2CR protein.  We obsd. incubation of cue reactivity (measured as lever presses reinforced by the discrete cue complex) between Day 1 and Day 30 of forced abstinence from cocaine relative to sucrose self-administration.  Pharmacol. and biochem. analyses revealed that the potency of the selective 5-HT2CR agonist WAY163909 to suppress cue reactivity, the expression of synaptosomal 5-HT2CR protein in the mPFC, and the membrane to cytoplasmic expression of the 5-HT2CR in mPFC were lower on Day 30 vs.  Day 1 of forced abstinence from cocaine self-administration.  Incubation of cue reactivity assessed during forced abstinence from sucrose self-administration did not assoc. with 5-HT2CR protein expression in the mPFC.  Collectively, these outcomes are the first indication that neuroadaptations in the 5-HT2CR system may contribute to incubation of cocaine cue reactivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqh97yjelNSobVg90H21EOLACvtfcHk0lhV1oSvn2vgdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFKis7s%253D&md5=256f04de29bce55c99bf332657a9d396</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2016.02.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2016.02.052%26sid%3Dliteratum%253Aachs%26aulast%3DSwinford-Jackson%26aufirst%3DS.%2BE.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DIncubation%2520of%2520cocaine%2520cue%2520reactivity%2520associates%2520with%2520neuroadaptations%2520in%2520the%2520cortical%2520serotonin%2520%25285-HT%2529%25205-HT2C%2520receptor%2520%25285-HT2CR%2529%2520system%26jtitle%3DNeuroscience%26date%3D2016%26volume%3D324%26spage%3D50%26epage%3D61%26doi%3D10.1016%2Fj.neuroscience.2016.02.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shram, M. J.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the abuse potential of lorcaserin, a serotonin 2C (5-HT2C) receptor agonist, in recreational polydrug users</span>. <i>Clin. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">692</span>, <span class="refDoi"> DOI: 10.1038/clpt.2011.20</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fclpt.2011.20" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=21412231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltVGnt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2011&pages=683-692&author=M.+J.+Shram&title=Evaluation+of+the+abuse+potential+of+lorcaserin%2C+a+serotonin+2C+%285-HT2C%29+receptor+agonist%2C+in+recreational+polydrug+users&doi=10.1038%2Fclpt.2011.20"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the Abuse Potential of Lorcaserin, a Serotonin 2C (5-HT2C) Receptor Agonist, in Recreational Polydrug Users</span></div><div class="casAuthors">Shram, M. J.; Schoedel, K. A.; Bartlett, C.; Shazer, R. L.; Anderson, C. M.; Sellers, E. M.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology & Therapeutics (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">683-692</span>CODEN:
                <span class="NLM_cas:coden">CLPTAT</span>;
        ISSN:<span class="NLM_cas:issn">0009-9236</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lorcaserin is a selective and potent serotonin 2C receptor subtype (5-HT2C) agonist under development for the treatment of obesity.  This study assessed the drug's abuse potential on the basis of its pharmacol. profile.  For this purpose, a double-blind, double-dummy, placebo-controlled, randomized seven-way crossover study with single oral doses of lorcaserin (20, 40, and 60 mg), zolpidem (15 and 30 mg), ketamine (100 mg), and placebo was conducted in recreational polydrug users (N = 35).  Subjective and objective measures were assessed up to 24 h after the dose.  We found that zolpidem and ketamine had significantly higher peak scores relative to placebo on the primary measures as well as on most of the secondary measures.  The subjective effects of a 20-mg dose of lorcaserin were similar to those of placebo, whereas supratherapeutic doses of lorcaserin were assocd. with significant levels of dislike by users as compared with placebo, zolpidem, and ketamine.  Perceptual effects were minimal after administration of lorcaserin and significantly lower than after administration of either ketamine or zolpidem.  The findings suggest that, at supratherapeutic doses, lorcaserin is assocd. with distinct, primarily neg., subjective effects and has low abuse potential.  Clin. Pharmacol. & Therapeutics (2011) 89 5, 683-692. doi:10.1038/clpt.2011.20.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocVZc136mBhLVg90H21EOLACvtfcHk0lhV1oSvn2vgdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltVGnt7g%253D&md5=8781e2e09ea5c4350f6647f8d4223173</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fclpt.2011.20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fclpt.2011.20%26sid%3Dliteratum%253Aachs%26aulast%3DShram%26aufirst%3DM.%2BJ.%26atitle%3DEvaluation%2520of%2520the%2520abuse%2520potential%2520of%2520lorcaserin%252C%2520a%2520serotonin%25202C%2520%25285-HT2C%2529%2520receptor%2520agonist%252C%2520in%2520recreational%2520polydrug%2520users%26jtitle%3DClin.%2520Pharmacol.%2520Ther.%26date%3D2011%26volume%3D89%26spage%3D683%26epage%3D692%26doi%3D10.1038%2Fclpt.2011.20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. R.</span></span> <span> </span><span class="NLM_article-title">Lorcaserin (APD356), a selective 5-HT(2C) agonist, reduces body weight in obese men and women</span>. <i>Obesity</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">494</span>– <span class="NLM_lpage">503</span>, <span class="refDoi"> DOI: 10.1038/oby.2008.537</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Foby.2008.537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=19057523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Oiu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=494-503&author=S.+R.+Smith&title=Lorcaserin+%28APD356%29%2C+a+selective+5-HT%282C%29+agonist%2C+reduces+body+weight+in+obese+men+and+women&doi=10.1038%2Foby.2008.537"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Lorcaserin (APD356), a Selective 5-HT2C Agonist, Reduces Body Weight in Obese Men and Women</span></div><div class="casAuthors">Smith, Steven R.; Prosser, Warren A.; Donahue, David J.; Morgan, Michael E.; Anderson, Christen M.; Shanahan, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Obesity</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">494-503</span>CODEN:
                <span class="NLM_cas:coden">OBESAX</span>;
        ISSN:<span class="NLM_cas:issn">1930-7381</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lorcaserin (APD356) is a potent, selective 5-HT2C agonist with ∼15-fold and 100-fold selectivity vs. 5-HT2A and 5-HT2B receptors, resp.  This study evaluated the safety and efficacy of lorcaserin for wt. redn. in obese patients during a 12-wk period.  The randomized, double-blind, placebo-controlled, parallel-arm study enrolled 469 men and women between ages 18 and 65 and with BMI 30-45 kg/m2.  Patients received placebo, lorcaserin 10 mg q.d., lorcaserin 15 mg q.d., or lorcaserin 10 mg b.i.d. for 12 wk, and were counseled to maintain their usual diet and activity.  The primary end point was change in wt. from baseline to day 85 by completer anal.  Safety analyses included echocardiograms at Screening and day 85/study exit.  Lorcaserin was assocd. with progressive wt. loss of 1.8 kg, 2.6 kg, and 3.6 kg at 10 mg q.d., 15 mg q.d., and 10 mg b.i.d., resp., compared to placebo wt. loss of 0.3 kg (P < 0.001 for each group).  Similar results were seen by intent-to-treat last observation-carried forward (ITT-LOCF) anal.  The proportions of completers achieving ≥5% of initial body wt. were 12.8, 19.5, 31.2, and 2.3% in the 10 mg q.d., 15 mg q.d., 10 mg b.i.d., and placebo groups, resp.  The most frequent adverse events (AEs) were transient headache, nausea, and dizziness.  Echocardiograms showed no apparent drug-related effects on heart valves or pulmonary artery pressure (PAP).  Lorcaserin was well tolerated and efficacious for wt. redn. in this 12-wk study.  Longer-term trials employing behavior modification will be needed to more fully assess its safety and efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3-A04UsnZ2LVg90H21EOLACvtfcHk0lhV1oSvn2vgdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Oiu7Y%253D&md5=dd54cdbec71ec7eaa7c37e16c979e14f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1038%2Foby.2008.537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Foby.2008.537%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%2BR.%26atitle%3DLorcaserin%2520%2528APD356%2529%252C%2520a%2520selective%25205-HT%25282C%2529%2520agonist%252C%2520reduces%2520body%2520weight%2520in%2520obese%2520men%2520and%2520women%26jtitle%3DObesity%26date%3D2009%26volume%3D17%26spage%3D494%26epage%3D503%26doi%3D10.1038%2Foby.2008.537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. R.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Multicenter, placebo-controlled trial of lorcaserin for weight management</span>. <i>N. Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>363</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1056/NEJMoa0909809</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1056%2FNEJMoa0909809" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=20647200" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVOgs74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=245-256&author=S.+R.+Smith&title=Multicenter%2C+placebo-controlled+trial+of+lorcaserin+for+weight+management&doi=10.1056%2FNEJMoa0909809"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Multicenter, placebo-controlled trial of lorcaserin for weight management</span></div><div class="casAuthors">Smith, Steven R.; Weissman, Neil J.; Anderson, Christen M.; Sanchez, Matilde; Chuang, Emil; Stubbe, Scott; Bays, Harold; Shanahan, William R.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-256</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Lorcaserin is a selective serotonin 2C receptor agonist that could be useful in reducing body wt.  In this double-blind clin. trial, we randomly assigned 3182 obese or overweight adults (mean body-mass index [the wt. in kilograms divided by the square of the height in meters] of 36.2) to receive lorcaserin at a dose of 10 mg, or placebo, twice daily for 52 wk.  All patients also underwent diet and exercise counseling.  At week 52, patients in the placebo group continued to receive placebo but patients in the lorcaserin group were randomly reassigned to receive either placebo or lorcaserin.  Primary outcomes were wt. loss at 1 yr and maintenance of wt. loss at 2 years.  Serial echocardiog. was used to identify patients in whom valvulopathy (as defined by the Food and Drug Administration) developed.  At 1 yr, 55.4% of patients (883 of 1595) receiving lorcaserin and 45.1% of patients (716 of 1587) receiving placebo remained in the trial; 1553 patients continued into year 2.  At 1 yr, 47.5% of patients in the lorcaserin group and 20.3% in the placebo group had lost 5% or more of their body wt. (P < 0.001), corresponding to an av. loss of 5.8 ± 0.2 kg with lorcaserin and 2.2 ± 0.1 kg with placebo during year 1 (P < 0.001).  Among the patients who received lorcaserin during year 1 and who had lost 5% or more of their baseline wt. at 1 yr, the loss was maintained in more patients who continued to receive lorcaserin during year 2 (67.9%) than in patients who received placebo during year 2 (50.3%, P < 0.001).  Among 2472 patients evaluated at 1 yr and 1127 evaluated at 2 years, the rate of cardiac valvulopathy was not increased with the use of lorcaserin.  Among the most frequent adverse events reported with lorcaserin were headache, dizziness, and nausea.  The rates of serious adverse events in the 2 groups were similar.  In conjunction with behavioral modification, lorcaserin was assocd. with significant wt. loss and improved maintenance of wt. loss, as compared with placebo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVKMO5NV5jwLVg90H21EOLACvtfcHk0ljcDwVOvwz2bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVOgs74%253D&md5=66979aed566bcda525610ccf6d659e03</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0909809&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0909809%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%2BR.%26atitle%3DMulticenter%252C%2520placebo-controlled%2520trial%2520of%2520lorcaserin%2520for%2520weight%2520management%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D245%26epage%3D256%26doi%3D10.1056%2FNEJMoa0909809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hutcheson, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merryman, W. D.</span></span> <span> </span><span class="NLM_article-title">Serotonin receptors and heart valve disease—It was meant 2B</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2011.03.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.pharmthera.2011.03.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=21440001" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFaksLnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2011&pages=146-157&author=J.+D.+Hutchesonauthor=V.+Setolaauthor=B.+L.+Rothauthor=W.+D.+Merryman&title=Serotonin+receptors+and+heart+valve+disease%E2%80%94It+was+meant+2B&doi=10.1016%2Fj.pharmthera.2011.03.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Serotonin receptors and heart valve disease-It was meant 2B</span></div><div class="casAuthors">Hutcheson, Joshua D.; Setola, Vincent; Roth, Bryan L.; Merryman, W. David</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-157</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Carcinoid heart disease was one of the first valvular pathologies studied in mol. detail, and early research identified serotonin produced by oncogenic enterochromaffin cells as the likely culprit in causing changes in heart valve tissue.  Researchers and physicians in the mid-1960s noted a connection between the use of several ergot-derived medications with structures similar to serotonin and the development of heart valve pathologies similar to those obsd. in carcinoid patients.  The exact serotonergic target that mediated valvular pathogenesis remained a mystery for many years until similar cases were reported in patients using the popular diet drug Fen-Phen in the late 1990s.  The Fen-Phen episode sparked renewed interest in serotonin-mediated valve disease, and studies led to the identification of the 5-HT2B receptor as the likely mol. target leading to heart valve tissue fibrosis.  Subsequent studies have identified numerous other activators of the 5-HT2B receptor, and consequently, the use of many of these mols. has been linked to heart valve disease.  Herein, we: review the mol. properties of the 5-HT2B receptor including factors that differentiate the 5-HT2B receptor from other 5-HT receptor subtypes, discuss the studies that led to the identification of the 5-HT2B receptor as the mediator of heart valve disease, present current efforts to identify potential valvulopathogens by screening for 5-HT2B receptor activity, and speculate on potential therapeutic benefits of 5-HT2B receptor targeting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4R8A9Ia-r3LVg90H21EOLACvtfcHk0ljcDwVOvwz2bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFaksLnO&md5=b97c1992208a501b1959c2f48f3ca9cd</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2011.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2011.03.008%26sid%3Dliteratum%253Aachs%26aulast%3DHutcheson%26aufirst%3DJ.%2BD.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DMerryman%26aufirst%3DW.%2BD.%26atitle%3DSerotonin%2520receptors%2520and%2520heart%2520valve%2520disease%25E2%2580%2594It%2520was%2520meant%25202B%26jtitle%3DPharmacol.%2520Ther.%26date%3D2011%26volume%3D132%26spage%3D146%26epage%3D157%26doi%3D10.1016%2Fj.pharmthera.2011.03.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span> <span> </span><span class="NLM_article-title">5-HT2C receptor modulators: a patent survey</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1429</span>– <span class="NLM_lpage">1455</span>, <span class="refDoi"> DOI: 10.1517/13543776.2010.518956</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1517%2F13543776.2010.518956" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=20849206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlWmtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1429-1455&author=J.+Leeauthor=M.+E.+Jungauthor=J.+Lee&title=5-HT2C+receptor+modulators%3A+a+patent+survey&doi=10.1517%2F13543776.2010.518956"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C receptor modulators: a patent survey</span></div><div class="casAuthors">Lee, Junwon; Jung, Myung Eun; Lee, Jinhwa</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1429-1455</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The 5-HT2C receptor is a GPCR and is one of the 14 subtypes that constitute the serotonin receptor family.  The 5-HT2C receptor is exclusively expressed in the CNS where it demonstrates a wide distribution and displays high-affinity interactions with a wide variety of psychiatric medications.  Modulators of 5-HT2C have been implicated as a potential treatment for diseases of significant unmet medical need, including obesity, schizophrenia, depression, anxiety, Parkinson's disease, drug addiction, erectile dysfunction and urinary incontinence.  Thus, there is a great interest in developing potent and selective 5-HT2C receptor modulators.  Areas covered in this review: This review article highlights the research progress in 5-HT2C receptor modulators published in the patent literature between Jan. 2003 and June 2010, giving emphasis to the medicinal chemist's standpoint.  What the reader will gain: Readers will rapidly gain an overview of the various 5-HT2C receptor modulators reported in the patent literature in the past 8 years.  Furthermore, the readers will learn which structure type can interact with the 5-HT2C receptor.  In addn., the readers will be aware of the pharmaceutical companies that have been the main players in the field.  Take home message: There is substantial evidence supporting the concept that a selective 5-HT2C receptor modulator should provide benefit in the treatment of a variety of CNS disorders.  Although research efforts have identified several promising 5-HT2C receptor modulators that display high functional selectivity, further clin. efficacy and safety data are needed to prove their actual clin. utility.  Therefore, the query for selectively acting 5-HT2C receptor modulators is still ongoing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowsaQEKrg_R7Vg90H21EOLACvtfcHk0ljcDwVOvwz2bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlWmtL%252FF&md5=43397f74d27751efdc505165ba96172c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.518956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.518956%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DJung%26aufirst%3DM.%2BE.%26aulast%3DLee%26aufirst%3DJ.%26atitle%3D5-HT2C%2520receptor%2520modulators%253A%2520a%2520patent%2520survey%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26spage%3D1429%26epage%3D1455%26doi%3D10.1517%2F13543776.2010.518956" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartley, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbertson, S. R.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure–activity relationships of tool compounds based on WAY163909, a 5-HT2C receptor agonist</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1004</span>– <span class="NLM_lpage">1010</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00439</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00439" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFCmurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1004-1010&author=Y.-C.+Chenauthor=R.+M.+Hartleyauthor=N.+C.+Anastasioauthor=K.+A.+Cunninghamauthor=S.+R.+Gilbertson&title=Synthesis+and+structure%E2%80%93activity+relationships+of+tool+compounds+based+on+WAY163909%2C+a+5-HT2C+receptor+agonist&doi=10.1021%2Facschemneuro.6b00439"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of Tool Compounds Based on WAY163909, a 5-HT2C Receptor Agonist</span></div><div class="casAuthors">Chen, Ying-Chu; Hartley, Rachel M.; Anastasio, Noelle C.; Cunningham, Kathryn A.; Gilbertson, Scott R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1004-1010</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of probe mols. that can be used to investigate G protein-coupled receptor (GPCR) pharmacol., trafficking, and relationship with other GPCRs is an important and growing area of research.  Here, the authors report the synthesis of analogs of the known selective serotonin (5-HT) 5-HT2C receptor (5-HT2CR) agonist WAY163909 which were designed to allow for the attachment of a second ligand, signaling or reporter mols., as well as immobilization agents to the parent mol. with the maintenance of agonist activity.  This goal was accomplished by the synthesis of novel mols. in which sites a-d were modified and resulting compds. were analyzed pharmacol. in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJeg1iODPDX7Vg90H21EOLACvtfcHk0lheOC-g2TQnWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFCmurc%253D&md5=812ac0958eaac00f68b73bd4899845ae</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00439%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.-C.%26aulast%3DHartley%26aufirst%3DR.%2BM.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DGilbertson%26aufirst%3DS.%2BR.%26atitle%3DSynthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520tool%2520compounds%2520based%2520on%2520WAY163909%252C%2520a%25205-HT2C%2520receptor%2520agonist%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D1004%26epage%3D1010%26doi%3D10.1021%2Facschemneuro.6b00439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomsen, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grottick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menzaghi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes-Saldana, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espitia, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuskin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whelan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Shamma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chalmers, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behan, D.</span></span> <span> </span><span class="NLM_article-title">Lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist: in vitro and in vivo pharmacological characterization</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>325</i></span>,  <span class="NLM_fpage">577</span>– <span class="NLM_lpage">587</span>, <span class="refDoi"> DOI: 10.1124/jpet.107.133348</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1124%2Fjpet.107.133348" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=18252809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVOjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=325&publication_year=2008&pages=577-587&author=W.+J.+Thomsenauthor=A.+J.+Grottickauthor=F.+Menzaghiauthor=H.+Reyes-Saldanaauthor=S.+Espitiaauthor=D.+Yuskinauthor=K.+Whelanauthor=M.+Martinauthor=M.+Morganauthor=W.+Chenauthor=H.+Al-Shammaauthor=B.+Smithauthor=D.+Chalmersauthor=D.+Behan&title=Lorcaserin%2C+a+novel+selective+human+5-hydroxytryptamine+2C+agonist%3A+in+vitro+and+in+vivo+pharmacological+characterization&doi=10.1124%2Fjpet.107.133348"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization</span></div><div class="casAuthors">Thomsen, William J.; Grottick, Andrew J.; Menzaghi, Frederique; Reyes-Saldana, Hazel; Espitia, Stephen; Yuskin, Diane; Whelan, Kevin; Martin, Michael; Morgan, Michael; Chen, Weichao; Al-Shamma, Hussein; Smith, Brian; Chalmers, Derek; Behan, Dominic</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">325</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">577-587</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">5-Hydroxytryptamine (5-HT)2C receptor agonists hold promise for the treatment of obesity.  In this study, we describe the in vitro and in vivo characteristics of lorcaserin [(1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3 benzazepine], a selective, high affinity 5-HT2C full agonist.  Lorcaserin bound to human and rat 5-HT2C receptors with high affinity (Ki = 15±1 nM, 29±7 nM, resp.), and it was a full agonist for the human 5-HT2C receptor in a functional inositol phosphate accumulation assay, with 18- and 104-fold selectivity over 5-HT2A and 5-HT2B receptors, resp.  Lorcaserin was also highly selective for human 5-HT2C over other human 5-HT receptors (5-HT1A, 5-HT3, 5-HT4C, 5-HT55A, 5-HT6, and 5-HT7), in addn. to a panel of 67 other G protein-coupled receptors and ion channels.  Lorcaserin did not compete for binding of ligands to serotonin, dopamine, and norepinephrine transporters, and it did not alter their function in vitro.  Behavioral observations indicated that unlike the 5-HT2A agonist (±)-1-(2,5-dimethoxy-4-phenyl)-2-aminopropane, lorcaserin did not induce behavioral changes indicative of functional 5-HT2A agonist activity.  Acutely, lorcaserin reduced food intake in rats, an effect that was reversed by pretreatment with the 5-HT2C-selective antagonist 6-chloro-5-methyl-1-[6-(2-methylpyridin-3-yloxy)pyridin-3-yl-carbamoyl]indoline (SB242,084) but not the 5-HT2A antagonist (R)-(+)-α-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenylethyl)]-4-piperidinemethanol (MDL 100,907), demonstrating mediation by the 5-HT2C receptor.  Chronic daily treatment with lorcaserin to rats maintained on a high fat diet produced dose-dependent redns. in food intake and body wt. gain that were maintained during the 4-wk study.  Upon discontinuation, body wt. returned to control levels.  These data demonstrate lorcaserin to be a potent, selective, and efficacious agonist of the 5-HT2C receptor, with potential for the treatment of obesity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqDHE28aF3k7Vg90H21EOLACvtfcHk0lheOC-g2TQnWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVOjtrc%253D&md5=0626c3dabb7e89066e45ecd12cbc81f8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.133348&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.133348%26sid%3Dliteratum%253Aachs%26aulast%3DThomsen%26aufirst%3DW.%2BJ.%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DMenzaghi%26aufirst%3DF.%26aulast%3DReyes-Saldana%26aufirst%3DH.%26aulast%3DEspitia%26aufirst%3DS.%26aulast%3DYuskin%26aufirst%3DD.%26aulast%3DWhelan%26aufirst%3DK.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DAl-Shamma%26aufirst%3DH.%26aulast%3DSmith%26aufirst%3DB.%26aulast%3DChalmers%26aufirst%3DD.%26aulast%3DBehan%26aufirst%3DD.%26atitle%3DLorcaserin%252C%2520a%2520novel%2520selective%2520human%25205-hydroxytryptamine%25202C%2520agonist%253A%2520in%2520vitro%2520and%2520in%2520vivo%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2008%26volume%3D325%26spage%3D577%26epage%3D587%26doi%3D10.1124%2Fjpet.107.133348" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wild, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Allosteric modulation of G protein-coupled receptors: an emerging approach of drug discovery</span>. <i>Austin J. Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=27148592" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2014&pages=1101&author=C.+Wildauthor=K.+A.+Cunninghamauthor=J.+Zhou&title=Allosteric+modulation+of+G+protein-coupled+receptors%3A+an+emerging+approach+of+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DC.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DAllosteric%2520modulation%2520of%2520G%2520protein-coupled%2520receptors%253A%2520an%2520emerging%2520approach%2520of%2520drug%2520discovery%26jtitle%3DAustin%2520J.%2520Pharmacol.%2520Ther.%26date%3D2014%26volume%3D2%26spage%3D1101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Melancon, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">Allosteric modulation of seven transmembrane spanning receptors: theory, practice, and opportunities for central nervous system drug discovery</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1445</span>– <span class="NLM_lpage">1464</span>, <span class="refDoi"> DOI: 10.1021/jm201139r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201139r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SmurnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1445-1464&author=B.+J.+Melanconauthor=C.+R.+Hopkinsauthor=M.+R.+Woodauthor=K.+A.+Emmitteauthor=C.+M.+Niswenderauthor=A.+Christopoulosauthor=P.+J.+Connauthor=C.+W.+Lindsley&title=Allosteric+modulation+of+seven+transmembrane+spanning+receptors%3A+theory%2C+practice%2C+and+opportunities+for+central+nervous+system+drug+discovery&doi=10.1021%2Fjm201139r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric Modulation of Seven Transmembrane Spanning Receptors: Theory, Practice, and Opportunities for Central Nervous System Drug Discovery</span></div><div class="casAuthors">Melancon, Bruce J.; Hopkins, Corey R.; Wood, Michael R.; Emmitte, Kyle A.; Niswender, Colleen M.; Christopoulos, Arthur; Conn, P. Jeffrey; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1445-1464</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Allosteric modulation of Seven transmembrane spanning receptors and the opportunities for CNS drug discovery is reviewed here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlr4lj_Wp-O7Vg90H21EOLACvtfcHk0lheOC-g2TQnWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SmurnJ&md5=7c70f066f1581f1ff327c0dce37bb0e1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm201139r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201139r%26sid%3Dliteratum%253Aachs%26aulast%3DMelancon%26aufirst%3DB.%2BJ.%26aulast%3DHopkins%26aufirst%3DC.%2BR.%26aulast%3DWood%26aufirst%3DM.%2BR.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAllosteric%2520modulation%2520of%2520seven%2520transmembrane%2520spanning%2520receptors%253A%2520theory%252C%2520practice%252C%2520and%2520opportunities%2520for%2520central%2520nervous%2520system%2520drug%2520discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1445%26epage%3D1464%26doi%3D10.1021%2Fjm201139r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nickols, H.
H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span> <span> </span><span class="NLM_article-title">Development of allosteric modulators of GPCRs for treatment of CNS disorders</span>. <i>Neurobiol. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1016/j.nbd.2013.09.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.nbd.2013.09.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=24076101" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A280%3ADC%252BC2c%252FitVejsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2014&pages=55-71&author=H.%0AH.+Nickolsauthor=P.+J.+Conn&title=Development+of+allosteric+modulators+of+GPCRs+for+treatment+of+CNS+disorders&doi=10.1016%2Fj.nbd.2013.09.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Development of allosteric modulators of GPCRs for treatment of CNS disorders</span></div><div class="casAuthors">Nickols Hilary Highfield; Conn P Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55-71</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The discovery of allosteric modulators of G protein-coupled receptors (GPCRs) provides a promising new strategy with potential for developing novel treatments for a variety of central nervous system (CNS) disorders.  Traditional drug discovery efforts targeting GPCRs have focused on developing ligands for orthosteric sites which bind endogenous ligands.  Allosteric modulators target a site separate from the orthosteric site to modulate receptor function.  These allosteric agents can either potentiate (positive allosteric modulator, PAM) or inhibit (negative allosteric modulator, NAM) the receptor response and often provide much greater subtype selectivity than orthosteric ligands for the same receptors.  Experimental evidence has revealed more nuanced pharmacological modes of action of allosteric modulators, with some PAMs showing allosteric agonism in combination with positive allosteric modulation in response to endogenous ligand (ago-potentiators) as well as "bitopic" ligands that interact with both the allosteric and orthosteric sites.  Drugs targeting the allosteric site allow for increased drug selectivity and potentially decreased adverse side effects.  Promising evidence has demonstrated potential utility of a number of allosteric modulators of GPCRs in multiple CNS disorders, including neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease, as well as psychiatric or neurobehavioral diseases such as anxiety, schizophrenia, and addiction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5AaOVGoQQ2DEC-75aqa5AfW6udTcc2eZWmrwfv-2Harntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c%252FitVejsA%253D%253D&md5=a1535b4448734bcae63e9797d2009737</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.nbd.2013.09.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nbd.2013.09.013%26sid%3Dliteratum%253Aachs%26aulast%3DNickols%26aufirst%3DH.%2BH.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26atitle%3DDevelopment%2520of%2520allosteric%2520modulators%2520of%2520GPCRs%2520for%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2014%26volume%3D61%26spage%3D55%26epage%3D71%26doi%3D10.1016%2Fj.nbd.2013.09.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Westhuizen, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valant, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span> <span> </span><span class="NLM_article-title">Endogenous allosteric modulators of G protein–coupled receptors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>353</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">260</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.221606</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1124%2Fjpet.114.221606" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=25650376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlvVWntb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2015&pages=246-260&author=E.+T.+van%0Ader+Westhuizenauthor=C.+Valantauthor=P.+M.+Sextonauthor=A.+Christopoulos&title=Endogenous+allosteric+modulators+of+G+protein%E2%80%93coupled+receptors&doi=10.1124%2Fjpet.114.221606"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Endogenous allosteric modulators of G protein-coupled receptors</span></div><div class="casAuthors">van der Westhuizen, Emma T.; Valant, Celine; Sexton, Patrick M.; Christopoulos, Christopoulos</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">246-260</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  G protein-coupled receptors (GPCRs) are the largest superfamily of receptors encoded by the human genome, and represent the largest class of current drug targets.  Over the last decade and a half, it has become widely accepted that most, if not all, GPCRs possess spatially distinct allosteric sites that can be targeted by exogenous substances to modulate the receptors' biol. state.  Although many of these allosteric sites are likely to serve other (e.g., structural) roles, they nonetheless possess appropriate properties to be serendipitously targeted by synthetic mols.  However, there are also examples of endogenous substances that can act as allosteric modulators of GPCRs.  These include not only the obvious example, i.e., the G protein, but also a variety of ions, lipids, amino acids, peptides, and accessory proteins that display different degrees of receptor-specific modulatory effects.  This also suggests that some GPCRs may possess true "orphan" allosteric sites for hitherto unappreciated endogenous modulators.  Of note, the increasing identification of allosteric modulator lipids, inflammatory peptides, and GPCR-targeted autoantibodies indicates that disease context plays an important role in the generation of putative endogenous GPCR modulators.  If an endogenous allosteric substance can be shown to play a role in disease, this could also serve as an impetus to pursue synthetic neutral allosteric ligands as novel therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptdf28zfijQrVg90H21EOLACvtfcHk0lg49P5I7kCyag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlvVWntb4%253D&md5=4e9eacb10df4523109feba729fbb9409</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.221606&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.221606%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BWesthuizen%26aufirst%3DE.%2BT.%26aulast%3DValant%26aufirst%3DC.%26aulast%3DSexton%26aufirst%3DP.%2BM.%26aulast%3DChristopoulos%26aufirst%3DA.%26atitle%3DEndogenous%2520allosteric%2520modulators%2520of%2520G%2520protein%25E2%2580%2593coupled%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D353%26spage%3D246%26epage%3D260%26doi%3D10.1124%2Fjpet.114.221606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harrington, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fotsch, C.</span></span> <span> </span><span class="NLM_article-title">Calcium sensing receptor activators: calcimimetics</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">3027</span>– <span class="NLM_lpage">3034</span>, <span class="refDoi"> DOI: 10.2174/092986707782794096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.2174%2F092986707782794096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=18220738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlSrs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=3027-3034&author=P.+E.+Harringtonauthor=C.+Fotsch&title=Calcium+sensing+receptor+activators%3A+calcimimetics&doi=10.2174%2F092986707782794096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Calcium sensing receptor activators: calcimimetics</span></div><div class="casAuthors">Harrington, Paul E.; Fotsch, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">3027-3034</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The calcium sensing receptor (CaR) is a G protein-coupled receptor (GPCR) that plays a fundamental role in serum calcium homeostasis.  The CaR is expressed on the chief cells of the parathyroid gland and is responsible for controlling the secretion of parathyroid hormone (PTH).  PTH acts on several organs including the bone, kidney, and intestine to tightly regulate the concn. of serum calcium.  Substances other than calcium that activate the CaR are referred to as calcimimetics.  Calcimimetics that bind to the CaR as agonists are referred to as type I.  Type II calcimimetics bind to a site that is distinct from the physiol. ligand and function as pos. allosteric modulators of the CaR.  Type II calcimimetics amplify the sensitivity of the CaR to serum calcium and are thus able to lower the concn. of serum PTH.  Calcimimetics are being pursued as therapeutics for the treatment of disorders that are characterized by elevated levels of PTH such as primary and secondary hyperparathyroidism (primary HPT and secondary HPT).  In this review, we provide an overview of key results in the discovery of cinacalcet HCl (Sensipar in the US, Mimpara in Europe).  In addn., other recently disclosed type II calcimimetics are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoBRgBPKixE4rVg90H21EOLACvtfcHk0lg49P5I7kCyag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlSrs7Y%253D&md5=7f519dd21f377ef76af4a43c722206f8</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F092986707782794096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707782794096%26sid%3Dliteratum%253Aachs%26aulast%3DHarrington%26aufirst%3DP.%2BE.%26aulast%3DFotsch%26aufirst%3DC.%26atitle%3DCalcium%2520sensing%2520receptor%2520activators%253A%2520calcimimetics%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D3027%26epage%3D3034%26doi%3D10.2174%2F092986707782794096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobbs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macartney, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rickett, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Burchnell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Napier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armour, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stammen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perros, M.</span></span> <span> </span><span class="NLM_article-title">Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">4721</span>– <span class="NLM_lpage">4732</span>, <span class="refDoi"> DOI: 10.1128/AAC.49.11.4721-4732.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1128%2FAAC.49.11.4721-4732.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=16251317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD2MXht1Siu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=4721-4732&author=P.+Dorrauthor=M.+Westbyauthor=S.+Dobbsauthor=P.+Griffinauthor=B.+Irvineauthor=M.+Macartneyauthor=J.+Moriauthor=G.+Rickettauthor=C.+Smith-Burchnellauthor=C.+Napierauthor=R.+Websterauthor=D.+Armourauthor=D.+Priceauthor=B.+Stammenauthor=A.+Woodauthor=M.+Perros&title=Maraviroc+%28UK-427%2C857%29%2C+a+potent%2C+orally+bioavailable%2C+and+selective+small-molecule+inhibitor+of+chemokine+receptor+CCR5+with+broad-spectrum+anti-human+immunodeficiency+virus+type+1+activity&doi=10.1128%2FAAC.49.11.4721-4732.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity</span></div><div class="casAuthors">Dorr, Patrick; Westby, Mike; Dobbs, Susan; Griffin, Paul; Irvine, Becky; Macartney, Malcolm; Mori, Julie; Rickett, Graham; Smith-Burchnell, Caroline; Napier, Carolyn; Webster, Rob; Armour, Duncan; Price, David; Stammen, Blanda; Wood, Anthony; Perros, Manos</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4721-4732</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Maraviroc (UK-427,857) is a selective CCR5 antagonist with potent antihuman immunodeficiency virus type 1 (HIV-1) activity and favorable pharmacol. properties.  Maraviroc is the product of a medicinal chem. effort initiated following identification of an imidazopyridine CCR5 ligand from a high-throughput screen of the Pfizer compd. file.  Maraviroc demonstrated potent antiviral activity against all CCR5-tropic HIV-1 viruses tested, including 43 primary isolates from various clades and diverse geog. origin (geometric mean 90% inhibitory concn. of 2.0 nM).  Maraviroc was active against 200 clin. derived HIV-1 envelope-recombinant pseudoviruses, 100 of which were derived from viruses resistant to existing drug classes.  There was little difference in the sensitivity of the 200 viruses to maraviroc, as illustrated by the biol. cutoff in this assay (= geometric mean plus two std. deviations [SD] of 1.7-fold).  The mechanism of action of maraviroc was established using cell-based assays, where it blocked binding of viral envelope, gp120, to CCR5 to prevent the membrane fusion events necessary for viral entry.  Maraviroc did not affect CCR5 cell surface levels or assocd. intracellular signaling, confirming it as a functional antagonist of CCR5.  Maraviroc has no detectable in vitro cytotoxicity and is highly selective for CCR5, as confirmed against a wide range of receptors and enzymes, including the hERG ion channel (50% inhibitory concn., > 10 μM), indicating potential for an excellent clin. safety profile.  Studies in preclin. in vitro and in vivo models predicted maraviroc to have human pharmacokinetics consistent with once- or twice-daily dosing following oral administration.  Clin. trials are ongoing to further investigate the potential of using maraviroc for the treatment of HIV-1 infection and AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN0Z8KdsHODrVg90H21EOLACvtfcHk0liq9Yx9X2LdNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXht1Siu7rM&md5=561aea68490f7c6d3ec0f65676450155</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FAAC.49.11.4721-4732.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.49.11.4721-4732.2005%26sid%3Dliteratum%253Aachs%26aulast%3DDorr%26aufirst%3DP.%26aulast%3DWestby%26aufirst%3DM.%26aulast%3DDobbs%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DP.%26aulast%3DIrvine%26aufirst%3DB.%26aulast%3DMacartney%26aufirst%3DM.%26aulast%3DMori%26aufirst%3DJ.%26aulast%3DRickett%26aufirst%3DG.%26aulast%3DSmith-Burchnell%26aufirst%3DC.%26aulast%3DNapier%26aufirst%3DC.%26aulast%3DWebster%26aufirst%3DR.%26aulast%3DArmour%26aufirst%3DD.%26aulast%3DPrice%26aufirst%3DD.%26aulast%3DStammen%26aufirst%3DB.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DPerros%26aufirst%3DM.%26atitle%3DMaraviroc%2520%2528UK-427%252C857%2529%252C%2520a%2520potent%252C%2520orally%2520bioavailable%252C%2520and%2520selective%2520small-molecule%2520inhibitor%2520of%2520chemokine%2520receptor%2520CCR5%2520with%2520broad-spectrum%2520anti-human%2520immunodeficiency%2520virus%2520type%25201%2520activity%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2005%26volume%3D49%26spage%3D4721%26epage%3D4732%26doi%3D10.1128%2FAAC.49.11.4721-4732.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christopoulos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span> <span> </span><span class="NLM_article-title">Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">41</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1038/nrd2760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fnrd2760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=19116626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFCkurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=41-54&author=P.+J.+Connauthor=A.+Christopoulosauthor=C.+W.+Lindsley&title=Allosteric+modulators+of+GPCRs%3A+a+novel+approach+for+the+treatment+of+CNS+disorders&doi=10.1038%2Fnrd2760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders</span></div><div class="casAuthors">Conn, P. Jeffrey; Christopoulos, Arthur; Lindsley, Craig W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">41-54</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite G-protein-coupled receptors (GPCRs) being among the most fruitful targets for marketed drugs, intense discovery efforts for several GPCR subtypes have failed to deliver selective drug candidates.  Historically, drug discovery programs for GPCR ligands have been dominated by efforts to develop agonists and antagonists that act at orthosteric sites for endogenous ligands.  However, in recent years, there have been tremendous advances in the discovery of novel ligands for GPCRs that act at allosteric sites to regulate receptor function.  These compds. provide high selectivity, novel modes of efficacy and may lead to novel therapeutic agents for the treatment of multiple psychiatric and neurol. human disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmn5h5XCcPKbVg90H21EOLACvtfcHk0liq9Yx9X2LdNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFCkurfF&md5=e109e94fe3e2c1fcfd480dc84c6609f7</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2Fnrd2760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2760%26sid%3Dliteratum%253Aachs%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DChristopoulos%26aufirst%3DA.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26atitle%3DAllosteric%2520modulators%2520of%2520GPCRs%253A%2520a%2520novel%2520approach%2520for%2520the%2520treatment%2520of%2520CNS%2520disorders%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D41%26epage%3D54%26doi%3D10.1038%2Fnrd2760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Im, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chio, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberts, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D. M.</span></span> <span> </span><span class="NLM_article-title">Positive allosteric modulator of the human 5-HT 2C receptor</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">78</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1124/mol.64.1.78</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1124%2Fmol.64.1.78" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=78-84&author=W.+B.+Imauthor=C.+L.+Chioauthor=G.+L.+Albertsauthor=D.+M.+Dinh&title=Positive+allosteric+modulator+of+the+human+5-HT+2C+receptor&doi=10.1124%2Fmol.64.1.78"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1124%2Fmol.64.1.78&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.64.1.78%26sid%3Dliteratum%253Aachs%26aulast%3DIm%26aufirst%3DW.%2BB.%26aulast%3DChio%26aufirst%3DC.%2BL.%26aulast%3DAlberts%26aufirst%3DG.%2BL.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26atitle%3DPositive%2520allosteric%2520modulator%2520of%2520the%2520human%25205-HT%25202C%2520receptor%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26spage%3D78%26epage%3D84%26doi%3D10.1124%2Fmol.64.1.78" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span> <span> </span><span class="NLM_article-title">Exploration of synthetic approaches and pharmacological evaluation of PNU-69176E and its stereoisomer as 5-HT2C receptor allosteric modulators</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">538</span>– <span class="NLM_lpage">545</span>, <span class="refDoi"> DOI: 10.1021/cn300020x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn300020x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC38XlslOqsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=538-545&author=C.+Dingauthor=N.+M.+Bremerauthor=T.+D.+Smithauthor=P.+K.+Seitzauthor=N.+C.+Anastasioauthor=K.+A.+Cunninghamauthor=J.+Zhou&title=Exploration+of+synthetic+approaches+and+pharmacological+evaluation+of+PNU-69176E+and+its+stereoisomer+as+5-HT2C+receptor+allosteric+modulators&doi=10.1021%2Fcn300020x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Exploration of Synthetic Approaches and Pharmacological Evaluation of PNU-69176E and Its Stereoisomer as 5-HT2C Receptor Allosteric Modulators</span></div><div class="casAuthors">Ding, Chunyong; Bremer, Nicole M.; Smith, Thressa D.; Seitz, Patricia K.; Anastasio, Noelle C.; Cunningham, Kathryn A.; Zhou, Jia</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">538-545</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Allosteric modulators of the serotonin (5-HT) 5-HT2C receptor (5-HT2CR) present a unique drug design strategy to augment the response to endogenous 5-HT in a site- and event-specific manner with great potential as novel central nervous system probes and therapeutics.  To date, PNU-69176E is the only reported selective pos. allosteric modulator for the 5-HT2CR.  For the first time, an optimized synthetic route to readily access PNU-69176E (1) and its diastereomer 2 has been established in moderate to good overall yields over 10 steps starting from com. available picolinic acid.  This synthetic approach not only enables a feasible prepn. of a sufficient amt. of 1 for use as a ref. compd. for secondary pharmacol. studies, but also provides an efficient synthesis of key intermediates to develop novel and simplified 5-HT2CR allosteric modulators.  Compd. 1 and its diastereomer 2 were functionally characterized in Chinese hamster ovary (CHO) cells stably transfected with the 5-HT2CR using an intracellular calcium (Cai2+) release assay.  Compd. 1 demonstrated efficacy and potency as an allosteric modulator for the 5-HT2CR with no intrinsic agonist activity.  Compd. 1 did not alter 5-HT-evoked Cai2+ in CHO cells stably transfected with the highly homologous 5-HT2AR.  In contrast, the diastereomer 2 did not alter 5-HT-evoked Cai2+ release in 5-HT2AR-CHO or 5-HT2CR-CHO cells or exhibit intrinsic agonist activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-ZC-7cVkBGrVg90H21EOLACvtfcHk0liq9Yx9X2LdNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlslOqsb0%253D&md5=1f635dd7796d2663f1ab08b92c7d7cb9</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fcn300020x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn300020x%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DC.%26aulast%3DBremer%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BD.%26aulast%3DSeitz%26aufirst%3DP.%2BK.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DExploration%2520of%2520synthetic%2520approaches%2520and%2520pharmacological%2520evaluation%2520of%2520PNU-69176E%2520and%2520its%2520stereoisomer%2520as%25205-HT2C%2520receptor%2520allosteric%2520modulators%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D538%26epage%3D545%26doi%3D10.1021%2Fcn300020x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">García-Cárceles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decara, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vázquez-Villa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codesido, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruces, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alén, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballesteros, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benhamú, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodríguez de Fonseca, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">López-Rodríguez, M. L.</span></span> <span> </span><span class="NLM_article-title">A positive allosteric modulator of the serotonin 5-HT2C receptor for obesity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9575</span>– <span class="NLM_lpage">9584</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00994</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00994" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9575-9584&author=J.+Garc%C3%ADa-C%C3%A1rcelesauthor=J.+M.+Decaraauthor=H.+V%C3%A1zquez-Villaauthor=R.+Rodr%C3%ADguezauthor=E.+Codesidoauthor=J.+Crucesauthor=J.+Breaauthor=M.+I.+Lozaauthor=F.+Al%C3%A9nauthor=J.+Bottaauthor=P.+J.+McCormickauthor=J.+A.+Ballesterosauthor=B.+Benham%C3%BAauthor=F.+Rodr%C3%ADguez+de+Fonsecaauthor=M.+L.+L%C3%B3pez-Rodr%C3%ADguez&title=A+positive+allosteric+modulator+of+the+serotonin+5-HT2C+receptor+for+obesity&doi=10.1021%2Facs.jmedchem.7b00994"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00994%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-C%25C3%25A1rceles%26aufirst%3DJ.%26aulast%3DDecara%26aufirst%3DJ.%2BM.%26aulast%3DV%25C3%25A1zquez-Villa%26aufirst%3DH.%26aulast%3DRodr%25C3%25ADguez%26aufirst%3DR.%26aulast%3DCodesido%26aufirst%3DE.%26aulast%3DCruces%26aufirst%3DJ.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DAl%25C3%25A9n%26aufirst%3DF.%26aulast%3DBotta%26aufirst%3DJ.%26aulast%3DMcCormick%26aufirst%3DP.%2BJ.%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26aulast%3DBenham%25C3%25BA%26aufirst%3DB.%26aulast%3DRodr%25C3%25ADguez%2Bde%2BFonseca%26aufirst%3DF.%26aulast%3DL%25C3%25B3pez-Rodr%25C3%25ADguez%26aufirst%3DM.%2BL.%26atitle%3DA%2520positive%2520allosteric%2520modulator%2520of%2520the%2520serotonin%25205-HT2C%2520receptor%2520for%2520obesity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9575%26epage%3D9584%26doi%3D10.1021%2Facs.jmedchem.7b00994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Farce, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dilly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yous, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berthelot, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavatte, P.</span></span> <span> </span><span class="NLM_article-title">Homology modelling of the serotoninergic 5-HT2c receptor</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">292</span>, <span class="refDoi"> DOI: 10.1080/14756360600700608</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1080%2F14756360600700608" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=16918076" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVKntLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2006&pages=285-292&author=A.+Farceauthor=S.+Dillyauthor=S.+Yousauthor=P.+Berthelotauthor=P.+Chavatte&title=Homology+modelling+of+the+serotoninergic+5-HT2c+receptor&doi=10.1080%2F14756360600700608"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Homology modelling of the serotoninergic 5-HT2c receptor</span></div><div class="casAuthors">Farce, Amaury; Dilly, Sebastien; Yous, Said; Berthelot, Pascal; Chavatte, Philippe</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">285-292</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Since its discovery, 5-hydroxytryptamine, more usually called serotonin, has been an elusive candidate as a major mood regulator.  This capacity gives it a great importance in the treatment of depression.  It is within this framework that the authors' work takes place, as it is related more particularly to a new therapeutic class whose leader is agomelatine.  This compd. binds to the melatoninergic receptors and to the serotoninergic 5-HT2c receptor, giving rise to the MASSA concept (Melatonin Agonist and Selective Serotonin Antagonist).  Like the majority of the serotoninergic receptors, the sub-type 5-HT2c is a G-protein coupled receptor (GPCR).  The three-dimensional structure of 5-HT2c is not exptl. known, and the authors thus resorted to comparative homol. modeling to build a model allowing the authors to study its interactions with agomelatine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKJDpbpA5GkbVg90H21EOLACvtfcHk0ljW8EJMA5Mz6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVKntLw%253D&md5=5ef644a7636eaab3fc9df8dee38a73f2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1080%2F14756360600700608&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14756360600700608%26sid%3Dliteratum%253Aachs%26aulast%3DFarce%26aufirst%3DA.%26aulast%3DDilly%26aufirst%3DS.%26aulast%3DYous%26aufirst%3DS.%26aulast%3DBerthelot%26aufirst%3DP.%26aulast%3DChavatte%26aufirst%3DP.%26atitle%3DHomology%2520modelling%2520of%2520the%2520serotoninergic%25205-HT2c%2520receptor%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2006%26volume%3D21%26spage%3D285%26epage%3D292%26doi%3D10.1080%2F14756360600700608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, Z.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists</span>. <i>Acta Biochim. Biophys. Sin.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">413</span>– <span class="NLM_lpage">422</span>, <span class="refDoi"> DOI: 10.1111/j.1745-7270.2007.00295.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1111%2Fj.1745-7270.2007.00295.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=17558446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1KmsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2007&pages=413-422&author=Z.+Zuo&title=Pharmacophore-directed+homology+modeling+and+molecular+dynamics+simulation+of+G+protein-coupled+receptor%3A+study+of+possible+binding+modes+of+5-HT2C+receptor+agonists&doi=10.1111%2Fj.1745-7270.2007.00295.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore-directed homology modeling and molecular dynamics simulation of G protein-coupled receptor: study of possible binding modes of 5-HT2C receptor agonists</span></div><div class="casAuthors">Zuo, Zhili; Chen, Gang; Luo, Xiaomin; Puah, Chummok; Zhu, Weiliang; Chen, Kaixian; Jiang, Hualiang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Biochimica et Biophysica Sinica</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">413-422</span>CODEN:
                <span class="NLM_cas:coden">ABBSC2</span>;
        ISSN:<span class="NLM_cas:issn">1672-9145</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Asia Pty Ltd.</span>)
        </div><div class="casAbstract">A new pharmacophore-based modeling procedure, including homol. modeling, pharmacophore study, flexible mol. docking, and long-time mol. dynamics (MD) simulations, was employed to construct the structure of the human 5-HT2C receptor and det. the characteristics of binding modes of 5-HT2C receptor agonists.  An agonist-receptor complex has been constructed based on homol. modeling and a pharmacophore hypothesis model based on some high active compds.  Then MD simulations of the ligand-receptor complex in an explicit membrane environment were carried out.  The conformation of the 5-HT2C receptor during MD simulation was explored, and the stable binding modes of the studied agonist were detd.  Flexible mol. docking of several structurally diverse agonists of the human 5-HT2C receptor was carried out, and the general binding modes of these agonists were investigated.  According to the models presented in this work and the results of Flexi-Dock, the involvement of the amino acid residues Asp134, Ser138, Asn210, Asn331, Tyr358, Ile131, Ser132, Val135, Thr139, Ile189, Val202, Val208, Leu209, Phe214, Val215, Gly218, Ser219, Phe223, Trp324, Phe327, and Phe328 in agonist recognition was studied.  The obtained binding modes of the human 5-HT2C receptor agonists have good agreement with the site-directed mutagenesis data and other studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9zYrIwMty4LVg90H21EOLACvtfcHk0ljW8EJMA5Mz6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1KmsLk%253D&md5=3904d907fe4c10d429fd3c3c2768c371</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1111%2Fj.1745-7270.2007.00295.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1745-7270.2007.00295.x%26sid%3Dliteratum%253Aachs%26aulast%3DZuo%26aufirst%3DZ.%26atitle%3DPharmacophore-directed%2520homology%2520modeling%2520and%2520molecular%2520dynamics%2520simulation%2520of%2520G%2520protein-coupled%2520receptor%253A%2520study%2520of%2520possible%2520binding%2520modes%2520of%25205-HT2C%2520receptor%2520agonists%26jtitle%3DActa%2520Biochim.%2520Biophys.%2520Sin.%26date%3D2007%26volume%3D39%26spage%3D413%26epage%3D422%26doi%3D10.1111%2Fj.1745-7270.2007.00295.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berg, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spampinato, U.</span></span> <span> </span><span class="NLM_article-title">Fine-tuning serotonin2c receptor function in the brain: Molecular and functional implications</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">969</span>– <span class="NLM_lpage">976</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.neuropharm.2008.06.014" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=969-976&author=K.+A.+Bergauthor=W.+P.+Clarkeauthor=K.+A.+Cunninghamauthor=U.+Spampinato&title=Fine-tuning+serotonin2c+receptor+function+in+the+brain%3A+Molecular+and+functional+implications&doi=10.1016%2Fj.neuropharm.2008.06.014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DK.%2BA.%26aulast%3DClarke%26aufirst%3DW.%2BP.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DSpampinato%26aufirst%3DU.%26atitle%3DFine-tuning%2520serotonin2c%2520receptor%2520function%2520in%2520the%2520brain%253A%2520Molecular%2520and%2520functional%2520implications%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D969%26epage%3D976%26doi%3D10.1016%2Fj.neuropharm.2008.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cho, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, N. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurome, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manzano, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malberg, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldarone, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Selective 5-hydroxytryptamine 2C receptor aonists derived from the lead compound tranylcypromine: identification of drugs with antidepressant-like action</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">1885</span>– <span class="NLM_lpage">1902</span>, <span class="refDoi"> DOI: 10.1021/jm801354e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm801354e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=1885-1902&author=S.+J.+Choauthor=N.+H.+Jensenauthor=T.+Kuromeauthor=S.+Kadariauthor=M.+L.+Manzanoauthor=J.+E.+Malbergauthor=B.+Caldaroneauthor=B.+L.+Rothauthor=A.+P.+Kozikowski&title=Selective+5-hydroxytryptamine+2C+receptor+aonists+derived+from+the+lead+compound+tranylcypromine%3A+identification+of+drugs+with+antidepressant-like+action&doi=10.1021%2Fjm801354e"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm801354e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm801354e%26sid%3Dliteratum%253Aachs%26aulast%3DCho%26aufirst%3DS.%2BJ.%26aulast%3DJensen%26aufirst%3DN.%2BH.%26aulast%3DKurome%26aufirst%3DT.%26aulast%3DKadari%26aufirst%3DS.%26aulast%3DManzano%26aufirst%3DM.%2BL.%26aulast%3DMalberg%26aufirst%3DJ.%2BE.%26aulast%3DCaldarone%26aufirst%3DB.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSelective%25205-hydroxytryptamine%25202C%2520receptor%2520aonists%2520derived%2520from%2520the%2520lead%2520compound%2520tranylcypromine%253A%2520identification%2520of%2520drugs%2520with%2520antidepressant-like%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D1885%26epage%3D1902%26doi%3D10.1021%2Fjm801354e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berg, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sailstad, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltzman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maayani, S.</span></span> <span> </span><span class="NLM_article-title">Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">484</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=477-484&author=K.+A.+Bergauthor=W.+P.+Clarkeauthor=C.+Sailstadauthor=A.+Saltzmanauthor=S.+Maayani&title=Signal+transduction+differences+between+5-hydroxytryptamine+type+2A+and+type+2C+receptor+systems"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBerg%26aufirst%3DK.%2BA.%26aulast%3DClarke%26aufirst%3DW.%2BP.%26aulast%3DSailstad%26aufirst%3DC.%26aulast%3DSaltzman%26aufirst%3DA.%26aulast%3DMaayani%26aufirst%3DS.%26atitle%3DSignal%2520transduction%2520differences%2520between%25205-hydroxytryptamine%2520type%25202A%2520and%2520type%25202C%2520receptor%2520systems%26jtitle%3DMol.%2520Pharmacol.%26date%3D1994%26volume%3D46%26spage%3D477%26epage%3D484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbertson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubar, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agarkov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swinford, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charendoff, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craft, J. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laezza, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briggs, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1615</span>– <span class="NLM_lpage">1630</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2656-12.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1523%2FJNEUROSCI.2656-12.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23345234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitVehsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1615-1630&author=N.+C.+Anastasioauthor=S.+R.+Gilbertsonauthor=M.+J.+Bubarauthor=A.+Agarkovauthor=S.+J.+Stutzauthor=Y.+Jengauthor=N.+M.+Bremerauthor=T.+D.+Smithauthor=R.+G.+Foxauthor=S.+E.+Swinfordauthor=P.+K.+Seitzauthor=M.+N.+Charendoffauthor=J.+W.+Craftauthor=F.+M.+Laezzaauthor=C.+S.+Watsonauthor=J.+M.+Briggsauthor=K.+A.+Cunningham&title=Peptide+inhibitors+disrupt+the+serotonin+5-HT2C+receptor+interaction+with+phosphatase+and+tensin+homolog+to+allosterically+modulate+cellular+signaling+and+behavior&doi=10.1523%2FJNEUROSCI.2656-12.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Peptide inhibitors disrupt the serotonin 5-HT2C receptor interaction with phosphatase and tensin homolog to allosterically modulate cellular signaling and behavior</span></div><div class="casAuthors">Anastasio, Noelle C.; Gilbertson, Scott R.; Bubar, Marcy J.; Agarkov, Anton; Stutz, Sonja J.; Jeng, Yowjiun; Bremer, Nicole M.; Smith, Thressa D.; Fox, Robert G.; Swinford, Sarah E.; Seitz, Patricia K.; Charendoff, Marc N.; Craft, John W., Jr.; Laezza, Fernanda M.; Watson, Cheryl S.; Briggs, James M.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1615-1630</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Serotonin (5-hydroxytryptamine; 5-HT) signaling through the 5-HT2C receptor (5-HT2CR) is essential in normal physiol., whereas aberrant 5-HT2CR function is thought to contribute to the pathogenesis of multiple neural disorders.  The 5-HT2CR interacts with specific protein partners, but the impact of such interactions on 5-HT2CR function is poorly understood.  Here, the authors report convergent cellular and behavioral data that the interaction between the 5-HT2CR and protein phosphatase and tensin homolog (PTEN) serves as a regulatory mechanism to control 5-HT2CR-mediated biol. but not that of the closely homologous 5-HT2AR.  A peptide derived from the third intracellular loop of the human 5-HT2CR [3L4F (third loop, fourth fragment)] disrupted the assocn., allosterically augmented 5-HT2CR-mediated signaling in live cells, and acted as a pos. allosteric modulator in rats in vivo.  The authors identified the crit. residues within an 8 aa fragment of the 3L4F peptide that maintained efficacy (within the picomolar range) in live cells similar to that of the 3L4F peptide.  Last, mol. modeling identified key structural features and potential interaction sites of the active 3L4F peptides against PTEN.  These compelling data demonstrate the specificity and importance of this protein assembly in cellular events and behaviors mediated by 5-HT2CR signaling and provide a chem. guidepost to the future development of drug-like peptide or small-mol. inhibitors as neuroprobes to study 5-HT2CR allostery and therapeutics for 5-HT2CR-mediated disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxfvdVf-m7RrVg90H21EOLACvtfcHk0ljsXlkUvYyNYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitVehsL4%253D&md5=f2b9ea10c27f043b1dee05e2a6890010</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2656-12.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2656-12.2013%26sid%3Dliteratum%253Aachs%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DGilbertson%26aufirst%3DS.%2BR.%26aulast%3DBubar%26aufirst%3DM.%2BJ.%26aulast%3DAgarkov%26aufirst%3DA.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DJeng%26aufirst%3DY.%26aulast%3DBremer%26aufirst%3DN.%2BM.%26aulast%3DSmith%26aufirst%3DT.%2BD.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DSwinford%26aufirst%3DS.%2BE.%26aulast%3DSeitz%26aufirst%3DP.%2BK.%26aulast%3DCharendoff%26aufirst%3DM.%2BN.%26aulast%3DCraft%26aufirst%3DJ.%2BW.%26aulast%3DLaezza%26aufirst%3DF.%2BM.%26aulast%3DWatson%26aufirst%3DC.%2BS.%26aulast%3DBriggs%26aufirst%3DJ.%2BM.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DPeptide%2520inhibitors%2520disrupt%2520the%2520serotonin%25205-HT2C%2520receptor%2520interaction%2520with%2520phosphatase%2520and%2520tensin%2520homolog%2520to%2520allosterically%2520modulate%2520cellular%2520signaling%2520and%2520behavior%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D1615%26epage%3D1630%26doi%3D10.1523%2FJNEUROSCI.2656-12.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melcher, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span> <span> </span><span class="NLM_article-title">Structural basis for molecular recognition at serotonin receptors</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">610</span>– <span class="NLM_lpage">614</span>, <span class="refDoi"> DOI: 10.1126/science.1232807</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1126%2Fscience.1232807" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23519210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=610-614&author=C.+Wangauthor=Y.+Jiangauthor=J.+Maauthor=H.+Wuauthor=D.+Wackerauthor=V.+Katritchauthor=G.+W.+Hanauthor=W.+Liuauthor=X.-P.+Huangauthor=E.+Vardyauthor=J.+D.+McCorvyauthor=X.+Gaoauthor=E.+Zhouauthor=K.+Melcherauthor=C.+Zhangauthor=F.+Baiauthor=H.+Yangauthor=L.+Yangauthor=H.+Jiangauthor=B.+L.+Rothauthor=V.+Cherezovauthor=R.+C.+Stevensauthor=H.+E.+Xu&title=Structural+basis+for+molecular+recognition+at+serotonin+receptors&doi=10.1126%2Fscience.1232807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for Molecular Recognition at Serotonin Receptors</span></div><div class="casAuthors">Wang, Chong; Jiang, Yi; Ma, Jinming; Wu, Huixian; Wacker, Daniel; Katritch, Vsevolod; Han, Gye Won; Liu, Wei; Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Gao, Xiang; Zhou, X. Edward; Melcher, Karsten; Zhang, Chenghai; Bai, Fang; Yang, Huaiyu; Yang, Linlin; Jiang, Hualiang; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.; Xu, H. Eric</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">610-614</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Serotonin or 5-hydroxytryptamine (5-HT) regulates a wide spectrum of human physiol. through the 5-HT receptor family.  The authors report the crystal structures of the human 5-HT1B G protein-coupled receptor bound to the agonist antimigraine medications ergotamine and dihydroergotamine.  The structures reveal similar binding modes for these ligands, which occupy the orthosteric pocket and an extended binding pocket close to the extracellular loops.  The orthosteric pocket is formed by residues conserved in the 5-HT receptor family, clarifying the family-wide agonist activity of 5-HT.  Compared with the structure of the 5-HT2B receptor, the 5-HT1B receptor displays a 3 angstrom outward shift at the extracellular end of helix V, resulting in a more open extended pocket that explains subtype selectivity.  Together with docking and mutagenesis studies, these structures provide a comprehensive structural basis for understanding receptor-ligand interactions and designing subtype-selective serotonergic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLc0rOIqg_2bVg90H21EOLACvtfcHk0ljsXlkUvYyNYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksbw%253D&md5=ce0773088a86f6a2c83b6cb77a63e708</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1126%2Fscience.1232807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1232807%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DGao%26aufirst%3DX.%26aulast%3DZhou%26aufirst%3DE.%26aulast%3DMelcher%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DBai%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DXu%26aufirst%3DH.%2BE.%26atitle%3DStructural%2520basis%2520for%2520molecular%2520recognition%2520at%2520serotonin%2520receptors%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D610%26epage%3D614%26doi%3D10.1126%2Fscience.1232807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vardy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherezov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span> <span> </span><span class="NLM_article-title">Structural features for functional selectivity at serotonin receptors</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>340</i></span>,  <span class="NLM_fpage">615</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1126/science.1232808</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1126%2Fscience.1232808" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23519215" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmslWksb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=340&publication_year=2013&pages=615-619&author=D.+Wackerauthor=C.+Wangauthor=V.+Katritchauthor=G.+W.+Hanauthor=X.-P.+Huangauthor=E.+Vardyauthor=J.+D.+McCorvyauthor=Y.+Jiangauthor=M.+Chuauthor=F.+Y.+Siuauthor=W.+Liuauthor=H.+E.+Xuauthor=V.+Cherezovauthor=B.+L.+Rothauthor=R.+C.+Stevens&title=Structural+features+for+functional+selectivity+at+serotonin+receptors&doi=10.1126%2Fscience.1232808"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Features for Functional Selectivity at Serotonin Receptors</span></div><div class="casAuthors">Wacker, Daniel; Wang, Chong; Katritch, Vsevolod; Han, Gye Won; Huang, Xi-Ping; Vardy, Eyal; McCorvy, John D.; Jiang, Yi; Chu, Meihua; Siu, Fai Yiu; Liu, Wei; Xu, H. Eric; Cherezov, Vadim; Roth, Bryan L.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">340</span>
        (<span class="NLM_cas:issue">6132</span>),
    <span class="NLM_cas:pages">615-619</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Drugs active at G protein-coupled receptors (GPCRs) can differentially modulate either canonical or noncanonical signaling pathways via a phenomenon known as functional selectivity or biased signaling.  The authors report biochem. studies showing that the hallucinogen lysergic acid diethylamide, its precursor ergotamine (ERG), and related ergolines display strong functional selectivity for β-arrestin signaling at the 5-HT2B 5-hydroxytryptamine (5-HT) receptor, whereas they are relatively unbiased at the 5-HT1B receptor.  To investigate the structural basis for biased signaling, the authors detd. the crystal structure of the human 5-HT2B receptor bound to ERG and compared it with the 5-HT1B/ERG structure.  Given the relatively poor understanding of GPCR structure and function to date, insight into different GPCR signaling pathways is important to better understand both adverse and favorable therapeutic activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreo_QegM-j7bVg90H21EOLACvtfcHk0lgoPCJbQv41VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmslWksb0%253D&md5=16e96d0255be3ac367aeda7187aa4c15</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1126%2Fscience.1232808&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1232808%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DVardy%26aufirst%3DE.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DChu%26aufirst%3DM.%26aulast%3DSiu%26aufirst%3DF.%2BY.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DXu%26aufirst%3DH.%2BE.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DStructural%2520features%2520for%2520functional%2520selectivity%2520at%2520serotonin%2520receptors%26jtitle%3DScience%26date%3D2013%26volume%3D340%26spage%3D615%26epage%3D619%26doi%3D10.1126%2Fscience.1232808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Betz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schools, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nichols, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoichet, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dror, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of an LSD-bound human serotonin receptor</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">377</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2016.12.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.cell.2016.12.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=28129538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaqs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2017&pages=377-389&author=D.+Wackerauthor=S.+Wangauthor=J.+D.+McCorvyauthor=R.+M.+Betzauthor=A.+J.+Venkatakrishnanauthor=A.+Levitauthor=K.+Lansuauthor=Z.+L.+Schoolsauthor=T.+Cheauthor=D.+E.+Nicholsauthor=B.+K.+Shoichetauthor=R.+O.+Drorauthor=B.+L.+Roth&title=Crystal+structure+of+an+LSD-bound+human+serotonin+receptor&doi=10.1016%2Fj.cell.2016.12.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of an LSD-bound human serotonin receptor</span></div><div class="casAuthors">Wacker, Daniel; Wang, Sheng; McCorvy, John D.; Betz, Robin M.; Venkatakrishnan, A. J.; Levit, Anat; Lansu, Katherine; Schools, Zachary L.; Che, Tao; Nichols, David E.; Shoichet, Brian K.; Dror, Ron O.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">377-389.e12</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The prototypical hallucinogen, LSD, acts via serotonin receptors, and here the authors describe the crystal structure of LSD in complex with human serotonin receptor 5-HT2B.  The complex revealed conformational rearrangements to accommodate LSD, providing a structural explanation for the conformational selectivity of LSD's key diethylamide moiety.  LSD dissocd. exceptionally slow from both 5-HT2BR and 5-HT2AR, a major target for its psychoactivity.  Mol. dynamics (MD) simulations suggested that LSD's slow binding kinetics may be due to a "lid" formed by extracellular loop 2 (EL2) at the entrance to the binding pocket.  A mutation predicted to increase the mobility of this lid greatly accelerated LSD's binding kinetics and selectively dampened LSD-mediated β-arrestin 2 recruitment.  Thus, this study reveals an unexpected binding mode of LSD, illuminates key features of its kinetics, stereochem., and signaling, and provides a mol. explanation for LSD's actions at human serotonin receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcU-96ccslG7Vg90H21EOLACvtfcHk0lgoPCJbQv41VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaqs7g%253D&md5=5eee71a2d385d97d9891b669e8c5afa1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2016.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2016.12.033%26sid%3Dliteratum%253Aachs%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DBetz%26aufirst%3DR.%2BM.%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DLevit%26aufirst%3DA.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DSchools%26aufirst%3DZ.%2BL.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DNichols%26aufirst%3DD.%2BE.%26aulast%3DShoichet%26aufirst%3DB.%2BK.%26aulast%3DDror%26aufirst%3DR.%2BO.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DCrystal%2520structure%2520of%2520an%2520LSD-bound%2520human%2520serotonin%2520receptor%26jtitle%3DCell%26date%3D2017%26volume%3D168%26spage%3D377%26epage%3D389%26doi%3D10.1016%2Fj.cell.2016.12.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCorvy, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harpsøe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolajsen, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bjørn-Yoshimoto, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wacker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katritch, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gloriam, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.-J.</span></span> <span> </span><span class="NLM_article-title">5-HT2C receptor structures reveal the structural basis of GPCR polypharmacology</span>. <i>Cell</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">730</span>, <span class="refDoi"> DOI: 10.1016/j.cell.2018.01.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.cell.2018.01.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=29398112" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSitrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=2018&pages=719-730&author=Y.+Pengauthor=J.+D.+McCorvyauthor=K.+Harps%C3%B8eauthor=K.+Lansuauthor=S.+Yuanauthor=P.+Popovauthor=L.+Quauthor=M.+Puauthor=T.+Cheauthor=L.+F.+Nikolajsenauthor=X.-P.+Huangauthor=Y.+Wuauthor=L.+Shenauthor=W.+E.+Bj%C3%B8rn-Yoshimotoauthor=K.+Dingauthor=D.+Wackerauthor=G.+W.+Hanauthor=J.+Chengauthor=V.+Katritchauthor=A.+A.+Jensenauthor=M.+A.+Hansonauthor=S.+Zhaoauthor=D.+E.+Gloriamauthor=B.+L.+Rothauthor=R.+C.+Stevensauthor=Z.-J.+Liu&title=5-HT2C+receptor+structures+reveal+the+structural+basis+of+GPCR+polypharmacology&doi=10.1016%2Fj.cell.2018.01.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology</span></div><div class="casAuthors">Peng, Yao; McCorvy, John D.; Harpsoee, Kasper; Lansu, Katherine; Yuan, Shuguang; Popov, Petr; Qu, Lu; Pu, Mengchen; Che, Tao; Nikolajsen, Louise F.; Huang, Xi-Ping; Wu, Yiran; Shen, Ling; Bjoern-Yoshimoto, Walden E.; Ding, Kang; Wacker, Daniel; Han, Gye Won; Cheng, Jianjun; Katritch, Vsevolod; Jensen, Anders A.; Hanson, Michael A.; Zhao, Suwen; Gloriam, David E.; Roth, Bryan L.; Stevens, Raymond C.; Liu, Zhi-Jie</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">719-730.e14</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Drugs frequently require interactions with multiple targets-via a process known as polypharmacol.-to achieve their therapeutic actions.  Currently, drugs targeting several serotonin receptors, including the 5-HT2C receptor, are useful for treating obesity, drug abuse, and schizophrenia.  The competing challenges of developing selective 5-HT2C receptor ligands or creating drugs with a defined polypharmacol. profile, esp. aimed at G protein-coupled receptors (GPCRs), remain extremely difficult.  Here, we solved two structures of the 5-HT2C receptor in complex with the highly promiscuous agonist ergotamine and the 5-HT2A-C receptor-selective inverse agonist ritanserin at resolns. of 3.0 Å and 2.7 Å, resp.  We analyzed their resp. binding poses to provide mechanistic insights into their receptor recognition and opposing pharmacol. actions.  This study investigates the structural basis of polypharmacol. at canonical GPCRs and illustrates how understanding characteristic patterns of ligand-receptor interaction and activation may ultimately facilitate drug design at multiple GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooMwdaPWz7FLVg90H21EOLACvtfcHk0lgoPCJbQv41VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSitrs%253D&md5=b6c7f55568544a8c363794fa12f18175</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2018.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2018.01.001%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DMcCorvy%26aufirst%3DJ.%2BD.%26aulast%3DHarps%25C3%25B8e%26aufirst%3DK.%26aulast%3DLansu%26aufirst%3DK.%26aulast%3DYuan%26aufirst%3DS.%26aulast%3DPopov%26aufirst%3DP.%26aulast%3DQu%26aufirst%3DL.%26aulast%3DPu%26aufirst%3DM.%26aulast%3DChe%26aufirst%3DT.%26aulast%3DNikolajsen%26aufirst%3DL.%2BF.%26aulast%3DHuang%26aufirst%3DX.-P.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DL.%26aulast%3DBj%25C3%25B8rn-Yoshimoto%26aufirst%3DW.%2BE.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DWacker%26aufirst%3DD.%26aulast%3DHan%26aufirst%3DG.%2BW.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DJensen%26aufirst%3DA.%2BA.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DGloriam%26aufirst%3DD.%2BE.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DLiu%26aufirst%3DZ.-J.%26atitle%3D5-HT2C%2520receptor%2520structures%2520reveal%2520the%2520structural%2520basis%2520of%2520GPCR%2520polypharmacology%26jtitle%3DCell%26date%3D2018%26volume%3D172%26spage%3D719%26epage%3D730%26doi%3D10.1016%2Fj.cell.2018.01.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ballesteros, J. A.</span>; <span class="NLM_string-name">Weinstein, H.</span></span> <span> </span><span class="NLM_article-title">Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors</span>. In  <i>Methods in Neuroscience</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sealfon, S. C.</span></span>, Ed.; <span class="NLM_publisher-name">Academic Press</span>: <span class="NLM_year">1995</span>; Vol.  <span class="NLM_volume">25</span>, Chapter 19, pp  <span class="NLM_fpage">366</span>– <span class="NLM_lpage">428</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2FS1043-9471%2805%2980049-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=366-428&author=J.+A.+Ballesteros&author=H.+Weinsteinauthor=S.+C.+Sealfon&title=Methods+in+Neuroscience"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2FS1043-9471%2805%2980049-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FS1043-9471%252805%252980049-7%26sid%3Dliteratum%253Aachs%26aulast%3DBallesteros%26aufirst%3DJ.%2BA.%26atitle%3DIntegrated%2520methods%2520for%2520the%2520construction%2520of%2520three-dimensional%2520models%2520and%2520computational%2520probing%2520of%2520structure-function%2520relations%2520in%2520G%2520protein-coupled%2520receptors%26btitle%3DMethods%2520in%2520Neuroscience%26aulast%3DSealfon%26aufirst%3DS.%2BC.%26pub%3DAcademic%2520Press%26date%3D1995%26volume%3D25%26spage%3D366%26epage%3D428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Manivet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, B. t.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, D.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maroteaux, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kellermann, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Launay, J.-M.</span></span> <span> </span><span class="NLM_article-title">The serotonin binding site of human and murine 5-HT2B receptors: molecular modeling and site-directed mutagenesis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>277</i></span>,  <span class="NLM_fpage">17170</span>– <span class="NLM_lpage">17178</span>, <span class="refDoi"> DOI: 10.1074/jbc.M200195200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1074%2Fjbc.M200195200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=2002&pages=17170-17178&author=P.+Manivetauthor=B.+t.+Schneiderauthor=J.+C.+Smithauthor=D.-S.+Choiauthor=L.+Maroteauxauthor=O.+Kellermannauthor=J.-M.+Launay&title=The+serotonin+binding+site+of+human+and+murine+5-HT2B+receptors%3A+molecular+modeling+and+site-directed+mutagenesis&doi=10.1074%2Fjbc.M200195200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M200195200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M200195200%26sid%3Dliteratum%253Aachs%26aulast%3DManivet%26aufirst%3DP.%26aulast%3DSchneider%26aufirst%3DB.%2Bt.%26aulast%3DSmith%26aufirst%3DJ.%2BC.%26aulast%3DChoi%26aufirst%3DD.-S.%26aulast%3DMaroteaux%26aufirst%3DL.%26aulast%3DKellermann%26aufirst%3DO.%26aulast%3DLaunay%26aufirst%3DJ.-M.%26atitle%3DThe%2520serotonin%2520binding%2520site%2520of%2520human%2520and%2520murine%25205-HT2B%2520receptors%253A%2520molecular%2520modeling%2520and%2520site-directed%2520mutagenesis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2002%26volume%3D277%26spage%3D17170%26epage%3D17178%26doi%3D10.1074%2Fjbc.M200195200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seager, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graufelds, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCampbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shughrue, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danziger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Regan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascarella, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreatsoulas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shipe, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuduk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sur, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinney, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seabrook, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, W. J.</span></span> <span> </span><span class="NLM_article-title">Selective activation of the M(1) muscarinic acetylcholine receptor achieved by allosteric potentiation</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>106</i></span>,  <span class="NLM_fpage">15950</span>– <span class="NLM_lpage">15955</span>, <span class="refDoi"> DOI: 10.1073/pnas.0900903106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1073%2Fpnas.0900903106" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2009&pages=15950-15955&author=L.+Maauthor=M.+A.+Seagerauthor=M.+Wittmannauthor=M.+Jacobsonauthor=D.+Bickelauthor=M.+Burnoauthor=K.+Jonesauthor=V.+K.+Graufeldsauthor=G.+Xuauthor=M.+Pearsonauthor=A.+McCampbellauthor=R.+Gasparauthor=P.+Shughrueauthor=A.+Danzigerauthor=C.+Reganauthor=R.+Flickauthor=D.+Pascarellaauthor=S.+Garsonauthor=S.+Doranauthor=C.+Kreatsoulasauthor=L.+Vengauthor=C.+W.+Lindsleyauthor=W.+Shipeauthor=S.+Kudukauthor=C.+Surauthor=G.+Kinneyauthor=G.+R.+Seabrookauthor=W.+J.+Ray&title=Selective+activation+of+the+M%281%29+muscarinic+acetylcholine+receptor+achieved+by+allosteric+potentiation&doi=10.1073%2Fpnas.0900903106"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0900903106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0900903106%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DSeager%26aufirst%3DM.%2BA.%26aulast%3DWittmann%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DM.%26aulast%3DBickel%26aufirst%3DD.%26aulast%3DBurno%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DK.%26aulast%3DGraufelds%26aufirst%3DV.%2BK.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DPearson%26aufirst%3DM.%26aulast%3DMcCampbell%26aufirst%3DA.%26aulast%3DGaspar%26aufirst%3DR.%26aulast%3DShughrue%26aufirst%3DP.%26aulast%3DDanziger%26aufirst%3DA.%26aulast%3DRegan%26aufirst%3DC.%26aulast%3DFlick%26aufirst%3DR.%26aulast%3DPascarella%26aufirst%3DD.%26aulast%3DGarson%26aufirst%3DS.%26aulast%3DDoran%26aufirst%3DS.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DVeng%26aufirst%3DL.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DShipe%26aufirst%3DW.%26aulast%3DKuduk%26aufirst%3DS.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DKinney%26aufirst%3DG.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DRay%26aufirst%3DW.%2BJ.%26atitle%3DSelective%2520activation%2520of%2520the%2520M%25281%2529%2520muscarinic%2520acetylcholine%2520receptor%2520achieved%2520by%2520allosteric%2520potentiation%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2009%26volume%3D106%26spage%3D15950%26epage%3D15955%26doi%3D10.1073%2Fpnas.0900903106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Venkatakrishnan, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deupi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schertler, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babu, M. M.</span></span> <span> </span><span class="NLM_article-title">Molecular signatures of G-protein-coupled receptors</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>494</i></span>,  <span class="NLM_fpage">185</span>, <span class="refDoi"> DOI: 10.1038/nature11896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fnature11896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23407534" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3sXis1Wrt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=494&publication_year=2013&pages=185&author=A.+J.+Venkatakrishnanauthor=X.+Deupiauthor=G.+Lebonauthor=C.+G.+Tateauthor=G.+F.+Schertlerauthor=M.+M.+Babu&title=Molecular+signatures+of+G-protein-coupled+receptors&doi=10.1038%2Fnature11896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular signatures of G-protein-coupled receptors</span></div><div class="casAuthors">Venkatakrishnan, A. J.; Deupi, Xavier; Lebon, Guillaume; Tate, Christopher G.; Schertler, Gebhard F.; Babu, M. Madan</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">494</span>
        (<span class="NLM_cas:issue">7436</span>),
    <span class="NLM_cas:pages">185-194</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  G-protein-coupled receptors (GPCRs) are physiol. important membrane proteins that sense signaling mols. such as hormones and neurotransmitters, and are the targets of several prescribed drugs.  Recent exciting developments are providing unprecedented insights into the structure and function of several medically important GPCRs.  Here, through a systematic anal. of high-resoln. GPCR structures, we uncover a conserved network of non-covalent contacts that defines the GPCR fold.  Furthermore, our comparative anal. reveals characteristic features of ligand binding and conformational changes during receptor activation.  A holistic understanding that integrates mol. and systems biol. of GPCRs holds promise for new therapeutics and personalized medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4fvI327bmkbVg90H21EOLACvtfcHk0ljLNdi4oCV71w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXis1Wrt7Y%253D&md5=5dd040bf5f3b4b81249c02d493a1fbf3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature11896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11896%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatakrishnan%26aufirst%3DA.%2BJ.%26aulast%3DDeupi%26aufirst%3DX.%26aulast%3DLebon%26aufirst%3DG.%26aulast%3DTate%26aufirst%3DC.%2BG.%26aulast%3DSchertler%26aufirst%3DG.%2BF.%26aulast%3DBabu%26aufirst%3DM.%2BM.%26atitle%3DMolecular%2520signatures%2520of%2520G-protein-coupled%2520receptors%26jtitle%3DNature%26date%3D2013%26volume%3D494%26spage%3D185%26doi%3D10.1038%2Fnature11896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Preininger, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meiler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamm, H. E.</span></span> <span> </span><span class="NLM_article-title">Conformational flexibility and structural dynamics in GPCR-mediated G protein activation: a perspective</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>425</i></span>,  <span class="NLM_fpage">2288</span>– <span class="NLM_lpage">2298</span>, <span class="refDoi"> DOI: 10.1016/j.jmb.2013.04.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.jmb.2013.04.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23602809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnt1aht7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2013&pages=2288-2298&author=A.+M.+Preiningerauthor=J.+Meilerauthor=H.+E.+Hamm&title=Conformational+flexibility+and+structural+dynamics+in+GPCR-mediated+G+protein+activation%3A+a+perspective&doi=10.1016%2Fj.jmb.2013.04.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Conformational flexibility and structural dynamics in GPCR-mediated G protein activation: A perspective</span></div><div class="casAuthors">Preininger, Anita M.; Meiler, Jens; Hamm, Heidi E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2288-2298</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The structure and dynamics of G proteins and their cognate receptors, both alone and in complex, are becoming increasingly accessible to exptl. techniques.  Understanding the conformational changes and timelines that govern these changes can lead to new insights into the processes of ligand binding and assocd. G protein activation.  Exptl. systems may involve the use of, or otherwise stabilize, non-native environments.  This can complicate the understanding of structural and dynamic features of processes such as the ionic lock, tryptophan toggle, and G protein flexibility.  While elements in the receptor's transmembrane helixes and the C-terminal α5 helix of Gα undergo well-defined structural changes, regions subject to conformational flexibility may be important in fine-tuning the interactions between activated receptors and G proteins.  The pairing of computational and exptl. approaches will continue to provide powerful tools to probe the conformation and dynamics of receptor-mediated G protein activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqa8wRL2jIHBbVg90H21EOLACvtfcHk0lhbq3dMtt38tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnt1aht7g%253D&md5=7af4574924a9a9d6e7b01311ba21d6be</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2013.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2013.04.011%26sid%3Dliteratum%253Aachs%26aulast%3DPreininger%26aufirst%3DA.%2BM.%26aulast%3DMeiler%26aufirst%3DJ.%26aulast%3DHamm%26aufirst%3DH.%2BE.%26atitle%3DConformational%2520flexibility%2520and%2520structural%2520dynamics%2520in%2520GPCR-mediated%2520G%2520protein%2520activation%253A%2520a%2520perspective%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2013%26volume%3D425%26spage%3D2288%26epage%3D2298%26doi%3D10.1016%2Fj.jmb.2013.04.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Besnard, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruda, G. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setola, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abecassis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguiz, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Norval, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sassano, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeons, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stojanovski, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prat, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidah, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constam, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bickerton, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Read, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wetsel, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, I. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span> <span> </span><span class="NLM_article-title">Automated design of ligands to polypharmacological profiles</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>492</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1038/nature11691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fnature11691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=23235874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=492&publication_year=2012&pages=215-220&author=J.+Besnardauthor=G.+F.+Rudaauthor=V.+Setolaauthor=K.+Abecassisauthor=R.+M.+Rodriguizauthor=X.+P.+Huangauthor=S.+Norvalauthor=M.+F.+Sassanoauthor=A.+I.+Shinauthor=L.+A.+Websterauthor=F.+R.+Simeonsauthor=L.+Stojanovskiauthor=A.+Pratauthor=N.+G.+Seidahauthor=D.+B.+Constamauthor=G.+R.+Bickertonauthor=K.+D.+Readauthor=W.+C.+Wetselauthor=I.+H.+Gilbertauthor=B.+L.+Rothauthor=A.+L.+Hopkins&title=Automated+design+of+ligands+to+polypharmacological+profiles&doi=10.1038%2Fnature11691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Automated design of ligands to polypharmacological profiles</span></div><div class="casAuthors">Besnard, Jeremy; Ruda, Gian Filippo; Setola, Vincent; Abecassis, Keren; Rodriguiz, Ramona M.; Huang, Xi-Ping; Norval, Suzanne; Sassano, Maria F.; Shin, Antony I.; Webster, Lauren A.; Simeons, Frederick R. C.; Stojanovski, Laste; Prat, Annik; Seidah, Nabil G.; Constam, Daniel B.; Bickerton, G. Richard; Read, Kevin D.; Wetsel, William C.; Gilbert, Ian H.; Roth, Bryan L.; Hopkins, Andrew L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">492</span>
        (<span class="NLM_cas:issue">7428</span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The clin. efficacy and safety of a drug is detd. by its activity profile across many proteins in the proteome.  However, designing drugs with a specific multi-target profile is both complex and difficult.  Therefore methods to design drugs rationally a priori against profiles of several proteins would have immense value in drug discovery.  Here is described a new approach for the automated design of ligands against profiles of multiple drug targets.  The method is demonstrated by the evolution of an approved acetylcholinesterase inhibitor drug donepezil (I) into brain-penetrable ligands with either specific polypharmacol. or exquisite selectivity profiles for G-protein-coupled receptors.  Overall, 800 ligand-target predictions of prospectively designed ligands were tested exptl., of which 75% were confirmed to be correct.  Target engagement in vivo is also demonstrated.  The approach can be a useful source of drug leads when multi-target profiles are required to achieve either selectivity over other drug targets or a desired polypharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNu5bwrBD3tbVg90H21EOLACvtfcHk0lhbq3dMtt38tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVamurfN&md5=ace6cced250cf968d327b482a5bf1798</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnature11691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11691%26sid%3Dliteratum%253Aachs%26aulast%3DBesnard%26aufirst%3DJ.%26aulast%3DRuda%26aufirst%3DG.%2BF.%26aulast%3DSetola%26aufirst%3DV.%26aulast%3DAbecassis%26aufirst%3DK.%26aulast%3DRodriguiz%26aufirst%3DR.%2BM.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DNorval%26aufirst%3DS.%26aulast%3DSassano%26aufirst%3DM.%2BF.%26aulast%3DShin%26aufirst%3DA.%2BI.%26aulast%3DWebster%26aufirst%3DL.%2BA.%26aulast%3DSimeons%26aufirst%3DF.%2BR.%26aulast%3DStojanovski%26aufirst%3DL.%26aulast%3DPrat%26aufirst%3DA.%26aulast%3DSeidah%26aufirst%3DN.%2BG.%26aulast%3DConstam%26aufirst%3DD.%2BB.%26aulast%3DBickerton%26aufirst%3DG.%2BR.%26aulast%3DRead%26aufirst%3DK.%2BD.%26aulast%3DWetsel%26aufirst%3DW.%2BC.%26aulast%3DGilbert%26aufirst%3DI.%2BH.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26atitle%3DAutomated%2520design%2520of%2520ligands%2520to%2520polypharmacological%2520profiles%26jtitle%3DNature%26date%3D2012%26volume%3D492%26spage%3D215%26epage%3D220%26doi%3D10.1038%2Fnature11691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">435</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1021/cn100008c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+rules%3A+the+development+of+a+central+nervous+system+multiparameter+optimization+%28CNS+MPO%29+approach+to+enable+alignment+of+druglike+properties&doi=10.1021%2Fcn100008c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lhbq3dMtt38tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520rules%253A%2520the%2520development%2520of%2520a%2520central%2520nervous%2520system%2520multiparameter%2520optimization%2520%2528CNS%2520MPO%2529%2520approach%2520to%2520enable%2520alignment%2520of%2520druglike%2520properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449%26doi%3D10.1021%2Fcn100008c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anastasio, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bubar, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stutz, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeller, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbertson, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenzweig-Lipson, S.</span></span> <span> </span><span class="NLM_article-title">Selective serotonin 5-HT(2C) receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">513</span>– <span class="NLM_lpage">523</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2011.04.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2Fj.neuropharm.2011.04.034" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=513-523&author=K.+A.+Cunninghamauthor=R.+G.+Foxauthor=N.+C.+Anastasioauthor=M.+J.+Bubarauthor=S.+J.+Stutzauthor=F.+G.+Moellerauthor=S.+R.+Gilbertsonauthor=S.+Rosenzweig-Lipson&title=Selective+serotonin+5-HT%282C%29+receptor+activation+suppresses+the+reinforcing+efficacy+of+cocaine+and+sucrose+but+differentially+affects+the+incentive-salience+value+of+cocaine-+vs.+sucrose-associated+cues&doi=10.1016%2Fj.neuropharm.2011.04.034"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2011.04.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2011.04.034%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DFox%26aufirst%3DR.%2BG.%26aulast%3DAnastasio%26aufirst%3DN.%2BC.%26aulast%3DBubar%26aufirst%3DM.%2BJ.%26aulast%3DStutz%26aufirst%3DS.%2BJ.%26aulast%3DMoeller%26aufirst%3DF.%2BG.%26aulast%3DGilbertson%26aufirst%3DS.%2BR.%26aulast%3DRosenzweig-Lipson%26aufirst%3DS.%26atitle%3DSelective%2520serotonin%25205-HT%25282C%2529%2520receptor%2520activation%2520suppresses%2520the%2520reinforcing%2520efficacy%2520of%2520cocaine%2520and%2520sucrose%2520but%2520differentially%2520affects%2520the%2520incentive-salience%2520value%2520of%2520cocaine-%2520vs.%2520sucrose-associated%2520cues%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D513%26epage%3D523%26doi%3D10.1016%2Fj.neuropharm.2011.04.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halberstadt, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Heijden, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruderman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risbrough, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingrich, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geyer, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, S. B.</span></span> <span> </span><span class="NLM_article-title">5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1958</span>– <span class="NLM_lpage">1967</span>, <span class="refDoi"> DOI: 10.1038/npp.2009.29</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1038%2Fnpp.2009.29" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=1958-1967&author=A.+L.+Halberstadtauthor=I.+van+der+Heijdenauthor=M.+A.+Rudermanauthor=V.+B.+Risbroughauthor=J.+A.+Gingrichauthor=M.+A.+Geyerauthor=S.+B.+Powell&title=5-HT%282A%29+and+5-HT%282C%29+receptors+exert+opposing+effects+on+locomotor+activity+in+mice&doi=10.1038%2Fnpp.2009.29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2009.29&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2009.29%26sid%3Dliteratum%253Aachs%26aulast%3DHalberstadt%26aufirst%3DA.%2BL.%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DI.%26aulast%3DRuderman%26aufirst%3DM.%2BA.%26aulast%3DRisbrough%26aufirst%3DV.%2BB.%26aulast%3DGingrich%26aufirst%3DJ.%2BA.%26aulast%3DGeyer%26aufirst%3DM.%2BA.%26aulast%3DPowell%26aufirst%3DS.%2BB.%26atitle%3D5-HT%25282A%2529%2520and%25205-HT%25282C%2529%2520receptors%2520exert%2520opposing%2520effects%2520on%2520locomotor%2520activity%2520in%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D1958%26epage%3D1967%26doi%3D10.1038%2Fnpp.2009.29" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, D. M.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain</span>. <i>Psychopharmacologia</i> <span class="NLM_year" style="font-weight: bold;">1975</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1007/BF00429052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1007%2FBF00429052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1215445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaE28XpvFyrug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1975&pages=139-149&author=D.+M.+Jackson&title=A+functional+effect+of+dopamine+in+the+nucleus+accumbens+and+in+some+other+dopamine-rich+parts+of+the+rat+brain&doi=10.1007%2FBF00429052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain</span></div><div class="casAuthors">Jackson, David M.; Anden, Nils E.; Dahlstrom, Annica</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacologia</span>
        (<span class="NLM_cas:date">1975</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">139-49</span>CODEN:
                <span class="NLM_cas:coden">PSYPAG</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">Dopamine HCl (I HCl) [62-31-7] (5 to 50 μg) applied bilaterally to the nucleus accumbens of reserpine-nialamide pretreated rats produced a marked dose-dependent increase in coordinated locomotor activity, devoid of stereotypes such as gnawing, rearing and licking seen after I application (50 μg) to the neostriatum.  The locomotor activity was blocked by pimozide but not by phenoxybenzamine.  The effects of apomorphine-HCl [314-19-2] or d-noradrenaline bitartrate [51-40-1] were similar to those of I.  In contrast, l-noradrenaline bitartrate [51-40-1] produced a convulsive syndrome devoid of coordinated locomotor activity, and this convulsive syndrome was blocked by phenoxybenzamine but not by pimozide.  Release of endogenous I by d [51-63-8] or 1-amphetamine sulfate [51-62-7] (10 and 50 μg) in the nucleus accumbens produced an increase in coordinated activity, the d-isomer was about 4 times as potent as the l-isomer, and the effect of the d-isomer was blocked completely by α-methyltyrosine.  Bilateral application of trifluoperazine to the nucleus accumbens completely blocked the effect of systemically administered d-amphetamine (1.5 and 3.0 mg/kg), but similar application to the area of the central nucleus of the amygdala or the neostriatum was much less effective.  Local application of metatyramine HCl [3458-98-8] (200 μg) to the nucleus accumbens resulted in a higher level of basal activity than in control animals.  Application of dopamine or noradrenaline to the area of the central nucleus of the amygdala or to the olfactory tubercles did not lead to any consistent changes in locomotor activity.  The nucleus accumbens and olfactory tubercles contained most of the I in the limbic forebrain, with noradrenaline more evenly distributed.  The nucleus accumbens may play an important role in the locomotor activity in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmGISaREaEZLVg90H21EOLACvtfcHk0ljCq3vOaBoGxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE28XpvFyrug%253D%253D&md5=a0d97f5e6fc213f81615a053c13d8d29</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2FBF00429052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00429052%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DD.%2BM.%26atitle%3DA%2520functional%2520effect%2520of%2520dopamine%2520in%2520the%2520nucleus%2520accumbens%2520and%2520in%2520some%2520other%2520dopamine-rich%2520parts%2520of%2520the%2520rat%2520brain%26jtitle%3DPsychopharmacologia%26date%3D1975%26volume%3D45%26spage%3D139%26epage%3D149%26doi%3D10.1007%2FBF00429052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lever, C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Rearing on hind legs, environmental novelty, and the hippocampal formation</span>. <i>Rev. Neurosci. (Berlin, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">133</span>, <span class="refDoi"> DOI: 10.1515/REVNEURO.2006.17.1-2.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1515%2FREVNEURO.2006.17.1-2.111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=16703946" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2006&pages=111-133&author=C.+Lever&title=Rearing+on+hind+legs%2C+environmental+novelty%2C+and+the+hippocampal+formation&doi=10.1515%2FREVNEURO.2006.17.1-2.111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1515%2FREVNEURO.2006.17.1-2.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252FREVNEURO.2006.17.1-2.111%26sid%3Dliteratum%253Aachs%26aulast%3DLever%26aufirst%3DC.%26atitle%3DRearing%2520on%2520hind%2520legs%252C%2520environmental%2520novelty%252C%2520and%2520the%2520hippocampal%2520formation%26jtitle%3DRev.%2520Neurosci.%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2006%26volume%3D17%26spage%3D111%26epage%3D133%26doi%3D10.1515%2FREVNEURO.2006.17.1-2.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummins, R. A.</span></span> <span> </span><span class="NLM_article-title">The Open-Field Test: a critical review</span>. <i>Psychol. bull.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">482</span>– <span class="NLM_lpage">504</span>, <span class="refDoi"> DOI: 10.1037/0033-2909.83.3.482</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1037%2F0033-2909.83.3.482" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=17582919" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A280%3ADC%252BD2szmvVCrsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1976&pages=482-504&author=R.+N.+Walshauthor=R.+A.+Cummins&title=The+Open-Field+Test%3A+a+critical+review&doi=10.1037%2F0033-2909.83.3.482"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The Open-Field Test: a critical review</span></div><div class="casAuthors">Walsh R N; Cummins R A</div><div class="citationInfo"><span class="NLM_cas:title">Psychological bulletin</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">482-504</span>
        ISSN:<span class="NLM_cas:issn">0033-2909</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYvoIgIf3zKFm8bhe6roZYfW6udTcc2eZDW9unYFLYn7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szmvVCrsg%253D%253D&md5=60c00d3638695d81c9a738e39a8c4b3d</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1037%2F0033-2909.83.3.482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252F0033-2909.83.3.482%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DR.%2BN.%26aulast%3DCummins%26aufirst%3DR.%2BA.%26atitle%3DThe%2520Open-Field%2520Test%253A%2520a%2520critical%2520review%26jtitle%3DPsychol.%2520bull.%26date%3D1976%26volume%3D83%26spage%3D482%26epage%3D504%26doi%3D10.1037%2F0033-2909.83.3.482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice</span>. <i>Psychopharmacology (Berlin, Ger.)</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">256</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1007/s00213-004-1944-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1007%2Fs00213-004-1944-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=15290006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVyltLrM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2005&pages=256-263&author=J.+Wu&title=Bimodal+effects+of+MK-801+on+locomotion+and+stereotypy+in+C57BL%2F6+mice&doi=10.1007%2Fs00213-004-1944-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice</span></div><div class="casAuthors">Wu, Jinhua; Zou, Hong; Strong, Judith A.; Yu, Jun; Zhou, Xuedong; Xie, Qinglian; Zhao, Guoping; Jin, Meilei; Yu, Lei</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">256-263</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Systemic injection of the non-competitive NMDA (N-methyl-D-aspartate:) receptor antagonist MK-801 (dizocilpine maleate) causes both increased locomotion in rodents and various stereotypic behaviors that are proposed to model certain aspects of schizophrenic symptoms in humans.  This study presents a comprehensive characterization of the bimodal effects of MK-801 on locomotion and stereotypy in the C57BL/6 mouse strain, a strain commonly used for genetically modified mice.  We found that it is important to analyze both locomotion and stereotypy in parallel, as MK-801-induced stereotypy results in abnormal movements that are recorded as locomotion by automated beam detection systems.  Furthermore, it is important to analyze the bimodal effects of MK-801 over an extended time span, rather than the commonly used narrower time window, as at higher doses (e.g., above 0.3 mg/kg) the hyperlocomotion phase develops only after the stereotypic phase subsides.  We also obsd. that the apparent dose-response curve is very sensitive to the particular time window chosen for anal. because MK-801 affects both the time course and max. value of stimulated locomotion.  We show that analyzing the abs. peak value of locomotion induced for each animal, rather than group-averaged time courses, provides a measure that is sensitive over a wider range of MK-801 doses.  Interestingly, MK-801 even at a very low dose of 0.02 mg/kg suppressed rather than enhanced rearing behavior, differing in this regard from amphetamine.  The non-competitive NMDA receptor antagonist MK-801 induces a complex pattern of behavioral modification in mice with respect to both the time course and the dose-response relation of behavioral changes.  The results of this study provide a foundation and frame of ref. for the growing interest in studying MK-801-induced behavior in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0W0Mdl64ciLVg90H21EOLACvtfcHk0li8OF_LUlUi7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVyltLrM&md5=66981daa6134177f1544fcebfa898403</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs00213-004-1944-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-004-1944-1%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DJ.%26atitle%3DBimodal%2520effects%2520of%2520MK-801%2520on%2520locomotion%2520and%2520stereotypy%2520in%2520C57BL%252F6%2520mice%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2005%26volume%3D177%26spage%3D256%26epage%3D263%26doi%3D10.1007%2Fs00213-004-1944-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colpaert, F. C.</span></span> <span> </span><span class="NLM_article-title">Drug discrimination in neurobiology</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">337</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1016/S0091-3057(99)00047-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2FS0091-3057%2899%2900047-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=1999&pages=337-345&author=F.+C.+Colpaert&title=Drug+discrimination+in+neurobiology&doi=10.1016%2FS0091-3057%2899%2900047-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2FS0091-3057%2899%2900047-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0091-3057%252899%252900047-7%26sid%3Dliteratum%253Aachs%26aulast%3DColpaert%26aufirst%3DF.%2BC.%26atitle%3DDrug%2520discrimination%2520in%2520neurobiology%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1999%26volume%3D64%26spage%3D337%26epage%3D345%26doi%3D10.1016%2FS0091-3057%2899%2900047-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Appel, J. B.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">The use of drug discrimination procedures to characterize hallucinogenic drug actions</span>. <i>Psychopharmacol. Bull.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">959</span>– <span class="NLM_lpage">967</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=3797596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaL2sXislahsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1986&pages=959-967&author=J.+B.+Appel&title=The+use+of+drug+discrimination+procedures+to+characterize+hallucinogenic+drug+actions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">The use of drug discrimination procedures to characterize hallucinogenic drug actions</span></div><div class="casAuthors">Appel, James B.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology Bulletin</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">959-67</span>CODEN:
                <span class="NLM_cas:coden">PSYBB9</span>;
        ISSN:<span class="NLM_cas:issn">0048-5764</span>.
    </div><div class="casAbstract">A review with 35 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquiDKeSuOAzrVg90H21EOLACvtfcHk0li8OF_LUlUi7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXislahsA%253D%253D&md5=08d9d6869e62031169377bfaa522700f</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAppel%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520use%2520of%2520drug%2520discrimination%2520procedures%2520to%2520characterize%2520hallucinogenic%2520drug%2520actions%26jtitle%3DPsychopharmacol.%2520Bull.%26date%3D1986%26volume%3D22%26spage%3D959%26epage%3D967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Negus, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, M. L.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic—pharmacodynamic (PKPD) analysis with drug discrimination</span>. <i>Curr. Top. Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>, <span class="refDoi"> DOI: 10.1007/7854_2016_36</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1007%2F7854_2016_36" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=27571746" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=S.+S.+Negusauthor=M.+L.+Banks&title=Pharmacokinetic%E2%80%94pharmacodynamic+%28PKPD%29+analysis+with+drug+discrimination&doi=10.1007%2F7854_2016_36"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1007%2F7854_2016_36&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F7854_2016_36%26sid%3Dliteratum%253Aachs%26aulast%3DNegus%26aufirst%3DS.%2BS.%26aulast%3DBanks%26aufirst%3DM.%2BL.%26atitle%3DPharmacokinetic%25E2%2580%2594pharmacodynamic%2520%2528PKPD%2529%2520analysis%2520with%2520drug%2520discrimination%26jtitle%3DCurr.%2520Top.%2520Behav.%2520Neurosci.%26date%3D2016%26doi%3D10.1007%2F7854_2016_36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filip, M.</span></span> <span> </span><span class="NLM_article-title">Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin(2C) (5-HT(2C)) receptors in rat prefrontal cortex</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>306</i></span>,  <span class="NLM_fpage">734</span>– <span class="NLM_lpage">743</span>, <span class="refDoi"> DOI: 10.1124/jpet.102.045716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1124%2Fjpet.102.045716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=12721337" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlslGlu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=306&publication_year=2003&pages=734-743&author=M.+Filip&title=Hyperlocomotive+and+discriminative+stimulus+effects+of+cocaine+are+under+the+control+of+serotonin%282C%29+%285-HT%282C%29%29+receptors+in+rat+prefrontal+cortex&doi=10.1124%2Fjpet.102.045716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Hyperlocomotive and discriminative stimulus effects of cocaine are under the control of serotonin2C (5-HT2C) receptors in rat prefrontal cortex</span></div><div class="casAuthors">Filip, Malgorzata; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">306</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">734-743</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The serotonin2C (5-hydroxytryptamine2C; 5-HT2C) receptor (5-HT2CR) is found in abundance in dopamine (DA) mesocorticolimbic pathways and is one of the important target proteins that modulates the behavioral effects of cocaine.  In the present study, the hypothesis was tested that the 5-HT2CR in the prefrontal cortex (PFC) may control either spontaneous or cocaine-evoked locomotor activity as well as the discriminative stimulus properties of cocaine.  In male Sprague-Dawley rats implanted with bilateral cannulae aimed at the PFC, local microinjections of the preferential 5-HT2CR agonist 6-chloro-2-(1-piperazinyl)pyrazine hydrochloride (MK 212) (0.05-0.5 μg/side) did not alter spontaneous activity, but dose-dependently decreased horizontal hyperactivity evoked by cocaine (10 mg/kg i.p.).  Given alone, the selective 5-HT2CR antagonist 8-5-[2,4-dimethoxy-5-(4-trifluorophenylsulfonamido)phenyl-5-oxopentyl]-1,3,8-triazo-spiro[4.5]decane-2,4-dione hydrochloride (RS 102221) (5 μg/side) increased basal locomotor activity of rats expressed in the vertical plane.  Microinjections of RS 102221 (5 μg/side, but not 0.15-1.5 μg/side) significantly enhanced the horizontal activity induced by cocaine (10 mg/kg).  In rats trained to discriminate cocaine (10 mg/kg i.p.) from saline (i.p.) in a two-lever, water-reinforced fixed ratio 20 task, intra-PFC microinjections of MK 212 (0.05 and 0.5 μg/side) did not substitute for cocaine, but attenuated the stimulus effects of cocaine.  However, intra-PFC microinjections of RS 102221 (1.5 and 5 μg/side) evoked 13 and 40% cocaine-lever responding when tested alone and enhanced the recognition of cocaine.  These data indicate that the PFC is a brain site at which the 5-HT2CR exerts an inhibitory control over the hyperactive and discriminative stimulus effects of cocaine known to be dependent upon activation of the DA mesoaccumbens circuit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrb_926Wi6DpbVg90H21EOLACvtfcHk0li8OF_LUlUi7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlslGlu7k%253D&md5=32e74280183a2de46da0722986839325</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.045716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.045716%26sid%3Dliteratum%253Aachs%26aulast%3DFilip%26aufirst%3DM.%26atitle%3DHyperlocomotive%2520and%2520discriminative%2520stimulus%2520effects%2520of%2520cocaine%2520are%2520under%2520the%2520control%2520of%2520serotonin%25282C%2529%2520%25285-HT%25282C%2529%2529%2520receptors%2520in%2520rat%2520prefrontal%2520cortex%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2003%26volume%3D306%26spage%3D734%26epage%3D743%26doi%3D10.1124%2Fjpet.102.045716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCreary, A. C.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discriminative stimulus properties of (/-)-fenfluramine: the role of 5-HT2 receptor subtypes</span>. <i>Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>117</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1037/0735-7044.117.2.212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1037%2F0735-7044.117.2.212" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=2003&pages=212-221&author=A.+C.+McCreary&title=Discriminative+stimulus+properties+of+%28%2F-%29-fenfluramine%3A+the+role+of+5-HT2+receptor+subtypes&doi=10.1037%2F0735-7044.117.2.212"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1037%2F0735-7044.117.2.212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252F0735-7044.117.2.212%26sid%3Dliteratum%253Aachs%26aulast%3DMcCreary%26aufirst%3DA.%2BC.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520%2528%252F-%2529-fenfluramine%253A%2520the%2520role%2520of%25205-HT2%2520receptor%2520subtypes%26jtitle%3DBehav.%2520Neurosci.%26date%3D2003%26volume%3D117%26spage%3D212%26epage%3D221%26doi%3D10.1037%2F0735-7044.117.2.212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
La Garza, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Detailed investigations of 5-HT3 compounds in a drug discrimination model</span>. <i>Pharmacol., Biochem. Behav.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">533</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1016/0091-3057(95)02207-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2F0091-3057%2895%2902207-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1996&pages=533-540&author=R.+De%0ALa+Garzaauthor=P.+M.+Callahanauthor=K.+A.+Cunningham&title=Detailed+investigations+of+5-HT3+compounds+in+a+drug+discrimination+model&doi=10.1016%2F0091-3057%2895%2902207-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2F0091-3057%2895%2902207-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0091-3057%252895%252902207-4%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BLa%2BGarza%26aufirst%3DR.%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DDetailed%2520investigations%2520of%25205-HT3%2520compounds%2520in%2520a%2520drug%2520discrimination%2520model%26jtitle%3DPharmacol.%252C%2520Biochem.%2520Behav.%26date%3D1996%26volume%3D54%26spage%3D533%26epage%3D540%26doi%3D10.1016%2F0091-3057%2895%2902207-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT): implications for understanding the actions of novel anxiolytics</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">29</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(87)90333-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2F0014-2999%2887%2990333-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=2887435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaL2sXlt1Kqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=1987&pages=29-36&author=K.+A.+Cunningham&title=Discriminative+stimulus+properties+of+8-hydroxy-2-%28di-n-propylamino%29tetralin+%288-OHDPAT%29%3A+implications+for+understanding+the+actions+of+novel+anxiolytics&doi=10.1016%2F0014-2999%2887%2990333-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT):  implications for understanding the actions of novel anxiolytics</span></div><div class="casAuthors">Cunningham, Kathryn A.; Callahan, Patrick M.; Appel, James B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">29-36</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">8-Hydroxy-2-(di-n-propylamino)tetralin (8-OHDPAT) has effects both characteristic of a serotonin (5-hydroxytryptamine; 5-HT) agonist and antagonist.  To investigate the mechanism(s) of action of 8-OHDPAT in vivo, rats were trained to discriminate 8-OHDPAT (0.4 mg/kg) from saline and given various neuroactive compds. during substitution test sessions.  Of the 5-HT agonists tested, d-lysergic acid diethylamide, 5-methoxy-n,n-dimethyltryptamine, quipazine, Ru 24969 and 1-(m-trifluoromethylphenyl)piperazine did not mimic the training drug; the dopamine agonists apomorphine and SKF 38393 as well as the α2-adrenoceptor agonist clonidine engendered predominantly saline-lever responding.  However, the novel anxiolytics buspirone and ipsapirone as well as the ergot deriv. lisuride substituted completely for 8-OHDPAT.  In combination tests, 5-HT (ketanserin, metergoline, methysergide, pirenperone), dopamine (haloperidol) and norepinephrine antagonists (prazosin, propranolol) failed to attenuate the 8-OHDPAT cue.  The similar stimulus properties of 8-OHDPAT and the novel anxiolytics (buspirone, ipsapirone) are mirrored by the common abilities of these agents to selectively inhibit 5-HT1A binding and release punished responding.  Thus, the subpopulation of 5-HT1A receptors may mediate the behavioral effects of these compds. in animals and, in turn, the anxiolytic effects of buspirone and ipsapirone in humans.  Although not primarily selective for 5-HT, lisuride may also mimic 8-OHDPAT by direct or indirect stimulation of 5-HT1A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwKhx2jaMKr7Vg90H21EOLACvtfcHk0liGVp-V7oDnog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXlt1Kqt7c%253D&md5=43d7ba8b67098e39f738db0cc9e69d75</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2887%2990333-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252887%252990333-5%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%25208-hydroxy-2-%2528di-n-propylamino%2529tetralin%2520%25288-OHDPAT%2529%253A%2520implications%2520for%2520understanding%2520the%2520actions%2520of%2520novel%2520anxiolytics%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1987%26volume%3D138%26spage%3D29%26epage%3D36%26doi%3D10.1016%2F0014-2999%2887%2990333-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>274</i></span>,  <span class="NLM_fpage">1414</span>– <span class="NLM_lpage">1424</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=7562516" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaK2MXot1yjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1995&pages=1414-1424&author=P.+M.+Callahanauthor=K.+A.+Cunningham&title=Modulation+of+the+discriminative+stimulus+properties+of+cocaine+by+5-HT1B+and+5-HT2C+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors</span></div><div class="casAuthors">Callahan, Patrick M.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">274</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1414-24</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">The present study assessed compds. displaying affinity for 5-HT1A, 5-HT1B, 5-HT2A and 5-HT2C receptors for their ability to substitute for, enhance or antagonize the discriminative stimulus effects of cocaine (10 mg/kg) in rats.  In substitution tests, the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT; 0.2-1.6 mg/kg), the 5-HT1A/B receptor agonists RU 24969 (0.25-2 mg/kg) and CGS 12066B (2-16 mg/kg), the 5-HT1B/2C receptor agonists m-chlorophenylpiperazine (mCPP; 0.25-2 mg/kg) and m-trifluoromethylphenylpiperazine (TFMPP; 0.125-2 mg/kg), the 5-HT2A/2C receptor agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane ([±]-DOB; 0.0625-0.5 mg/kg), the 5-HT2C receptor agonist MK 212 (0.25-1 mg/kg) and the nonselective 5-HT receptor agonist quipazine (1-8 mg/kg) engendered 30% to 70% cocaine-appropriate responding.  The DA receptor antagonists SCH 23390 (0.025 or 0.05 mg/kg) and haloperidol (0.125 or 0.25 mg/kg) failed to block the partial substitution of RU 24969 (1mg/kg) for cocaine.  In combination tests, a fixed dose of either quipazine (4 mg/kg), RU 24969 (0.25, 0.5 or 1 mg/kg) or TFMPP (0.5 mg/kg) but not 8-OH-DPAT (0.4 mg/kg) or CGS 12066B (16 mg/kg) produced a leftward shift in the cocaine dose-response curve (0.625-5 mg/kg).  In contrast, coadministration of either mCPP (0.25-2 mg/kg) or MK 212 (0.125-2 mg/kg) plus a dose of cocaine (5 mg/kg) that produced >85% cocaine-appropriate responding when given alone partially antagonized cocaine; mCPP (1 mg/kg) also produced a rightward shift in the cocaine dose-response curve.  Neither 8-OH-DPAT (0.2-1.6 mg/kg), (±)-DOB (0.125-0.5 mg/kg) nor quipazine (2-8 mg/kg) blocked the cocaine stimulus.  The 5-HT1A receptor antagonist NAN 190 (0.2-0.8 mg/kg), the 5-HT2A/2C receptor antagonist LY 53857 (0.5-4 mg/kg) and the 5-HT/DA receptor antagonist pirenperone (0.5-4 mg/kg) neither substituted for not enhanced cocaine; however, pirenperone but not NAN 190 or LY 53857 partially blocked the cocaine (10 mg/kg) response.  Although 5-HT receptor compds. do not substitute for cocaine, several 5-HT receptor agonists (i.e., the indole deriv. RU 24969 and the arylpiperazines mCPP, MK 212, TFMPP and quipazine), but not antagonists, differentially modulate the stimulus effects of cocaine.  Moreover, 5-HT1B and 5-HT2C receptors may be responsible for the obsd. enhancements and antagonisms, resp., produced by the 5-HT receptor compds., whereas 5-HT1A and 5-HT2A receptors do not appear to modulate the cocaine discrimination in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosQbq4pssZw7Vg90H21EOLACvtfcHk0liGVp-V7oDnog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXot1yjtrc%253D&md5=44ab623964643e18eefc06f6e1d3e4ae</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DModulation%2520of%2520the%2520discriminative%2520stimulus%2520properties%2520of%2520cocaine%2520by%25205-HT1B%2520and%25205-HT2C%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1995%26volume%3D274%26spage%3D1414%26epage%3D1424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP)</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>257</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">38</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(94)90690-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2F0014-2999%2894%2990690-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=8082704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaK2cXkt1Kktrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=257&publication_year=1994&pages=27-38&author=P.+M.+Callahanauthor=K.+A.+Cunningham&title=Involvement+of+5-HT2C+receptors+in+mediating+the+discriminative+stimulus+properties+of+m-chlorophenylpiperazine+%28mCPP%29&doi=10.1016%2F0014-2999%2894%2990690-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP)</span></div><div class="casAuthors">Callahan, Patrick M.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">257</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">27-38</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Rats were trained to discriminate the 5-HT receptor agonist m-chlorophenylpiperazine (mCPP; 1 mg/kg) from saline using a two-lever, water-reinforced drug discrimination task.  The antidepressant trazodone (1-8 mg/kg), the 5-HT1B/2C receptor agonists 1-(m-trifluoromethylphenyl)piperazine (TFMPP; 0.25-1 mg/kg) and MK 212 (0.125-1 mg/kg), and the mixed 5-HT1A/B receptor agonist RU 24969 (0.25-2 mg/kg) substituted fully for mCPP.  The 5-HT2A/2C receptor agonists 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI; 0.25-1 mg/kg) and d-lysergic acid diethylamide (LSD; 0.02-0.08 mg/kg) and the 5-HT releaser fenfluramine (0.5-2 mg/kg) also mimicked mCPP.  Agonists selective for the 5-HT1A or 5-HT3 receptor or the 5-HT reuptake site produced saline-lever responding.  The ergoline deriv. mesulergine (0.5-4 mg/kg) produced a partial agonist/antagonist profile.  The 5-HT1/2 receptor antagonist metergoline (0.125-1 mg/kg) completely blocked the mCPP cue whereas the 5-HT2A/2C receptor antagonists ketanserin and LY 53857 as well as all other 5-HT receptor antagonists failed to block the mCPP cue.  The dopamine receptor antagonists SCH 23390 and haloperidol were also ineffective mCPP antagonists.  Following pretreatment with the 5-HT synthesis inhibitor p-chlorophenylalanine (pCPA; 100 mg/kg/day) for 3 consecutive days, the discriminability of low doses of mCPP increased, whereas the effects of fenfluramine decreased.  The present results suggest that the discriminative stimulus effects of mCPP in rats are mediated primarily by postsynaptic 5-HT2C receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrebmnBj2zsK7Vg90H21EOLACvtfcHk0liGVp-V7oDnog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkt1Kktrk%253D&md5=98623ad672842986facfc5cf3fa0a345</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2990690-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252990690-4%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DInvolvement%2520of%25205-HT2C%2520receptors%2520in%2520mediating%2520the%2520discriminative%2520stimulus%2520properties%2520of%2520m-chlorophenylpiperazine%2520%2528mCPP%2529%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D257%26spage%3D27%26epage%3D38%26doi%3D10.1016%2F0014-2999%2894%2990690-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Discriminative stimulus properties of clonidine: substitution by ergot derivatives</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>119</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">229</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(85)90299-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2F0014-2999%2885%2990299-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=2868902" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADyaL28XotF2jtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1985&pages=225-229&author=K.+A.+Cunningham&title=Discriminative+stimulus+properties+of+clonidine%3A+substitution+by+ergot+derivatives&doi=10.1016%2F0014-2999%2885%2990299-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discriminative stimulus properties of clonidine:  substitution by ergot derivatives</span></div><div class="casAuthors">Cunningham, Kathryn A.; Callahan, Patrick M.; Craigmyle, Nancy A.; Appel, James B.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">225-9</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Bromocriptine mesylate  [22260-51-1], lergotrile mesylate  [51473-23-5], and lisuride hydrogen maleate  [19875-60-6] but not apomorphine  [58-00-4], ergonovine maleate  [129-51-1], or LSD  [50-37-3] mimicked clonidine  [4205-90-7] in rats trained to discriminate this compd. (0.02 mg/kg) from saline.  BC 105 maleate  [24359-22-6], ketanserin tartrate  [83846-83-7] and haloperidol  [52-86-8] failed to block the clonidine cue.  Yohimbine  [146-48-5] was an effective antagonist of clonidine but not of the lisuride substitution for clonidine.  Since dopamine does not appear to be involved in the stimulus effects of clonidine, the behavioral similarities between clonidine and some ergots may be related to α-adrenoceptor stimulation; however, the role of blood pressure changes in the stimulus effects of all of these compds. should not be overlooked.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaVjl8mnDOi7Vg90H21EOLACvtfcHk0lhdWVpvnzu7Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XotF2jtg%253D%253D&md5=59cde0c564026acc10f30927555ee473</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2885%2990299-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252885%252990299-7%26sid%3Dliteratum%253Aachs%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DDiscriminative%2520stimulus%2520properties%2520of%2520clonidine%253A%2520substitution%2520by%2520ergot%2520derivatives%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1985%26volume%3D119%26spage%3D225%26epage%3D229%26doi%3D10.1016%2F0014-2999%2885%2990299-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">m-Chlorophenylpiperazine (mCPP) modulates the discriminative stimulus effects of cocaine through actions at the 5-HT2C receptor</span>. <i>Behav. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>118</i></span>,  <span class="NLM_fpage">157</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1037/0735-7044.118.1.157</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1037%2F0735-7044.118.1.157" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=14979792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitVyqtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2004&pages=157-162&author=P.+S.+Frankelauthor=K.+A.+Cunningham&title=m-Chlorophenylpiperazine+%28mCPP%29+modulates+the+discriminative+stimulus+effects+of+cocaine+through+actions+at+the+5-HT2C+receptor&doi=10.1037%2F0735-7044.118.1.157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">m-Chlorophenylpiperazine (mCPP) modulates the discriminative stimulus effects of cocaine through actions at the 5-HT2C receptor</span></div><div class="casAuthors">Frankel, Paul S.; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">Behavioral Neuroscience</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">118</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">157-162</span>CODEN:
                <span class="NLM_cas:coden">BENEDJ</span>;
        ISSN:<span class="NLM_cas:issn">0735-7044</span>.
    
            (<span class="NLM_cas:orgname">American Psychological Association</span>)
        </div><div class="casAbstract">Agonists acting at the serotonin-1B receptor (5-HT1BR) and 5-HT2CR have been reported to potentiate and block, resp., the discriminative stimulus effects of cocaine.  The present investigation reassessed the antagonistic effects of the mixed 5-HT2C/1BR agonist m-chlorophenylpiperazine (mCPP) on the discriminative stimulus effects of cocaine in the presence or absence of selective antagonism of the 5-HT1BR or 5-HT2CR.  The stimulus effects of cocaine were attenuated by mCPP at doses that reduced response rates.  The selective 5-HT2CR antagonist SB 242084, but not the selective 5-HT1BR antagonist GR 127935, reversed the mCPP-evoked attenuation of the cocaine cue and the suppression of response rates.  These results demonstrate that the suppressive effects of mCPP on cocaine discrimination are related to stimulation of the 5-HT2CR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq822S6caSBpLVg90H21EOLACvtfcHk0lhdWVpvnzu7Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitVyqtb0%253D&md5=6c61e7a449610957fc9c819edec93d4c</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1037%2F0735-7044.118.1.157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1037%252F0735-7044.118.1.157%26sid%3Dliteratum%253Aachs%26aulast%3DFrankel%26aufirst%3DP.%2BS.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3Dm-Chlorophenylpiperazine%2520%2528mCPP%2529%2520modulates%2520the%2520discriminative%2520stimulus%2520effects%2520of%2520cocaine%2520through%2520actions%2520at%2520the%25205-HT2C%2520receptor%26jtitle%3DBehav.%2520Neurosci.%26date%3D2004%26volume%3D118%26spage%3D157%26epage%3D162%26doi%3D10.1037%2F0735-7044.118.1.157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span> <span> </span><span class="NLM_article-title">Modulation of the discriminative stimulus properties of cocaine: comparison of the effects of fluoxetine with 5-HT1A and 5-HT1B receptor agonists</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">381</span>, <span class="refDoi"> DOI: 10.1016/S0028-3908(97)00010-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1016%2FS0028-3908%2897%2900010-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1997&pages=373-381&author=P.+M.+Callahanauthor=K.+A.+Cunningham&title=Modulation+of+the+discriminative+stimulus+properties+of+cocaine%3A+comparison+of+the+effects+of+fluoxetine+with+5-HT1A+and+5-HT1B+receptor+agonists&doi=10.1016%2FS0028-3908%2897%2900010-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2FS0028-3908%2897%2900010-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0028-3908%252897%252900010-5%26sid%3Dliteratum%253Aachs%26aulast%3DCallahan%26aufirst%3DP.%2BM.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26atitle%3DModulation%2520of%2520the%2520discriminative%2520stimulus%2520properties%2520of%2520cocaine%253A%2520comparison%2520of%2520the%2520effects%2520of%2520fluoxetine%2520with%25205-HT1A%2520and%25205-HT1B%2520receptor%2520agonists%26jtitle%3DNeuropharmacology%26date%3D1997%26volume%3D36%26spage%3D373%26epage%3D381%26doi%3D10.1016%2FS0028-3908%2897%2900010-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glennon, R. A.</span>; <span class="NLM_string-name">Young, R.</span></span> <span> </span><span class="NLM_article-title">Drug Discrimination and Development of Novel Agents and Pharmacological Tools</span>. In  <i>Drug Discrimination: Applications to Medicinal Chemistry and Drug Discovery</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glennon, R. A.</span>, <span class="NLM_string-name">Young, R.</span></span>, Eds.; <span class="NLM_publisher-name">John Wiley and Sons</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>, <span class="NLM_year">2011</span>; pp  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">238</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1002%2F9781118023150.ch7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=217-238&author=R.+A.+Glennon&author=R.+Youngauthor=R.+A.+Glennon&author=R.+Young&title=Drug+Discrimination%3A+Applications+to+Medicinal+Chemistry+and+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1002%2F9781118023150.ch7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118023150.ch7%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DDrug%2520Discrimination%2520and%2520Development%2520of%2520Novel%2520Agents%2520and%2520Pharmacological%2520Tools%26btitle%3DDrug%2520Discrimination%253A%2520Applications%2520to%2520Medicinal%2520Chemistry%2520and%2520Drug%2520Discovery%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26pub%3DJohn%2520Wiley%2520and%2520Sons%26date%3D2011%26spage%3D217%26epage%3D238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neelakantan, H.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">Lorcaserin suppresses oxycodone self-administration and relapse vulnerability in rats</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1065</span>– <span class="NLM_lpage">1073</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00413</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00413" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1Klt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1065-1073&author=H.+Neelakantan&title=Lorcaserin+suppresses+oxycodone+self-administration+and+relapse+vulnerability+in+rats&doi=10.1021%2Facschemneuro.6b00413"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Lorcaserin Suppresses Oxycodone Self-Administration and Relapse Vulnerability in Rats</span></div><div class="casAuthors">Neelakantan, Harshini; Holliday, Erica D.; Fox, Robert G.; Stutz, Sonja J.; Comer, Sandra D.; Haney, Margaret; Anastasio, Noelle C.; Moeller, F. Gerard; Cunningham, Kathryn A.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1065-1073</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Opioid use disorder (OUD) is a major public health problem.  High relapse rates and poor treatment retention continue to pose major challenges in OUD treatment.  Of the abused opioids, oxycodone is well described to maintain self-administration and evoke the durable conditioned responses ("cue reactivity") that result from pairing of opioid-related stimuli (e.g., paraphernalia) with repeated abuse.  Serotonin (5-HT) neurotransmission, particularly through the 5-HT2C receptor (5-HT2CR), regulates psychostimulant reward and cue reactivity, and in the present expts., the authors investigated the hypothesis that the selective 5-HT2CR agonist lorcaserin, which is FDA-approved for the treatment of obesity, will suppress oxycodone self-administration and oxycodone-assocd. cue reactivity in rats.  The authors found that lorcaserin inhibited oxycodone intake, an effect blocked by the selective 5-HT2CR antagonist SB242084.  Lorcaserin also decreased responding for the discrete cue complex ("cue reactivity") previously assocd. with delivery of oxycodone (i.e., stimulus lights, infusion pump sounds) in both abstinence and extinction-reinstatement models.  The selected dose range of lorcaserin (0.25-1 mg/kg) does not overtly alter spontaneous behaviors nor operant responding on inactive levers in the present study.  Taken together, the ability of lorcaserin to reduce the oxycodone self-administration and decrease cue reactivity assocd. with relapse highlights the therapeutic potential for lorcaserin in the treatment of OUD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmhGr8KOEwb7Vg90H21EOLACvtfcHk0lhdWVpvnzu7Ag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1Klt7k%253D&md5=e67d9cd3074b5ea47b43d870b34e12b7</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00413%26sid%3Dliteratum%253Aachs%26aulast%3DNeelakantan%26aufirst%3DH.%26atitle%3DLorcaserin%2520suppresses%2520oxycodone%2520self-administration%2520and%2520relapse%2520vulnerability%2520in%2520rats%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D1065%26epage%3D1073%26doi%3D10.1021%2Facschemneuro.6b00413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miller, W. R.</span></span><span class="NLM_etal"></span> <span> </span><span class="NLM_article-title">PPARγ agonism attenuates cocaine cue reactivity</span>. <i>Addict. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1111/adb.12471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1111%2Fadb.12471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=27862692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKgtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=55-68&author=W.+R.+Miller&title=PPAR%CE%B3+agonism+attenuates+cocaine+cue+reactivity&doi=10.1111%2Fadb.12471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">PPARγ agonism attenuates cocaine cue reactivity</span></div><div class="casAuthors">Miller, William R.; Fox, Robert G.; Stutz, Sonja J.; Lane, Scott D.; Denner, Larry; Cunningham, Kathryn A.; Dineley, Kelly T.</div><div class="citationInfo"><span class="NLM_cas:title">Addiction Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-68</span>CODEN:
                <span class="NLM_cas:coden">ADBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1369-1600</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Cocaine use disorder is a chronic relapsing condition characterized by compulsive drug seeking and taking even after prolonged abstinence periods.  Subsequent exposure to drug-assocd. cues can promote intense craving and lead to relapse in abstinent humans and rodent models.  The responsiveness to these cocaine-related cues, or 'cue reactivity', can trigger relapse and cocaine-seeking behaviors; cue reactivity is measurable in cocaine-dependent humans as well as rodent models.  Cue reactivity is thought to be predictive of cocaine craving and relapse.  Here we report that PPARγ agonism during abstinence from cocaine self-administration reduced previously active lever pressing in Sprague Dawley rats during cue-reactivity tests, while administration of the PPARγ antagonist, GW9662, reversed this effect.  PPARγ agonism also normalized nuclear ERK activity in the medial prefrontal cortex and hippocampus which was reversed with GW9662.  Our results support the utility of PPARγ agonism as a relapse prevention strategy to maintain abstinence in the presence of cocaine-assocd. cues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp62oUcpb-5_7Vg90H21EOLACvtfcHk0lhQ7Ul1ObruQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKgtLg%253D&md5=a207ac0847d2f1512b42b7166357ebb7</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1111%2Fadb.12471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fadb.12471%26sid%3Dliteratum%253Aachs%26aulast%3DMiller%26aufirst%3DW.%2BR.%26atitle%3DPPAR%25CE%25B3%2520agonism%2520attenuates%2520cocaine%2520cue%2520reactivity%26jtitle%3DAddict.%2520Biol.%26date%3D2018%26volume%3D23%26spage%3D55%26epage%3D68%26doi%3D10.1111%2Fadb.12471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grottick, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higgins, G. A.</span></span> <span> </span><span class="NLM_article-title">Studies to investigate the role of 5-HT2C receptors on cocaine- and food-maintained behavior</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>295</i></span>,  <span class="NLM_fpage">1183</span>– <span class="NLM_lpage">1191</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=11082456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BD3cXosVKisb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=295&publication_year=2000&pages=1183-1191&author=A.+J.+Grottickauthor=P.+J.+Fletcherauthor=G.+A.+Higgins&title=Studies+to+investigate+the+role+of+5-HT2C+receptors+on+cocaine-+and+food-maintained+behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Studies to investigate the role of 5-HT2C receptors on cocaine- and food-maintained behavior</span></div><div class="casAuthors">Grottick, Andrew J.; Fletcher, Paul J.; Higgins, Guy A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">295</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1183-1191</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The present series of studies were designed to investigate the 5-HT2C receptor agonist Ro 60-0175 on cocaine- and food-maintained behavior in the rat.  Ro 60-0175 (0.1-3 mg/kg, s.c.) reduced cocaine (15 mg/kg, i.p.)-induced hyperactivity.  This inhibitory effect of Ro 60-0175 (1 mg/kg, s.c.) was completely blocked by pretreatment with the selective 5-HT2C antagonist SB 242,084 (0.5 mg/kg, i.p.).  In further studies, Ro 60-0175 (1-3 mg/kg, s.c.) reduced responding for both food (45-mg Noyes pellet) and cocaine (0.25 mg/infusion) maintained under identical schedules of reinforcement (fixed ratio (5), time out 1 min, 60-min duration).  The effect on food-maintained responding was blocked by SB 242,084 (0.5 mg/kg, i.p.).  Ro 60-0175 (0.3-3 mg/kg, s.c.) also reduced the breakpoint for cocaine self-administration under a progressive ratio schedule of reinforcement.  After a period of extinction training, where cocaine soln. was substituted with saline, an acute priming injection of cocaine (15 mg/kg, i.p.) but not Ro 60-0175 (1 mg/kg, s.c.) reinstated cocaine responding.  In this model of relapse, Ro 60-0175 (1-3 mg/kg, s.c.) pretreatment attenuated the priming effect of acute cocaine injection.  In a final series of studies to examine the cataleptogenic properties of Ro 60-0175, very mild indexes of catalepsy were obsd. at the 3 mg/kg dose only.  These catalepsy scores were significantly lower than that produced by haloperidol (0.5 mg/kg, s.c.).  In further tests of motor function using the Rotarod, deficits were again seen at the 3 mg/kg dose, but not at lower doses.  Taken together, these studies suggest that, in addn. to reducing food intake, 5-HT2C receptor agonists reduce cocaine-reinforced behavior.  This would be consistent with electrophysiol. and biochem. evidence suggesting an important modulatory influence of 5-HT2C receptor activation on mesolimbic dopamine function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD1ztgAEhZKrVg90H21EOLACvtfcHk0lhQ7Ul1ObruQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXosVKisb0%253D&md5=b0566e8a98afb4bc610a54456cf808ef</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrottick%26aufirst%3DA.%2BJ.%26aulast%3DFletcher%26aufirst%3DP.%2BJ.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26atitle%3DStudies%2520to%2520investigate%2520the%2520role%2520of%25205-HT2C%2520receptors%2520on%2520cocaine-%2520and%2520food-maintained%2520behavior%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2000%26volume%3D295%26spage%3D1183%26epage%3D1191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Neisewander, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Acosta, J. I.</span></span> <span> </span><span class="NLM_article-title">Stimulation of 5-HT2C receptors attenuates cue and cocaine-primed reinstatement of cocaine-seeking behavior in rats</span>. <i>Behav. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">791</span>– <span class="NLM_lpage">800</span>, <span class="refDoi"> DOI: 10.1097/FBP.0b013e3282f1c94b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1097%2FFBP.0b013e3282f1c94b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=791-800&author=J.+L.+Neisewanderauthor=J.+I.+Acosta&title=Stimulation+of+5-HT2C+receptors+attenuates+cue+and+cocaine-primed+reinstatement+of+cocaine-seeking+behavior+in+rats&doi=10.1097%2FFBP.0b013e3282f1c94b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1097%2FFBP.0b013e3282f1c94b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FFBP.0b013e3282f1c94b%26sid%3Dliteratum%253Aachs%26aulast%3DNeisewander%26aufirst%3DJ.%2BL.%26aulast%3DAcosta%26aufirst%3DJ.%2BI.%26atitle%3DStimulation%2520of%25205-HT2C%2520receptors%2520attenuates%2520cue%2520and%2520cocaine-primed%2520reinstatement%2520of%2520cocaine-seeking%2520behavior%2520in%2520rats%26jtitle%3DBehav.%2520Pharmacol.%26date%3D2007%26volume%3D18%26spage%3D791%26epage%3D800%26doi%3D10.1097%2FFBP.0b013e3282f1c94b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seitz, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremer, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGinnis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C. S.</span></span> <span> </span><span class="NLM_article-title">Quantitative changes in intracellular calcium and extracellular-regulated kinase activation measured in parallel in CHO cells stably expressing serotonin (5-HT) 5-HT2A or 5-HT2C receptors</span>. <i>BMC Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">25</span>, <span class="refDoi"> DOI: 10.1186/1471-2202-13-25</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=10.1186%2F1471-2202-13-25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=22397586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFCgu7nL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=25&author=P.+K.+Seitzauthor=N.+M.+Bremerauthor=A.+McGinnisauthor=K.+A.+Cunninghamauthor=C.+S.+Watson&title=Quantitative+changes+in+intracellular+calcium+and+extracellular-regulated+kinase+activation+measured+in+parallel+in+CHO+cells+stably+expressing+serotonin+%285-HT%29+5-HT2A+or+5-HT2C+receptors&doi=10.1186%2F1471-2202-13-25"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative changes in intracellular calcium and extracellular-regulated kinase activation measured in parallel in CHO cells stably expressing serotonin (5-HT) 5-HT2A or 5-HT2C receptors</span></div><div class="casAuthors">Seitz, Patricia K.; Bremer, Nicole M.; McGinnis, Andrew G.; Cunningham, Kathryn A.; Watson, Cheryl S.</div><div class="citationInfo"><span class="NLM_cas:title">BMC Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25</span>CODEN:
                <span class="NLM_cas:coden">BNMEA6</span>;
        ISSN:<span class="NLM_cas:issn">1471-2202</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The serotonin (5-HT) 2A and 2C receptors (5-HT2AR and 5-HT2CR) are involved in a wide range of physiol. and behavioral processes in the mammalian central and peripheral nervous systems.  These receptors share a high degree of homol., have overlapping pharmacol. profiles, and utilize many of the same and richly diverse second messenger signaling systems.  We have developed quant. assays for cells stably expressing these two receptors involving minimal cell sample manipulations that dramatically improve parallel assessments of two signaling responses: intracellular calcium (Cai++) changes and activation (phosphorylation) of downstream kinases.  Such profiles are needed to begin to understand the simultaneous contributions from the multiplicity of signaling cascades likely to be initiated by serotonergic ligands.  Results: We optimized the Cai++ assay for stable cell lines expressing either 5-HT2AR or 5-HT2CR (including dye use and measurement parameters; cell d. and serum requirements).  We adapted a quant. 96-well plate immunoassay for pERK in the same cell lines.  Similar cell d. optima and time courses were obsd. for 5-HT2AR- and 5-HT2CR-expressing cells in generating both types of signaling.  Both cell lines also require serum-free preincubation for maximal agonist responses in the pERK assay.  However, 5-HT2AR-expressing cells showed significant release of Cai++ in response to 5-HT stimulation even when preincubated in serum-replete medium, while the response was completely eliminated by serum in 5-HT2CR-expressing cells.  Response to another serotonergic ligand (DOI) was eliminated by serum-replete preincubation in both cells lines.  Conclusions: These data expand our knowledge of differences in ligand-stimulated signaling cascades between 5-HT2AR and 5-HT2CR.  Our parallel assays can be applied to other cell and receptor systems for monitoring and dissecting concurrent signaling responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6M4u7LVn5PbVg90H21EOLACvtfcHk0lhQ7Ul1ObruQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFCgu7nL&md5=6b1b3b3c45590bda79f49f89d8e7fdbb</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1186%2F1471-2202-13-25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2202-13-25%26sid%3Dliteratum%253Aachs%26aulast%3DSeitz%26aufirst%3DP.%2BK.%26aulast%3DBremer%26aufirst%3DN.%2BM.%26aulast%3DMcGinnis%26aufirst%3DA.%26aulast%3DCunningham%26aufirst%3DK.%2BA.%26aulast%3DWatson%26aufirst%3DC.%2BS.%26atitle%3DQuantitative%2520changes%2520in%2520intracellular%2520calcium%2520and%2520extracellular-regulated%2520kinase%2520activation%2520measured%2520in%2520parallel%2520in%2520CHO%2520cells%2520stably%2520expressing%2520serotonin%2520%25285-HT%2529%25205-HT2A%2520or%25205-HT2C%2520receptors%26jtitle%3DBMC%2520Neurosci.%26date%3D2012%26volume%3D13%26spage%3D25%26doi%3D10.1186%2F1471-2202-13-25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6BQG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6BQG','PDB','6BQG'); return false;">PDB: 6BQG</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i58"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00401">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_18785"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00401">10.1021/acs.jmedchem.8b00401</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Calculated physicochemical properties, radioligand binding data, cytotoxicity data, additional cellular assay data, CNS-MPO values, docking protocol, drug discrimination time course study, <sup>1</sup>H and <sup>13</sup>C NMR spectra for the compounds described in this paper, X-ray data for compounds <b>32</b> and <b>35</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_001.pdf">jm8b00401_si_001.pdf (3.24 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00401/suppl_file/jm8b00401_si_002.csv">jm8b00401_si_002.csv (2.01 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00401&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00401%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-1%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00401" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994890dc572290","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
